[{"name":"BNF.Adenosine.Adenosine","imports":["BNF.Theophylline.Theophylline"],"interactioninfo":["Aminophylline is predicted to decrease the efficacy of adenosine. Manufacturer advises separate administration by 24 hours.","Bupivacaine is predicted to increase the risk of cardiodepression when given with adenosine.","Caffeine citrate decreases the efficacy of adenosine. Manufacturer advises separate administration by 24 hours.","Dipyridamole increases the exposure to adenosine. Manufacturer advises avoid or adjust dose.","Levobupivacaine is predicted to increase the risk of cardiodepression when given with adenosine.","Mepivacaine is predicted to increase the risk of cardiodepression when given with adenosine.","Oxybuprocaine is predicted to increase the risk of cardiodepression when given with adenosine.","Prilocaine is predicted to increase the risk of cardiodepression when given with adenosine.","Proxymetacaine is predicted to increase the risk of cardiodepression when given with adenosine.","Ropivacaine is predicted to increase the risk of cardiodepression when given with adenosine.","Tetracaine is predicted to increase the risk of cardiodepression when given with adenosine.","Theophylline decreases the efficacy of adenosine. Manufacturer advises separate administration by 24 hours."]},{"name":"BNF.Amiloride.Amiloride","imports":["BNF.Amitriptyline.Amitriptyline","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Carbamazepine.Carbamazepine","BNF.Citalopram.Citalopram","BNF.Diclofenac.Diclofenac","BNF.Enoxaparin.Enoxaparin","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Naproxen.Naproxen","BNF.Ramipril.Ramipril","BNF.Sertraline.Sertraline","BNF.Spironolactone.Spironolactone","BNF.Trimethoprim.Trimethoprim"],"interactioninfo":["Concurrent use of amiloride and aceclofenac can increase the risk of hyponatraemia.","Concurrent use of amiloride and aceclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and acemetacin can increase the risk of hyponatraemia.","Concurrent use of amiloride and acemetacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and aliskiren can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and amitriptyline can increase the risk of hyponatraemia.","Concurrent use of amiloride and azilsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and bendroflumethiazide can increase the risk of hyponatraemia.","Concurrent use of amiloride and benzydamine can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and bromfenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and bumetanide can increase the risk of hyponatraemia.","Concurrent use of amiloride and candesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and captopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and carbamazepine can increase the risk of hyponatraemia.","Concurrent use of amiloride and celecoxib can increase the risk of hyponatraemia.","Concurrent use of amiloride and celecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and chlorothiazide can increase the risk of hyponatraemia.","Concurrent use of amiloride and chlortalidone can increase the risk of hyponatraemia.","Concurrent use of amiloride and ciclosporin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and citalopram can increase the risk of hyponatraemia.","Concurrent use of amiloride and clomipramine can increase the risk of hyponatraemia.","Concurrent use of amiloride and clopamide can increase the risk of hyponatraemia.","Concurrent use of amiloride and cyclopenthiazide can increase the risk of hyponatraemia.","Concurrent use of amiloride and dalteparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and dapoxetine can increase the risk of hyponatraemia.","Concurrent use of amiloride and darbepoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and desmopressin can increase the risk of hyponatraemia.","Concurrent use of amiloride and dexibuprofen can increase the risk of hyponatraemia.","Concurrent use of amiloride and dexibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and dexketoprofen can increase the risk of hyponatraemia.","Concurrent use of amiloride and dexketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and diclofenac can increase the risk of hyponatraemia.","Concurrent use of amiloride and diclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and dosulepin can increase the risk of hyponatraemia.","Concurrent use of amiloride and doxepin can increase the risk of hyponatraemia.","Concurrent use of amiloride and drospirenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and duloxetine can increase the risk of hyponatraemia.","Concurrent use of amiloride and enalapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and enoxaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and eplerenone can increase the risk of hyponatraemia.","Concurrent use of amiloride and eplerenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and epoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and epoetin beta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and epoetin zeta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and eprosartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and escitalopram can increase the risk of hyponatraemia.","Concurrent use of amiloride and etodolac can increase the risk of hyponatraemia.","Concurrent use of amiloride and etodolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and etoricoxib can increase the risk of hyponatraemia.","Concurrent use of amiloride and etoricoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and felbinac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and fenoprofen can increase the risk of hyponatraemia.","Concurrent use of amiloride and fenoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and fluoxetine can increase the risk of hyponatraemia.","Concurrent use of amiloride and flurbiprofen can increase the risk of hyponatraemia.","Concurrent use of amiloride and flurbiprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and fluvoxamine can increase the risk of hyponatraemia.","Concurrent use of amiloride and furosemide can increase the risk of hyponatraemia.","Concurrent use of amiloride and heparin (unfractionated) can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and hydrochlorothiazide can increase the risk of hyponatraemia.","Concurrent use of amiloride and hydroflumethiazide can increase the risk of hyponatraemia.","Concurrent use of amiloride and ibuprofen can increase the risk of hyponatraemia.","Concurrent use of amiloride and ibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and imidapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and imipramine can increase the risk of hyponatraemia.","Concurrent use of amiloride and indapamide can increase the risk of hyponatraemia.","Concurrent use of amiloride and indometacin can increase the risk of hyponatraemia.","Concurrent use of amiloride and indometacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and irbesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and ketoprofen can increase the risk of hyponatraemia.","Concurrent use of amiloride and ketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and ketorolac can increase the risk of hyponatraemia.","Concurrent use of amiloride and ketorolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and lisinopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and losartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and mefenamic acid can increase the risk of hyponatraemia.","Concurrent use of amiloride and mefenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and meloxicam can increase the risk of hyponatraemia.","Concurrent use of amiloride and meloxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and metolazone can increase the risk of hyponatraemia.","Concurrent use of amiloride and moexipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and nabumetone can increase the risk of hyponatraemia.","Concurrent use of amiloride and nabumetone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and naproxen can increase the risk of hyponatraemia.","Concurrent use of amiloride and naproxen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and nepafenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and nortriptyline can increase the risk of hyponatraemia.","Concurrent use of amiloride and olmesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and parecoxib can increase the risk of hyponatraemia.","Concurrent use of amiloride and parecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and paroxetine can increase the risk of hyponatraemia.","Concurrent use of amiloride and perindopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and piroxicam can increase the risk of hyponatraemia.","Concurrent use of amiloride and piroxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and potassium canrenoate can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and potassium chloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and quinapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and ramipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and sertraline can increase the risk of hyponatraemia.","Concurrent use of amiloride and sodium picosulfate can increase the risk of hyponatraemia.","Concurrent use of amiloride and spironolactone can increase the risk of hyponatraemia.","Concurrent use of amiloride and spironolactone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and sulindac can increase the risk of hyponatraemia.","Concurrent use of amiloride and sulindac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and tacrolimus can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and telmisartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and tenoxicam can increase the risk of hyponatraemia.","Concurrent use of amiloride and tenoxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and tiaprofenic acid can increase the risk of hyponatraemia.","Concurrent use of amiloride and tiaprofenic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and tinzaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and tolfenamic acid can increase the risk of hyponatraemia.","Concurrent use of amiloride and tolfenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and tolvaptan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and torasemide can increase the risk of hyponatraemia.","Concurrent use of amiloride and trandolapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and triamterene can increase the risk of hyponatraemia.","Concurrent use of amiloride and triamterene can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and trimethoprim can increase the risk of hyponatraemia.","Concurrent use of amiloride and trimethoprim can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and trimipramine can increase the risk of hyponatraemia.","Concurrent use of amiloride and valsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of amiloride and xipamide can increase the risk of hyponatraemia."]},{"name":"BNF.Amiodarone.Amiodarone","imports":["BNF.Atenolol.Atenolol","BNF.Atorvastatin.Atorvastatin","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisacodyl.Bisacodyl","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Digoxin.Digoxin","BNF.Diltiazem.Diltiazem","BNF.Fentanyl.Fentanyl","BNF.Furosemide.Furosemide","BNF.Gliclazide.Gliclazide","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Levomepromazine.Levomepromazine","BNF.Levothyroxine.Levothyroxine","BNF.Ondansetron.Ondansetron","BNF.Phenytoin.Phenytoin","BNF.Quinine.Quinine","BNF.Salbutamol.Salbutamol","BNF.Senna.Senna","BNF.Simvastatin.Simvastatin","BNF.Theophylline.Theophylline","BNF.Venlafaxine.Venlafaxine","BNF.Warfarin.Warfarin"],"interactioninfo":["Both amiodarone and acebutolol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with acebutolol. Manufacturer advises use with caution or avoid.","Amiodarone increases the anticoagulant effect of acenocoumarol.","Amiodarone is predicted to increase the exposure to afatinib. Manufacturer advises separate administration by 12 hours.","Amiodarone is predicted to decrease the effects of agalsidase. Manufacturer advises avoid.","Both amiodarone and alectinib can increase the risk of bradycardia.","Both amiodarone and alfentanil can increase the risk of bradycardia.","Amiodarone is predicted to increase the exposure to aliskiren.","Amiodarone is predicted to increase the exposure to alitretinoin. Manufacturer advises adjust alitretinoin dose.","Both amiodarone and amifampridine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Aminophylline is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and amisulpride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amphotericin is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and apomorphine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and apraclonidine can increase the risk of bradycardia.","Both amiodarone and arsenic trioxide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and artemether prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and artenimol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Atazanavir is predicted to increase the exposure to amiodarone. Manufacturer advises avoid.","Both amiodarone and atenolol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with atenolol. Manufacturer advises use with caution or avoid.","Amiodarone is predicted to increase the risk of rhabdomyolysis when given with atorvastatin. Manufacturer advises monitor and adjust dose.","Bambuterol is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Beclometasone is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and bedaquiline prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Betamethasone is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and betaxolol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with betaxolol. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and bisoprolol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with bisoprolol. Manufacturer advises use with caution or avoid.","Concurrent use of amiodarone and bortezomib can increase the risk of peripheral neuropathy.","Both amiodarone and bosutinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of amiodarone and brentuximab vedotin can increase the risk of peripheral neuropathy.","Both amiodarone and brimonidine can increase the risk of bradycardia.","Budesonide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Bumetanide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Bupivacaine is predicted to increase the risk of cardiodepression when given with amiodarone.","Concurrent use of amiodarone and cabazitaxel can increase the risk of peripheral neuropathy.","Both amiodarone and cabozantinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and carteolol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with carteolol. Manufacturer advises use with caution or avoid.","Both amiodarone and carvedilol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with carvedilol. Manufacturer advises use with caution or avoid.","Both amiodarone and celiprolol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with celiprolol. Manufacturer advises use with caution or avoid.","Both amiodarone and ceritinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone is predicted to increase the exposure to ceritinib.","Chlorothiazide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and chlorpromazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Chlortalidone is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Amiodarone increases the concentration of ciclosporin. Manufacturer advises monitor concentration and adjust dose.","Cimetidine increases the exposure to amiodarone.","Both amiodarone and cisatracurium can increase the risk of bradycardia.","Concurrent use of amiodarone and cisplatin can increase the risk of peripheral neuropathy.","Both amiodarone and citalopram prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and clarithromycin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and clomipramine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and clonidine can increase the risk of bradycardia.","Clopamide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and crizotinib can increase the risk of bradycardia.","Both amiodarone and crizotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Cyclopenthiazide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Amiodarone increases the exposure to dabigatran. Manufacturer advises adjust dabigatran dose.","Daclatasvir is predicted to increase the risk of severe bradycardia or heart block when given with amiodarone. Refer to specialist literature.","Dantron is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Darunavir is predicted to increase the exposure to amiodarone. Manufacturer advises avoid.","Both amiodarone and dasatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Deflazacort is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and delamanid prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Dexamethasone is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Concurrent use of amiodarone and didanosine can increase the risk of peripheral neuropathy.","Both amiodarone and digoxin can increase the risk of bradycardia.","Amiodarone is predicted to moderately increase the exposure to digoxin. Manufacturer advises monitor and adjust digoxin dose.","Both amiodarone and diltiazem can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiodepression when given with diltiazem. Manufacturer advises avoid.","Both amiodarone and disopyramide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of amiodarone and disulfiram can increase the risk of peripheral neuropathy.","Concurrent use of amiodarone and docetaxel can increase the risk of peripheral neuropathy.","Docusate sodium is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Domperidone increases the risk of QT-prolongation when given with amiodarone. Manufacturer advises avoid.","Both amiodarone and donepezil can increase the risk of bradycardia.","Amiodarone increases the risk of bradycardia when given with donepezil.","Both amiodarone and dronedarone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and droperidol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone slightly increases the exposure to edoxaban.","Amiodarone is predicted to increase the exposure to eplerenone. Manufacturer advises adjust eplerenone dose.","Concurrent use of amiodarone and eribulin can increase the risk of peripheral neuropathy.","Both amiodarone and eribulin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone is predicted to increase the exposure to erlotinib.","Intravenous erythromycin increases the risk of QT-prolongation when given with amiodarone. Manufacturer advises avoid or monitor.","Both amiodarone and escitalopram prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and esmolol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with esmolol. Manufacturer advises use with caution or avoid.","Both amiodarone and fentanyl can increase the risk of bradycardia.","Amiodarone is predicted to increase the concentration of fentanyl.","Amiodarone is predicted to increase the exposure to fidaxomicin. Manufacturer advises avoid.","Both amiodarone and fingolimod can increase the risk of bradycardia.","Fingolimod increases the risk of QT-prolongation when given with amiodarone. Manufacturer advises avoid.","Both amiodarone and flecainide can increase the risk of bradycardia.","Both amiodarone and flecainide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone increases the concentration of flecainide. Manufacturer advises adjust flecainide dose and monitor side effects.","Fludrocortisone is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and fluphenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone is predicted to increase the exposure to fluvastatin.","Formoterol is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Fosamprenavir is predicted to increase the exposure to amiodarone. Manufacturer advises avoid.","Concurrent use of amiodarone and fosphenytoin can increase the risk of peripheral neuropathy.","Amiodarone is predicted to slightly increase the concentration of fosphenytoin. Manufacturer advises monitor and adjust dose.","Furosemide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and galantamine can increase the risk of bradycardia.","Amiodarone increases the risk of bradycardia when given with galantamine.","Amiodarone is predicted to increase the exposure to glibenclamide. Manufacturer advises use with caution and adjust dose.","Amiodarone is predicted to increase the exposure to gliclazide. Manufacturer advises use with caution and adjust dose.","Amiodarone is predicted to increase the exposure to glimepiride. Manufacturer advises use with caution and adjust dose.","Amiodarone is predicted to increase the exposure to glipizide. Manufacturer advises use with caution and adjust dose.","Glycerol is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Granisetron is predicted to increase the risk of QT-prolongation when given with amiodarone.","Grapefruit juice increases the exposure to amiodarone. Manufacturer advises avoid.","Both amiodarone and haloperidol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Hydrochlorothiazide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Hydrocortisone is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Hydroflumethiazide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and hydroxyzine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Indacaterol is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Indinavir is predicted to increase the exposure to amiodarone. Manufacturer advises avoid.","Concurrent use of amiodarone and isoniazid can increase the risk of peripheral neuropathy.","Both amiodarone and ivabradine can increase the risk of bradycardia.","Ivabradine is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises avoid.","Both amiodarone and labetalol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with labetalol. Manufacturer advises use with caution or avoid.","Concurrent use of amiodarone and lamivudine can increase the risk of peripheral neuropathy.","Both amiodarone and lapatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Ledipasvir increases the risk of severe bradycardia or heart block when given with amiodarone. Refer to specialist literature.","Both amiodarone and levobunolol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with levobunolol. Manufacturer advises use with caution or avoid.","Levobupivacaine is predicted to increase the risk of cardiodepression when given with amiodarone.","Both amiodarone and levomepromazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone is predicted to increase the risk of thyroid dysfunction when given with levothyroxine. Manufacturer advises avoid.","Amiodarone is predicted to increase the risk of thyroid dysfunction when given with liothyronine. Manufacturer advises avoid.","Both amiodarone and lithium prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and lofexidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone is predicted to increase the exposure to lomitapide. Manufacturer advises separate administration by 12 hours.","Lopinavir is predicted to increase the exposure to amiodarone. Manufacturer advises avoid.","Mefloquine is predicted to increase the risk of QT-prolongation when given with amiodarone.","Mepivacaine is predicted to increase the risk of cardiodepression when given with amiodarone.","Both amiodarone and methadone can increase the risk of bradycardia.","Both amiodarone and methadone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Methylprednisolone is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Metolazone is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and metoprolol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with metoprolol. Manufacturer advises use with caution or avoid.","Concurrent use of amiodarone and metronidazole can increase the risk of peripheral neuropathy.","Mizolastine is predicted to increase the risk of QT-prolongation when given with amiodarone. Manufacturer advises avoid.","Both amiodarone and moxifloxacin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and nadolol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with nadolol. Manufacturer advises use with caution or avoid.","Both amiodarone and nebivolol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with nebivolol. Manufacturer advises use with caution or avoid.","Both amiodarone and neostigmine can increase the risk of bradycardia.","Both amiodarone and nilotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone is predicted to increase the exposure to nintedanib.","Olodaterol is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and ondansetron prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and osimertinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and oxprenolol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with oxprenolol. Manufacturer advises use with caution or avoid.","Oxybuprocaine is predicted to increase the risk of cardiodepression when given with amiodarone.","Concurrent use of amiodarone and paclitaxel can increase the risk of peripheral neuropathy.","Both amiodarone and paliperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Palonosetron is predicted to increase the risk of QT-prolongation when given with amiodarone.","Both amiodarone and panobinostat prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and pasireotide can increase the risk of bradycardia.","Both amiodarone and pasireotide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and pazopanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Intravenous pentamidine potentially increases the risk of QT-prolongation when given with amiodarone.","Concurrent use of amiodarone and phenytoin can increase the risk of peripheral neuropathy.","Amiodarone is predicted to slightly increase the concentration of phenytoin. Manufacturer advises monitor and adjust dose.","Both amiodarone and pimozide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and pindolol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with pindolol. Manufacturer advises use with caution or avoid.","Prednisolone is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Prednisone is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Prilocaine is predicted to increase the risk of cardiodepression when given with amiodarone.","Propafenone is predicted to increase the risk of cardiodepression when given with amiodarone. Manufacturer advises monitor and adjust dose.","Both amiodarone and propranolol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with propranolol. Manufacturer advises use with caution or avoid.","Proxymetacaine is predicted to increase the risk of cardiodepression when given with amiodarone.","Both amiodarone and pyridostigmine can increase the risk of bradycardia.","Both amiodarone and quinine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and ranolazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and remifentanil can increase the risk of bradycardia.","Both amiodarone and risperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Ritonavir is predicted to increase the exposure to amiodarone. Manufacturer advises avoid.","Both amiodarone and rivastigmine can increase the risk of bradycardia.","Amiodarone increases the risk of bradycardia when given with rivastigmine.","Ropivacaine is predicted to increase the risk of cardiodepression when given with amiodarone.","Salbutamol is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Salmeterol is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and saquinavir prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Saquinavir is predicted to increase the exposure to amiodarone. Manufacturer advises avoid.","Both amiodarone and selegiline can increase the risk of bradycardia.","Senna is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and sildenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Simeprevir is predicted to increase the concentration of amiodarone. Refer to specialist literature.","Amiodarone increases the risk of rhabdomyolysis when given with simvastatin. Manufacturer advises adjust simvastatin dose.","Amiodarone is predicted to increase the concentration of sirolimus.","Sodium picosulfate is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Sofosbuvir is predicted to increase the risk of severe bradycardia or heart block when given with amiodarone. Refer to specialist literature.","Both amiodarone and sorafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and sotalol can increase the risk of bradycardia.","Both amiodarone and sotalol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with sotalol. Manufacturer advises use with caution or avoid.","Concurrent use of amiodarone and stavudine can increase the risk of peripheral neuropathy.","Both amiodarone and sufentanil can increase the risk of bradycardia.","Both amiodarone and sulpiride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and sunitinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone is predicted to increase the concentration of tacrolimus.","Both amiodarone and telavancin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Terbutaline is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and tetrabenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Tetracaine is predicted to increase the risk of cardiodepression when given with amiodarone.","Both amiodarone and thalidomide can increase the risk of bradycardia.","Concurrent use of amiodarone and thalidomide can increase the risk of peripheral neuropathy.","Theophylline is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Amiodarone is predicted to increase the exposure to ticagrelor. Manufacturer advises use with caution or avoid.","Both amiodarone and timolol can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with timolol. Manufacturer advises use with caution or avoid.","Tipranavir is predicted to increase the exposure to amiodarone. Manufacturer advises avoid.","Both amiodarone and tizanidine can increase the risk of bradycardia.","Both amiodarone and tizanidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone is predicted to increase the exposure to tolbutamide. Manufacturer advises use with caution and adjust dose.","Both amiodarone and tolterodine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone is predicted to increase the exposure to topotecan.","Torasemide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and toremifene prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone is predicted to increase the concentration of trametinib.","Triamcinolone is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and vandetanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and vardenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone is predicted to increase the concentration of velpatasvir. Manufacturer advises avoid or monitor.","Both amiodarone and vemurafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone is predicted to increase the exposure to venetoclax. Manufacturer advises avoid or monitor for toxicity.","Both amiodarone and venlafaxine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both amiodarone and verapamil can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiodepression when given with verapamil. Manufacturer advises avoid.","Vilanterol is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Concurrent use of amiodarone and vinblastine can increase the risk of peripheral neuropathy.","Concurrent use of amiodarone and vincristine can increase the risk of peripheral neuropathy.","Concurrent use of amiodarone and vindesine can increase the risk of peripheral neuropathy.","Concurrent use of amiodarone and vinflunine can increase the risk of peripheral neuropathy.","Both amiodarone and vinflunine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of amiodarone and vinorelbine can increase the risk of peripheral neuropathy.","Both amiodarone and voriconazole prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amiodarone increases the anticoagulant effect of warfarin.","Xipamide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Both amiodarone and zuclopenthixol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation."]},{"name":"BNF.Amitriptyline.Amitriptyline","imports":["BNF.Amiloride.Amiloride","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Carbamazepine.Carbamazepine","BNF.Citalopram.Citalopram","BNF.Cyclizine.Cyclizine","BNF.Diclofenac.Diclofenac","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Ipratropium.Ipratropium","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Naproxen.Naproxen","BNF.Nefopam.Nefopam","BNF.Nifedipine.Nifedipine","BNF.Prochlorperazine.Prochlorperazine","BNF.Ramipril.Ramipril","BNF.Sertraline.Sertraline","BNF.Spironolactone.Spironolactone","BNF.Tiotropium.Tiotropium","BNF.Trimethoprim.Trimethoprim"],"interactioninfo":["Concurrent use of amitriptyline and acebutolol can increase the risk of hypotension.","Concurrent use of amitriptyline and aceclofenac can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and acemetacin can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and aclidinium can increase the risk of antimuscarinic effects.","Amitriptyline increases the effects of adrenaline/epinephrine. Manufacturer advises avoid.","Concurrent use of amitriptyline and alcohol (beverage) can increase the risk of hypotension.","Concurrent use of amitriptyline and alfuzosin can increase the risk of hypotension.","Concurrent use of amitriptyline and aliskiren can increase the risk of hypotension.","Concurrent use of amitriptyline and alprostadil can increase the risk of hypotension.","Concurrent use of amitriptyline and amantadine can increase the risk of hypotension.","Concurrent use of amitriptyline and amantadine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and amiloride can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and amlodipine can increase the risk of hypotension.","Concurrent use of amitriptyline and apomorphine can increase the risk of hypotension.","Concurrent use of amitriptyline and apraclonidine can increase the risk of hypotension.","Concurrent use of amitriptyline and aripiprazole can increase the risk of hypotension.","Concurrent use of amitriptyline and asenapine can increase the risk of hypotension.","Concurrent use of amitriptyline and atenolol can increase the risk of hypotension.","Concurrent use of amitriptyline and atropine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and avanafil can increase the risk of hypotension.","Concurrent use of amitriptyline and azilsartan can increase the risk of hypotension.","Concurrent use of amitriptyline and baclofen can increase the risk of hypotension.","Concurrent use of amitriptyline and baclofen can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and bendroflumethiazide can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of amitriptyline and benperidol can increase the risk of hypotension.","Concurrent use of amitriptyline and betaxolol can increase the risk of hypotension.","Concurrent use of amitriptyline and bisoprolol can increase the risk of hypotension.","Concurrent use of amitriptyline and bortezomib can increase the risk of hypotension.","Concurrent use of amitriptyline and brimonidine can increase the risk of hypotension.","Concurrent use of amitriptyline and bromocriptine can increase the risk of hypotension.","Concurrent use of amitriptyline and bumetanide can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and bumetanide can increase the risk of hypotension.","Bupropion is predicted to increase the exposure to amitriptyline. Manufacturer advises monitor for toxicity and adjust dose.","Concurrent use of amitriptyline and cabergoline can increase the risk of hypotension.","Concurrent use of amitriptyline and canagliflozin can increase the risk of hypotension.","Concurrent use of amitriptyline and candesartan can increase the risk of hypotension.","Concurrent use of amitriptyline and captopril can increase the risk of hypotension.","Concurrent use of amitriptyline and carbamazepine can increase the risk of hyponatraemia.","Carbamazepine decreases the exposure to amitriptyline. Manufacturer advises adjust dose.","Concurrent use of amitriptyline and carteolol can increase the risk of hypotension.","Concurrent use of amitriptyline and carvedilol can increase the risk of hypotension.","Concurrent use of amitriptyline and celecoxib can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and celiprolol can increase the risk of hypotension.","Concurrent use of amitriptyline and chlorothiazide can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and chlorothiazide can increase the risk of hypotension.","Concurrent use of amitriptyline and chlorphenamine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and chlorpromazine can increase the risk of hypotension.","Concurrent use of amitriptyline and chlorpromazine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and chlortalidone can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and chlortalidone can increase the risk of hypotension.","Cimetidine increases the exposure to amitriptyline.","Cinacalcet is predicted to increase the exposure to amitriptyline. Manufacturer advises monitor for toxicity and adjust dose.","Concurrent use of amitriptyline and citalopram can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and clemastine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and clevidipine can increase the risk of hypotension.","Concurrent use of amitriptyline and clomipramine can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and clomipramine can increase the risk of hypotension.","Concurrent use of amitriptyline and clomipramine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and clonidine can increase the risk of hypotension.","Amitriptyline decreases the antihypertensive effects of clonidine. Manufacturer advises monitor and adjust dose.","Concurrent use of amitriptyline and clopamide can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and clopamide can increase the risk of hypotension.","Concurrent use of amitriptyline and clozapine can increase the risk of hypotension.","Concurrent use of amitriptyline and clozapine can increase the risk of antimuscarinic effects.","Cobicistat is predicted to slightly increase the exposure to amitriptyline.","Concurrent use of amitriptyline and cyclizine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and cyclopenthiazide can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of amitriptyline and cyclopentolate can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and cyproheptadine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and dapagliflozin can increase the risk of hypotension.","Concurrent use of amitriptyline and dapoxetine can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and darifenacin can increase the risk of antimuscarinic effects.","Darifenacin is predicted to increase the exposure to amitriptyline.","Concurrent use of amitriptyline and desflurane can increase the risk of hypotension.","Concurrent use of amitriptyline and desmopressin can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and dexibuprofen can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and dexketoprofen can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and diazoxide can increase the risk of hypotension.","Concurrent use of amitriptyline and diclofenac can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and dicycloverine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and diltiazem can increase the risk of hypotension.","Concurrent use of amitriptyline and dimenhydrinate can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and dipyridamole can increase the risk of hypotension.","Concurrent use of amitriptyline and disopyramide can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and dosulepin can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and dosulepin can increase the risk of hypotension.","Concurrent use of amitriptyline and dosulepin can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and doxazosin can increase the risk of hypotension.","Concurrent use of amitriptyline and doxepin can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and doxepin can increase the risk of hypotension.","Concurrent use of amitriptyline and doxepin can increase the risk of antimuscarinic effects.","Dronedarone is predicted to increase the exposure to amitriptyline. Manufacturer advises avoid.","Concurrent use of amitriptyline and droperidol can increase the risk of hypotension.","Concurrent use of amitriptyline and duloxetine can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and empagliflozin can increase the risk of hypotension.","Concurrent use of amitriptyline and enalapril can increase the risk of hypotension.","Amitriptyline is predicted to decrease the effects of ephedrine. Manufacturer advises avoid.","Concurrent use of amitriptyline and eplerenone can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and eplerenone can increase the risk of hypotension.","Concurrent use of amitriptyline and eprosartan can increase the risk of hypotension.","Concurrent use of amitriptyline and escitalopram can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and esmolol can increase the risk of hypotension.","Concurrent use of amitriptyline and etodolac can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and etomidate can increase the risk of hypotension.","Concurrent use of amitriptyline and etoricoxib can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and felodipine can increase the risk of hypotension.","Concurrent use of amitriptyline and fenoprofen can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and fesoterodine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and flavoxate can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and fluoxetine can increase the risk of hyponatraemia.","Fluoxetine is predicted to increase the exposure to amitriptyline. Manufacturer advises monitor for toxicity and adjust dose.","Concurrent use of amitriptyline and flupentixol can increase the risk of hypotension.","Concurrent use of amitriptyline and fluphenazine can increase the risk of hypotension.","Concurrent use of amitriptyline and flurbiprofen can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and fluvoxamine can increase the risk of hyponatraemia.","Fluvoxamine increases the exposure to amitriptyline. Manufacturer advises adjust dose.","Concurrent use of amitriptyline and fosinopril can increase the risk of hypotension.","Concurrent use of amitriptyline and furosemide can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and furosemide can increase the risk of hypotension.","Concurrent use of amitriptyline and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of amitriptyline and glycopyrronium can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and guanethidine can increase the risk of hypotension.","Amitriptyline is predicted to decrease the antihypertensive effects of guanethidine.","Concurrent use of amitriptyline and guanfacine can increase the risk of hypotension.","Concurrent use of amitriptyline and haloperidol can increase the risk of hypotension.","Concurrent use of amitriptyline and haloperidol can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and histamine can increase the risk of hypotension.","Amitriptyline is predicted to decrease the effects of histamine. Manufacturer advises avoid.","Concurrent use of amitriptyline and homatropine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and hydralazine can increase the risk of hypotension.","Concurrent use of amitriptyline and hydrochlorothiazide can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of amitriptyline and hydroflumethiazide can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and hydroflumethiazide can increase the risk of hypotension.","Concurrent use of amitriptyline and hydroxyzine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and hyoscine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and ibuprofen can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and imidapril can increase the risk of hypotension.","Concurrent use of amitriptyline and imipramine can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and imipramine can increase the risk of hypotension.","Concurrent use of amitriptyline and imipramine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and indapamide can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and indapamide can increase the risk of hypotension.","Concurrent use of amitriptyline and indometacin can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and indoramin can increase the risk of hypotension.","Concurrent use of amitriptyline and ipratropium can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and irbesartan can increase the risk of hypotension.","Concurrent use of amitriptyline and isocarboxazid can increase the risk of hypotension.","Amitriptyline is predicted to increase the effects of isocarboxazid. Manufacturer advises avoid.","Concurrent use of amitriptyline and isoflurane can increase the risk of hypotension.","Concurrent use of amitriptyline and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of amitriptyline and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of amitriptyline and isradipine can increase the risk of hypotension.","Concurrent use of amitriptyline and ketamine can increase the risk of hypotension.","Concurrent use of amitriptyline and ketoprofen can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and ketorolac can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and labetalol can increase the risk of hypotension.","Concurrent use of amitriptyline and lacidipine can increase the risk of hypotension.","Concurrent use of amitriptyline and lercanidipine can increase the risk of hypotension.","Concurrent use of amitriptyline and levobunolol can increase the risk of hypotension.","Concurrent use of amitriptyline and levodopa can increase the risk of hypotension.","Amitriptyline decreases the absorption of levodopa.","Concurrent use of amitriptyline and levomepromazine can increase the risk of hypotension.","Concurrent use of amitriptyline and levomepromazine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and lisinopril can increase the risk of hypotension.","Amitriptyline potentially increases the risk of neurotoxicity when given with lithium.","Concurrent use of amitriptyline and lofepramine can increase the risk of hypotension.","Concurrent use of amitriptyline and lofepramine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and lofexidine can increase the risk of hypotension.","Concurrent use of amitriptyline and losartan can increase the risk of hypotension.","Concurrent use of amitriptyline and loxapine can increase the risk of hypotension.","Concurrent use of amitriptyline and loxapine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and lurasidone can increase the risk of hypotension.","Concurrent use of amitriptyline and mefenamic acid can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and meloxicam can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and methyldopa can increase the risk of hypotension.","Concurrent use of amitriptyline and metolazone can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and metolazone can increase the risk of hypotension.","Concurrent use of amitriptyline and metoprolol can increase the risk of hypotension.","Amitriptyline decreases the effects of metyrapone. Manufacturer advises avoid.","Concurrent use of amitriptyline and minoxidil can increase the risk of hypotension.","Amitriptyline is predicted to increase the effects of moclobemide. Manufacturer advises avoid.","Concurrent use of amitriptyline and moexipril can increase the risk of hypotension.","Concurrent use of amitriptyline and moxisylyte can increase the risk of hypotension.","Concurrent use of amitriptyline and moxonidine can increase the risk of hypotension.","Amitriptyline is predicted to decrease the effects of moxonidine. Manufacturer advises avoid.","Concurrent use of amitriptyline and nabumetone can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and nadolol can increase the risk of hypotension.","Concurrent use of amitriptyline and naproxen can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and nebivolol can increase the risk of hypotension.","Concurrent use of amitriptyline and nefopam can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and nicardipine can increase the risk of hypotension.","Concurrent use of amitriptyline and nicorandil can increase the risk of hypotension.","Concurrent use of amitriptyline and nifedipine can increase the risk of hypotension.","Concurrent use of amitriptyline and nimodipine can increase the risk of hypotension.","Concurrent use of amitriptyline and nitrous oxide can increase the risk of hypotension.","Amitriptyline increases the effects of noradrenaline/norepinephrine. Manufacturer advises avoid.","Concurrent use of amitriptyline and nortriptyline can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and nortriptyline can increase the risk of hypotension.","Concurrent use of amitriptyline and nortriptyline can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and olanzapine can increase the risk of hypotension.","Concurrent use of amitriptyline and olmesartan can increase the risk of hypotension.","Concurrent use of amitriptyline and orphenadrine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and oxprenolol can increase the risk of hypotension.","Concurrent use of amitriptyline and oxybutynin can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and paliperidone can increase the risk of hypotension.","Concurrent use of amitriptyline and parecoxib can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and paroxetine can increase the risk of hyponatraemia.","Paroxetine is predicted to increase the exposure to amitriptyline. Manufacturer advises monitor for toxicity and adjust dose.","Concurrent use of amitriptyline and pergolide can increase the risk of hypotension.","Concurrent use of amitriptyline and pericyazine can increase the risk of hypotension.","Concurrent use of amitriptyline and perindopril can increase the risk of hypotension.","Concurrent use of amitriptyline and perphenazine can increase the risk of hypotension.","Concurrent use of amitriptyline and perphenazine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and phenelzine can increase the risk of hypotension.","Amitriptyline is predicted to increase the effects of phenelzine. Manufacturer advises avoid.","Phenobarbital is predicted to decrease the exposure to amitriptyline.","Amitriptyline increases the effects of phenylephrine. Manufacturer advises avoid.","Concurrent use of amitriptyline and pimozide can increase the risk of hypotension.","Concurrent use of amitriptyline and pimozide can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and pindolol can increase the risk of hypotension.","Concurrent use of amitriptyline and piroxicam can increase the risk of hyponatraemia.","Amitriptyline is predicted to decrease the efficacy of pitolisant.","Concurrent use of amitriptyline and pramipexole can increase the risk of hypotension.","Concurrent use of amitriptyline and prazosin can increase the risk of hypotension.","Primidone is predicted to decrease the exposure to amitriptyline.","Concurrent use of amitriptyline and prochlorperazine can increase the risk of hypotension.","Concurrent use of amitriptyline and prochlorperazine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and procyclidine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and promazine can increase the risk of hypotension.","Concurrent use of amitriptyline and promethazine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and propafenone can increase the risk of antimuscarinic effects.","Propafenone is predicted to increase the concentration of amitriptyline.","Concurrent use of amitriptyline and propantheline can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and propiverine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and propofol can increase the risk of hypotension.","Concurrent use of amitriptyline and propranolol can increase the risk of hypotension.","Concurrent use of amitriptyline and quetiapine can increase the risk of hypotension.","Concurrent use of amitriptyline and quinagolide can increase the risk of hypotension.","Concurrent use of amitriptyline and quinapril can increase the risk of hypotension.","Concurrent use of amitriptyline and ramipril can increase the risk of hypotension.","Concurrent use of amitriptyline and riociguat can increase the risk of hypotension.","Concurrent use of amitriptyline and risperidone can increase the risk of hypotension.","Ritonavir is predicted to increase the exposure to amitriptyline.","Concurrent use of amitriptyline and ropinirole can increase the risk of hypotension.","Concurrent use of amitriptyline and rotigotine can increase the risk of hypotension.","Concurrent use of amitriptyline and sacubitril can increase the risk of hypotension.","Concurrent use of amitriptyline and sapropterin can increase the risk of hypotension.","Concurrent use of amitriptyline and selegiline can increase the risk of hypotension.","Concurrent use of amitriptyline and sertraline can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and sevoflurane can increase the risk of hypotension.","Concurrent use of amitriptyline and sildenafil can increase the risk of hypotension.","Concurrent use of amitriptyline and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of amitriptyline and sodium oxybate can increase the risk of hypotension.","Concurrent use of amitriptyline and sodium picosulfate can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and solifenacin can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and sotalol can increase the risk of hypotension.","Concurrent use of amitriptyline and spironolactone can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and spironolactone can increase the risk of hypotension.","Sucralfate is predicted to decrease the absorption of amitriptyline.","Concurrent use of amitriptyline and sulindac can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and sulpiride can increase the risk of hypotension.","Concurrent use of amitriptyline and tadalafil can increase the risk of hypotension.","Concurrent use of amitriptyline and tamsulosin can increase the risk of hypotension.","Concurrent use of amitriptyline and telmisartan can increase the risk of hypotension.","Concurrent use of amitriptyline and tenoxicam can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and terazosin can increase the risk of hypotension.","Terbinafine is predicted to increase the exposure to amitriptyline. Manufacturer advises monitor for toxicity and adjust dose.","Concurrent use of amitriptyline and thiopental can increase the risk of hypotension.","Amitriptyline increases the risk of cardiac arrhythmias and hypotension when given with thiopental.","Concurrent use of amitriptyline and tiaprofenic acid can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and timolol can increase the risk of hypotension.","Concurrent use of amitriptyline and tiotropium can increase the risk of antimuscarinic effects.","Tipranavir is predicted to increase the exposure to amitriptyline.","Concurrent use of amitriptyline and tizanidine can increase the risk of hypotension.","Concurrent use of amitriptyline and tolfenamic acid can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and tolterodine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and torasemide can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and torasemide can increase the risk of hypotension.","Concurrent use of amitriptyline and trandolapril can increase the risk of hypotension.","Concurrent use of amitriptyline and tranylcypromine can increase the risk of hypotension.","Amitriptyline is predicted to increase the effects of tranylcypromine. Manufacturer advises avoid.","Concurrent use of amitriptyline and triamterene can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and trifluoperazine can increase the risk of hypotension.","Concurrent use of amitriptyline and trifluoperazine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and trihexyphenidyl can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and trimethoprim can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and trimipramine can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and trimipramine can increase the risk of hypotension.","Concurrent use of amitriptyline and trimipramine can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and tropicamide can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and trospium can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and umeclidinium can increase the risk of antimuscarinic effects.","Concurrent use of amitriptyline and valsartan can increase the risk of hypotension.","Concurrent use of amitriptyline and vardenafil can increase the risk of hypotension.","Concurrent use of amitriptyline and verapamil can increase the risk of hypotension.","Concurrent use of amitriptyline and xipamide can increase the risk of hyponatraemia.","Concurrent use of amitriptyline and xipamide can increase the risk of hypotension.","Concurrent use of amitriptyline and zuclopenthixol can increase the risk of hypotension."]},{"name":"BNF.Amlodipine.Amlodipine","imports":["BNF.Amitriptyline.Amitriptyline","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Carbamazepine.Carbamazepine","BNF.Clarithromycin.Clarithromycin","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Nifedipine.Nifedipine","BNF.Phenytoin.Phenytoin","BNF.Prochlorperazine.Prochlorperazine","BNF.Ramipril.Ramipril","BNF.Simvastatin.Simvastatin","BNF.Spironolactone.Spironolactone"],"interactioninfo":["Concurrent use of amlodipine and acebutolol can increase the risk of hypotension.","Concurrent use of amlodipine and alcohol (beverage) can increase the risk of hypotension.","Concurrent use of amlodipine and alfuzosin can increase the risk of hypotension.","Concurrent use of amlodipine and aliskiren can increase the risk of hypotension.","Concurrent use of amlodipine and alprostadil can increase the risk of hypotension.","Concurrent use of amlodipine and amantadine can increase the risk of hypotension.","Concurrent use of amlodipine and amitriptyline can increase the risk of hypotension.","Concurrent use of amlodipine and apomorphine can increase the risk of hypotension.","Concurrent use of amlodipine and apraclonidine can increase the risk of hypotension.","Aprepitant is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and aripiprazole can increase the risk of hypotension.","Concurrent use of amlodipine and asenapine can increase the risk of hypotension.","Atazanavir is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and atenolol can increase the risk of hypotension.","Concurrent use of amlodipine and avanafil can increase the risk of hypotension.","Concurrent use of amlodipine and azilsartan can increase the risk of hypotension.","Concurrent use of amlodipine and baclofen can increase the risk of hypotension.","Concurrent use of amlodipine and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of amlodipine and benperidol can increase the risk of hypotension.","Concurrent use of amlodipine and betaxolol can increase the risk of hypotension.","Concurrent use of amlodipine and bisoprolol can increase the risk of hypotension.","Concurrent use of amlodipine and bortezomib can increase the risk of hypotension.","Bosentan is predicted to decrease the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and brimonidine can increase the risk of hypotension.","Concurrent use of amlodipine and bromocriptine can increase the risk of hypotension.","Concurrent use of amlodipine and bumetanide can increase the risk of hypotension.","Concurrent use of amlodipine and cabergoline can increase the risk of hypotension.","Concurrent use of amlodipine and canagliflozin can increase the risk of hypotension.","Concurrent use of amlodipine and candesartan can increase the risk of hypotension.","Concurrent use of amlodipine and captopril can increase the risk of hypotension.","Carbamazepine is predicted to decrease the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and carteolol can increase the risk of hypotension.","Concurrent use of amlodipine and carvedilol can increase the risk of hypotension.","Concurrent use of amlodipine and celiprolol can increase the risk of hypotension.","Concurrent use of amlodipine and chlorothiazide can increase the risk of hypotension.","Concurrent use of amlodipine and chlorpromazine can increase the risk of hypotension.","Concurrent use of amlodipine and chlortalidone can increase the risk of hypotension.","Clarithromycin is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and clevidipine can increase the risk of hypotension.","Concurrent use of amlodipine and clomipramine can increase the risk of hypotension.","Concurrent use of amlodipine and clonidine can increase the risk of hypotension.","Concurrent use of amlodipine and clopamide can increase the risk of hypotension.","Concurrent use of amlodipine and clozapine can increase the risk of hypotension.","Cobicistat is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Crizotinib is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of amlodipine and dapagliflozin can increase the risk of hypotension.","Darunavir is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and desflurane can increase the risk of hypotension.","Concurrent use of amlodipine and diazoxide can increase the risk of hypotension.","Concurrent use of amlodipine and diltiazem can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and dipyridamole can increase the risk of hypotension.","Concurrent use of amlodipine and dosulepin can increase the risk of hypotension.","Concurrent use of amlodipine and doxazosin can increase the risk of hypotension.","Concurrent use of amlodipine and doxepin can increase the risk of hypotension.","Dronedarone is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and droperidol can increase the risk of hypotension.","Efavirenz is predicted to decrease the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and empagliflozin can increase the risk of hypotension.","Concurrent use of amlodipine and enalapril can increase the risk of hypotension.","Enzalutamide is predicted to decrease the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and eplerenone can increase the risk of hypotension.","Concurrent use of amlodipine and eprosartan can increase the risk of hypotension.","Erythromycin is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and esmolol can increase the risk of hypotension.","Concurrent use of amlodipine and etomidate can increase the risk of hypotension.","Concurrent use of amlodipine and felodipine can increase the risk of hypotension.","Fluconazole is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and flupentixol can increase the risk of hypotension.","Concurrent use of amlodipine and fluphenazine can increase the risk of hypotension.","Fosamprenavir is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and fosinopril can increase the risk of hypotension.","Fosphenytoin is predicted to decrease the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and furosemide can increase the risk of hypotension.","Concurrent use of amlodipine and glyceryl trinitrate can increase the risk of hypotension.","Grapefruit juice very slightly increases the exposure to amlodipine. Manufacturer advises avoid.","Concurrent use of amlodipine and guanethidine can increase the risk of hypotension.","Concurrent use of amlodipine and guanfacine can increase the risk of hypotension.","Concurrent use of amlodipine and haloperidol can increase the risk of hypotension.","Concurrent use of amlodipine and histamine can increase the risk of hypotension.","Concurrent use of amlodipine and hydralazine can increase the risk of hypotension.","Concurrent use of amlodipine and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of amlodipine and hydroflumethiazide can increase the risk of hypotension.","Idelalisib is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Imatinib is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and imidapril can increase the risk of hypotension.","Concurrent use of amlodipine and imipramine can increase the risk of hypotension.","Concurrent use of amlodipine and indapamide can increase the risk of hypotension.","Indinavir is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and indoramin can increase the risk of hypotension.","Concurrent use of amlodipine and irbesartan can increase the risk of hypotension.","Isavuconazole is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and isocarboxazid can increase the risk of hypotension.","Concurrent use of amlodipine and isoflurane can increase the risk of hypotension.","Concurrent use of amlodipine and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of amlodipine and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of amlodipine and isradipine can increase the risk of hypotension.","Itraconazole is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and ketamine can increase the risk of hypotension.","Ketoconazole is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and labetalol can increase the risk of hypotension.","Concurrent use of amlodipine and lacidipine can increase the risk of hypotension.","Concurrent use of amlodipine and lercanidipine can increase the risk of hypotension.","Concurrent use of amlodipine and levobunolol can increase the risk of hypotension.","Concurrent use of amlodipine and levodopa can increase the risk of hypotension.","Concurrent use of amlodipine and levomepromazine can increase the risk of hypotension.","Concurrent use of amlodipine and lisinopril can increase the risk of hypotension.","Concurrent use of amlodipine and lofepramine can increase the risk of hypotension.","Concurrent use of amlodipine and lofexidine can increase the risk of hypotension.","Amlodipine is predicted to increase the exposure to lomitapide. Manufacturer advises separate administration by 12 hours.","Lopinavir is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and losartan can increase the risk of hypotension.","Concurrent use of amlodipine and loxapine can increase the risk of hypotension.","Concurrent use of amlodipine and lurasidone can increase the risk of hypotension.","Intravenous magnesium potentially increases the risk of hypotension when given with amlodipine (in pregnant women).","Mefloquine is predicted to increase the risk of bradycardia when given with amlodipine.","Concurrent use of amlodipine and methyldopa can increase the risk of hypotension.","Concurrent use of amlodipine and metolazone can increase the risk of hypotension.","Concurrent use of amlodipine and metoprolol can increase the risk of hypotension.","Miconazole is predicted to increase the exposure to amlodipine. Manufacturer advises use with caution and adjust dose.","Concurrent use of amlodipine and minoxidil can increase the risk of hypotension.","Concurrent use of amlodipine and moexipril can increase the risk of hypotension.","Concurrent use of amlodipine and moxisylyte can increase the risk of hypotension.","Concurrent use of amlodipine and moxonidine can increase the risk of hypotension.","Concurrent use of amlodipine and nadolol can increase the risk of hypotension.","Concurrent use of amlodipine and nebivolol can increase the risk of hypotension.","Netupitant is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Nevirapine is predicted to decrease the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and nicardipine can increase the risk of hypotension.","Concurrent use of amlodipine and nicorandil can increase the risk of hypotension.","Concurrent use of amlodipine and nifedipine can increase the risk of hypotension.","Nilotinib is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and nimodipine can increase the risk of hypotension.","Concurrent use of amlodipine and nitrous oxide can increase the risk of hypotension.","Concurrent use of amlodipine and nortriptyline can increase the risk of hypotension.","Concurrent use of amlodipine and olanzapine can increase the risk of hypotension.","Concurrent use of amlodipine and olmesartan can increase the risk of hypotension.","Concurrent use of amlodipine and oxprenolol can increase the risk of hypotension.","Concurrent use of amlodipine and paliperidone can increase the risk of hypotension.","Concurrent use of amlodipine and pergolide can increase the risk of hypotension.","Concurrent use of amlodipine and pericyazine can increase the risk of hypotension.","Concurrent use of amlodipine and perindopril can increase the risk of hypotension.","Concurrent use of amlodipine and perphenazine can increase the risk of hypotension.","Concurrent use of amlodipine and phenelzine can increase the risk of hypotension.","Phenobarbital is predicted to decrease the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and pimozide can increase the risk of hypotension.","Concurrent use of amlodipine and pindolol can increase the risk of hypotension.","Posaconazole is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and pramipexole can increase the risk of hypotension.","Concurrent use of amlodipine and prazosin can increase the risk of hypotension.","Primidone is predicted to decrease the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and prochlorperazine can increase the risk of hypotension.","Concurrent use of amlodipine and promazine can increase the risk of hypotension.","Concurrent use of amlodipine and propofol can increase the risk of hypotension.","Concurrent use of amlodipine and propranolol can increase the risk of hypotension.","Concurrent use of amlodipine and quetiapine can increase the risk of hypotension.","Concurrent use of amlodipine and quinagolide can increase the risk of hypotension.","Concurrent use of amlodipine and quinapril can increase the risk of hypotension.","Concurrent use of amlodipine and ramipril can increase the risk of hypotension.","Rifampicin is predicted to decrease the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and riociguat can increase the risk of hypotension.","Concurrent use of amlodipine and risperidone can increase the risk of hypotension.","Ritonavir is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and ropinirole can increase the risk of hypotension.","Concurrent use of amlodipine and rotigotine can increase the risk of hypotension.","Concurrent use of amlodipine and sacubitril can increase the risk of hypotension.","Concurrent use of amlodipine and sapropterin can increase the risk of hypotension.","Saquinavir is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and selegiline can increase the risk of hypotension.","Concurrent use of amlodipine and sevoflurane can increase the risk of hypotension.","Concurrent use of amlodipine and sildenafil can increase the risk of hypotension.","Amlodipine slightly increases the exposure to simvastatin. Manufacturer advises adjust simvastatin dose.","Concurrent use of amlodipine and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of amlodipine and sodium oxybate can increase the risk of hypotension.","Concurrent use of amlodipine and sotalol can increase the risk of hypotension.","Concurrent use of amlodipine and spironolactone can increase the risk of hypotension.","St John's Wort is predicted to decrease the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and sulpiride can increase the risk of hypotension.","Concurrent use of amlodipine and tadalafil can increase the risk of hypotension.","Concurrent use of amlodipine and tamsulosin can increase the risk of hypotension.","Concurrent use of amlodipine and telmisartan can increase the risk of hypotension.","Concurrent use of amlodipine and terazosin can increase the risk of hypotension.","Concurrent use of amlodipine and thiopental can increase the risk of hypotension.","Concurrent use of amlodipine and timolol can increase the risk of hypotension.","Tipranavir is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and tizanidine can increase the risk of hypotension.","Concurrent use of amlodipine and torasemide can increase the risk of hypotension.","Concurrent use of amlodipine and trandolapril can increase the risk of hypotension.","Concurrent use of amlodipine and tranylcypromine can increase the risk of hypotension.","Concurrent use of amlodipine and trifluoperazine can increase the risk of hypotension.","Concurrent use of amlodipine and trimipramine can increase the risk of hypotension.","Concurrent use of amlodipine and valsartan can increase the risk of hypotension.","Concurrent use of amlodipine and vardenafil can increase the risk of hypotension.","Concurrent use of amlodipine and verapamil can increase the risk of hypotension.","Verapamil is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Voriconazole is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of amlodipine and xipamide can increase the risk of hypotension.","Concurrent use of amlodipine and zuclopenthixol can increase the risk of hypotension."]},{"name":"BNF.Amoxicillin.Amoxicillin","imports":["BNF.Warfarin.Warfarin"],"interactioninfo":["Amoxicillin potentially alters the anticoagulant effect of acenocoumarol. Manufacturer advises monitor INR and adjust dose.","Allopurinol increases the risk of skin rash when given with amoxicillin.","Amoxicillin is predicted to increase the risk of toxicity when given with methotrexate.","Amoxicillin is predicted to increase the risk of bleeding events when given with phenindione.","Amoxicillin potentially alters the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose."]},{"name":"BNF.Apixaban.Apixaban","imports":["BNF.Carbamazepine.Carbamazepine","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Diclofenac.Diclofenac","BNF.Enoxaparin.Enoxaparin","BNF.Fluoxetine.Fluoxetine","BNF.Glucose.Glucose","BNF.Ibuprofen.Ibuprofen","BNF.Naproxen.Naproxen","BNF.Phenytoin.Phenytoin","BNF.Rivaroxaban.Rivaroxaban","BNF.Sertraline.Sertraline","BNF.Venlafaxine.Venlafaxine","BNF.Warfarin.Warfarin"],"interactioninfo":["Apixaban is predicted to increase the risk of bleeding events when given with abciximab. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with aceclofenac. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with acemetacin. Manufacturer advises use with caution or avoid.","Both apixaban and acenocoumarol can increase the risk of bleeding.","Both apixaban and alteplase can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with anagrelide. Manufacturer advises use with caution or avoid.","Both apixaban and argatroban can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with aspirin. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with bevacizumab. Manufacturer advises use with caution or avoid.","Both apixaban and bivalirudin can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with cangrelor. Manufacturer advises use with caution or avoid.","Carbamazepine is predicted to moderately decrease the exposure to apixaban. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with celecoxib. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with cilostazol. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to apixaban. Manufacturer advises avoid.","Apixaban is predicted to increase the risk of bleeding events when given with clopidogrel. Manufacturer advises use with caution or avoid.","Both apixaban and dabigatran can increase the risk of bleeding.","Both apixaban and dalteparin can increase the risk of bleeding.","Both apixaban and danaparoid can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with dapoxetine. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with dasatinib. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with dexibuprofen. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with dexketoprofen. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with dipyridamole. Manufacturer advises use with caution or avoid.","Dronedarone is predicted to increase the exposure to apixaban.","Apixaban is predicted to increase the risk of bleeding events when given with duloxetine. Manufacturer advises use with caution or avoid.","Both apixaban and edoxaban can increase the risk of bleeding.","Both apixaban and enoxaparin can increase the risk of bleeding.","Enzalutamide is predicted to moderately decrease the exposure to apixaban. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with epoprostenol. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with eptifibatide. Manufacturer advises use with caution or avoid.","Erythromycin is predicted to increase the exposure to apixaban.","Apixaban is predicted to increase the risk of bleeding events when given with escitalopram. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with etodolac. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with etoricoxib. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with fenoprofen. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with flurbiprofen. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with fluvoxamine. Manufacturer advises use with caution or avoid.","Both apixaban and fondaparinux can increase the risk of bleeding.","Fosphenytoin is predicted to moderately decrease the exposure to apixaban. Manufacturer advises use with caution or avoid.","Both apixaban and glucose can increase the risk of bleeding.","Both apixaban and heparin (unfractionated) can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with ibrutinib. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with iloprost. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with indometacin. Manufacturer advises use with caution or avoid.","Itraconazole is predicted to increase the exposure to apixaban. Manufacturer advises avoid.","Ketoconazole slightly to moderately increases the exposure to apixaban. Manufacturer advises avoid.","Apixaban is predicted to increase the risk of bleeding events when given with ketoprofen. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with ketorolac. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with mefenamic acid. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with meloxicam. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with nabumetone. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Both apixaban and nicotinic acid can increase the risk of bleeding.","Both apixaban and omega-3-acid ethyl esters can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with parecoxib. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with paroxetine. Manufacturer advises use with caution or avoid.","Both apixaban and phenindione can increase the risk of bleeding.","Phenobarbital is predicted to moderately decrease the exposure to apixaban. Manufacturer advises use with caution or avoid.","Phenytoin is predicted to moderately decrease the exposure to apixaban. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with piroxicam. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with prasugrel. Manufacturer advises use with caution or avoid.","Primidone is predicted to moderately decrease the exposure to apixaban. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with regorafenib. Manufacturer advises use with caution or avoid.","Both apixaban and reteplase can increase the risk of bleeding.","Rifampicin is predicted to moderately decrease the exposure to apixaban. Manufacturer advises use with caution or avoid.","Ritonavir is predicted to increase the exposure to apixaban. Manufacturer advises avoid.","Both apixaban and rivaroxaban can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","St John's Wort is predicted to decrease the exposure to apixaban. Manufacturer advises use with caution or avoid.","Both apixaban and streptokinase can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with sulfinpyrazone. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with sulindac. Manufacturer advises use with caution or avoid.","Both apixaban and tenecteplase can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with tenoxicam. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with tiaprofenic acid. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with ticagrelor. Manufacturer advises use with caution or avoid.","Both apixaban and tinzaparin can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with tirofiban. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with tolfenamic acid. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with trastuzumab. Manufacturer advises use with caution or avoid.","Apixaban is predicted to increase the risk of bleeding events when given with trastuzumab emtansine. Manufacturer advises use with caution or avoid.","Both apixaban and urokinase can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Verapamil is predicted to increase the exposure to apixaban.","Apixaban is predicted to increase the risk of bleeding events when given with vortioxetine. Manufacturer advises use with caution or avoid.","Both apixaban and warfarin can increase the risk of bleeding."]},{"name":"BNF.Atenolol.Atenolol","imports":["BNF.Amiodarone.Amiodarone","BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Digoxin.Digoxin","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Fentanyl.Fentanyl","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Nifedipine.Nifedipine","BNF.Prochlorperazine.Prochlorperazine","BNF.Ramipril.Ramipril","BNF.Spironolactone.Spironolactone","BNF.Theophylline.Theophylline"],"interactioninfo":["Both atenolol and acebutolol can increase the risk of bradycardia.","Concurrent use of atenolol and acebutolol can increase the risk of hypotension.","Atenolol is predicted to increase the risk of hypertension and bradycardia when given with adrenaline/epinephrine.","Concurrent use of atenolol and alcohol (beverage) can increase the risk of hypotension.","Both atenolol and alectinib can increase the risk of bradycardia.","Both atenolol and alfentanil can increase the risk of bradycardia.","Concurrent use of atenolol and alfuzosin can increase the risk of hypotension.","Concurrent use of atenolol and aliskiren can increase the risk of hypotension.","Concurrent use of atenolol and alprostadil can increase the risk of hypotension.","Concurrent use of atenolol and amantadine can increase the risk of hypotension.","Atenolol is predicted to increase the risk of bronchospasm when given with aminophylline. Manufacturer advises avoid.","Both atenolol and amiodarone can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with atenolol. Manufacturer advises use with caution or avoid.","Concurrent use of atenolol and amitriptyline can increase the risk of hypotension.","Concurrent use of atenolol and amlodipine can increase the risk of hypotension.","Concurrent use of atenolol and apomorphine can increase the risk of hypotension.","Both atenolol and apraclonidine can increase the risk of bradycardia.","Concurrent use of atenolol and apraclonidine can increase the risk of hypotension.","Concurrent use of atenolol and aripiprazole can increase the risk of hypotension.","Concurrent use of atenolol and asenapine can increase the risk of hypotension.","Concurrent use of atenolol and avanafil can increase the risk of hypotension.","Concurrent use of atenolol and azilsartan can increase the risk of hypotension.","Concurrent use of atenolol and baclofen can increase the risk of hypotension.","Concurrent use of atenolol and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of atenolol and benperidol can increase the risk of hypotension.","Both atenolol and betaxolol can increase the risk of bradycardia.","Concurrent use of atenolol and betaxolol can increase the risk of hypotension.","Both atenolol and bisoprolol can increase the risk of bradycardia.","Concurrent use of atenolol and bisoprolol can increase the risk of hypotension.","Concurrent use of atenolol and bortezomib can increase the risk of hypotension.","Both atenolol and brimonidine can increase the risk of bradycardia.","Concurrent use of atenolol and brimonidine can increase the risk of hypotension.","Concurrent use of atenolol and bromocriptine can increase the risk of hypotension.","Concurrent use of atenolol and bumetanide can increase the risk of hypotension.","Concurrent use of atenolol and cabergoline can increase the risk of hypotension.","Concurrent use of atenolol and canagliflozin can increase the risk of hypotension.","Concurrent use of atenolol and candesartan can increase the risk of hypotension.","Concurrent use of atenolol and captopril can increase the risk of hypotension.","Both atenolol and carteolol can increase the risk of bradycardia.","Concurrent use of atenolol and carteolol can increase the risk of hypotension.","Both atenolol and carvedilol can increase the risk of bradycardia.","Concurrent use of atenolol and carvedilol can increase the risk of hypotension.","Both atenolol and celiprolol can increase the risk of bradycardia.","Concurrent use of atenolol and celiprolol can increase the risk of hypotension.","Concurrent use of atenolol and chlorothiazide can increase the risk of hypotension.","Concurrent use of atenolol and chlorpromazine can increase the risk of hypotension.","Concurrent use of atenolol and chlortalidone can increase the risk of hypotension.","Both atenolol and cisatracurium can increase the risk of bradycardia.","Concurrent use of atenolol and clevidipine can increase the risk of hypotension.","Concurrent use of atenolol and clomipramine can increase the risk of hypotension.","Both atenolol and clonidine can increase the risk of bradycardia.","Concurrent use of atenolol and clonidine can increase the risk of hypotension.","Concurrent use of atenolol and clopamide can increase the risk of hypotension.","Concurrent use of atenolol and clozapine can increase the risk of hypotension.","Both atenolol and crizotinib can increase the risk of bradycardia.","Concurrent use of atenolol and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of atenolol and dapagliflozin can increase the risk of hypotension.","Concurrent use of atenolol and desflurane can increase the risk of hypotension.","Concurrent use of atenolol and diazoxide can increase the risk of hypotension.","Both atenolol and digoxin can increase the risk of bradycardia.","Both atenolol and diltiazem can increase the risk of bradycardia.","Concurrent use of atenolol and diltiazem can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with atenolol.","Concurrent use of atenolol and dipyridamole can increase the risk of hypotension.","Disopyramide is predicted to increase the risk of cardiovascular side-effects when given with atenolol. Manufacturer advises use with caution or avoid.","Atenolol increases the risk of hypertension and bradycardia when given with dobutamine.","Both atenolol and donepezil can increase the risk of bradycardia.","Donepezil is predicted to increase the risk of bradycardia when given with atenolol.","Concurrent use of atenolol and dosulepin can increase the risk of hypotension.","Concurrent use of atenolol and doxazosin can increase the risk of hypotension.","Concurrent use of atenolol and doxepin can increase the risk of hypotension.","Dronedarone is predicted to increase the risk of cardiovascular side-effects when given with atenolol. Manufacturer advises use with caution or avoid.","Concurrent use of atenolol and droperidol can increase the risk of hypotension.","Concurrent use of atenolol and empagliflozin can increase the risk of hypotension.","Concurrent use of atenolol and enalapril can increase the risk of hypotension.","Concurrent use of atenolol and eplerenone can increase the risk of hypotension.","Concurrent use of atenolol and eprosartan can increase the risk of hypotension.","Atenolol is predicted to increase the risk of peripheral vasoconstriction when given with ergometrine.","Atenolol is predicted to increase the risk of peripheral vasoconstriction when given with ergotamine.","Both atenolol and esmolol can increase the risk of bradycardia.","Concurrent use of atenolol and esmolol can increase the risk of hypotension.","Concurrent use of atenolol and etomidate can increase the risk of hypotension.","Concurrent use of atenolol and felodipine can increase the risk of hypotension.","Both atenolol and fentanyl can increase the risk of bradycardia.","Both atenolol and fingolimod can increase the risk of bradycardia.","Both atenolol and flecainide can increase the risk of bradycardia.","Flecainide is predicted to increase the risk of cardiovascular side-effects when given with atenolol. Manufacturer advises use with caution or avoid.","Concurrent use of atenolol and flupentixol can increase the risk of hypotension.","Concurrent use of atenolol and fluphenazine can increase the risk of hypotension.","Concurrent use of atenolol and fosinopril can increase the risk of hypotension.","Concurrent use of atenolol and furosemide can increase the risk of hypotension.","Both atenolol and galantamine can increase the risk of bradycardia.","Galantamine is predicted to increase the risk of bradycardia when given with atenolol.","Concurrent use of atenolol and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of atenolol and guanethidine can increase the risk of hypotension.","Concurrent use of atenolol and guanfacine can increase the risk of hypotension.","Concurrent use of atenolol and haloperidol can increase the risk of hypotension.","Concurrent use of atenolol and histamine can increase the risk of hypotension.","Concurrent use of atenolol and hydralazine can increase the risk of hypotension.","Concurrent use of atenolol and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of atenolol and hydroflumethiazide can increase the risk of hypotension.","Concurrent use of atenolol and imidapril can increase the risk of hypotension.","Concurrent use of atenolol and imipramine can increase the risk of hypotension.","Concurrent use of atenolol and indapamide can increase the risk of hypotension.","Concurrent use of atenolol and indoramin can increase the risk of hypotension.","Concurrent use of atenolol and irbesartan can increase the risk of hypotension.","Concurrent use of atenolol and isocarboxazid can increase the risk of hypotension.","Concurrent use of atenolol and isoflurane can increase the risk of hypotension.","Concurrent use of atenolol and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of atenolol and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of atenolol and isradipine can increase the risk of hypotension.","Both atenolol and ivabradine can increase the risk of bradycardia.","Concurrent use of atenolol and ketamine can increase the risk of hypotension.","Both atenolol and labetalol can increase the risk of bradycardia.","Concurrent use of atenolol and labetalol can increase the risk of hypotension.","Concurrent use of atenolol and lacidipine can increase the risk of hypotension.","Atenolol is predicted to increase the risk of bradycardia when given with lanreotide.","Concurrent use of atenolol and lercanidipine can increase the risk of hypotension.","Both atenolol and levobunolol can increase the risk of bradycardia.","Concurrent use of atenolol and levobunolol can increase the risk of hypotension.","Concurrent use of atenolol and levodopa can increase the risk of hypotension.","Concurrent use of atenolol and levomepromazine can increase the risk of hypotension.","Lidocaine is predicted to increase the risk of cardiovascular side-effects when given with atenolol. Manufacturer advises use with caution or avoid.","Concurrent use of atenolol and lisinopril can increase the risk of hypotension.","Concurrent use of atenolol and lofepramine can increase the risk of hypotension.","Concurrent use of atenolol and lofexidine can increase the risk of hypotension.","Concurrent use of atenolol and losartan can increase the risk of hypotension.","Concurrent use of atenolol and loxapine can increase the risk of hypotension.","Concurrent use of atenolol and lurasidone can increase the risk of hypotension.","Mefloquine is predicted to increase the risk of bradycardia when given with atenolol.","Both atenolol and methadone can increase the risk of bradycardia.","Concurrent use of atenolol and methyldopa can increase the risk of hypotension.","Concurrent use of atenolol and metolazone can increase the risk of hypotension.","Both atenolol and metoprolol can increase the risk of bradycardia.","Concurrent use of atenolol and metoprolol can increase the risk of hypotension.","Concurrent use of atenolol and minoxidil can increase the risk of hypotension.","Concurrent use of atenolol and moexipril can increase the risk of hypotension.","Concurrent use of atenolol and moxisylyte can increase the risk of hypotension.","Concurrent use of atenolol and moxonidine can increase the risk of hypotension.","Both atenolol and nadolol can increase the risk of bradycardia.","Concurrent use of atenolol and nadolol can increase the risk of hypotension.","Both atenolol and nebivolol can increase the risk of bradycardia.","Concurrent use of atenolol and nebivolol can increase the risk of hypotension.","Both atenolol and neostigmine can increase the risk of bradycardia.","Concurrent use of atenolol and nicardipine can increase the risk of hypotension.","Concurrent use of atenolol and nicorandil can increase the risk of hypotension.","Concurrent use of atenolol and nifedipine can increase the risk of hypotension.","Concurrent use of atenolol and nimodipine can increase the risk of hypotension.","Concurrent use of atenolol and nitrous oxide can increase the risk of hypotension.","Atenolol is predicted to increase the risk of hypertension and bradycardia when given with noradrenaline/norepinephrine.","Concurrent use of atenolol and nortriptyline can increase the risk of hypotension.","Concurrent use of atenolol and olanzapine can increase the risk of hypotension.","Concurrent use of atenolol and olmesartan can increase the risk of hypotension.","Both atenolol and oxprenolol can increase the risk of bradycardia.","Concurrent use of atenolol and oxprenolol can increase the risk of hypotension.","Concurrent use of atenolol and paliperidone can increase the risk of hypotension.","Both atenolol and pasireotide can increase the risk of bradycardia.","Concurrent use of atenolol and pergolide can increase the risk of hypotension.","Concurrent use of atenolol and pericyazine can increase the risk of hypotension.","Concurrent use of atenolol and perindopril can increase the risk of hypotension.","Concurrent use of atenolol and perphenazine can increase the risk of hypotension.","Concurrent use of atenolol and phenelzine can increase the risk of hypotension.","Concurrent use of atenolol and pimozide can increase the risk of hypotension.","Both atenolol and pindolol can increase the risk of bradycardia.","Concurrent use of atenolol and pindolol can increase the risk of hypotension.","Concurrent use of atenolol and pramipexole can increase the risk of hypotension.","Concurrent use of atenolol and prazosin can increase the risk of hypotension.","Concurrent use of atenolol and prochlorperazine can increase the risk of hypotension.","Concurrent use of atenolol and promazine can increase the risk of hypotension.","Propafenone is predicted to increase the risk of cardiovascular side-effects when given with atenolol. Manufacturer advises use with caution or avoid.","Concurrent use of atenolol and propofol can increase the risk of hypotension.","Both atenolol and propranolol can increase the risk of bradycardia.","Concurrent use of atenolol and propranolol can increase the risk of hypotension.","Both atenolol and pyridostigmine can increase the risk of bradycardia.","Concurrent use of atenolol and quetiapine can increase the risk of hypotension.","Concurrent use of atenolol and quinagolide can increase the risk of hypotension.","Concurrent use of atenolol and quinapril can increase the risk of hypotension.","Concurrent use of atenolol and ramipril can increase the risk of hypotension.","Both atenolol and remifentanil can increase the risk of bradycardia.","Concurrent use of atenolol and riociguat can increase the risk of hypotension.","Concurrent use of atenolol and risperidone can increase the risk of hypotension.","Both atenolol and rivastigmine can increase the risk of bradycardia.","Rivastigmine is predicted to increase the risk of bradycardia when given with atenolol.","Concurrent use of atenolol and ropinirole can increase the risk of hypotension.","Concurrent use of atenolol and rotigotine can increase the risk of hypotension.","Concurrent use of atenolol and sacubitril can increase the risk of hypotension.","Concurrent use of atenolol and sapropterin can increase the risk of hypotension.","Both atenolol and selegiline can increase the risk of bradycardia.","Concurrent use of atenolol and selegiline can increase the risk of hypotension.","Concurrent use of atenolol and sevoflurane can increase the risk of hypotension.","Concurrent use of atenolol and sildenafil can increase the risk of hypotension.","Concurrent use of atenolol and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of atenolol and sodium oxybate can increase the risk of hypotension.","Both atenolol and sotalol can increase the risk of bradycardia.","Concurrent use of atenolol and sotalol can increase the risk of hypotension.","Concurrent use of atenolol and spironolactone can increase the risk of hypotension.","Both atenolol and sufentanil can increase the risk of bradycardia.","Concurrent use of atenolol and sulpiride can increase the risk of hypotension.","Concurrent use of atenolol and tadalafil can increase the risk of hypotension.","Concurrent use of atenolol and tamsulosin can increase the risk of hypotension.","Concurrent use of atenolol and telmisartan can increase the risk of hypotension.","Concurrent use of atenolol and terazosin can increase the risk of hypotension.","Both atenolol and thalidomide can increase the risk of bradycardia.","Atenolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Concurrent use of atenolol and thiopental can increase the risk of hypotension.","Both atenolol and timolol can increase the risk of bradycardia.","Concurrent use of atenolol and timolol can increase the risk of hypotension.","Both atenolol and tizanidine can increase the risk of bradycardia.","Concurrent use of atenolol and tizanidine can increase the risk of hypotension.","Concurrent use of atenolol and torasemide can increase the risk of hypotension.","Concurrent use of atenolol and trandolapril can increase the risk of hypotension.","Concurrent use of atenolol and tranylcypromine can increase the risk of hypotension.","Concurrent use of atenolol and trifluoperazine can increase the risk of hypotension.","Concurrent use of atenolol and trimipramine can increase the risk of hypotension.","Concurrent use of atenolol and valsartan can increase the risk of hypotension.","Concurrent use of atenolol and vardenafil can increase the risk of hypotension.","Both atenolol and verapamil can increase the risk of bradycardia.","Concurrent use of atenolol and verapamil can increase the risk of hypotension.","Intravenous verapamil increases the risk of cardiovascular side-effects when given with atenolol. Manufacturer advises avoid.","Oral verapamil increases the risk of cardiovascular side-effects when given with atenolol.","Concurrent use of atenolol and xipamide can increase the risk of hypotension.","Concurrent use of atenolol and zuclopenthixol can increase the risk of hypotension."]},{"name":"BNF.Atorvastatin.Atorvastatin","imports":["BNF.Amiodarone.Amiodarone","BNF.Carbamazepine.Carbamazepine","BNF.Clarithromycin.Clarithromycin","BNF.Diltiazem.Diltiazem","BNF.Doxycycline.Doxycycline","BNF.Paracetamol.Paracetamol","BNF.Phenytoin.Phenytoin","BNF.Pravastatin.Pravastatin","BNF.Simvastatin.Simvastatin"],"interactioninfo":["Concurrent use of atorvastatin and alcohol (beverage) can increase the risk of hepatotoxicity.","Concurrent use of atorvastatin and alectinib can increase the risk of hepatotoxicity.","Atorvastatin slightly to moderately increases the exposure to aliskiren.","Amiodarone is predicted to increase the risk of rhabdomyolysis when given with atorvastatin. Manufacturer advises monitor and adjust dose.","Aprepitant is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of atorvastatin and asparaginase can increase the risk of hepatotoxicity.","Atazanavir is predicted to increase the exposure to atorvastatin. Manufacturer advises avoid or adjust dose and monitor rhabdomyolysis.","Bezafibrate increases the risk of rhabdomyolysis when given with atorvastatin.","Bosentan slightly decreases the exposure to atorvastatin.","Concurrent use of atorvastatin and carbamazepine can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Ceftobiprole is predicted to increase the concentration of atorvastatin.","Ciclosporin very markedly increases the exposure to atorvastatin. Manufacturer advises avoid or adjust atorvastatin dose.","Ciprofibrate increases the risk of rhabdomyolysis when given with atorvastatin. Manufacturer advises avoid or adjust dose.","Clarithromycin is predicted to increase the exposure to atorvastatin. Manufacturer advises avoid or adjust dose and monitor rhabdomyolysis.","Cobicistat is predicted to increase the exposure to atorvastatin. Manufacturer advises avoid or adjust dose and monitor rhabdomyolysis.","Colchicine increases the risk of rhabdomyolysis when given with atorvastatin.","Concurrent use of atorvastatin and crisantaspase can increase the risk of hepatotoxicity.","Crizotinib is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of atorvastatin and daclizumab can increase the risk of hepatotoxicity.","Concurrent use of atorvastatin and dactinomycin can increase the risk of hepatotoxicity.","Danazol is predicted to increase the risk of rhabdomyolysis when given with atorvastatin.","Concurrent use of atorvastatin and dantrolene can increase the risk of hepatotoxicity.","Atorvastatin is predicted to increase the risk of rhabdomyolysis when given with daptomycin.","Darunavir is predicted to increase the exposure to atorvastatin. Manufacturer advises avoid or adjust dose and monitor rhabdomyolysis.","Concurrent use of atorvastatin and demeclocycline can increase the risk of hepatotoxicity.","Concurrent use of atorvastatin and didanosine can increase the risk of hepatotoxicity.","Diltiazem is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of atorvastatin and doxycycline can increase the risk of hepatotoxicity.","Dronedarone is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Efavirenz slightly decreases the exposure to atorvastatin.","Elbasvir potentially increases the exposure to atorvastatin. Manufacturer advises adjust atorvastatin dose.","Eltrombopag is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Eluxadoline is predicted to increase the exposure to atorvastatin.","Erythromycin is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Eslicarbazepine is predicted to decrease the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Ezetimibe potentially increases the risk of rhabdomyolysis when given with atorvastatin.","Fenofibrate increases the risk of rhabdomyolysis when given with atorvastatin. Manufacturer advises adjust fenofibrate dose.","Concurrent use of atorvastatin and fluconazole can increase the risk of hepatotoxicity.","Fluconazole is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of atorvastatin and fluvastatin can increase the risk of hepatotoxicity.","Fosamprenavir is predicted to increase the exposure to atorvastatin. Manufacturer advises avoid or adjust dose and monitor rhabdomyolysis.","Fosphenytoin potentially decreases the exposure to atorvastatin.","Fusidic acid increases the risk of rhabdomyolysis when given with atorvastatin. Manufacturer advises avoid.","Gemfibrozil increases the risk of rhabdomyolysis when given with atorvastatin. Manufacturer advises avoid.","Grapefruit juice increases the exposure to atorvastatin.","Grazoprevir increases the exposure to atorvastatin. Manufacturer advises adjust atorvastatin dose.","Idelalisib is predicted to increase the exposure to atorvastatin. Manufacturer advises avoid or adjust dose and monitor rhabdomyolysis.","Imatinib is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Indinavir is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Isavuconazole is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of atorvastatin and isoniazid can increase the risk of hepatotoxicity.","Concurrent use of atorvastatin and itraconazole can increase the risk of hepatotoxicity.","Itraconazole is predicted to increase the exposure to atorvastatin. Manufacturer advises avoid or adjust dose and monitor rhabdomyolysis.","Ketoconazole is predicted to increase the exposure to atorvastatin. Manufacturer advises avoid or adjust dose and monitor rhabdomyolysis.","Ledipasvir is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of atorvastatin and leflunomide can increase the risk of hepatotoxicity.","Concurrent use of atorvastatin and lenalidomide can increase the risk of hepatotoxicity.","Concurrent use of atorvastatin and lomitapide can increase the risk of hepatotoxicity.","Lomitapide increases the exposure to atorvastatin. Manufacturer advises adjust lomitapide dose or separate administration by 12 hours.","Lopinavir is predicted to increase the exposure to atorvastatin. Manufacturer advises avoid or adjust dose and monitor rhabdomyolysis.","Concurrent use of atorvastatin and lymecycline can increase the risk of hepatotoxicity.","Concurrent use of atorvastatin and mercaptopurine can increase the risk of hepatotoxicity.","Concurrent use of atorvastatin and methotrexate can increase the risk of hepatotoxicity.","Concurrent use of atorvastatin and micafungin can increase the risk of hepatotoxicity.","Miconazole potentially increases the exposure to atorvastatin.","Concurrent use of atorvastatin and minocycline can increase the risk of hepatotoxicity.","Netupitant is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Nevirapine slightly decreases the exposure to atorvastatin.","Nicotinic acid is predicted to increase the risk of rhabdomyolysis when given with atorvastatin.","Nilotinib is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of atorvastatin and oxytetracycline can increase the risk of hepatotoxicity.","Concurrent use of atorvastatin and paracetamol can increase the risk of hepatotoxicity.","Concurrent use of atorvastatin and pegaspargase can increase the risk of hepatotoxicity.","Phenytoin potentially decreases the exposure to atorvastatin.","Posaconazole is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of atorvastatin and pravastatin can increase the risk of hepatotoxicity.","Ranolazine is predicted to increase the exposure to atorvastatin.","Regorafenib is predicted to increase the exposure to atorvastatin.","Rifampicin markedly decreases the exposure to atorvastatin. Manufacturer advises atorvastatin should be taken at the same time as rifampicin.","Ritonavir is predicted to increase the exposure to atorvastatin. Manufacturer advises avoid or adjust dose and monitor rhabdomyolysis.","Concurrent use of atorvastatin and rosuvastatin can increase the risk of hepatotoxicity.","Sacubitril is predicted to increase the exposure to atorvastatin.","Saquinavir is predicted to increase the exposure to atorvastatin. Manufacturer advises avoid or adjust dose and monitor rhabdomyolysis.","Simeprevir moderately increases the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of atorvastatin and simvastatin can increase the risk of hepatotoxicity.","St John's Wort slightly decreases the exposure to atorvastatin.","Concurrent use of atorvastatin and sulfasalazine can increase the risk of hepatotoxicity.","Concurrent use of atorvastatin and tetracycline can increase the risk of hepatotoxicity.","Concurrent use of atorvastatin and tigecycline can increase the risk of hepatotoxicity.","Tipranavir is predicted to increase the exposure to atorvastatin. Manufacturer advises avoid or adjust dose and monitor rhabdomyolysis.","Tocilizumab is predicted to decrease the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of atorvastatin and trabectedin can increase the risk of hepatotoxicity.","Concurrent use of atorvastatin and valproate can increase the risk of hepatotoxicity.","Velpatasvir is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor side effects and adjust dose.","Verapamil is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of atorvastatin and vincristine can increase the risk of hepatotoxicity.","Voriconazole is predicted to increase the exposure to atorvastatin. Manufacturer advises avoid or adjust dose and monitor rhabdomyolysis."]},{"name":"BNF.Bendroflumethiazide.Bendroflumethiazide","imports":["BNF.Amiloride.Amiloride","BNF.Amiodarone.Amiodarone","BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bisacodyl.Bisacodyl","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Carbamazepine.Carbamazepine","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Diclofenac.Diclofenac","BNF.Digoxin.Digoxin","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Naproxen.Naproxen","BNF.Nifedipine.Nifedipine","BNF.Ondansetron.Ondansetron","BNF.Prochlorperazine.Prochlorperazine","BNF.Quinine.Quinine","BNF.Ramipril.Ramipril","BNF.Salbutamol.Salbutamol","BNF.Senna.Senna","BNF.Sertraline.Sertraline","BNF.Spironolactone.Spironolactone","BNF.Theophylline.Theophylline","BNF.Trimethoprim.Trimethoprim","BNF.Venlafaxine.Venlafaxine"],"interactioninfo":["Concurrent use of bendroflumethiazide and acebutolol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and aceclofenac can increase the risk of hyponatraemia.","Aceclofenac increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and acemetacin can increase the risk of hyponatraemia.","Acemetacin increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and alcohol (beverage) can increase the risk of hypotension.","Bendroflumethiazide increases the risk of hypercalcaemia when given with alfacalcidol.","Concurrent use of bendroflumethiazide and alfuzosin can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and aliskiren can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of hypersensitivity reactions when given with allopurinol.","Concurrent use of bendroflumethiazide and alprostadil can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and amantadine can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with amifampridine. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and amiloride can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and aminophylline can increase the risk of hypokalaemia.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with amisulpride. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and amitriptyline can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and amitriptyline can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and amlodipine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and amphotericin can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and apomorphine can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with apomorphine. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and apraclonidine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and aripiprazole can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with arsenic trioxide. Manufacturer advises use with caution or avoid.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with artemether. Manufacturer advises use with caution or avoid.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with artenimol. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and asenapine can increase the risk of hypotension.","Aspirin (high-dose) increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and atenolol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and avanafil can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and azilsartan can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and baclofen can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and bambuterol can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and beclometasone can increase the risk of hypokalaemia.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with bedaquiline. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and benperidol can increase the risk of hypotension.","Benzydamine increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and betamethasone can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and betaxolol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and bisacodyl can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and bisoprolol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and bortezomib can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with bosutinib. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and brimonidine can increase the risk of hypotension.","Bromfenac increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and bromocriptine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and budesonide can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and bumetanide can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and bumetanide can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and bumetanide can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and cabergoline can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with cabozantinib. Manufacturer advises use with caution or avoid.","Bendroflumethiazide increases the risk of hypercalcaemia when given with calcipotriol.","Bendroflumethiazide increases the risk of hypercalcaemia when given with calcitriol.","Bendroflumethiazide increases the risk of hypercalcaemia when given with calcium acetate.","Bendroflumethiazide increases the risk of hypercalcaemia when given with calcium carbonate.","Bendroflumethiazide increases the risk of hypercalcaemia when given with calcium chloride.","Bendroflumethiazide increases the risk of hypercalcaemia when given with calcium gluconate.","Bendroflumethiazide increases the risk of hypercalcaemia when given with calcium lactate.","Bendroflumethiazide increases the risk of hypercalcaemia when given with calcium phosphate.","Concurrent use of bendroflumethiazide and canagliflozin can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and candesartan can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and captopril can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and carbamazepine can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and carteolol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and carvedilol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and celecoxib can increase the risk of hyponatraemia.","Celecoxib increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and celiprolol can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with ceritinib. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and chlorothiazide can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and chlorothiazide can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and chlorothiazide can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and chlorpromazine can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with chlorpromazine. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and chlortalidone can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and chlortalidone can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and chlortalidone can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and citalopram can increase the risk of hyponatraemia.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and clevidipine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and clomipramine can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and clomipramine can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with clomipramine. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and clonidine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and clopamide can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and clopamide can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and clopamide can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and clozapine can increase the risk of hypotension.","Bendroflumethiazide increases the risk of hypercalcaemia when given with colecalciferol.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with crizotinib. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and cyclopenthiazide can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and cyclopenthiazide can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and dantron can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and dapagliflozin can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and dapoxetine can increase the risk of hyponatraemia.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with dasatinib. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and deflazacort can increase the risk of hypokalaemia.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with delamanid. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and desflurane can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and desmopressin can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and dexamethasone can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and dexibuprofen can increase the risk of hyponatraemia.","Dexibuprofen increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and dexketoprofen can increase the risk of hyponatraemia.","Dexketoprofen increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and diazoxide can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and diclofenac can increase the risk of hyponatraemia.","Diclofenac increases the risk of acute renal failure when given with bendroflumethiazide.","Bendroflumethiazide is predicted to increase the risk of digoxin toxicity when given with digoxin.","Bendroflumethiazide increases the risk of hypercalcaemia when given with dihydrotachysterol.","Concurrent use of bendroflumethiazide and diltiazem can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and dipyridamole can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with disopyramide. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and docusate sodium can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and dosulepin can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and dosulepin can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and doxazosin can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and doxepin can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and doxepin can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with dronedarone. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and droperidol can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with droperidol. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and duloxetine can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and empagliflozin can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and enalapril can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and eplerenone can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and eplerenone can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and eprosartan can increase the risk of hypotension.","Bendroflumethiazide increases the risk of hypercalcaemia when given with ergocalciferol.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with eribulin. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and escitalopram can increase the risk of hyponatraemia.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with escitalopram. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and esmolol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and etodolac can increase the risk of hyponatraemia.","Etodolac increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and etomidate can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and etoricoxib can increase the risk of hyponatraemia.","Etoricoxib increases the risk of acute renal failure when given with bendroflumethiazide.","Felbinac increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and felodipine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and fenoprofen can increase the risk of hyponatraemia.","Fenoprofen increases the risk of acute renal failure when given with bendroflumethiazide.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with flecainide. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and fludrocortisone can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and fluoxetine can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and flupentixol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and fluphenazine can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with fluphenazine. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and flurbiprofen can increase the risk of hyponatraemia.","Flurbiprofen increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and fluvoxamine can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and formoterol can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and fosinopril can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and furosemide can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and furosemide can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and furosemide can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and glycerol can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and guanethidine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and guanfacine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and haloperidol can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and histamine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and hydralazine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and hydrochlorothiazide can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and hydrochlorothiazide can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and hydrocortisone can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and hydroflumethiazide can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and hydroflumethiazide can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and hydroflumethiazide can increase the risk of hypokalaemia.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with hydroxyzine. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and ibuprofen can increase the risk of hyponatraemia.","Ibuprofen increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and imidapril can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and imipramine can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and imipramine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and indacaterol can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and indapamide can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and indapamide can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and indapamide can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and indometacin can increase the risk of hyponatraemia.","Indometacin increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and indoramin can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and irbesartan can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and isocarboxazid can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and isoflurane can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and isradipine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and ketamine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and ketoprofen can increase the risk of hyponatraemia.","Ketoprofen increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and ketorolac can increase the risk of hyponatraemia.","Ketorolac increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and labetalol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and lacidipine can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with lapatinib. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and lercanidipine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and levobunolol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and levodopa can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and levomepromazine can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and lisinopril can increase the risk of hypotension.","Bendroflumethiazide increases the concentration of lithium. Manufacturer advises avoid or adjust dose and monitor concentration.","Concurrent use of bendroflumethiazide and lofepramine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and lofexidine can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with lofexidine. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and losartan can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and loxapine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and lurasidone can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and mefenamic acid can increase the risk of hyponatraemia.","Mefenamic acid increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and meloxicam can increase the risk of hyponatraemia.","Meloxicam increases the risk of acute renal failure when given with bendroflumethiazide.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with methadone. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and methyldopa can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and methylprednisolone can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and metolazone can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and metolazone can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and metolazone can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and metoprolol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and minoxidil can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and moexipril can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with moxifloxacin. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and moxisylyte can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and moxonidine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and nabumetone can increase the risk of hyponatraemia.","Nabumetone increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and nadolol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and naproxen can increase the risk of hyponatraemia.","Naproxen increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and nebivolol can increase the risk of hypotension.","Nepafenac increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and nicardipine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and nicorandil can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and nifedipine can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with nilotinib. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and nimodipine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and nitrous oxide can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and nortriptyline can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and nortriptyline can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and olanzapine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and olmesartan can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and olodaterol can increase the risk of hypokalaemia.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with osimertinib. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and oxprenolol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and paliperidone can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with paliperidone. Manufacturer advises use with caution or avoid.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with panobinostat. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and parecoxib can increase the risk of hyponatraemia.","Parecoxib increases the risk of acute renal failure when given with bendroflumethiazide.","Bendroflumethiazide increases the risk of hypercalcaemia when given with paricalcitol.","Concurrent use of bendroflumethiazide and paroxetine can increase the risk of hyponatraemia.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with pasireotide. Manufacturer advises use with caution or avoid.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with pazopanib. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and pergolide can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and pericyazine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and perindopril can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and perphenazine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and phenelzine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and pimozide can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with pimozide. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and pindolol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and piroxicam can increase the risk of hyponatraemia.","Piroxicam increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and pramipexole can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and prazosin can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and prednisolone can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and prednisone can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and prochlorperazine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and promazine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and propofol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and propranolol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and quetiapine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and quinagolide can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and quinapril can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and ramipril can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with ranolazine. Manufacturer advises use with caution or avoid.","Reboxetine is predicted to increase the risk of hypokalaemia when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and riociguat can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and risperidone can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with risperidone. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and ropinirole can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and rotigotine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and sacubitril can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and salbutamol can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and salmeterol can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and sapropterin can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with saquinavir. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and selegiline can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and senna can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and sertraline can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and sevoflurane can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and sildenafil can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with sildenafil. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and sodium oxybate can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and sodium picosulfate can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and sodium picosulfate can increase the risk of hypokalaemia.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with sorafenib. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and sotalol can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with sotalol. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and spironolactone can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and spironolactone can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and sulindac can increase the risk of hyponatraemia.","Sulindac increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and sulpiride can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with sulpiride. Manufacturer advises use with caution or avoid.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with sunitinib. Manufacturer advises use with caution or avoid.","Bendroflumethiazide increases the risk of hypercalcaemia when given with tacalcitol.","Concurrent use of bendroflumethiazide and tadalafil can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and tamsulosin can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with telavancin. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and telmisartan can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and tenoxicam can increase the risk of hyponatraemia.","Tenoxicam increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and terazosin can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and terbutaline can increase the risk of hypokalaemia.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with tetrabenazine. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and theophylline can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and thiopental can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and tiaprofenic acid can increase the risk of hyponatraemia.","Tiaprofenic acid increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of bendroflumethiazide and timolol can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and tizanidine can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with tizanidine. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and tolfenamic acid can increase the risk of hyponatraemia.","Tolfenamic acid increases the risk of acute renal failure when given with bendroflumethiazide.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with tolterodine. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and torasemide can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and torasemide can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and torasemide can increase the risk of hypokalaemia.","Bendroflumethiazide is predicted to increase the risk of hypercalcaemia when given with toremifene.","Concurrent use of bendroflumethiazide and trandolapril can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and tranylcypromine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and triamcinolone can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and triamterene can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and trifluoperazine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and trimethoprim can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and trimipramine can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and trimipramine can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and valsartan can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with vandetanib. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and vardenafil can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with vardenafil. Manufacturer advises use with caution or avoid.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with vemurafenib. Manufacturer advises use with caution or avoid.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and verapamil can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and vilanterol can increase the risk of hypokalaemia.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with vinflunine. Manufacturer advises use with caution or avoid.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with voriconazole. Manufacturer advises use with caution or avoid.","Concurrent use of bendroflumethiazide and xipamide can increase the risk of hyponatraemia.","Concurrent use of bendroflumethiazide and xipamide can increase the risk of hypotension.","Concurrent use of bendroflumethiazide and xipamide can increase the risk of hypokalaemia.","Concurrent use of bendroflumethiazide and zuclopenthixol can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with zuclopenthixol. Manufacturer advises use with caution or avoid."]},{"name":"BNF.Bisacodyl.Bisacodyl","imports":["BNF.Amiodarone.Amiodarone","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bumetanide.Bumetanide","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Digoxin.Digoxin","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Levomepromazine.Levomepromazine","BNF.Ondansetron.Ondansetron","BNF.Quinine.Quinine","BNF.Salbutamol.Salbutamol","BNF.Senna.Senna","BNF.Theophylline.Theophylline","BNF.Venlafaxine.Venlafaxine"],"interactioninfo":["Bisacodyl is predicted to increase the risk of torsade de pointes when given with amifampridine. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and aminophylline can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with amisulpride. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and amphotericin can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with apomorphine. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with arsenic trioxide. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with artemether. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with artenimol. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and bambuterol can increase the risk of hypokalaemia.","Concurrent use of bisacodyl and beclometasone can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with bedaquiline. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and bendroflumethiazide can increase the risk of hypokalaemia.","Concurrent use of bisacodyl and betamethasone can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with bosutinib. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and budesonide can increase the risk of hypokalaemia.","Concurrent use of bisacodyl and bumetanide can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with cabozantinib. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with ceritinib. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and chlorothiazide can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with chlorpromazine. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and chlortalidone can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with clomipramine. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and clopamide can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with crizotinib. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and cyclopenthiazide can increase the risk of hypokalaemia.","Concurrent use of bisacodyl and dantron can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with dasatinib. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and deflazacort can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with delamanid. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and dexamethasone can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of digoxin toxicity when given with digoxin.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with disopyramide. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and docusate sodium can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with dronedarone. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with droperidol. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with eribulin. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with escitalopram. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with flecainide. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and fludrocortisone can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with fluphenazine. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and formoterol can increase the risk of hypokalaemia.","Concurrent use of bisacodyl and furosemide can increase the risk of hypokalaemia.","Concurrent use of bisacodyl and glycerol can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and hydrochlorothiazide can increase the risk of hypokalaemia.","Concurrent use of bisacodyl and hydrocortisone can increase the risk of hypokalaemia.","Concurrent use of bisacodyl and hydroflumethiazide can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with hydroxyzine. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and indacaterol can increase the risk of hypokalaemia.","Concurrent use of bisacodyl and indapamide can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with lapatinib. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with lithium. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with lofexidine. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with methadone. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and methylprednisolone can increase the risk of hypokalaemia.","Concurrent use of bisacodyl and metolazone can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with moxifloxacin. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with nilotinib. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and olodaterol can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with osimertinib. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with paliperidone. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with panobinostat. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with pasireotide. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with pazopanib. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with pimozide. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and prednisolone can increase the risk of hypokalaemia.","Concurrent use of bisacodyl and prednisone can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with ranolazine. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with risperidone. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and salbutamol can increase the risk of hypokalaemia.","Concurrent use of bisacodyl and salmeterol can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with saquinavir. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and senna can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with sildenafil. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and sodium picosulfate can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with sorafenib. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with sotalol. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with sulpiride. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with sunitinib. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with telavancin. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and terbutaline can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with tetrabenazine. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and theophylline can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with tizanidine. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with tolterodine. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and torasemide can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with toremifene. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and triamcinolone can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with vandetanib. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with vardenafil. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with vemurafenib. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and vilanterol can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with vinflunine. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with voriconazole. Manufacturer advises use with caution or avoid.","Concurrent use of bisacodyl and xipamide can increase the risk of hypokalaemia.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with zuclopenthixol. Manufacturer advises use with caution or avoid."]},{"name":"BNF.Bisoprolol.Bisoprolol","imports":["BNF.Amiodarone.Amiodarone","BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Digoxin.Digoxin","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Fentanyl.Fentanyl","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Nifedipine.Nifedipine","BNF.Prochlorperazine.Prochlorperazine","BNF.Ramipril.Ramipril","BNF.Spironolactone.Spironolactone","BNF.Theophylline.Theophylline"],"interactioninfo":["Both bisoprolol and acebutolol can increase the risk of bradycardia.","Concurrent use of bisoprolol and acebutolol can increase the risk of hypotension.","Bisoprolol is predicted to increase the risk of hypertension and bradycardia when given with adrenaline/epinephrine.","Concurrent use of bisoprolol and alcohol (beverage) can increase the risk of hypotension.","Both bisoprolol and alectinib can increase the risk of bradycardia.","Both bisoprolol and alfentanil can increase the risk of bradycardia.","Concurrent use of bisoprolol and alfuzosin can increase the risk of hypotension.","Concurrent use of bisoprolol and aliskiren can increase the risk of hypotension.","Concurrent use of bisoprolol and alprostadil can increase the risk of hypotension.","Concurrent use of bisoprolol and amantadine can increase the risk of hypotension.","Bisoprolol is predicted to increase the risk of bronchospasm when given with aminophylline. Manufacturer advises avoid.","Both bisoprolol and amiodarone can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiovascular side-effects when given with bisoprolol. Manufacturer advises use with caution or avoid.","Concurrent use of bisoprolol and amitriptyline can increase the risk of hypotension.","Concurrent use of bisoprolol and amlodipine can increase the risk of hypotension.","Concurrent use of bisoprolol and apomorphine can increase the risk of hypotension.","Both bisoprolol and apraclonidine can increase the risk of bradycardia.","Concurrent use of bisoprolol and apraclonidine can increase the risk of hypotension.","Concurrent use of bisoprolol and aripiprazole can increase the risk of hypotension.","Concurrent use of bisoprolol and asenapine can increase the risk of hypotension.","Both bisoprolol and atenolol can increase the risk of bradycardia.","Concurrent use of bisoprolol and atenolol can increase the risk of hypotension.","Concurrent use of bisoprolol and avanafil can increase the risk of hypotension.","Concurrent use of bisoprolol and azilsartan can increase the risk of hypotension.","Concurrent use of bisoprolol and baclofen can increase the risk of hypotension.","Concurrent use of bisoprolol and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of bisoprolol and benperidol can increase the risk of hypotension.","Both bisoprolol and betaxolol can increase the risk of bradycardia.","Concurrent use of bisoprolol and betaxolol can increase the risk of hypotension.","Concurrent use of bisoprolol and bortezomib can increase the risk of hypotension.","Both bisoprolol and brimonidine can increase the risk of bradycardia.","Concurrent use of bisoprolol and brimonidine can increase the risk of hypotension.","Concurrent use of bisoprolol and bromocriptine can increase the risk of hypotension.","Concurrent use of bisoprolol and bumetanide can increase the risk of hypotension.","Concurrent use of bisoprolol and cabergoline can increase the risk of hypotension.","Concurrent use of bisoprolol and canagliflozin can increase the risk of hypotension.","Concurrent use of bisoprolol and candesartan can increase the risk of hypotension.","Concurrent use of bisoprolol and captopril can increase the risk of hypotension.","Both bisoprolol and carteolol can increase the risk of bradycardia.","Concurrent use of bisoprolol and carteolol can increase the risk of hypotension.","Both bisoprolol and carvedilol can increase the risk of bradycardia.","Concurrent use of bisoprolol and carvedilol can increase the risk of hypotension.","Both bisoprolol and celiprolol can increase the risk of bradycardia.","Concurrent use of bisoprolol and celiprolol can increase the risk of hypotension.","Concurrent use of bisoprolol and chlorothiazide can increase the risk of hypotension.","Concurrent use of bisoprolol and chlorpromazine can increase the risk of hypotension.","Concurrent use of bisoprolol and chlortalidone can increase the risk of hypotension.","Both bisoprolol and cisatracurium can increase the risk of bradycardia.","Concurrent use of bisoprolol and clevidipine can increase the risk of hypotension.","Concurrent use of bisoprolol and clomipramine can increase the risk of hypotension.","Both bisoprolol and clonidine can increase the risk of bradycardia.","Concurrent use of bisoprolol and clonidine can increase the risk of hypotension.","Concurrent use of bisoprolol and clopamide can increase the risk of hypotension.","Concurrent use of bisoprolol and clozapine can increase the risk of hypotension.","Both bisoprolol and crizotinib can increase the risk of bradycardia.","Concurrent use of bisoprolol and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of bisoprolol and dapagliflozin can increase the risk of hypotension.","Concurrent use of bisoprolol and desflurane can increase the risk of hypotension.","Concurrent use of bisoprolol and diazoxide can increase the risk of hypotension.","Both bisoprolol and digoxin can increase the risk of bradycardia.","Both bisoprolol and diltiazem can increase the risk of bradycardia.","Concurrent use of bisoprolol and diltiazem can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with bisoprolol.","Concurrent use of bisoprolol and dipyridamole can increase the risk of hypotension.","Disopyramide is predicted to increase the risk of cardiovascular side-effects when given with bisoprolol. Manufacturer advises use with caution or avoid.","Bisoprolol increases the risk of hypertension and bradycardia when given with dobutamine.","Both bisoprolol and donepezil can increase the risk of bradycardia.","Donepezil is predicted to increase the risk of bradycardia when given with bisoprolol.","Concurrent use of bisoprolol and dosulepin can increase the risk of hypotension.","Concurrent use of bisoprolol and doxazosin can increase the risk of hypotension.","Concurrent use of bisoprolol and doxepin can increase the risk of hypotension.","Dronedarone is predicted to increase the risk of cardiovascular side-effects when given with bisoprolol. Manufacturer advises use with caution or avoid.","Concurrent use of bisoprolol and droperidol can increase the risk of hypotension.","Concurrent use of bisoprolol and empagliflozin can increase the risk of hypotension.","Concurrent use of bisoprolol and enalapril can increase the risk of hypotension.","Concurrent use of bisoprolol and eplerenone can increase the risk of hypotension.","Concurrent use of bisoprolol and eprosartan can increase the risk of hypotension.","Bisoprolol is predicted to increase the risk of peripheral vasoconstriction when given with ergometrine.","Bisoprolol is predicted to increase the risk of peripheral vasoconstriction when given with ergotamine.","Both bisoprolol and esmolol can increase the risk of bradycardia.","Concurrent use of bisoprolol and esmolol can increase the risk of hypotension.","Concurrent use of bisoprolol and etomidate can increase the risk of hypotension.","Concurrent use of bisoprolol and felodipine can increase the risk of hypotension.","Both bisoprolol and fentanyl can increase the risk of bradycardia.","Both bisoprolol and fingolimod can increase the risk of bradycardia.","Both bisoprolol and flecainide can increase the risk of bradycardia.","Flecainide is predicted to increase the risk of cardiovascular side-effects when given with bisoprolol. Manufacturer advises use with caution or avoid.","Concurrent use of bisoprolol and flupentixol can increase the risk of hypotension.","Concurrent use of bisoprolol and fluphenazine can increase the risk of hypotension.","Concurrent use of bisoprolol and fosinopril can increase the risk of hypotension.","Concurrent use of bisoprolol and furosemide can increase the risk of hypotension.","Both bisoprolol and galantamine can increase the risk of bradycardia.","Galantamine is predicted to increase the risk of bradycardia when given with bisoprolol.","Concurrent use of bisoprolol and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of bisoprolol and guanethidine can increase the risk of hypotension.","Concurrent use of bisoprolol and guanfacine can increase the risk of hypotension.","Concurrent use of bisoprolol and haloperidol can increase the risk of hypotension.","Concurrent use of bisoprolol and histamine can increase the risk of hypotension.","Concurrent use of bisoprolol and hydralazine can increase the risk of hypotension.","Concurrent use of bisoprolol and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of bisoprolol and hydroflumethiazide can increase the risk of hypotension.","Concurrent use of bisoprolol and imidapril can increase the risk of hypotension.","Concurrent use of bisoprolol and imipramine can increase the risk of hypotension.","Concurrent use of bisoprolol and indapamide can increase the risk of hypotension.","Concurrent use of bisoprolol and indoramin can increase the risk of hypotension.","Concurrent use of bisoprolol and irbesartan can increase the risk of hypotension.","Concurrent use of bisoprolol and isocarboxazid can increase the risk of hypotension.","Concurrent use of bisoprolol and isoflurane can increase the risk of hypotension.","Concurrent use of bisoprolol and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of bisoprolol and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of bisoprolol and isradipine can increase the risk of hypotension.","Both bisoprolol and ivabradine can increase the risk of bradycardia.","Concurrent use of bisoprolol and ketamine can increase the risk of hypotension.","Both bisoprolol and labetalol can increase the risk of bradycardia.","Concurrent use of bisoprolol and labetalol can increase the risk of hypotension.","Concurrent use of bisoprolol and lacidipine can increase the risk of hypotension.","Bisoprolol is predicted to increase the risk of bradycardia when given with lanreotide.","Concurrent use of bisoprolol and lercanidipine can increase the risk of hypotension.","Both bisoprolol and levobunolol can increase the risk of bradycardia.","Concurrent use of bisoprolol and levobunolol can increase the risk of hypotension.","Concurrent use of bisoprolol and levodopa can increase the risk of hypotension.","Concurrent use of bisoprolol and levomepromazine can increase the risk of hypotension.","Lidocaine is predicted to increase the risk of cardiovascular side-effects when given with bisoprolol. Manufacturer advises use with caution or avoid.","Concurrent use of bisoprolol and lisinopril can increase the risk of hypotension.","Concurrent use of bisoprolol and lofepramine can increase the risk of hypotension.","Concurrent use of bisoprolol and lofexidine can increase the risk of hypotension.","Concurrent use of bisoprolol and losartan can increase the risk of hypotension.","Concurrent use of bisoprolol and loxapine can increase the risk of hypotension.","Concurrent use of bisoprolol and lurasidone can increase the risk of hypotension.","Mefloquine is predicted to increase the risk of bradycardia when given with bisoprolol.","Both bisoprolol and methadone can increase the risk of bradycardia.","Concurrent use of bisoprolol and methyldopa can increase the risk of hypotension.","Concurrent use of bisoprolol and metolazone can increase the risk of hypotension.","Both bisoprolol and metoprolol can increase the risk of bradycardia.","Concurrent use of bisoprolol and metoprolol can increase the risk of hypotension.","Concurrent use of bisoprolol and minoxidil can increase the risk of hypotension.","Concurrent use of bisoprolol and moexipril can increase the risk of hypotension.","Concurrent use of bisoprolol and moxisylyte can increase the risk of hypotension.","Concurrent use of bisoprolol and moxonidine can increase the risk of hypotension.","Both bisoprolol and nadolol can increase the risk of bradycardia.","Concurrent use of bisoprolol and nadolol can increase the risk of hypotension.","Both bisoprolol and nebivolol can increase the risk of bradycardia.","Concurrent use of bisoprolol and nebivolol can increase the risk of hypotension.","Both bisoprolol and neostigmine can increase the risk of bradycardia.","Concurrent use of bisoprolol and nicardipine can increase the risk of hypotension.","Concurrent use of bisoprolol and nicorandil can increase the risk of hypotension.","Concurrent use of bisoprolol and nifedipine can increase the risk of hypotension.","Concurrent use of bisoprolol and nimodipine can increase the risk of hypotension.","Concurrent use of bisoprolol and nitrous oxide can increase the risk of hypotension.","Bisoprolol is predicted to increase the risk of hypertension and bradycardia when given with noradrenaline/norepinephrine.","Concurrent use of bisoprolol and nortriptyline can increase the risk of hypotension.","Concurrent use of bisoprolol and olanzapine can increase the risk of hypotension.","Concurrent use of bisoprolol and olmesartan can increase the risk of hypotension.","Both bisoprolol and oxprenolol can increase the risk of bradycardia.","Concurrent use of bisoprolol and oxprenolol can increase the risk of hypotension.","Concurrent use of bisoprolol and paliperidone can increase the risk of hypotension.","Both bisoprolol and pasireotide can increase the risk of bradycardia.","Concurrent use of bisoprolol and pergolide can increase the risk of hypotension.","Concurrent use of bisoprolol and pericyazine can increase the risk of hypotension.","Concurrent use of bisoprolol and perindopril can increase the risk of hypotension.","Concurrent use of bisoprolol and perphenazine can increase the risk of hypotension.","Concurrent use of bisoprolol and phenelzine can increase the risk of hypotension.","Phenobarbital is predicted to decrease the exposure to bisoprolol.","Concurrent use of bisoprolol and pimozide can increase the risk of hypotension.","Both bisoprolol and pindolol can increase the risk of bradycardia.","Concurrent use of bisoprolol and pindolol can increase the risk of hypotension.","Concurrent use of bisoprolol and pramipexole can increase the risk of hypotension.","Concurrent use of bisoprolol and prazosin can increase the risk of hypotension.","Primidone is predicted to decrease the exposure to bisoprolol.","Concurrent use of bisoprolol and prochlorperazine can increase the risk of hypotension.","Concurrent use of bisoprolol and promazine can increase the risk of hypotension.","Propafenone is predicted to increase the risk of cardiovascular side-effects when given with bisoprolol. Manufacturer advises use with caution or avoid.","Concurrent use of bisoprolol and propofol can increase the risk of hypotension.","Both bisoprolol and propranolol can increase the risk of bradycardia.","Concurrent use of bisoprolol and propranolol can increase the risk of hypotension.","Both bisoprolol and pyridostigmine can increase the risk of bradycardia.","Concurrent use of bisoprolol and quetiapine can increase the risk of hypotension.","Concurrent use of bisoprolol and quinagolide can increase the risk of hypotension.","Concurrent use of bisoprolol and quinapril can increase the risk of hypotension.","Concurrent use of bisoprolol and ramipril can increase the risk of hypotension.","Both bisoprolol and remifentanil can increase the risk of bradycardia.","Rifampicin slightly decreases the exposure to bisoprolol.","Concurrent use of bisoprolol and riociguat can increase the risk of hypotension.","Concurrent use of bisoprolol and risperidone can increase the risk of hypotension.","Both bisoprolol and rivastigmine can increase the risk of bradycardia.","Rivastigmine is predicted to increase the risk of bradycardia when given with bisoprolol.","Concurrent use of bisoprolol and ropinirole can increase the risk of hypotension.","Concurrent use of bisoprolol and rotigotine can increase the risk of hypotension.","Concurrent use of bisoprolol and sacubitril can increase the risk of hypotension.","Concurrent use of bisoprolol and sapropterin can increase the risk of hypotension.","Both bisoprolol and selegiline can increase the risk of bradycardia.","Concurrent use of bisoprolol and selegiline can increase the risk of hypotension.","Concurrent use of bisoprolol and sevoflurane can increase the risk of hypotension.","Concurrent use of bisoprolol and sildenafil can increase the risk of hypotension.","Concurrent use of bisoprolol and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of bisoprolol and sodium oxybate can increase the risk of hypotension.","Both bisoprolol and sotalol can increase the risk of bradycardia.","Concurrent use of bisoprolol and sotalol can increase the risk of hypotension.","Concurrent use of bisoprolol and spironolactone can increase the risk of hypotension.","Both bisoprolol and sufentanil can increase the risk of bradycardia.","Concurrent use of bisoprolol and sulpiride can increase the risk of hypotension.","Concurrent use of bisoprolol and tadalafil can increase the risk of hypotension.","Concurrent use of bisoprolol and tamsulosin can increase the risk of hypotension.","Concurrent use of bisoprolol and telmisartan can increase the risk of hypotension.","Concurrent use of bisoprolol and terazosin can increase the risk of hypotension.","Both bisoprolol and thalidomide can increase the risk of bradycardia.","Bisoprolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Concurrent use of bisoprolol and thiopental can increase the risk of hypotension.","Both bisoprolol and timolol can increase the risk of bradycardia.","Concurrent use of bisoprolol and timolol can increase the risk of hypotension.","Both bisoprolol and tizanidine can increase the risk of bradycardia.","Concurrent use of bisoprolol and tizanidine can increase the risk of hypotension.","Concurrent use of bisoprolol and torasemide can increase the risk of hypotension.","Concurrent use of bisoprolol and trandolapril can increase the risk of hypotension.","Concurrent use of bisoprolol and tranylcypromine can increase the risk of hypotension.","Concurrent use of bisoprolol and trifluoperazine can increase the risk of hypotension.","Concurrent use of bisoprolol and trimipramine can increase the risk of hypotension.","Concurrent use of bisoprolol and valsartan can increase the risk of hypotension.","Concurrent use of bisoprolol and vardenafil can increase the risk of hypotension.","Both bisoprolol and verapamil can increase the risk of bradycardia.","Concurrent use of bisoprolol and verapamil can increase the risk of hypotension.","Intravenous verapamil increases the risk of cardiovascular side-effects when given with bisoprolol. Manufacturer advises avoid.","Oral verapamil increases the risk of cardiovascular side-effects when given with bisoprolol.","Concurrent use of bisoprolol and xipamide can increase the risk of hypotension.","Concurrent use of bisoprolol and zuclopenthixol can increase the risk of hypotension."]},{"name":"BNF.Bumetanide.Bumetanide","imports":["BNF.Amiloride.Amiloride","BNF.Amiodarone.Amiodarone","BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisacodyl.Bisacodyl","BNF.Bisoprolol.Bisoprolol","BNF.Candesartan.Candesartan","BNF.Carbamazepine.Carbamazepine","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Diclofenac.Diclofenac","BNF.Digoxin.Digoxin","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Naproxen.Naproxen","BNF.Nifedipine.Nifedipine","BNF.Ondansetron.Ondansetron","BNF.Prochlorperazine.Prochlorperazine","BNF.Quinine.Quinine","BNF.Ramipril.Ramipril","BNF.Salbutamol.Salbutamol","BNF.Senna.Senna","BNF.Sertraline.Sertraline","BNF.Spironolactone.Spironolactone","BNF.Theophylline.Theophylline","BNF.Trimethoprim.Trimethoprim","BNF.Vancomycin.Vancomycin","BNF.Venlafaxine.Venlafaxine"],"interactioninfo":["Concurrent use of bumetanide and acebutolol can increase the risk of hypotension.","Concurrent use of bumetanide and aceclofenac can increase the risk of hyponatraemia.","Concurrent use of bumetanide and acemetacin can increase the risk of hyponatraemia.","Concurrent use of bumetanide and alcohol (beverage) can increase the risk of hypotension.","Concurrent use of bumetanide and alfuzosin can increase the risk of hypotension.","Concurrent use of bumetanide and aliskiren can increase the risk of hypotension.","Concurrent use of bumetanide and alprostadil can increase the risk of hypotension.","Concurrent use of bumetanide and amantadine can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with amifampridine. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and amikacin can increase the risk of ototoxicity.","Bumetanide increases the risk of nephrotoxicity when given with amikacin. Manufacturer advises avoid.","Concurrent use of bumetanide and amiloride can increase the risk of hyponatraemia.","Concurrent use of bumetanide and aminophylline can increase the risk of hypokalaemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Bumetanide is predicted to increase the risk of torsade de pointes when given with amisulpride. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and amitriptyline can increase the risk of hyponatraemia.","Concurrent use of bumetanide and amitriptyline can increase the risk of hypotension.","Concurrent use of bumetanide and amlodipine can increase the risk of hypotension.","Concurrent use of bumetanide and amphotericin can increase the risk of hypokalaemia.","Concurrent use of bumetanide and apomorphine can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with apomorphine. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and apraclonidine can increase the risk of hypotension.","Concurrent use of bumetanide and aripiprazole can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with arsenic trioxide. Manufacturer advises use with caution or avoid.","Bumetanide is predicted to increase the risk of torsade de pointes when given with artemether. Manufacturer advises use with caution or avoid.","Bumetanide is predicted to increase the risk of torsade de pointes when given with artenimol. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and asenapine can increase the risk of hypotension.","Concurrent use of bumetanide and atenolol can increase the risk of hypotension.","Concurrent use of bumetanide and avanafil can increase the risk of hypotension.","Concurrent use of bumetanide and azilsartan can increase the risk of hypotension.","Concurrent use of bumetanide and baclofen can increase the risk of hypotension.","Concurrent use of bumetanide and bambuterol can increase the risk of hypokalaemia.","Concurrent use of bumetanide and beclometasone can increase the risk of hypokalaemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with bedaquiline. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and bendroflumethiazide can increase the risk of hyponatraemia.","Concurrent use of bumetanide and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of bumetanide and bendroflumethiazide can increase the risk of hypokalaemia.","Concurrent use of bumetanide and benperidol can increase the risk of hypotension.","Concurrent use of bumetanide and betamethasone can increase the risk of hypokalaemia.","Concurrent use of bumetanide and betaxolol can increase the risk of hypotension.","Concurrent use of bumetanide and bisacodyl can increase the risk of hypokalaemia.","Concurrent use of bumetanide and bisoprolol can increase the risk of hypotension.","Concurrent use of bumetanide and bortezomib can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with bosutinib. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and brimonidine can increase the risk of hypotension.","Concurrent use of bumetanide and bromocriptine can increase the risk of hypotension.","Concurrent use of bumetanide and budesonide can increase the risk of hypokalaemia.","Concurrent use of bumetanide and cabergoline can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with cabozantinib. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and canagliflozin can increase the risk of hypotension.","Concurrent use of bumetanide and candesartan can increase the risk of hypotension.","Concurrent use of bumetanide and capreomycin can increase the risk of ototoxicity.","Concurrent use of bumetanide and captopril can increase the risk of hypotension.","Concurrent use of bumetanide and carbamazepine can increase the risk of hyponatraemia.","Concurrent use of bumetanide and carboplatin can increase the risk of ototoxicity.","Concurrent use of bumetanide and carteolol can increase the risk of hypotension.","Concurrent use of bumetanide and carvedilol can increase the risk of hypotension.","Concurrent use of bumetanide and celecoxib can increase the risk of hyponatraemia.","Concurrent use of bumetanide and celiprolol can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with ceritinib. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and chlorothiazide can increase the risk of hyponatraemia.","Concurrent use of bumetanide and chlorothiazide can increase the risk of hypotension.","Concurrent use of bumetanide and chlorothiazide can increase the risk of hypokalaemia.","Concurrent use of bumetanide and chlorpromazine can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with chlorpromazine. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and chlortalidone can increase the risk of hyponatraemia.","Concurrent use of bumetanide and chlortalidone can increase the risk of hypotension.","Concurrent use of bumetanide and chlortalidone can increase the risk of hypokalaemia.","Concurrent use of bumetanide and cisplatin can increase the risk of ototoxicity.","Concurrent use of bumetanide and citalopram can increase the risk of hyponatraemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Bumetanide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and clevidipine can increase the risk of hypotension.","Concurrent use of bumetanide and clomipramine can increase the risk of hyponatraemia.","Concurrent use of bumetanide and clomipramine can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with clomipramine. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and clonidine can increase the risk of hypotension.","Concurrent use of bumetanide and clopamide can increase the risk of hyponatraemia.","Concurrent use of bumetanide and clopamide can increase the risk of hypotension.","Concurrent use of bumetanide and clopamide can increase the risk of hypokalaemia.","Concurrent use of bumetanide and clozapine can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with crizotinib. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and cyclopenthiazide can increase the risk of hyponatraemia.","Concurrent use of bumetanide and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of bumetanide and cyclopenthiazide can increase the risk of hypokalaemia.","Concurrent use of bumetanide and dantron can increase the risk of hypokalaemia.","Concurrent use of bumetanide and dapagliflozin can increase the risk of hypotension.","Concurrent use of bumetanide and dapoxetine can increase the risk of hyponatraemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with dasatinib. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and deflazacort can increase the risk of hypokalaemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with delamanid. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and desflurane can increase the risk of hypotension.","Concurrent use of bumetanide and desmopressin can increase the risk of hyponatraemia.","Concurrent use of bumetanide and dexamethasone can increase the risk of hypokalaemia.","Concurrent use of bumetanide and dexibuprofen can increase the risk of hyponatraemia.","Concurrent use of bumetanide and dexketoprofen can increase the risk of hyponatraemia.","Concurrent use of bumetanide and diazoxide can increase the risk of hypotension.","Concurrent use of bumetanide and diclofenac can increase the risk of hyponatraemia.","Bumetanide is predicted to increase the risk of digoxin toxicity when given with digoxin.","Concurrent use of bumetanide and diltiazem can increase the risk of hypotension.","Concurrent use of bumetanide and dipyridamole can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with disopyramide. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and docusate sodium can increase the risk of hypokalaemia.","Concurrent use of bumetanide and dosulepin can increase the risk of hyponatraemia.","Concurrent use of bumetanide and dosulepin can increase the risk of hypotension.","Concurrent use of bumetanide and doxazosin can increase the risk of hypotension.","Concurrent use of bumetanide and doxepin can increase the risk of hyponatraemia.","Concurrent use of bumetanide and doxepin can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with dronedarone. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and droperidol can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with droperidol. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and duloxetine can increase the risk of hyponatraemia.","Concurrent use of bumetanide and empagliflozin can increase the risk of hypotension.","Concurrent use of bumetanide and enalapril can increase the risk of hypotension.","Concurrent use of bumetanide and eplerenone can increase the risk of hyponatraemia.","Concurrent use of bumetanide and eplerenone can increase the risk of hypotension.","Concurrent use of bumetanide and eprosartan can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with eribulin. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and escitalopram can increase the risk of hyponatraemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with escitalopram. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and esmolol can increase the risk of hypotension.","Concurrent use of bumetanide and etodolac can increase the risk of hyponatraemia.","Concurrent use of bumetanide and etomidate can increase the risk of hypotension.","Concurrent use of bumetanide and etoricoxib can increase the risk of hyponatraemia.","Concurrent use of bumetanide and felodipine can increase the risk of hypotension.","Concurrent use of bumetanide and fenoprofen can increase the risk of hyponatraemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with flecainide. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and fludrocortisone can increase the risk of hypokalaemia.","Concurrent use of bumetanide and fluoxetine can increase the risk of hyponatraemia.","Concurrent use of bumetanide and flupentixol can increase the risk of hypotension.","Concurrent use of bumetanide and fluphenazine can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with fluphenazine. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and flurbiprofen can increase the risk of hyponatraemia.","Concurrent use of bumetanide and fluvoxamine can increase the risk of hyponatraemia.","Concurrent use of bumetanide and formoterol can increase the risk of hypokalaemia.","Concurrent use of bumetanide and fosinopril can increase the risk of hypotension.","Concurrent use of bumetanide and furosemide can increase the risk of hyponatraemia.","Concurrent use of bumetanide and furosemide can increase the risk of hypotension.","Concurrent use of bumetanide and furosemide can increase the risk of ototoxicity.","Concurrent use of bumetanide and furosemide can increase the risk of hypokalaemia.","Concurrent use of bumetanide and gentamicin can increase the risk of ototoxicity.","Bumetanide increases the risk of nephrotoxicity when given with gentamicin. Manufacturer advises avoid.","Concurrent use of bumetanide and glycerol can increase the risk of hypokalaemia.","Concurrent use of bumetanide and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of bumetanide and guanethidine can increase the risk of hypotension.","Concurrent use of bumetanide and guanfacine can increase the risk of hypotension.","Concurrent use of bumetanide and haloperidol can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and histamine can increase the risk of hypotension.","Concurrent use of bumetanide and hydralazine can increase the risk of hypotension.","Concurrent use of bumetanide and hydrochlorothiazide can increase the risk of hyponatraemia.","Concurrent use of bumetanide and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of bumetanide and hydrochlorothiazide can increase the risk of hypokalaemia.","Concurrent use of bumetanide and hydrocortisone can increase the risk of hypokalaemia.","Concurrent use of bumetanide and hydroflumethiazide can increase the risk of hyponatraemia.","Concurrent use of bumetanide and hydroflumethiazide can increase the risk of hypotension.","Concurrent use of bumetanide and hydroflumethiazide can increase the risk of hypokalaemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with hydroxyzine. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and ibuprofen can increase the risk of hyponatraemia.","Concurrent use of bumetanide and imidapril can increase the risk of hypotension.","Concurrent use of bumetanide and imipramine can increase the risk of hyponatraemia.","Concurrent use of bumetanide and imipramine can increase the risk of hypotension.","Concurrent use of bumetanide and indacaterol can increase the risk of hypokalaemia.","Concurrent use of bumetanide and indapamide can increase the risk of hyponatraemia.","Concurrent use of bumetanide and indapamide can increase the risk of hypotension.","Concurrent use of bumetanide and indapamide can increase the risk of hypokalaemia.","Concurrent use of bumetanide and indometacin can increase the risk of hyponatraemia.","Concurrent use of bumetanide and indoramin can increase the risk of hypotension.","Concurrent use of bumetanide and irbesartan can increase the risk of hypotension.","Concurrent use of bumetanide and isocarboxazid can increase the risk of hypotension.","Concurrent use of bumetanide and isoflurane can increase the risk of hypotension.","Concurrent use of bumetanide and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of bumetanide and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of bumetanide and isradipine can increase the risk of hypotension.","Concurrent use of bumetanide and ketamine can increase the risk of hypotension.","Concurrent use of bumetanide and ketoprofen can increase the risk of hyponatraemia.","Concurrent use of bumetanide and ketorolac can increase the risk of hyponatraemia.","Concurrent use of bumetanide and labetalol can increase the risk of hypotension.","Concurrent use of bumetanide and lacidipine can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with lapatinib. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and lercanidipine can increase the risk of hypotension.","Concurrent use of bumetanide and levobunolol can increase the risk of hypotension.","Concurrent use of bumetanide and levodopa can increase the risk of hypotension.","Concurrent use of bumetanide and levomepromazine can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and lisinopril can increase the risk of hypotension.","Bumetanide increases the concentration of lithium. Manufacturer advises monitor and adjust dose.","Concurrent use of bumetanide and lofepramine can increase the risk of hypotension.","Concurrent use of bumetanide and lofexidine can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with lofexidine. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and losartan can increase the risk of hypotension.","Concurrent use of bumetanide and loxapine can increase the risk of hypotension.","Concurrent use of bumetanide and lurasidone can increase the risk of hypotension.","Concurrent use of bumetanide and mefenamic acid can increase the risk of hyponatraemia.","Concurrent use of bumetanide and meloxicam can increase the risk of hyponatraemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with methadone. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and methyldopa can increase the risk of hypotension.","Concurrent use of bumetanide and methylprednisolone can increase the risk of hypokalaemia.","Concurrent use of bumetanide and metolazone can increase the risk of hyponatraemia.","Concurrent use of bumetanide and metolazone can increase the risk of hypotension.","Concurrent use of bumetanide and metolazone can increase the risk of hypokalaemia.","Concurrent use of bumetanide and metoprolol can increase the risk of hypotension.","Concurrent use of bumetanide and minoxidil can increase the risk of hypotension.","Concurrent use of bumetanide and moexipril can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with moxifloxacin. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and moxisylyte can increase the risk of hypotension.","Concurrent use of bumetanide and moxonidine can increase the risk of hypotension.","Concurrent use of bumetanide and nabumetone can increase the risk of hyponatraemia.","Concurrent use of bumetanide and nadolol can increase the risk of hypotension.","Concurrent use of bumetanide and naproxen can increase the risk of hyponatraemia.","Concurrent use of bumetanide and nebivolol can increase the risk of hypotension.","Concurrent use of bumetanide and neomycin can increase the risk of ototoxicity.","Concurrent use of bumetanide and nicardipine can increase the risk of hypotension.","Concurrent use of bumetanide and nicorandil can increase the risk of hypotension.","Concurrent use of bumetanide and nifedipine can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with nilotinib. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and nimodipine can increase the risk of hypotension.","Concurrent use of bumetanide and nitrous oxide can increase the risk of hypotension.","Concurrent use of bumetanide and nortriptyline can increase the risk of hyponatraemia.","Concurrent use of bumetanide and nortriptyline can increase the risk of hypotension.","Concurrent use of bumetanide and olanzapine can increase the risk of hypotension.","Concurrent use of bumetanide and olmesartan can increase the risk of hypotension.","Concurrent use of bumetanide and olodaterol can increase the risk of hypokalaemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Bumetanide is predicted to increase the risk of torsade de pointes when given with osimertinib. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and oxaliplatin can increase the risk of ototoxicity.","Concurrent use of bumetanide and oxprenolol can increase the risk of hypotension.","Concurrent use of bumetanide and paliperidone can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with paliperidone. Manufacturer advises use with caution or avoid.","Bumetanide is predicted to increase the risk of torsade de pointes when given with panobinostat. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and parecoxib can increase the risk of hyponatraemia.","Concurrent use of bumetanide and paroxetine can increase the risk of hyponatraemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with pasireotide. Manufacturer advises use with caution or avoid.","Bumetanide is predicted to increase the risk of torsade de pointes when given with pazopanib. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and pergolide can increase the risk of hypotension.","Concurrent use of bumetanide and pericyazine can increase the risk of hypotension.","Concurrent use of bumetanide and perindopril can increase the risk of hypotension.","Concurrent use of bumetanide and perphenazine can increase the risk of hypotension.","Concurrent use of bumetanide and phenelzine can increase the risk of hypotension.","Concurrent use of bumetanide and pimozide can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with pimozide. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and pindolol can increase the risk of hypotension.","Concurrent use of bumetanide and piroxicam can increase the risk of hyponatraemia.","Concurrent use of bumetanide and pramipexole can increase the risk of hypotension.","Concurrent use of bumetanide and prazosin can increase the risk of hypotension.","Concurrent use of bumetanide and prednisolone can increase the risk of hypokalaemia.","Concurrent use of bumetanide and prednisone can increase the risk of hypokalaemia.","Concurrent use of bumetanide and prochlorperazine can increase the risk of hypotension.","Concurrent use of bumetanide and promazine can increase the risk of hypotension.","Concurrent use of bumetanide and propofol can increase the risk of hypotension.","Concurrent use of bumetanide and propranolol can increase the risk of hypotension.","Concurrent use of bumetanide and quetiapine can increase the risk of hypotension.","Concurrent use of bumetanide and quinagolide can increase the risk of hypotension.","Concurrent use of bumetanide and quinapril can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and ramipril can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with ranolazine. Manufacturer advises use with caution or avoid.","Reboxetine is predicted to increase the risk of hypokalaemia when given with bumetanide.","Concurrent use of bumetanide and riociguat can increase the risk of hypotension.","Concurrent use of bumetanide and risperidone can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with risperidone. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and ropinirole can increase the risk of hypotension.","Concurrent use of bumetanide and rotigotine can increase the risk of hypotension.","Concurrent use of bumetanide and sacubitril can increase the risk of hypotension.","Concurrent use of bumetanide and salbutamol can increase the risk of hypokalaemia.","Concurrent use of bumetanide and salmeterol can increase the risk of hypokalaemia.","Concurrent use of bumetanide and sapropterin can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with saquinavir. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and selegiline can increase the risk of hypotension.","Concurrent use of bumetanide and senna can increase the risk of hypokalaemia.","Concurrent use of bumetanide and sertraline can increase the risk of hyponatraemia.","Concurrent use of bumetanide and sevoflurane can increase the risk of hypotension.","Concurrent use of bumetanide and sildenafil can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with sildenafil. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of bumetanide and sodium oxybate can increase the risk of hypotension.","Concurrent use of bumetanide and sodium picosulfate can increase the risk of hyponatraemia.","Concurrent use of bumetanide and sodium picosulfate can increase the risk of hypokalaemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with sorafenib. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and sotalol can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with sotalol. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and spironolactone can increase the risk of hyponatraemia.","Concurrent use of bumetanide and spironolactone can increase the risk of hypotension.","Concurrent use of bumetanide and streptomycin can increase the risk of ototoxicity.","Bumetanide increases the risk of nephrotoxicity when given with streptomycin. Manufacturer advises avoid.","Concurrent use of bumetanide and sulindac can increase the risk of hyponatraemia.","Concurrent use of bumetanide and sulpiride can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with sulpiride. Manufacturer advises use with caution or avoid.","Bumetanide is predicted to increase the risk of torsade de pointes when given with sunitinib. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and tadalafil can increase the risk of hypotension.","Concurrent use of bumetanide and tamsulosin can increase the risk of hypotension.","Concurrent use of bumetanide and telavancin can increase the risk of ototoxicity.","Bumetanide is predicted to increase the risk of torsade de pointes when given with telavancin. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and telmisartan can increase the risk of hypotension.","Concurrent use of bumetanide and tenoxicam can increase the risk of hyponatraemia.","Concurrent use of bumetanide and terazosin can increase the risk of hypotension.","Concurrent use of bumetanide and terbutaline can increase the risk of hypokalaemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with tetrabenazine. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and theophylline can increase the risk of hypokalaemia.","Concurrent use of bumetanide and thiopental can increase the risk of hypotension.","Concurrent use of bumetanide and tiaprofenic acid can increase the risk of hyponatraemia.","Concurrent use of bumetanide and timolol can increase the risk of hypotension.","Concurrent use of bumetanide and tizanidine can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with tizanidine. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and tobramycin can increase the risk of ototoxicity.","Bumetanide increases the risk of nephrotoxicity when given with tobramycin. Manufacturer advises avoid.","Concurrent use of bumetanide and tolfenamic acid can increase the risk of hyponatraemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with tolterodine. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and torasemide can increase the risk of hyponatraemia.","Concurrent use of bumetanide and torasemide can increase the risk of hypotension.","Concurrent use of bumetanide and torasemide can increase the risk of ototoxicity.","Concurrent use of bumetanide and torasemide can increase the risk of hypokalaemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with toremifene. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and trandolapril can increase the risk of hypotension.","Concurrent use of bumetanide and tranylcypromine can increase the risk of hypotension.","Concurrent use of bumetanide and triamcinolone can increase the risk of hypokalaemia.","Concurrent use of bumetanide and triamterene can increase the risk of hyponatraemia.","Concurrent use of bumetanide and trifluoperazine can increase the risk of hypotension.","Concurrent use of bumetanide and trimethoprim can increase the risk of hyponatraemia.","Concurrent use of bumetanide and trimipramine can increase the risk of hyponatraemia.","Concurrent use of bumetanide and trimipramine can increase the risk of hypotension.","Concurrent use of bumetanide and valsartan can increase the risk of hypotension.","Concurrent use of bumetanide and vancomycin can increase the risk of ototoxicity.","Bumetanide is predicted to increase the risk of torsade de pointes when given with vandetanib. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and vardenafil can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with vardenafil. Manufacturer advises use with caution or avoid.","Bumetanide is predicted to increase the risk of torsade de pointes when given with vemurafenib. Manufacturer advises use with caution or avoid.","Bumetanide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and verapamil can increase the risk of hypotension.","Concurrent use of bumetanide and vilanterol can increase the risk of hypokalaemia.","Concurrent use of bumetanide and vinblastine can increase the risk of ototoxicity.","Concurrent use of bumetanide and vincristine can increase the risk of ototoxicity.","Concurrent use of bumetanide and vindesine can increase the risk of ototoxicity.","Concurrent use of bumetanide and vinflunine can increase the risk of ototoxicity.","Bumetanide is predicted to increase the risk of torsade de pointes when given with vinflunine. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and vinorelbine can increase the risk of ototoxicity.","Bumetanide is predicted to increase the risk of torsade de pointes when given with voriconazole. Manufacturer advises use with caution or avoid.","Concurrent use of bumetanide and xipamide can increase the risk of hyponatraemia.","Concurrent use of bumetanide and xipamide can increase the risk of hypotension.","Concurrent use of bumetanide and xipamide can increase the risk of hypokalaemia.","Concurrent use of bumetanide and zuclopenthixol can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with zuclopenthixol. Manufacturer advises use with caution or avoid."]},{"name":"BNF.Candesartan.Candesartan","imports":["BNF.Amiloride.Amiloride","BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Diclofenac.Diclofenac","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Enoxaparin.Enoxaparin","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Naproxen.Naproxen","BNF.Nifedipine.Nifedipine","BNF.Prochlorperazine.Prochlorperazine","BNF.Ramipril.Ramipril","BNF.Spironolactone.Spironolactone","BNF.Trimethoprim.Trimethoprim"],"interactioninfo":["Concurrent use of candesartan and acebutolol can increase the risk of hypotension.","Concurrent use of candesartan and aceclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and acemetacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and alcohol (beverage) can increase the risk of hypotension.","Concurrent use of candesartan and alfuzosin can increase the risk of first-dose hypotension.","Concurrent use of candesartan and alfuzosin can increase the risk of hypotension.","Concurrent use of candesartan and aliskiren can increase the risk of hypotension.","Concurrent use of candesartan and aliskiren can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Candesartan increases the risk of renal impairment when given with aliskiren. Manufacturer advises use with caution or avoid aliskiren in selected patients.","Concurrent use of candesartan and alprostadil can increase the risk of hypotension.","Concurrent use of candesartan and amantadine can increase the risk of hypotension.","Concurrent use of candesartan and amiloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and amitriptyline can increase the risk of hypotension.","Concurrent use of candesartan and amlodipine can increase the risk of hypotension.","Concurrent use of candesartan and apomorphine can increase the risk of hypotension.","Concurrent use of candesartan and apraclonidine can increase the risk of hypotension.","Concurrent use of candesartan and aripiprazole can increase the risk of hypotension.","Concurrent use of candesartan and asenapine can increase the risk of hypotension.","Concurrent use of candesartan and atenolol can increase the risk of hypotension.","Concurrent use of candesartan and avanafil can increase the risk of hypotension.","Concurrent use of candesartan and azilsartan can increase the risk of first-dose hypotension.","Concurrent use of candesartan and azilsartan can increase the risk of hypotension.","Concurrent use of candesartan and azilsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and baclofen can increase the risk of hypotension.","Concurrent use of candesartan and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of candesartan and benperidol can increase the risk of hypotension.","Concurrent use of candesartan and benzydamine can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and betaxolol can increase the risk of hypotension.","Concurrent use of candesartan and bisoprolol can increase the risk of hypotension.","Concurrent use of candesartan and bortezomib can increase the risk of hypotension.","Concurrent use of candesartan and brimonidine can increase the risk of hypotension.","Concurrent use of candesartan and bromfenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and bromocriptine can increase the risk of hypotension.","Concurrent use of candesartan and bumetanide can increase the risk of hypotension.","Concurrent use of candesartan and cabergoline can increase the risk of hypotension.","Concurrent use of candesartan and canagliflozin can increase the risk of hypotension.","Concurrent use of candesartan and captopril can increase the risk of first-dose hypotension.","Concurrent use of candesartan and captopril can increase the risk of hypotension.","Concurrent use of candesartan and captopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and carteolol can increase the risk of hypotension.","Concurrent use of candesartan and carvedilol can increase the risk of hypotension.","Concurrent use of candesartan and celecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and celiprolol can increase the risk of hypotension.","Concurrent use of candesartan and chlorothiazide can increase the risk of hypotension.","Concurrent use of candesartan and chlorpromazine can increase the risk of hypotension.","Concurrent use of candesartan and chlortalidone can increase the risk of hypotension.","Concurrent use of candesartan and ciclosporin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and clevidipine can increase the risk of hypotension.","Concurrent use of candesartan and clomipramine can increase the risk of hypotension.","Concurrent use of candesartan and clonidine can increase the risk of hypotension.","Concurrent use of candesartan and clopamide can increase the risk of hypotension.","Concurrent use of candesartan and clozapine can increase the risk of hypotension.","Concurrent use of candesartan and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of candesartan and dalteparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and dapagliflozin can increase the risk of hypotension.","Concurrent use of candesartan and darbepoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and desflurane can increase the risk of hypotension.","Concurrent use of candesartan and dexibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and dexketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and diazoxide can increase the risk of hypotension.","Concurrent use of candesartan and diclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and diltiazem can increase the risk of hypotension.","Concurrent use of candesartan and dipyridamole can increase the risk of hypotension.","Concurrent use of candesartan and dosulepin can increase the risk of hypotension.","Concurrent use of candesartan and doxazosin can increase the risk of first-dose hypotension.","Concurrent use of candesartan and doxazosin can increase the risk of hypotension.","Concurrent use of candesartan and doxepin can increase the risk of hypotension.","Concurrent use of candesartan and droperidol can increase the risk of hypotension.","Concurrent use of candesartan and drospirenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and empagliflozin can increase the risk of hypotension.","Concurrent use of candesartan and enalapril can increase the risk of first-dose hypotension.","Concurrent use of candesartan and enalapril can increase the risk of hypotension.","Concurrent use of candesartan and enalapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and enoxaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and eplerenone can increase the risk of hypotension.","Concurrent use of candesartan and eplerenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and epoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and epoetin beta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and epoetin zeta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and eprosartan can increase the risk of first-dose hypotension.","Concurrent use of candesartan and eprosartan can increase the risk of hypotension.","Concurrent use of candesartan and eprosartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and esmolol can increase the risk of hypotension.","Concurrent use of candesartan and etodolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and etomidate can increase the risk of hypotension.","Concurrent use of candesartan and etoricoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and felbinac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and felodipine can increase the risk of hypotension.","Concurrent use of candesartan and fenoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and flupentixol can increase the risk of hypotension.","Concurrent use of candesartan and fluphenazine can increase the risk of hypotension.","Concurrent use of candesartan and flurbiprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and fosinopril can increase the risk of first-dose hypotension.","Concurrent use of candesartan and fosinopril can increase the risk of hypotension.","Concurrent use of candesartan and furosemide can increase the risk of hypotension.","Concurrent use of candesartan and glyceryl trinitrate can increase the risk of first-dose hypotension.","Concurrent use of candesartan and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of candesartan and guanethidine can increase the risk of hypotension.","Concurrent use of candesartan and guanfacine can increase the risk of hypotension.","Concurrent use of candesartan and haloperidol can increase the risk of hypotension.","Concurrent use of candesartan and heparin (unfractionated) can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and histamine can increase the risk of hypotension.","Concurrent use of candesartan and hydralazine can increase the risk of hypotension.","Concurrent use of candesartan and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of candesartan and hydroflumethiazide can increase the risk of hypotension.","Concurrent use of candesartan and ibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and imidapril can increase the risk of first-dose hypotension.","Concurrent use of candesartan and imidapril can increase the risk of hypotension.","Concurrent use of candesartan and imidapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and imipramine can increase the risk of hypotension.","Concurrent use of candesartan and indapamide can increase the risk of hypotension.","Concurrent use of candesartan and indometacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and indoramin can increase the risk of first-dose hypotension.","Concurrent use of candesartan and indoramin can increase the risk of hypotension.","Concurrent use of candesartan and irbesartan can increase the risk of first-dose hypotension.","Concurrent use of candesartan and irbesartan can increase the risk of hypotension.","Concurrent use of candesartan and irbesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and isocarboxazid can increase the risk of hypotension.","Concurrent use of candesartan and isoflurane can increase the risk of hypotension.","Concurrent use of candesartan and isosorbide dinitrate can increase the risk of first-dose hypotension.","Concurrent use of candesartan and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of candesartan and isosorbide mononitrate can increase the risk of first-dose hypotension.","Concurrent use of candesartan and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of candesartan and isradipine can increase the risk of hypotension.","Concurrent use of candesartan and ketamine can increase the risk of hypotension.","Concurrent use of candesartan and ketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and ketorolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and labetalol can increase the risk of hypotension.","Concurrent use of candesartan and lacidipine can increase the risk of hypotension.","Concurrent use of candesartan and lercanidipine can increase the risk of hypotension.","Concurrent use of candesartan and levobunolol can increase the risk of hypotension.","Concurrent use of candesartan and levodopa can increase the risk of hypotension.","Concurrent use of candesartan and levomepromazine can increase the risk of hypotension.","Concurrent use of candesartan and lisinopril can increase the risk of first-dose hypotension.","Concurrent use of candesartan and lisinopril can increase the risk of hypotension.","Concurrent use of candesartan and lisinopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Candesartan potentially increases the concentration of lithium. Manufacturer advises monitor concentration and adjust dose.","Concurrent use of candesartan and lofepramine can increase the risk of hypotension.","Concurrent use of candesartan and lofexidine can increase the risk of hypotension.","Concurrent use of candesartan and losartan can increase the risk of first-dose hypotension.","Concurrent use of candesartan and losartan can increase the risk of hypotension.","Concurrent use of candesartan and losartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and loxapine can increase the risk of hypotension.","Concurrent use of candesartan and lurasidone can increase the risk of hypotension.","Concurrent use of candesartan and mefenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and meloxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and methyldopa can increase the risk of hypotension.","Concurrent use of candesartan and metolazone can increase the risk of hypotension.","Concurrent use of candesartan and metoprolol can increase the risk of hypotension.","Concurrent use of candesartan and minoxidil can increase the risk of hypotension.","Concurrent use of candesartan and moexipril can increase the risk of first-dose hypotension.","Concurrent use of candesartan and moexipril can increase the risk of hypotension.","Concurrent use of candesartan and moexipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and moxisylyte can increase the risk of hypotension.","Concurrent use of candesartan and moxonidine can increase the risk of hypotension.","Concurrent use of candesartan and nabumetone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and nadolol can increase the risk of hypotension.","Concurrent use of candesartan and naproxen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and nebivolol can increase the risk of hypotension.","Concurrent use of candesartan and nepafenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and nicardipine can increase the risk of hypotension.","Concurrent use of candesartan and nicorandil can increase the risk of hypotension.","Concurrent use of candesartan and nifedipine can increase the risk of hypotension.","Concurrent use of candesartan and nimodipine can increase the risk of hypotension.","Concurrent use of candesartan and nitrous oxide can increase the risk of hypotension.","Concurrent use of candesartan and nortriptyline can increase the risk of hypotension.","Concurrent use of candesartan and olanzapine can increase the risk of hypotension.","Concurrent use of candesartan and olmesartan can increase the risk of first-dose hypotension.","Concurrent use of candesartan and olmesartan can increase the risk of hypotension.","Concurrent use of candesartan and olmesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and oxprenolol can increase the risk of hypotension.","Concurrent use of candesartan and paliperidone can increase the risk of hypotension.","Concurrent use of candesartan and parecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and pergolide can increase the risk of hypotension.","Concurrent use of candesartan and pericyazine can increase the risk of hypotension.","Concurrent use of candesartan and perindopril can increase the risk of first-dose hypotension.","Concurrent use of candesartan and perindopril can increase the risk of hypotension.","Concurrent use of candesartan and perindopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and perphenazine can increase the risk of hypotension.","Concurrent use of candesartan and phenelzine can increase the risk of hypotension.","Concurrent use of candesartan and pimozide can increase the risk of hypotension.","Concurrent use of candesartan and pindolol can increase the risk of hypotension.","Concurrent use of candesartan and piroxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and potassium canrenoate can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and potassium chloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and pramipexole can increase the risk of hypotension.","Concurrent use of candesartan and prazosin can increase the risk of first-dose hypotension.","Concurrent use of candesartan and prazosin can increase the risk of hypotension.","Concurrent use of candesartan and prochlorperazine can increase the risk of hypotension.","Concurrent use of candesartan and promazine can increase the risk of hypotension.","Concurrent use of candesartan and propofol can increase the risk of hypotension.","Concurrent use of candesartan and propranolol can increase the risk of hypotension.","Concurrent use of candesartan and quetiapine can increase the risk of hypotension.","Concurrent use of candesartan and quinagolide can increase the risk of hypotension.","Concurrent use of candesartan and quinapril can increase the risk of first-dose hypotension.","Concurrent use of candesartan and quinapril can increase the risk of hypotension.","Concurrent use of candesartan and quinapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and ramipril can increase the risk of first-dose hypotension.","Concurrent use of candesartan and ramipril can increase the risk of hypotension.","Concurrent use of candesartan and ramipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and riociguat can increase the risk of hypotension.","Concurrent use of candesartan and risperidone can increase the risk of hypotension.","Concurrent use of candesartan and ropinirole can increase the risk of hypotension.","Concurrent use of candesartan and rotigotine can increase the risk of hypotension.","Concurrent use of candesartan and sacubitril can increase the risk of hypotension.","Concurrent use of candesartan and sapropterin can increase the risk of hypotension.","Concurrent use of candesartan and selegiline can increase the risk of hypotension.","Concurrent use of candesartan and sevoflurane can increase the risk of hypotension.","Concurrent use of candesartan and sildenafil can increase the risk of hypotension.","Concurrent use of candesartan and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of candesartan and sodium oxybate can increase the risk of hypotension.","Concurrent use of candesartan and sotalol can increase the risk of hypotension.","Concurrent use of candesartan and spironolactone can increase the risk of hypotension.","Concurrent use of candesartan and spironolactone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and sulindac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and sulpiride can increase the risk of hypotension.","Concurrent use of candesartan and tacrolimus can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and tadalafil can increase the risk of hypotension.","Concurrent use of candesartan and tamsulosin can increase the risk of first-dose hypotension.","Concurrent use of candesartan and tamsulosin can increase the risk of hypotension.","Concurrent use of candesartan and telmisartan can increase the risk of first-dose hypotension.","Concurrent use of candesartan and telmisartan can increase the risk of hypotension.","Concurrent use of candesartan and telmisartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and tenoxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and terazosin can increase the risk of first-dose hypotension.","Concurrent use of candesartan and terazosin can increase the risk of hypotension.","Concurrent use of candesartan and thiopental can increase the risk of hypotension.","Concurrent use of candesartan and tiaprofenic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and timolol can increase the risk of hypotension.","Concurrent use of candesartan and tinzaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and tizanidine can increase the risk of hypotension.","Concurrent use of candesartan and tolfenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and tolvaptan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and torasemide can increase the risk of hypotension.","Concurrent use of candesartan and trandolapril can increase the risk of first-dose hypotension.","Concurrent use of candesartan and trandolapril can increase the risk of hypotension.","Concurrent use of candesartan and trandolapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and tranylcypromine can increase the risk of hypotension.","Concurrent use of candesartan and triamterene can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and trifluoperazine can increase the risk of hypotension.","Concurrent use of candesartan and trimethoprim can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and trimipramine can increase the risk of hypotension.","Concurrent use of candesartan and valsartan can increase the risk of first-dose hypotension.","Concurrent use of candesartan and valsartan can increase the risk of hypotension.","Concurrent use of candesartan and valsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of candesartan and vardenafil can increase the risk of hypotension.","Concurrent use of candesartan and verapamil can increase the risk of hypotension.","Concurrent use of candesartan and xipamide can increase the risk of hypotension.","Concurrent use of candesartan and zuclopenthixol can increase the risk of hypotension."]},{"name":"BNF.Carbamazepine.Carbamazepine","imports":["BNF.Amiloride.Amiloride","BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Apixaban.Apixaban","BNF.Atorvastatin.Atorvastatin","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bumetanide.Bumetanide","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Diclofenac.Diclofenac","BNF.Diltiazem.Diltiazem","BNF.Doxycycline.Doxycycline","BNF.Fentanyl.Fentanyl","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Levothyroxine.Levothyroxine","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Naproxen.Naproxen","BNF.Nifedipine.Nifedipine","BNF.Ondansetron.Ondansetron","BNF.Oxycodone.Oxycodone","BNF.Paracetamol.Paracetamol","BNF.Phenytoin.Phenytoin","BNF.Pravastatin.Pravastatin","BNF.Rivaroxaban.Rivaroxaban","BNF.Sertraline.Sertraline","BNF.Simvastatin.Simvastatin","BNF.Spironolactone.Spironolactone","BNF.Theophylline.Theophylline","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Trimethoprim.Trimethoprim","BNF.Warfarin.Warfarin","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Carbamazepine is predicted to decrease the exposure to abacavir.","Carbamazepine is predicted to decrease the exposure to abiraterone. Manufacturer advises avoid.","Concurrent use of carbamazepine and aceclofenac can increase the risk of hyponatraemia.","Concurrent use of carbamazepine and acemetacin can increase the risk of hyponatraemia.","Carbamazepine decreases the effects of acenocoumarol. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to afatinib.","Carbamazepine decreases the concentration of albendazole.","Concurrent use of carbamazepine and alcohol (beverage) can increase the risk of hepatotoxicity.","Concurrent use of carbamazepine and alectinib can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the effects of alfacalcidol.","Carbamazepine is predicted to decrease the exposure to alfentanil.","Carbamazepine decreases the exposure to aliskiren.","Carbamazepine is predicted to decrease the exposure to alprazolam. Manufacturer advises adjust dose.","Concurrent use of carbamazepine and amiloride can increase the risk of hyponatraemia.","Concurrent use of carbamazepine and amitriptyline can increase the risk of hyponatraemia.","Carbamazepine decreases the exposure to amitriptyline. Manufacturer advises adjust dose.","Carbamazepine is predicted to decrease the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to moderately decrease the exposure to apixaban. Manufacturer advises use with caution or avoid.","Carbamazepine moderately decreases the exposure to apremilast. Manufacturer advises avoid.","Carbamazepine is predicted to markedly decrease the exposure to aprepitant. Manufacturer advises avoid.","Carbamazepine is predicted to moderately decrease the exposure to aripiprazole. Manufacturer advises adjust aripiprazole dose.","Carbamazepine is predicted to decrease the exposure to artemether (with lumafantrine). Manufacturer advises avoid.","Concurrent use of carbamazepine and asparaginase can increase the risk of hepatotoxicity.","Atazanavir is predicted to increase the exposure to carbamazepine and carbamazepine is predicted to decrease the exposure to atazanavir. Manufacturer advises monitor and adjust dose.","Concurrent use of carbamazepine and atorvastatin can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the effects of (but acute use increases the effects of) atracurium. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to avanafil. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to axitinib. Manufacturer advises avoid or adjust dose.","Carbamazepine is predicted to decrease the exposure to bazedoxifene.","Carbamazepine decreases the exposure to bedaquiline. Manufacturer advises avoid.","Concurrent use of carbamazepine and bendroflumethiazide can increase the risk of hyponatraemia.","Carbamazepine slightly decreases the exposure to bortezomib. Manufacturer advises avoid.","Carbamazepine affects the exposure to bosentan. Manufacturer advises avoid.","Carbamazepine is predicted to very markedly decrease the exposure to bosutinib. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the effects of brentuximab vedotin.","Carbamazepine decreases the concentration of brivaracetam.","Carbamazepine is predicted to decrease the exposure to budesonide. Manufacturer advises monitor and adjust dose.","Concurrent use of carbamazepine and bumetanide can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to buprenorphine. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to markedly decrease the exposure to bupropion.","Carbamazepine is predicted to decrease the exposure to buspirone. Manufacturer advises use with caution and adjust dose.","Carbamazepine is predicted to decrease the exposure to cabazitaxel. Manufacturer advises avoid.","Carbamazepine moderately decreases the exposure to cabozantinib. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the effects of calcipotriol.","Carbamazepine is predicted to decrease the effects of calcitriol.","Carbamazepine is predicted to decrease the exposure to cannabis extract. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the concentration of caspofungin. Manufacturer advises adjust caspofungin dose.","Concurrent use of carbamazepine and celecoxib can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to ceritinib. Manufacturer advises avoid.","Concurrent use of carbamazepine and chlorothiazide can increase the risk of hyponatraemia.","Concurrent use of carbamazepine and chlortalidone can increase the risk of hyponatraemia.","Carbamazepine decreases the concentration of ciclosporin.","Carbamazepine is predicted to alter the effects of cilostazol.","Cimetidine transiently increases the concentration of carbamazepine. Manufacturer advises monitor concentration and adjust dose.","Carbamazepine is predicted to decrease the effects of (but acute use increases the effects of) cisatracurium. Manufacturer advises monitor and adjust dose.","Concurrent use of carbamazepine and citalopram can increase the risk of hyponatraemia.","Clarithromycin slightly increases the concentration of carbamazepine. Manufacturer advises monitor concentration and adjust dose.","Carbamazepine decreases the exposure to clomethiazole. Manufacturer advises monitor and adjust dose.","Concurrent use of carbamazepine and clomipramine can increase the risk of hyponatraemia.","Carbamazepine decreases the exposure to clomipramine. Manufacturer advises adjust dose.","Concurrent use of carbamazepine and clopamide can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to cobicistat. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to cobimetinib. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the effects of colecalciferol.","Carbamazepine is predicted to decrease the efficacy of combined hormonal contraceptives. For FSRH guidance, see Contraceptives, interactions.","Concurrent use of carbamazepine and crisantaspase can increase the risk of hepatotoxicity.","Carbamazepine is predicted to markedly decrease the exposure to crizotinib. Manufacturer advises avoid.","Concurrent use of carbamazepine and cyclopenthiazide can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to dabigatran. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to dabrafenib. Manufacturer advises avoid.","Carbamazepine is predicted to moderately decrease the exposure to daclatasvir. Manufacturer advises avoid.","Concurrent use of carbamazepine and daclizumab can increase the risk of hepatotoxicity.","Concurrent use of carbamazepine and dactinomycin can increase the risk of hepatotoxicity.","Danazol moderately increases the concentration of carbamazepine. Manufacturer advises monitor and adjust dose.","Concurrent use of carbamazepine and dantrolene can increase the risk of hepatotoxicity.","Concurrent use of carbamazepine and dapoxetine can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to darifenacin.","Darunavir is predicted to increase the exposure to carbamazepine and carbamazepine is predicted to decrease the exposure to darunavir. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to dasabuvir. Manufacturer advises avoid.","Carbamazepine is predicted to markedly decrease the exposure to dasatinib. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to deferasirox. Manufacturer advises monitor serum ferritin and adjust dose.","Carbamazepine is predicted to slightly decrease the exposure to delamanid. Manufacturer advises avoid.","Concurrent use of carbamazepine and demeclocycline can increase the risk of hepatotoxicity.","Concurrent use of carbamazepine and desmopressin can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the efficacy of desogestrel. For FSRH guidance, see Contraceptives, interactions.","Carbamazepine is predicted to decrease the exposure to dexamethasone. Manufacturer advises monitor and adjust dose.","Concurrent use of carbamazepine and dexibuprofen can increase the risk of hyponatraemia.","Concurrent use of carbamazepine and dexketoprofen can increase the risk of hyponatraemia.","Concurrent use of carbamazepine and diclofenac can increase the risk of hyponatraemia.","Concurrent use of carbamazepine and didanosine can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the effects of dihydrotachysterol.","Carbamazepine decreases the exposure to diltiazem.","Diltiazem increases the concentration of carbamazepine. Manufacturer advises monitor concentration and adjust dose.","Carbamazepine is predicted to decrease the exposure to disopyramide. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to docetaxel.","Carbamazepine decreases the exposure to dolutegravir. Manufacturer advises adjust dose.","Carbamazepine is predicted to decrease the exposure to donepezil.","Concurrent use of carbamazepine and dosulepin can increase the risk of hyponatraemia.","Carbamazepine decreases the exposure to dosulepin. Manufacturer advises adjust dose.","Concurrent use of carbamazepine and doxepin can increase the risk of hyponatraemia.","Carbamazepine decreases the exposure to doxepin. Manufacturer advises adjust dose.","Concurrent use of carbamazepine and doxycycline can increase the risk of hepatotoxicity.","Carbamazepine decreases the exposure to doxycycline. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to dronedarone. Manufacturer advises avoid.","Concurrent use of carbamazepine and duloxetine can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to edoxaban.","Carbamazepine slightly decreases the exposure to efavirenz and efavirenz slightly decreases the exposure to carbamazepine.","Carbamazepine is predicted to decrease the exposure to elbasvir. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to eliglustat. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the concentration of elvitegravir. Manufacturer advises avoid.","Concurrent use of carbamazepine and eplerenone can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to eplerenone. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the effects of ergocalciferol.","Carbamazepine is predicted to decrease the effects of ergotamine.","Carbamazepine is predicted to decrease the exposure to erlotinib. Manufacturer advises avoid or adjust erlotinib dose.","Erythromycin markedly increases the concentration of carbamazepine. Manufacturer advises monitor concentration and adjust dose.","Concurrent use of carbamazepine and escitalopram can increase the risk of hyponatraemia.","Carbamazepine slightly decreases the exposure to eslicarbazepine. Manufacturer advises monitor and adjust dose.","Concurrent use of carbamazepine and etodolac can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the efficacy of etonogestrel. For FSRH guidance, see Contraceptives, interactions.","Carbamazepine is predicted to decrease the efficacy of etoposide.","Concurrent use of carbamazepine and etoricoxib can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to etravirine. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the concentration of everolimus. Manufacturer advises avoid or adjust dose.","Carbamazepine moderately decreases the exposure to exemestane.","Carbamazepine is predicted to decrease the exposure to felodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of carbamazepine and fenoprofen can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to fentanyl.","Carbamazepine is predicted to decrease the exposure to fesoterodine. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to fingolimod.","Concurrent use of carbamazepine and fluconazole can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the efficacy of fluconazole and fluconazole increases the concentration of carbamazepine. Manufacturer advises avoid or monitor carbamazepine concentration and adjust dose accordingly.","Concurrent use of carbamazepine and fluoxetine can increase the risk of hyponatraemia.","Concurrent use of carbamazepine and flurbiprofen can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to fluticasone.","Concurrent use of carbamazepine and fluvastatin can increase the risk of hepatotoxicity.","Concurrent use of carbamazepine and fluvoxamine can increase the risk of hyponatraemia.","Fosamprenavir is predicted to increase the exposure to carbamazepine and carbamazepine is predicted to decrease the exposure to fosamprenavir. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to fosaprepitant. Manufacturer advises avoid.","Carbamazepine affects the concentration of fosphenytoin and fosphenytoin decreases the concentration of carbamazepine. Manufacturer advises monitor and adjust dose.","Concurrent use of carbamazepine and furosemide can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to gefitinib. Manufacturer advises avoid.","Grapefruit juice slightly increases the exposure to carbamazepine. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to grazoprevir. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the concentration of guanfacine. Manufacturer advises adjust guanfacine dose.","Carbamazepine decreases the concentration of haloperidol. Manufacturer advises adjust dose.","Carbamazepine is predicted to decrease the effects of Hormone replacement therapy.","Concurrent use of carbamazepine and hydrochlorothiazide can increase the risk of hyponatraemia.","Concurrent use of carbamazepine and hydroflumethiazide can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to ibrutinib. Manufacturer advises avoid.","Concurrent use of carbamazepine and ibuprofen can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to idelalisib. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to imatinib. Manufacturer advises avoid.","Concurrent use of carbamazepine and imipramine can increase the risk of hyponatraemia.","Carbamazepine decreases the exposure to imipramine. Manufacturer advises adjust dose.","Concurrent use of carbamazepine and indapamide can increase the risk of hyponatraemia.","Indinavir is predicted to increase the exposure to carbamazepine and carbamazepine is predicted to decrease the exposure to indinavir. Manufacturer advises monitor and adjust dose.","Concurrent use of carbamazepine and indometacin can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to irinotecan. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to isavuconazole. Manufacturer advises avoid.","Concurrent use of carbamazepine and isoniazid can increase the risk of hepatotoxicity.","Isoniazid markedly increases the concentration of carbamazepine and carbamazepine increases the risk of hepatotoxicity when given with isoniazid. Manufacturer advises monitor concentration and adjust dose.","Carbamazepine decreases the exposure to isradipine. Manufacturer advises avoid.","Concurrent use of carbamazepine and itraconazole can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the efficacy of itraconazole and itraconazole increases the concentration of carbamazepine. Manufacturer advises avoid or adjust dose.","Carbamazepine is predicted to decrease the exposure to ivabradine. Manufacturer advises adjust dose.","Carbamazepine markedly decreases the exposure to ivacaftor. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to ixazomib. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the efficacy of ketoconazole and ketoconazole slightly increases the concentration of carbamazepine. Manufacturer advises avoid or monitor carbamazepine concentration and adjust dose accordingly.","Concurrent use of carbamazepine and ketoprofen can increase the risk of hyponatraemia.","Concurrent use of carbamazepine and ketorolac can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to lacidipine. Manufacturer advises monitor and adjust dose.","Lamotrigine potentially increases the concentration of carbamazepine and carbamazepine decreases the concentration of lamotrigine. Manufacturer advises adjust lamotrigine dose and monitor carbamazepine concentration.","Carbamazepine is predicted to decrease the exposure to lapatinib. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to ledipasvir. Manufacturer advises avoid.","Concurrent use of carbamazepine and leflunomide can increase the risk of hepatotoxicity.","Concurrent use of carbamazepine and lenalidomide can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the exposure to lercanidipine. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the efficacy of levonorgestrel. For FSRH guidance, see Contraceptives, interactions.","Carbamazepine is predicted to increase the risk of hypothyroidism when given with levothyroxine.","Carbamazepine is predicted to decrease the exposure to linagliptin.","Carbamazepine is predicted to increase the risk of hypothyroidism when given with liothyronine.","Carbamazepine is predicted to increase the risk of neurotoxicity when given with lithium.","Carbamazepine decreases the exposure to lofepramine. Manufacturer advises adjust dose.","Concurrent use of carbamazepine and lomitapide can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the exposure to lomitapide. Manufacturer advises monitor and adjust dose.","Lopinavir is predicted to increase the exposure to carbamazepine and carbamazepine is predicted to decrease the exposure to lopinavir. Manufacturer advises monitor and adjust dose.","Lumacaftor is predicted to decrease the exposure to carbamazepine. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to lurasidone. Manufacturer advises avoid.","Concurrent use of carbamazepine and lymecycline can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the exposure to macitentan. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to maraviroc. Manufacturer advises adjust dose.","Concurrent use of carbamazepine and mefenamic acid can increase the risk of hyponatraemia.","Concurrent use of carbamazepine and meloxicam can increase the risk of hyponatraemia.","Concurrent use of carbamazepine and mercaptopurine can increase the risk of hepatotoxicity.","Carbamazepine decreases the exposure to methadone. Manufacturer advises monitor and adjust dose.","Concurrent use of carbamazepine and methotrexate can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the exposure to methylprednisolone. Manufacturer advises monitor and adjust dose.","Concurrent use of carbamazepine and metolazone can increase the risk of hyponatraemia.","Carbamazepine markedly decreases the exposure to mianserin. Manufacturer advises adjust dose.","Concurrent use of carbamazepine and micafungin can increase the risk of hepatotoxicity.","Miconazole increases the risk of carbamazepine toxicity when given with carbamazepine. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to midazolam. Manufacturer advises monitor and adjust dose.","Concurrent use of carbamazepine and minocycline can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the exposure to mirtazapine. Manufacturer advises adjust dose.","Carbamazepine is predicted to decrease the exposure to modafinil.","Carbamazepine is predicted to decrease the exposure to montelukast.","Concurrent use of carbamazepine and nabumetone can increase the risk of hyponatraemia.","Carbamazepine is predicted to markedly decrease the exposure to naloxegol. Manufacturer advises avoid.","Concurrent use of carbamazepine and naproxen can increase the risk of hyponatraemia.","Carbamazepine is predicted to slightly decrease the exposure to nateglinide.","Carbamazepine is predicted to decrease the exposure to netupitant. Manufacturer advises avoid.","Nevirapine is predicted to decrease the concentration of carbamazepine and carbamazepine is predicted to decrease the concentration of nevirapine.","Carbamazepine is predicted to decrease the exposure to nicardipine. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to moderately decrease the exposure to nilotinib. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to nimodipine. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to nintedanib.","Carbamazepine is predicted to decrease the exposure to nitisinone. Manufacturer advises adjust dose.","Carbamazepine is predicted to decrease the efficacy of norethisterone. For FSRH guidance, see Contraceptives, interactions.","Concurrent use of carbamazepine and nortriptyline can increase the risk of hyponatraemia.","Carbamazepine decreases the exposure to nortriptyline. Manufacturer advises adjust dose.","Carbamazepine potentially decreases the exposure to olanzapine. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to olaparib. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to ombitasvir. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to ondansetron.","Carbamazepine is predicted to moderately decrease the exposure to osimertinib. Manufacturer advises avoid.","Carbamazepine slightly decreases the exposure to oxcarbazepine. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of carbamazepine and oxytetracycline can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the exposure to paclitaxel. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to palbociclib. Manufacturer advises avoid.","Carbamazepine decreases the concentration of paliperidone. Manufacturer advises adjust dose.","Carbamazepine is predicted to decrease the effects of (but acute use increases the effects of) pancuronium. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to panobinostat. Manufacturer advises avoid.","Concurrent use of carbamazepine and paracetamol can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the exposure to paracetamol.","Concurrent use of carbamazepine and parecoxib can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the effects of paricalcitol.","Carbamazepine is predicted to decrease the exposure to paritaprevir (with ritonavir and ombitasvir). Manufacturer advises avoid.","Concurrent use of carbamazepine and paroxetine can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to pazopanib. Manufacturer advises avoid.","Concurrent use of carbamazepine and pegaspargase can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the exposure to perampanel. Manufacturer advises monitor and adjust dose.","Phenobarbital affects the concentration of carbamazepine and carbamazepine increases the concentration of phenobarbital. Manufacturer advises adjust dose.","Carbamazepine affects the concentration of phenytoin and phenytoin decreases the concentration of carbamazepine. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the concentration of piperaquine. Manufacturer advises avoid.","Concurrent use of carbamazepine and piroxicam can increase the risk of hyponatraemia.","Carbamazepine is predicted to moderately decrease the exposure to pitolisant.","Carbamazepine is predicted to decrease the exposure to ponatinib. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the efficacy of posaconazole and posaconazole increases the concentration of carbamazepine. Manufacturer advises avoid.","Concurrent use of carbamazepine and pravastatin can increase the risk of hepatotoxicity.","Carbamazepine is predicted to markedly decrease the exposure to praziquantel. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to prednisolone. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to prednisone.","Carbamazepine potentially decreases the concentration of primidone and primidone potentially decreases the concentration of carbamazepine. Manufacturer advises adjust dose.","Carbamazepine is predicted to increase the risk of hypersensitivity reactions when given with procarbazine.","Carbamazepine is predicted to decrease the efficacy of propafenone.","Carbamazepine is predicted to decrease the exposure to quetiapine.","Carbamazepine is predicted to decrease the exposure to ranolazine. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to reboxetine.","Carbamazepine is predicted to decrease the exposure to regorafenib. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to repaglinide. Manufacturer advises monitor blood glucose and adjust dose.","Carbamazepine slightly increases the clearance of retigabine.","Carbamazepine markedly decreases the exposure to rilpivirine. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to risperidone. Manufacturer advises adjust dose.","Ritonavir is predicted to increase the exposure to carbamazepine and carbamazepine is predicted to decrease the exposure to ritonavir. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to moderately decrease the exposure to rivaroxaban. Manufacturer advises avoid unless patient can be monitored for signs of thrombosis.","Carbamazepine is predicted to decrease the effects of (but acute use increases the effects of) rocuronium. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to roflumilast. Manufacturer advises avoid.","Carbamazepine is predicted to markedly decrease the exposure to rolapitant. Manufacturer advises avoid.","Concurrent use of carbamazepine and rosuvastatin can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the exposure to ruxolitinib. Manufacturer advises monitor and adjust dose.","Saquinavir is predicted to increase the exposure to carbamazepine and carbamazepine is predicted to decrease the exposure to saquinavir. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to moderately decrease the exposure to saxagliptin.","Carbamazepine is predicted to decrease the exposure to the active metabolite of selexipag. Manufacturer advises adjust dose.","Concurrent use of carbamazepine and sertraline can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to sildenafil.","Carbamazepine is predicted to decrease the exposure to simeprevir. Manufacturer advises avoid.","Concurrent use of carbamazepine and simvastatin can increase the risk of hepatotoxicity.","Carbamazepine moderately decreases the exposure to simvastatin. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the concentration of sirolimus. Manufacturer advises avoid.","Concurrent use of carbamazepine and sodium picosulfate can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to sofosbuvir. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to solifenacin.","Carbamazepine is predicted to decrease the exposure to sorafenib.","Concurrent use of carbamazepine and spironolactone can increase the risk of hyponatraemia.","St John's Wort is predicted to decrease the concentration of carbamazepine. Manufacturer advises monitor and adjust dose.","Stiripentol increases the concentration of carbamazepine. Manufacturer advises avoid in Dravet syndrome.","Concurrent use of carbamazepine and sulfasalazine can increase the risk of hepatotoxicity.","Concurrent use of carbamazepine and sulindac can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to sunitinib. Manufacturer advises avoid or adjust sunitinib dose.","Carbamazepine increases the risk of prolonged neuromuscular blockade when given with suxamethonium.","Carbamazepine is predicted to decrease the effects of tacalcitol.","Carbamazepine decreases the concentration of tacrolimus. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to tadalafil. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the concentration of temsirolimus. Manufacturer advises avoid.","Concurrent use of carbamazepine and tenoxicam can increase the risk of hyponatraemia.","Concurrent use of carbamazepine and tetracycline can increase the risk of hepatotoxicity.","Carbamazepine potentially increases the clearance of theophylline and theophylline decreases the exposure to carbamazepine. Manufacturer advises adjust dose.","Carbamazepine decreases the exposure to tiagabine. Manufacturer advises monitor and adjust tiagabine dose.","Concurrent use of carbamazepine and tiaprofenic acid can increase the risk of hyponatraemia.","Carbamazepine is predicted to markedly decrease the exposure to ticagrelor. Manufacturer advises avoid.","Concurrent use of carbamazepine and tigecycline can increase the risk of hepatotoxicity.","Tipranavir is predicted to increase the exposure to carbamazepine and carbamazepine is predicted to decrease the exposure to tipranavir. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to tofacitinib. Manufacturer advises avoid.","Concurrent use of carbamazepine and tolfenamic acid can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to tolvaptan. Manufacturer advises avoid.","Topiramate increases the risk of carbamazepine toxicity when given with carbamazepine.","Concurrent use of carbamazepine and torasemide can increase the risk of hyponatraemia.","Carbamazepine is predicted to decrease the exposure to toremifene. Manufacturer advises adjust dose.","Concurrent use of carbamazepine and trabectedin can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the exposure to trabectedin. Manufacturer advises avoid.","Carbamazepine decreases the concentration of tramadol. Manufacturer advises adjust dose.","Carbamazepine is predicted to decrease the exposure to trastuzumab emtansine.","Carbamazepine decreases the concentration of trazodone. Manufacturer advises adjust dose.","Concurrent use of carbamazepine and triamterene can increase the risk of hyponatraemia.","Concurrent use of carbamazepine and trimethoprim can increase the risk of hyponatraemia.","Concurrent use of carbamazepine and trimipramine can increase the risk of hyponatraemia.","Carbamazepine decreases the exposure to trimipramine. Manufacturer advises adjust dose.","Carbamazepine decreases the efficacy of ulipristal. For FSRH guidance, see Contraceptives, interactions.","Concurrent use of carbamazepine and valproate can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the exposure to vandetanib. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to vardenafil.","Carbamazepine is predicted to decrease the effects of (but acute use increases the effects of) vecuronium. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to moderately decrease the exposure to velpatasvir. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to vemurafenib. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to venetoclax. Manufacturer advises avoid.","Verapamil increases the concentration of carbamazepine.","Carbamazepine is predicted to decrease the exposure to verapamil.","Carbamazepine is predicted to decrease the exposure to vinblastine.","Concurrent use of carbamazepine and vincristine can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the exposure to vincristine.","Carbamazepine is predicted to decrease the exposure to vindesine.","Carbamazepine is predicted to decrease the exposure to vinflunine. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the exposure to vinorelbine. Manufacturer advises use with caution or avoid.","Carbamazepine is predicted to decrease the exposure to vismodegib. Manufacturer advises avoid.","Carbamazepine is predicted to decrease the efficacy of voriconazole and voriconazole increases the concentration of carbamazepine. Manufacturer advises avoid or adjust dose.","Carbamazepine is predicted to decrease the exposure to vortioxetine. Manufacturer advises monitor and adjust dose.","Carbamazepine decreases the effects of warfarin. Manufacturer advises monitor and adjust dose.","Concurrent use of carbamazepine and xipamide can increase the risk of hyponatraemia.","Carbamazepine moderately decreases the exposure to zolpidem.","Carbamazepine slightly to moderately decreases the concentration of zonisamide and zonisamide affects the concentration of carbamazepine. Manufacturer advises monitor and adjust dose.","Carbamazepine is predicted to decrease the exposure to zopiclone. Manufacturer advises adjust dose."]},{"name":"BNF.Ceftazidime.Ceftazidime","imports":["BNF.Cefuroxime.Cefuroxime","BNF.Diclofenac.Diclofenac","BNF.Ibuprofen.Ibuprofen","BNF.Naproxen.Naproxen","BNF.Trimethoprim.Trimethoprim","BNF.Vancomycin.Vancomycin"],"interactioninfo":["Concurrent use of ceftazidime and aceclofenac can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and acemetacin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and aciclovir can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and amikacin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and amphotericin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and bacitracin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and capreomycin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and carboplatin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and cefaclor can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and cefadroxil can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and cefalexin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and cefixime can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and cefotaxime can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and cefradine can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and ceftaroline can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and ceftobiprole can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and ceftolozane can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and ceftriaxone can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and cefuroxime can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and celecoxib can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and ciclosporin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and cisplatin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and colistimethate can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and dexibuprofen can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and dexketoprofen can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and diclofenac can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and etodolac can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and etoricoxib can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and fenoprofen can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and flurbiprofen can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and foscarnet can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and ganciclovir can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and gentamicin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and ibuprofen can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and ifosfamide can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and indometacin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and ketoprofen can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and ketorolac can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and mefenamic acid can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and meloxicam can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and methotrexate can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and nabumetone can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and naproxen can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and neomycin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and oxaliplatin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and parecoxib can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and pemetrexed can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and penicillamine can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and pentamidine can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and piroxicam can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and polymyxins can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and streptomycin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and sulindac can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and tacrolimus can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and telavancin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and tenofovir can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and tenoxicam can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and tiaprofenic acid can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and tobramycin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and tolfenamic acid can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and trimethoprim can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and valaciclovir can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and valganciclovir can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and vancomycin can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and zidovudine can increase the risk of nephrotoxicity.","Concurrent use of ceftazidime and zoledronic acid can increase the risk of nephrotoxicity."]},{"name":"BNF.Cefuroxime.Cefuroxime","imports":["BNF.Ceftazidime.Ceftazidime","BNF.Diclofenac.Diclofenac","BNF.Ibuprofen.Ibuprofen","BNF.Naproxen.Naproxen","BNF.Trimethoprim.Trimethoprim","BNF.Vancomycin.Vancomycin"],"interactioninfo":["Concurrent use of cefuroxime and aceclofenac can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and acemetacin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and aciclovir can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and amikacin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and amphotericin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and bacitracin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and capreomycin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and carboplatin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and cefaclor can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and cefadroxil can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and cefalexin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and cefixime can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and cefotaxime can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and cefradine can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and ceftaroline can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and ceftazidime can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and ceftobiprole can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and ceftolozane can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and ceftriaxone can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and celecoxib can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and ciclosporin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and cisplatin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and colistimethate can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and dexibuprofen can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and dexketoprofen can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and diclofenac can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and etodolac can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and etoricoxib can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and fenoprofen can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and flurbiprofen can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and foscarnet can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and ganciclovir can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and gentamicin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and ibuprofen can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and ifosfamide can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and indometacin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and ketoprofen can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and ketorolac can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and mefenamic acid can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and meloxicam can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and methotrexate can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and nabumetone can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and naproxen can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and neomycin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and oxaliplatin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and parecoxib can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and pemetrexed can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and penicillamine can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and pentamidine can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and piroxicam can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and polymyxins can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and streptomycin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and sulindac can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and tacrolimus can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and telavancin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and tenofovir can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and tenoxicam can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and tiaprofenic acid can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and tobramycin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and tolfenamic acid can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and trimethoprim can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and valaciclovir can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and valganciclovir can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and vancomycin can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and zidovudine can increase the risk of nephrotoxicity.","Concurrent use of cefuroxime and zoledronic acid can increase the risk of nephrotoxicity."]},{"name":"BNF.Chlordiazepoxide.Chlordiazepoxide","imports":["BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Fentanyl.Fentanyl","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Oxycodone.Oxycodone","BNF.Phenytoin.Phenytoin","BNF.Prochlorperazine.Prochlorperazine","BNF.Temazepam.Temazepam","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of chlordiazepoxide and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Chlordiazepoxide affects the concentration of fosphenytoin.","Concurrent use of chlordiazepoxide and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Chlordiazepoxide affects the concentration of phenytoin.","Concurrent use of chlordiazepoxide and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Rifampicin is predicted to decrease the exposure to chlordiazepoxide.","Concurrent use of chlordiazepoxide and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of chlordiazepoxide and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Ciprofloxacin.Ciprofloxacin","imports":["BNF.Diclofenac.Diclofenac","BNF.Ibuprofen.Ibuprofen","BNF.Naproxen.Naproxen","BNF.Phenytoin.Phenytoin","BNF.Theophylline.Theophylline","BNF.Warfarin.Warfarin"],"interactioninfo":["Aceclofenac potentially increases the risk of seizures when given with ciprofloxacin.","Acemetacin potentially increases the risk of seizures when given with ciprofloxacin.","Ciprofloxacin increases the anticoagulant effect of acenocoumarol.","Ciprofloxacin is predicted to increase the exposure to agomelatine.","Aluminium hydroxide decreases the absorption of ciprofloxacin. Manufacturer advises ciprofloxacin should be taken 2 hours before or 4 hours after aluminium hydroxide.","Ciprofloxacin is predicted to increase the exposure to aminophylline. Manufacturer advises adjust dose.","Ciprofloxacin is predicted to increase the exposure to anagrelide.","Benzydamine potentially increases the risk of seizures when given with ciprofloxacin.","Bromfenac potentially increases the risk of seizures when given with ciprofloxacin.","Calcium carbonate decreases the absorption of ciprofloxacin. Manufacturer advises separate administration by 2 hours.","Celecoxib potentially increases the risk of seizures when given with ciprofloxacin.","Ciprofloxacin increases the concentration of clozapine. Manufacturer advises monitor side effects and adjust dose.","Dexibuprofen potentially increases the risk of seizures when given with ciprofloxacin.","Dexketoprofen potentially increases the risk of seizures when given with ciprofloxacin.","Diclofenac potentially increases the risk of seizures when given with ciprofloxacin.","Didanosine (buffered) is predicted to greatly decrease the exposure to oral ciprofloxacin. Manufacturer advises didanosine should be taken 2 hours after quinolones.","Ciprofloxacin is predicted to increase the exposure to duloxetine. Manufacturer advises avoid.","Ciprofloxacin is predicted to increase the exposure to eliglustat. Manufacturer advises avoid or adjust doseconsult product literature.","Enteral feeds decrease the exposure to ciprofloxacin.","Ciprofloxacin slightly increases the exposure to erlotinib. Manufacturer advises monitor side effects and adjust dose.","Etodolac potentially increases the risk of seizures when given with ciprofloxacin.","Etoricoxib potentially increases the risk of seizures when given with ciprofloxacin.","Felbinac potentially increases the risk of seizures when given with ciprofloxacin.","Fenoprofen potentially increases the risk of seizures when given with ciprofloxacin.","Ferric maltol decreases the exposure to ciprofloxacin. Manufacturer advises separate administration by at least 2 hours.","Ferrous fumarate decreases the exposure to ciprofloxacin. Manufacturer advises separate administration by at least 2 hours.","Ferrous gluconate decreases the exposure to ciprofloxacin. Manufacturer advises separate administration by at least 2 hours.","Ferrous sulfate decreases the exposure to ciprofloxacin. Manufacturer advises separate administration by at least 2 hours.","Flurbiprofen potentially increases the risk of seizures when given with ciprofloxacin.","Ciprofloxacin affects the concentration of fosphenytoin. Manufacturer advises monitor concentration and adjust dose.","Ciprofloxacin is predicted to increase the exposure to ibrutinib. Manufacturer advises avoid or adjust ibrutinib dose.","Ibuprofen potentially increases the risk of seizures when given with ciprofloxacin.","Indometacin potentially increases the risk of seizures when given with ciprofloxacin.","Ketoprofen potentially increases the risk of seizures when given with ciprofloxacin.","Ketorolac potentially increases the risk of seizures when given with ciprofloxacin.","Lanthanum moderately decreases the exposure to ciprofloxacin. Manufacturer advises ciprofloxacin should be taken 2 hours before or 4 hours after lanthanum.","Ciprofloxacin slightly increases the exposure to lidocaine.","Ciprofloxacin is predicted to increase the exposure to loxapine. Manufacturer advises avoid.","Magnesium carbonate decreases the absorption of ciprofloxacin. Manufacturer advises ciprofloxacin should be taken 2 hours before or 4 hours after magnesium carbonate.","Magnesium trisilicate decreases the absorption of ciprofloxacin. Manufacturer advises ciprofloxacin should be taken 2 hours before or 4 hours after magnesium trisilicate.","Mefenamic acid potentially increases the risk of seizures when given with ciprofloxacin.","Ciprofloxacin is predicted to increase the exposure to melatonin.","Meloxicam potentially increases the risk of seizures when given with ciprofloxacin.","Ciprofloxacin potentially increases the risk of toxicity when given with methotrexate. Manufacturer advises avoid.","Nabumetone potentially increases the risk of seizures when given with ciprofloxacin.","Naproxen potentially increases the risk of seizures when given with ciprofloxacin.","Nepafenac potentially increases the risk of seizures when given with ciprofloxacin.","Parecoxib potentially increases the risk of seizures when given with ciprofloxacin.","Ciprofloxacin very slightly increases the exposure to pentoxifylline.","Ciprofloxacin affects the concentration of phenytoin. Manufacturer advises monitor concentration and adjust dose.","Ciprofloxacin is predicted to increase the exposure to pirfenidone. Manufacturer advises use with caution and adjust dose.","Piroxicam potentially increases the risk of seizures when given with ciprofloxacin.","Polysaccharide-iron complex decreases the exposure to ciprofloxacin. Manufacturer advises separate administration by at least 2 hours.","Ciprofloxacin is predicted to increase the exposure to pomalidomide. Manufacturer advises adjust pomalidomide dose.","Ciprofloxacin slightly increases the exposure to rasagiline.","Ciprofloxacin is predicted to increase the exposure to roflumilast.","Ciprofloxacin is predicted to increase the exposure to ropinirole. Manufacturer advises adjust dose.","Sodium feredetate decreases the exposure to ciprofloxacin. Manufacturer advises separate administration by at least 2 hours.","Strontium ranelate is predicted to decrease the absorption of ciprofloxacin. Manufacturer advises avoid.","Sucralfate decreases the exposure to ciprofloxacin. Manufacturer advises separate administration by 2 hours.","Sulindac potentially increases the risk of seizures when given with ciprofloxacin.","Tenoxicam potentially increases the risk of seizures when given with ciprofloxacin.","Ciprofloxacin is predicted to increase the exposure to theophylline. Manufacturer advises monitor and adjust dose.","Tiaprofenic acid potentially increases the risk of seizures when given with ciprofloxacin.","Ciprofloxacin increases the exposure to tizanidine. Manufacturer advises avoid.","Tolfenamic acid potentially increases the risk of seizures when given with ciprofloxacin.","Ciprofloxacin increases the anticoagulant effect of warfarin.","Zinc is predicted to decrease the exposure to ciprofloxacin. Manufacturer advises separate administration by 2 hours.","Ciprofloxacin is predicted to increase the exposure to zolmitriptan. Manufacturer advises adjust zolmitriptan dose."]},{"name":"BNF.Citalopram.Citalopram","imports":["BNF.Amiloride.Amiloride","BNF.Amiodarone.Amiodarone","BNF.Amitriptyline.Amitriptyline","BNF.Apixaban.Apixaban","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisacodyl.Bisacodyl","BNF.Bumetanide.Bumetanide","BNF.Carbamazepine.Carbamazepine","BNF.Clarithromycin.Clarithromycin","BNF.Diclofenac.Diclofenac","BNF.Enoxaparin.Enoxaparin","BNF.Esomeprazole.Esomeprazole","BNF.Fentanyl.Fentanyl","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Glucose.Glucose","BNF.Haloperidol.Haloperidol","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Levomepromazine.Levomepromazine","BNF.Mirtazapine.Mirtazapine","BNF.Naproxen.Naproxen","BNF.Omeprazole.Omeprazole","BNF.Ondansetron.Ondansetron","BNF.Quinine.Quinine","BNF.Rivaroxaban.Rivaroxaban","BNF.Salbutamol.Salbutamol","BNF.Senna.Senna","BNF.Sertraline.Sertraline","BNF.Spironolactone.Spironolactone","BNF.Theophylline.Theophylline","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Trimethoprim.Trimethoprim","BNF.Venlafaxine.Venlafaxine","BNF.Warfarin.Warfarin"],"interactioninfo":["Concurrent use of citalopram and St John's Wort can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and abciximab can increase the risk of bleeding.","Concurrent use of citalopram and aceclofenac can increase the risk of hyponatraemia.","Both citalopram and aceclofenac can increase the risk of bleeding.","Concurrent use of citalopram and acemetacin can increase the risk of hyponatraemia.","Both citalopram and acemetacin can increase the risk of bleeding.","Acenocoumarol is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and almotriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Alteplase is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and amifampridine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and amiloride can increase the risk of hyponatraemia.","Aminophylline is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and amiodarone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and amisulpride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and amitriptyline can increase the risk of hyponatraemia.","Amphotericin is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and anagrelide can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and apomorphine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Argatroban is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and arsenic trioxide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and artemether prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and artenimol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and aspirin can increase the risk of bleeding.","Bambuterol is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Beclometasone is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and bedaquiline prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and bendroflumethiazide can increase the risk of hyponatraemia.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Betamethasone is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and bevacizumab can increase the risk of bleeding.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Bivalirudin is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and bosutinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Budesonide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and bumetanide can increase the risk of hyponatraemia.","Bumetanide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and bupropion can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of citalopram and buspirone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and cabozantinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and cangrelor can increase the risk of bleeding.","Concurrent use of citalopram and carbamazepine can increase the risk of hyponatraemia.","Concurrent use of citalopram and celecoxib can increase the risk of hyponatraemia.","Both citalopram and celecoxib can increase the risk of bleeding.","Both citalopram and ceritinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and chlorothiazide can increase the risk of hyponatraemia.","Chlorothiazide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and chlorpromazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and chlortalidone can increase the risk of hyponatraemia.","Chlortalidone is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and cilostazol can increase the risk of bleeding.","Cimetidine slightly increases the exposure to citalopram. Manufacturer advises adjust dose.","Both citalopram and clarithromycin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and clomipramine can increase the risk of hyponatraemia.","Concurrent use of citalopram and clomipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and clomipramine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and clopamide can increase the risk of hyponatraemia.","Clopamide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and clopidogrel can increase the risk of bleeding.","Both citalopram and crizotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and cyclopenthiazide can increase the risk of hyponatraemia.","Cyclopenthiazide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Cyproheptadine potentially decreases the effects of citalopram.","Dabigatran is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Dalteparin is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Danaparoid is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Dantron is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and dapoxetine can increase the risk of hyponatraemia.","Concurrent use of citalopram and dapoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and dapoxetine can increase the risk of bleeding.","Both citalopram and dasatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and dasatinib can increase the risk of bleeding.","Deflazacort is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and delamanid prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and desmopressin can increase the risk of hyponatraemia.","Dexamethasone is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and dexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of citalopram and dexibuprofen can increase the risk of hyponatraemia.","Both citalopram and dexibuprofen can increase the risk of bleeding.","Concurrent use of citalopram and dexketoprofen can increase the risk of hyponatraemia.","Both citalopram and dexketoprofen can increase the risk of bleeding.","Concurrent use of citalopram and diclofenac can increase the risk of hyponatraemia.","Both citalopram and diclofenac can increase the risk of bleeding.","Both citalopram and dipyridamole can increase the risk of bleeding.","Both citalopram and disopyramide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Docusate sodium is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Domperidone increases the risk of QT-prolongation when given with citalopram. Manufacturer advises avoid.","Concurrent use of citalopram and dosulepin can increase the risk of hyponatraemia.","Concurrent use of citalopram and doxepin can increase the risk of hyponatraemia.","Both citalopram and dronedarone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Dronedarone is predicted to increase the exposure to citalopram.","Both citalopram and droperidol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and duloxetine can increase the risk of hyponatraemia.","Concurrent use of citalopram and duloxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and duloxetine can increase the risk of bleeding.","Edoxaban is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and eletriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Enoxaparin is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and eplerenone can increase the risk of hyponatraemia.","Both citalopram and epoprostenol can increase the risk of bleeding.","Both citalopram and eptifibatide can increase the risk of bleeding.","Both citalopram and eribulin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Intravenous erythromycin increases the risk of QT-prolongation when given with citalopram. Manufacturer advises avoid or monitor.","Concurrent use of citalopram and escitalopram can increase the risk of hyponatraemia.","Concurrent use of citalopram and escitalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and escitalopram prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and escitalopram can increase the risk of bleeding.","Esomeprazole is predicted to slightly to moderately increase the exposure to citalopram. Manufacturer advises monitor and adjust dose.","Concurrent use of citalopram and etodolac can increase the risk of hyponatraemia.","Both citalopram and etodolac can increase the risk of bleeding.","Concurrent use of citalopram and etoricoxib can increase the risk of hyponatraemia.","Both citalopram and etoricoxib can increase the risk of bleeding.","Concurrent use of citalopram and fenoprofen can increase the risk of hyponatraemia.","Both citalopram and fenoprofen can increase the risk of bleeding.","Concurrent use of citalopram and fentanyl can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fingolimod increases the risk of QT-prolongation when given with citalopram. Manufacturer advises avoid.","Both citalopram and flecainide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Fludrocortisone is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and fluoxetine can increase the risk of hyponatraemia.","Concurrent use of citalopram and fluoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and fluoxetine can increase the risk of bleeding.","Both citalopram and fluphenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and flurbiprofen can increase the risk of hyponatraemia.","Both citalopram and flurbiprofen can increase the risk of bleeding.","Concurrent use of citalopram and fluvoxamine can increase the risk of hyponatraemia.","Concurrent use of citalopram and fluvoxamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and fluvoxamine can increase the risk of bleeding.","Fondaparinux is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Formoterol is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and frovatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of citalopram and furosemide can increase the risk of hyponatraemia.","Furosemide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Glycerol is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and granisetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Granisetron is predicted to increase the risk of QT-prolongation when given with citalopram.","Both citalopram and haloperidol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Heparin (unfractionated) is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and hydrochlorothiazide can increase the risk of hyponatraemia.","Hydrochlorothiazide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Hydrocortisone is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and hydroflumethiazide can increase the risk of hyponatraemia.","Hydroflumethiazide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and hydroxyzine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and ibrutinib can increase the risk of bleeding.","Concurrent use of citalopram and ibuprofen can increase the risk of hyponatraemia.","Both citalopram and ibuprofen can increase the risk of bleeding.","Both citalopram and iloprost can increase the risk of bleeding.","Concurrent use of citalopram and imipramine can increase the risk of hyponatraemia.","Concurrent use of citalopram and imipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Indacaterol is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and indapamide can increase the risk of hyponatraemia.","Indapamide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and indometacin can increase the risk of hyponatraemia.","Both citalopram and indometacin can increase the risk of bleeding.","Concurrent use of citalopram and isocarboxazid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Ivabradine is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises avoid.","Concurrent use of citalopram and ketoprofen can increase the risk of hyponatraemia.","Both citalopram and ketoprofen can increase the risk of bleeding.","Concurrent use of citalopram and ketorolac can increase the risk of hyponatraemia.","Both citalopram and ketorolac can increase the risk of bleeding.","Both citalopram and lapatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and levomepromazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and linezolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of citalopram and lisdexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of citalopram and lithium can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and lithium prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and lofexidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Lumacaftor is predicted to decrease the exposure to citalopram. Manufacturer advises adjust dose.","Concurrent use of citalopram and mefenamic acid can increase the risk of hyponatraemia.","Both citalopram and mefenamic acid can increase the risk of bleeding.","Mefloquine is predicted to increase the risk of QT-prolongation when given with citalopram.","Concurrent use of citalopram and meloxicam can increase the risk of hyponatraemia.","Both citalopram and meloxicam can increase the risk of bleeding.","Concurrent use of citalopram and methadone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and methadone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Methylprednisolone is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and methylthioninium chloride can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of citalopram and metolazone can increase the risk of hyponatraemia.","Metolazone is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and mianserin can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of citalopram and mirtazapine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Citalopram potentially increases the risk of prolonged neuromuscular blockade when given with mivacurium.","Mizolastine is predicted to increase the risk of QT-prolongation when given with citalopram. Manufacturer advises avoid.","Concurrent use of citalopram and moclobemide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and moxifloxacin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and nabumetone can increase the risk of hyponatraemia.","Both citalopram and nabumetone can increase the risk of bleeding.","Concurrent use of citalopram and naproxen can increase the risk of hyponatraemia.","Both citalopram and naproxen can increase the risk of bleeding.","Concurrent use of citalopram and naratriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Nicotinic acid is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and nilotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and nortriptyline can increase the risk of hyponatraemia.","Olodaterol is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Omega-3-acid ethyl esters is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Omeprazole slightly to moderately increases the exposure to citalopram. Manufacturer advises monitor and adjust dose.","Concurrent use of citalopram and ondansetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and ondansetron prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and osimertinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and paliperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and palonosetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Palonosetron is predicted to increase the risk of QT-prolongation when given with citalopram.","Both citalopram and panobinostat prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and parecoxib can increase the risk of hyponatraemia.","Both citalopram and parecoxib can increase the risk of bleeding.","Concurrent use of citalopram and paroxetine can increase the risk of hyponatraemia.","Concurrent use of citalopram and paroxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and paroxetine can increase the risk of bleeding.","Both citalopram and pasireotide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and pazopanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Intravenous pentamidine potentially increases the risk of QT-prolongation when given with citalopram.","Concurrent use of citalopram and pentazocine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of citalopram and pethidine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of citalopram and phenelzine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Phenindione is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and pimozide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and piroxicam can increase the risk of hyponatraemia.","Both citalopram and piroxicam can increase the risk of bleeding.","Both citalopram and prasugrel can increase the risk of bleeding.","Prednisolone is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Prednisone is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and procarbazine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and quinine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and ranolazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and rasagiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and regorafenib can increase the risk of bleeding.","Reteplase is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and risperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Rivaroxaban is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and rizatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of citalopram and safinamide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Salbutamol is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Salmeterol is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and saquinavir prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and selegiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Senna is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and sertraline can increase the risk of hyponatraemia.","Concurrent use of citalopram and sertraline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and sertraline can increase the risk of bleeding.","Both citalopram and sildenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and sodium picosulfate can increase the risk of hyponatraemia.","Sodium picosulfate is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and sorafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and sotalol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and spironolactone can increase the risk of hyponatraemia.","Streptokinase is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and sulfinpyrazone can increase the risk of bleeding.","Concurrent use of citalopram and sulindac can increase the risk of hyponatraemia.","Both citalopram and sulindac can increase the risk of bleeding.","Both citalopram and sulpiride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and sumatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and sunitinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Citalopram potentially increases the risk of prolonged neuromuscular blockade when given with suxamethonium.","Concurrent use of citalopram and tapentadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of citalopram and tedizolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and telavancin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Tenecteplase is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and tenoxicam can increase the risk of hyponatraemia.","Both citalopram and tenoxicam can increase the risk of bleeding.","Terbinafine is predicted to increase the exposure to citalopram.","Terbutaline is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and tetrabenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Theophylline is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and tiaprofenic acid can increase the risk of hyponatraemia.","Both citalopram and tiaprofenic acid can increase the risk of bleeding.","Both citalopram and ticagrelor can increase the risk of bleeding.","Tinzaparin is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and tirofiban can increase the risk of bleeding.","Both citalopram and tizanidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and tolfenamic acid can increase the risk of hyponatraemia.","Both citalopram and tolfenamic acid can increase the risk of bleeding.","Both citalopram and tolterodine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and torasemide can increase the risk of hyponatraemia.","Torasemide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and toremifene prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and tramadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of citalopram and tranylcypromine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and trastuzumab can increase the risk of bleeding.","Both citalopram and trastuzumab emtansine can increase the risk of bleeding.","Concurrent use of citalopram and trazodone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Triamcinolone is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and triamterene can increase the risk of hyponatraemia.","Concurrent use of citalopram and trimethoprim can increase the risk of hyponatraemia.","Concurrent use of citalopram and trimipramine can increase the risk of hyponatraemia.","Urokinase is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and vandetanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and vardenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and vemurafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of citalopram and venlafaxine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and venlafaxine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and venlafaxine can increase the risk of bleeding.","Vilanterol is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Both citalopram and vinflunine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both citalopram and voriconazole prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Voriconazole is predicted to increase the exposure to citalopram.","Concurrent use of citalopram and vortioxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and vortioxetine can increase the risk of bleeding.","Warfarin is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and xipamide can increase the risk of hyponatraemia.","Xipamide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Concurrent use of citalopram and zolmitriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both citalopram and zuclopenthixol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation."]},{"name":"BNF.Clarithromycin.Clarithromycin","imports":["BNF.Amiodarone.Amiodarone","BNF.Amlodipine.Amlodipine","BNF.Apixaban.Apixaban","BNF.Atorvastatin.Atorvastatin","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisacodyl.Bisacodyl","BNF.Bumetanide.Bumetanide","BNF.Carbamazepine.Carbamazepine","BNF.Citalopram.Citalopram","BNF.Digoxin.Digoxin","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Fentanyl.Fentanyl","BNF.Furosemide.Furosemide","BNF.Gliclazide.Gliclazide","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Levomepromazine.Levomepromazine","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Nifedipine.Nifedipine","BNF.Ondansetron.Ondansetron","BNF.Oxycodone.Oxycodone","BNF.Pravastatin.Pravastatin","BNF.Quinine.Quinine","BNF.Salbutamol.Salbutamol","BNF.Senna.Senna","BNF.Simvastatin.Simvastatin","BNF.Theophylline.Theophylline","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Warfarin.Warfarin","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Clarithromycin is predicted to increase the exposure to abiraterone.","Clarithromycin increases the anticoagulant effect of acenocoumarol. Manufacturer advises monitor INR and adjust dose.","Clarithromycin is predicted to increase the exposure to afatinib. Manufacturer advises separate administration by 12 hours.","Clarithromycin is predicted to increase the exposure to alfentanil. Manufacturer advises monitor and adjust dose.","Clarithromycin is predicted to moderately increase the exposure to alfuzosin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to aliskiren.","Clarithromycin is predicted to increase the exposure to alitretinoin. Manufacturer advises adjust alitretinoin dose.","Clarithromycin increases the exposure to almotriptan.","Clarithromycin moderately increases the exposure to alprazolam. Manufacturer advises avoid.","Both clarithromycin and amifampridine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Aminophylline is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to aminophylline. Manufacturer advises adjust dose.","Both clarithromycin and amiodarone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both clarithromycin and amisulpride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Amphotericin is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to apixaban. Manufacturer advises avoid.","Both clarithromycin and apomorphine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to markedly increase the exposure to aprepitant.","Clarithromycin is predicted to slightly increase the exposure to aripiprazole. Manufacturer advises adjust aripiprazole dose.","Both clarithromycin and arsenic trioxide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both clarithromycin and artemether prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to artemether (with lumafantrine).","Both clarithromycin and artenimol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Atazanavir is predicted to increase the exposure to clarithromycin. Manufacturer advises adjust dose in renal impairment.","Clarithromycin is predicted to increase the exposure to atorvastatin. Manufacturer advises avoid or adjust dose and monitor rhabdomyolysis.","Clarithromycin is predicted to increase the exposure to avanafil. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to axitinib. Manufacturer advises avoid or adjust dose.","Bambuterol is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Beclometasone is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Both clarithromycin and bedaquiline prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to bedaquiline. Manufacturer advises avoid prolonged use.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Betamethasone is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin slightly increases the exposure to bortezomib.","Clarithromycin is predicted to increase the exposure to bosentan.","Both clarithromycin and bosutinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to markedly increase the exposure to bosutinib. Manufacturer advises avoid or adjust dose.","Clarithromycin increases the risk of neutropenia when given with brentuximab vedotin. Manufacturer advises monitor and adjust dose.","Clarithromycin increases the exposure to bromocriptine.","Budesonide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to budesonide. Manufacturer advises avoid.","Bumetanide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to buprenorphine. Manufacturer advises monitor and adjust dose.","Clarithromycin is predicted to increase the exposure to buspirone. Manufacturer advises adjust buspirone dose.","Clarithromycin is predicted to increase the exposure to cabazitaxel. Manufacturer advises avoid.","Clarithromycin increases the exposure to cabergoline.","Both clarithromycin and cabozantinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin slightly increases the exposure to cabozantinib.","Clarithromycin is predicted to increase the exposure to cannabis extract. Manufacturer advises use with caution and adjust dose.","Clarithromycin slightly increases the concentration of carbamazepine. Manufacturer advises monitor concentration and adjust dose.","Both clarithromycin and ceritinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to ceritinib. Manufacturer advises avoid or adjust ceritinib dose.","Chlorothiazide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Both clarithromycin and chlorpromazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Chlortalidone is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to ciclesonide. Manufacturer advises avoid.","Clarithromycin increases the concentration of ciclosporin.","Clarithromycin is predicted to moderately increase the exposure to cilostazol. Manufacturer advises adjust cilostazol dose.","Clarithromycin is predicted to moderately increase the exposure to cinacalcet. Manufacturer advises adjust dose.","Both clarithromycin and citalopram prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both clarithromycin and clomipramine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clopamide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to markedly increase the exposure to cobimetinib. Manufacturer advises avoid or monitor for toxicity.","Clarithromycin is predicted to increase the exposure to colchicine. Manufacturer advises avoid or adjust colchicine dose.","Both clarithromycin and crizotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to moderately increase the exposure to crizotinib. Manufacturer advises avoid.","Cyclopenthiazide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to dabigatran.","Clarithromycin is predicted to increase the exposure to dabrafenib. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to moderately increase the exposure to daclatasvir. Manufacturer advises adjust daclatasvir dose.","Dantron is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to moderately increase the exposure to dapoxetine. Manufacturer advises avoid or adjust dapoxetine dose.","Clarithromycin is predicted to markedly to very markedly increase the exposure to darifenacin. Manufacturer advises avoid.","Darunavir (boosted with ritonavir) is predicted to increase the exposure to clarithromycin. Manufacturer advises adjust dose in renal impairment.","Both clarithromycin and dasatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to markedly increase the exposure to dasatinib. Manufacturer advises avoid.","Deflazacort is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Both clarithromycin and delamanid prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin very slightly increases the exposure to delamanid.","Dexamethasone is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to dexamethasone. Manufacturer advises monitor and adjust dose.","Clarithromycin increases the concentration of digoxin.","Clarithromycin is predicted to increase the exposure to diltiazem.","Both clarithromycin and disopyramide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to moderately increase the exposure to docetaxel. Manufacturer advises avoid or adjust dose.","Docusate sodium is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Domperidone increases the risk of QT-prolongation when given with clarithromycin. Manufacturer advises avoid.","Clarithromycin increases the risk of QT-prolongation when given with domperidone. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to doxazosin.","Both clarithromycin and dronedarone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin very markedly increases the exposure to dronedarone. Manufacturer advises avoid.","Both clarithromycin and droperidol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to dutasteride. Manufacturer advises monitor side effects and adjust dose.","Clarithromycin is predicted to slightly increase the exposure to edoxaban.","Efavirenz decreases the exposure to clarithromycin.","Clarithromycin slightly to moderately increases the exposure to elbasvir. Manufacturer advises avoid.","Clarithromycin is predicted to markedly increase the exposure to eletriptan. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to eliglustat. Manufacturer advises avoid or adjust doseconsult product literature.","Clarithromycin is predicted to markedly increase the exposure to eplerenone. Manufacturer advises avoid.","Clarithromycin is predicted to increase the risk of ergotism when given with ergometrine. Manufacturer advises avoid.","Clarithromycin is predicted to increase the risk of ergotism when given with ergotamine. Manufacturer advises avoid.","Both clarithromycin and eribulin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to slightly increase the exposure to erlotinib. Manufacturer advises use with caution and adjust dose.","Intravenous erythromycin increases the risk of QT-prolongation when given with clarithromycin. Manufacturer advises avoid or monitor.","Both clarithromycin and escitalopram prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Etravirine decreases the exposure to clarithromycin.","Clarithromycin is predicted to increase the concentration of everolimus. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to felodipine. Manufacturer advises monitor and adjust dose.","Clarithromycin is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Clarithromycin is predicted to moderately increase the exposure to fesoterodine. Manufacturer advises adjust fesoterodine dose; avoid in hepatic and renal impairment.","Clarithromycin is predicted to increase the exposure to fidaxomicin. Manufacturer advises avoid.","Fingolimod increases the risk of QT-prolongation when given with clarithromycin. Manufacturer advises avoid.","Both clarithromycin and flecainide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Fludrocortisone is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Both clarithromycin and fluphenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to inhaled fluticasone.","Formoterol is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Fosamprenavir (boosted with ritonavir) is predicted to increase the exposure to clarithromycin. Manufacturer advises adjust dose in renal impairment.","Clarithromycin is predicted to increase the exposure to fosaprepitant.","Furosemide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to galantamine. Manufacturer advises monitor and adjust dose.","Clarithromycin is predicted to increase the exposure to gefitinib.","Clarithromycin is predicted to slightly increase the exposure to glibenclamide.","Clarithromycin is predicted to slightly increase the exposure to gliclazide.","Clarithromycin is predicted to slightly increase the exposure to glimepiride.","Clarithromycin is predicted to slightly increase the exposure to glipizide.","Glycerol is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Granisetron is predicted to increase the risk of QT-prolongation when given with clarithromycin.","Clarithromycin is predicted to moderately to markedly increase the exposure to grazoprevir. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to guanfacine. Manufacturer advises adjust guanfacine dose.","Both clarithromycin and haloperidol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Hydrochlorothiazide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Hydrocortisone is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Hydroflumethiazide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Both clarithromycin and hydroxyzine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to very markedly increase the exposure to ibrutinib. Manufacturer advises avoid or adjust ibrutinib dose.","Clarithromycin is predicted to increase the exposure to imatinib.","Indacaterol is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Indinavir (boosted with ritonavir) is predicted to increase the exposure to clarithromycin. Manufacturer advises adjust dose in renal impairment.","Clarithromycin is predicted to increase the risk of toxicity when given with irinotecan. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to isavuconazole. Manufacturer advises avoid or monitor side effects.","Clarithromycin is predicted to increase the exposure to isradipine. Manufacturer advises monitor and adjust dose.","Ivabradine is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to ivabradine. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to ivacaftor. Manufacturer advises adjust ivacaftor or lumacaftor with ivacaftor dose.","Clarithromycin is predicted to increase the exposure to lacidipine. Manufacturer advises monitor and adjust dose.","Both clarithromycin and lapatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to lapatinib. Manufacturer advises avoid.","Clarithromycin is predicted to markedly increase the exposure to lercanidipine. Manufacturer advises avoid.","Both clarithromycin and levomepromazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to lidocaine.","Both clarithromycin and lithium prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both clarithromycin and lofexidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to markedly increase the exposure to lomitapide. Manufacturer advises avoid.","Lopinavir (boosted with ritonavir) is predicted to increase the exposure to clarithromycin. Manufacturer advises adjust dose in renal impairment.","Lumacaftor is predicted to decrease the exposure to clarithromycin.","Clarithromycin is predicted to increase the exposure to lurasidone. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to macitentan.","Clarithromycin is predicted to markedly increase the exposure to maraviroc. Manufacturer advises adjust dose.","Mefloquine is predicted to increase the risk of QT-prolongation when given with clarithromycin.","Both clarithromycin and methadone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to methadone.","Methylprednisolone is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to methylprednisolone. Manufacturer advises monitor and adjust dose.","Metolazone is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to markedly to very markedly increase the exposure to midazolam. Manufacturer advises avoid or adjust dose.","Clarithromycin is predicted to increase the exposure to mirabegron. Manufacturer advises adjust mirabegron dose in hepatic and renal impairment.","Clarithromycin is predicted to increase the exposure to mirtazapine.","Mizolastine is predicted to increase the risk of QT-prolongation when given with clarithromycin. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to mizolastine. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to modafinil.","Clarithromycin is predicted to increase the exposure to mometasone.","Both clarithromycin and moxifloxacin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to nadolol.","Clarithromycin is predicted to markedly increase the exposure to naloxegol. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to netupitant.","Nevirapine decreases the exposure to clarithromycin.","Clarithromycin is predicted to increase the exposure to nicardipine. Manufacturer advises monitor and adjust dose.","Clarithromycin is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Both clarithromycin and nilotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to moderately increase the exposure to nilotinib. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to nimodipine. Manufacturer advises monitor and adjust dose.","Clarithromycin is predicted to increase the exposure to nintedanib.","Clarithromycin is predicted to increase the exposure to nitisinone. Manufacturer advises adjust dose.","Clarithromycin is predicted to increase the exposure to olaparib. Manufacturer advises avoid or adjust olaparib dose.","Olodaterol is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Both clarithromycin and ondansetron prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both clarithromycin and osimertinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to oxybutynin.","Clarithromycin is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Clarithromycin is predicted to increase the exposure to paclitaxel.","Clarithromycin is predicted to increase the exposure to palbociclib. Manufacturer advises avoid or adjust palbociclib dose.","Both clarithromycin and paliperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Palonosetron is predicted to increase the risk of QT-prolongation when given with clarithromycin.","Both clarithromycin and panobinostat prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to panobinostat. Manufacturer advises adjust panobinostat dose; in hepatic impairment avoid.","Clarithromycin is predicted to increase the exposure to paricalcitol.","Clarithromycin is predicted to increase the exposure to paritaprevir (with ritonavir and ombitasvir). Manufacturer advises avoid.","Both clarithromycin and pasireotide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both clarithromycin and pazopanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to pazopanib. Manufacturer advises avoid or adjust pazopanib dose.","Intravenous pentamidine potentially increases the risk of QT-prolongation when given with clarithromycin.","Clarithromycin is predicted to slightly increase the exposure to perampanel.","Both clarithromycin and pimozide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to pimozide. Manufacturer advises avoid.","Clarithromycin is predicted to increase the concentration of piperaquine.","Clarithromycin is predicted to slightly increase the exposure to ponatinib. Manufacturer advises monitor and adjust ponatinib dose.","Clarithromycin moderately increases the exposure to pravastatin.","Clarithromycin is predicted to moderately increase the exposure to praziquantel.","Prednisolone is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Prednisone is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to propafenone. Manufacturer advises monitor and adjust dose.","Clarithromycin is predicted to increase the exposure to quetiapine. Manufacturer advises avoid.","Both clarithromycin and quinine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both clarithromycin and ranolazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to ranolazine. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to reboxetine. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to regorafenib. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to repaglinide.","Clarithromycin increases the risk of uveitis when given with rifabutin. Manufacturer advises adjust dose.","Rifampicin decreases the concentration of clarithromycin.","Both clarithromycin and risperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to risperidone. Manufacturer advises adjust dose.","Ritonavir increases the exposure to clarithromycin. Manufacturer advises adjust dose in renal impairment.","Clarithromycin is predicted to increase the exposure to rupatadine. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to ruxolitinib. Manufacturer advises adjust dose and monitor side effects.","Salbutamol is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to salmeterol. Manufacturer advises avoid.","Salmeterol is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Both clarithromycin and saquinavir prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin increases the exposure to saquinavir and saquinavir increases the exposure to clarithromycin. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to saxagliptin.","Senna is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Both clarithromycin and sildenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to sildenafil. Manufacturer advises avoid or adjust sildenafil dose.","Clarithromycin is predicted to increase the exposure to simeprevir. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to simvastatin. Manufacturer advises avoid.","Clarithromycin is predicted to increase the concentration of sirolimus. Manufacturer advises avoid.","Sodium picosulfate is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to solifenacin. Manufacturer advises adjust solifenacin or tamsulosin with solifenacin dose; avoid in hepatic and renal impairment.","Both clarithromycin and sorafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both clarithromycin and sotalol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to sufentanil. Manufacturer advises monitor and adjust dose.","Both clarithromycin and sulpiride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both clarithromycin and sunitinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to slightly increase the exposure to sunitinib. Manufacturer advises avoid or adjust sunitinib dose.","Clarithromycin is predicted to increase the concentration of tacrolimus. Manufacturer advises monitor and adjust dose.","Clarithromycin is predicted to increase the exposure to tadalafil. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to moderately increase the exposure to tamsulosin. Manufacturer advises use with caution or avoid.","Both clarithromycin and telavancin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the concentration of temsirolimus. Manufacturer advises avoid.","Terbutaline is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Both clarithromycin and tetrabenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Theophylline is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to theophylline. Manufacturer advises adjust dose.","Clarithromycin is predicted to markedly increase the exposure to ticagrelor. Manufacturer advises avoid.","Tipranavir (boosted with ritonavir) increases the exposure to clarithromycin and clarithromycin increases the exposure to tipranavir (boosted with ritonavir). Manufacturer advises monitor; adjust dose in renal impairment.","Both clarithromycin and tizanidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to tofacitinib. Manufacturer advises adjust tofacitinib dose.","Clarithromycin is predicted to slightly increase the exposure to tolbutamide.","Both clarithromycin and tolterodine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to tolterodine. Manufacturer advises avoid.","Clarithromycin is predicted to increase the exposure to tolvaptan. Manufacturer advises adjust dose.","Clarithromycin is predicted to increase the exposure to topotecan.","Torasemide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Both clarithromycin and toremifene prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to toremifene.","Clarithromycin is predicted to increase the exposure to trabectedin. Manufacturer advises avoid or adjust dose.","Clarithromycin is predicted to increase the concentration of trametinib.","Clarithromycin is predicted to increase the exposure to trastuzumab emtansine. Manufacturer advises avoid.","Clarithromycin is predicted to moderately increase the exposure to trazodone. Manufacturer advises avoid or adjust dose.","Triamcinolone is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the risk of side-effects when given with triamcinolone.","Clarithromycin is predicted to increase the exposure to ulipristal. Manufacturer advises avoid if used for uterine fibroids.","Both clarithromycin and vandetanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both clarithromycin and vardenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to vardenafil. Manufacturer advises avoid.","Both clarithromycin and vemurafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to vemurafenib.","Clarithromycin is predicted to increase the exposure to venetoclax. Manufacturer advises avoid or adjust venetoclax dose.","Both clarithromycin and venlafaxine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to venlafaxine.","Clarithromycin is predicted to increase the exposure to verapamil.","Vilanterol is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to vinblastine.","Clarithromycin is predicted to increase the exposure to vincristine.","Clarithromycin is predicted to increase the exposure to vindesine.","Both clarithromycin and vinflunine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to vinflunine.","Clarithromycin is predicted to increase the exposure to vinorelbine.","Both clarithromycin and voriconazole prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin increases the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Xipamide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin decreases the absorption of zidovudine. Manufacturer advises separate administration by at least 2 hours.","Clarithromycin is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Both clarithromycin and zuclopenthixol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation."]},{"name":"BNF.Clindamycin.Clindamycin","imports":[""],"interactioninfo":["Clindamycin increases the effects of atracurium.","Clindamycin increases the effects of cisatracurium.","Clindamycin increases the effects of mivacurium.","Clindamycin increases the effects of pancuronium.","Clindamycin increases the effects of rocuronium.","Clindamycin increases the effects of suxamethonium.","Clindamycin increases the effects of vecuronium."]},{"name":"BNF.Clonazepam.Clonazepam","imports":["BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Fentanyl.Fentanyl","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Oxycodone.Oxycodone","BNF.Phenytoin.Phenytoin","BNF.Prochlorperazine.Prochlorperazine","BNF.Temazepam.Temazepam","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of clonazepam and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Clonazepam potentially affects the concentration of fosphenytoin.","Concurrent use of clonazepam and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Clonazepam potentially affects the concentration of phenytoin.","Concurrent use of clonazepam and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of clonazepam and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Codeine.Codeine","imports":["BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Clonazepam.Clonazepam","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Fentanyl.Fentanyl","BNF.Fluoxetine.Fluoxetine","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Oxycodone.Oxycodone","BNF.Prochlorperazine.Prochlorperazine","BNF.Temazepam.Temazepam","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of codeine and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Buprenorphine is predicted to increase the risk of opiate withdrawal when given with codeine.","Bupropion is predicted to decrease the efficacy of codeine.","Concurrent use of codeine and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Cinacalcet is predicted to decrease the efficacy of codeine.","Concurrent use of codeine and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Fluoxetine is predicted to decrease the efficacy of codeine.","Concurrent use of codeine and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Codeine is predicted to increase the risk of CNS excitation or depression when given with isocarboxazid. Manufacturer advises avoid.","Concurrent use of codeine and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Nalmefene is predicted to decrease the efficacy of codeine. Manufacturer advises avoid.","Concurrent use of codeine and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Paroxetine is predicted to decrease the efficacy of codeine.","Concurrent use of codeine and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Pentazocine is predicted to increase the risk of opiate withdrawal when given with codeine.","Concurrent use of codeine and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Codeine is predicted to increase the risk of CNS excitation or depression when given with phenelzine. Manufacturer advises avoid.","Concurrent use of codeine and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Rifampicin decreases the exposure to codeine.","Concurrent use of codeine and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Terbinafine is predicted to decrease the efficacy of codeine.","Concurrent use of codeine and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Codeine is predicted to increase the risk of CNS excitation or depression when given with tranylcypromine. Manufacturer advises avoid.","Concurrent use of codeine and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of codeine and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Cyclizine.Cyclizine","imports":["BNF.Amitriptyline.Amitriptyline","BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Fentanyl.Fentanyl","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ipratropium.Ipratropium","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Nefopam.Nefopam","BNF.Oxycodone.Oxycodone","BNF.Prochlorperazine.Prochlorperazine","BNF.Temazepam.Temazepam","BNF.Tiotropium.Tiotropium","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of cyclizine and aclidinium can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and amantadine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and amitriptyline can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and atropine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and baclofen can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Cyclizine is predicted to decrease the effects of betahistine.","Concurrent use of cyclizine and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and chlorphenamine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and chlorpromazine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and clemastine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and clomipramine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and clozapine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and cyclopentolate can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and cyproheptadine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and darifenacin can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and dicycloverine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and dimenhydrinate can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and disopyramide can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and dosulepin can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and doxepin can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and fesoterodine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and flavoxate can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and glycopyrronium can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and haloperidol can increase the risk of antimuscarinic effects.","Cyclizine is predicted to decrease the effects of histamine. Manufacturer advises avoid.","Concurrent use of cyclizine and homatropine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and hydroxyzine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and hyoscine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and imipramine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and ipratropium can increase the risk of antimuscarinic effects.","Isocarboxazid is predicted to increase the risk of antimuscarinic side-effects when given with cyclizine. Manufacturer advises avoid.","Concurrent use of cyclizine and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Cyclizine decreases the absorption of levodopa.","Concurrent use of cyclizine and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and levomepromazine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and lofepramine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and loxapine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and nefopam can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and nortriptyline can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and orphenadrine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and oxybutynin can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and perphenazine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Phenelzine is predicted to increase the risk of antimuscarinic side-effects when given with cyclizine. Manufacturer advises avoid.","Concurrent use of cyclizine and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and pimozide can increase the risk of antimuscarinic effects.","Cyclizine is predicted to decrease the efficacy of pitolisant.","Concurrent use of cyclizine and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and prochlorperazine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and procyclidine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and promethazine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and propafenone can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and propantheline can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and propiverine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and solifenacin can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and tiotropium can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and tolterodine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Tranylcypromine is predicted to increase the risk of antimuscarinic side-effects when given with cyclizine. Manufacturer advises avoid.","Concurrent use of cyclizine and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and trifluoperazine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and trihexyphenidyl can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and trimipramine can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and tropicamide can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and trospium can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and umeclidinium can increase the risk of antimuscarinic effects.","Concurrent use of cyclizine and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of cyclizine and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Diazepam.Diazepam","imports":["BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Fentanyl.Fentanyl","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Oxycodone.Oxycodone","BNF.Phenytoin.Phenytoin","BNF.Prochlorperazine.Prochlorperazine","BNF.Temazepam.Temazepam","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of diazepam and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Fluconazole moderately increases the exposure to diazepam. Manufacturer advises monitor and adjust dose.","Concurrent use of diazepam and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Fluvoxamine moderately increases the exposure to diazepam.","Diazepam potentially affects the concentration of fosphenytoin. Manufacturer advises monitor concentration and adjust dose.","Concurrent use of diazepam and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Diazepam potentially affects the concentration of phenytoin. Manufacturer advises monitor concentration and adjust dose.","Concurrent use of diazepam and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Rifampicin moderately decreases the exposure to diazepam. Manufacturer advises avoid.","Concurrent use of diazepam and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ritonavir is predicted to increase the exposure to diazepam. Manufacturer advises avoid.","Concurrent use of diazepam and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Voriconazole moderately increases the exposure to diazepam. Manufacturer advises monitor and adjust dose.","Concurrent use of diazepam and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of diazepam and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Diclofenac.Diclofenac","imports":["BNF.Amiloride.Amiloride","BNF.Amitriptyline.Amitriptyline","BNF.Apixaban.Apixaban","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Carbamazepine.Carbamazepine","BNF.Ceftazidime.Ceftazidime","BNF.Cefuroxime.Cefuroxime","BNF.Ciprofloxacin.Ciprofloxacin","BNF.Citalopram.Citalopram","BNF.Enoxaparin.Enoxaparin","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Glucose.Glucose","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Levofloxacin.Levofloxacin","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Naproxen.Naproxen","BNF.Ramipril.Ramipril","BNF.Rivaroxaban.Rivaroxaban","BNF.Sertraline.Sertraline","BNF.Spironolactone.Spironolactone","BNF.Trimethoprim.Trimethoprim","BNF.Vancomycin.Vancomycin","BNF.Venlafaxine.Venlafaxine","BNF.Warfarin.Warfarin"],"interactioninfo":["Both diclofenac and abciximab can increase the risk of bleeding.","Concurrent use of diclofenac and aceclofenac can increase the risk of hyponatraemia.","Concurrent use of diclofenac and aceclofenac can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and aceclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and aceclofenac can increase the risk of bleeding.","Concurrent use of diclofenac and acemetacin can increase the risk of hyponatraemia.","Concurrent use of diclofenac and acemetacin can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and acemetacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and acemetacin can increase the risk of bleeding.","Acenocoumarol is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and aciclovir can increase the risk of nephrotoxicity.","Diclofenac is predicted to increase the risk of gastrointestinal irritation when given with alendronic acid.","Concurrent use of diclofenac and aliskiren can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Alteplase is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and amikacin can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and amiloride can increase the risk of hyponatraemia.","Concurrent use of diclofenac and amiloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and amitriptyline can increase the risk of hyponatraemia.","Concurrent use of diclofenac and amphotericin can increase the risk of nephrotoxicity.","Both diclofenac and anagrelide can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Argatroban is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Both diclofenac and aspirin can increase the risk of bleeding.","Concurrent use of diclofenac and azilsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and bacitracin can increase the risk of nephrotoxicity.","Diclofenac increases the risk of gastrointestinal bleeding when given with beclometasone.","Concurrent use of diclofenac and bendroflumethiazide can increase the risk of hyponatraemia.","Diclofenac increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of diclofenac and benzydamine can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Diclofenac increases the risk of gastrointestinal bleeding when given with betamethasone.","Both diclofenac and bevacizumab can increase the risk of bleeding.","Bivalirudin is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and bromfenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Diclofenac increases the risk of gastrointestinal bleeding when given with budesonide.","Concurrent use of diclofenac and bumetanide can increase the risk of hyponatraemia.","Concurrent use of diclofenac and candesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and cangrelor can increase the risk of bleeding.","Concurrent use of diclofenac and capreomycin can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and captopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and carbamazepine can increase the risk of hyponatraemia.","Concurrent use of diclofenac and carboplatin can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and cefaclor can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and cefadroxil can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and cefalexin can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and cefixime can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and cefotaxime can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and cefradine can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and ceftaroline can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and ceftazidime can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and ceftobiprole can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and ceftolozane can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and ceftriaxone can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and cefuroxime can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and celecoxib can increase the risk of hyponatraemia.","Concurrent use of diclofenac and celecoxib can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and celecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and celecoxib can increase the risk of bleeding.","Ceritinib is predicted to increase the exposure to diclofenac. Manufacturer advises adjust dose.","Concurrent use of diclofenac and chlorothiazide can increase the risk of hyponatraemia.","Concurrent use of diclofenac and chlortalidone can increase the risk of hyponatraemia.","Diclofenac increases the risk of acute renal failure when given with chlortalidone.","Diclofenac increases the risk of gastrointestinal bleeding when given with ciclesonide.","Concurrent use of diclofenac and ciclosporin can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and ciclosporin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Ciclosporin increases the concentration of diclofenac.","Both diclofenac and cilostazol can increase the risk of bleeding.","Diclofenac potentially increases the risk of seizures when given with ciprofloxacin.","Concurrent use of diclofenac and cisplatin can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and citalopram can increase the risk of hyponatraemia.","Both diclofenac and citalopram can increase the risk of bleeding.","Concurrent use of diclofenac and clomipramine can increase the risk of hyponatraemia.","Concurrent use of diclofenac and clopamide can increase the risk of hyponatraemia.","Diclofenac increases the risk of acute renal failure when given with clopamide.","Both diclofenac and clopidogrel can increase the risk of bleeding.","Concurrent use of diclofenac and colistimethate can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and cyclopenthiazide can increase the risk of hyponatraemia.","Diclofenac increases the risk of acute renal failure when given with cyclopenthiazide.","Dabigatran is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and dalteparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Dalteparin is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Danaparoid is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and dapoxetine can increase the risk of hyponatraemia.","Both diclofenac and dapoxetine can increase the risk of bleeding.","Diclofenac increases the risk of renal impairment when given with daptomycin.","Concurrent use of diclofenac and darbepoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and dasatinib can increase the risk of bleeding.","Diclofenac is predicted to increase the risk of gastrointestinal bleeding when given with deferasirox.","Diclofenac increases the risk of gastrointestinal bleeding when given with deflazacort.","Concurrent use of diclofenac and desmopressin can increase the risk of hyponatraemia.","Diclofenac increases the risk of gastrointestinal bleeding when given with dexamethasone.","Concurrent use of diclofenac and dexibuprofen can increase the risk of hyponatraemia.","Concurrent use of diclofenac and dexibuprofen can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and dexibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and dexibuprofen can increase the risk of bleeding.","Concurrent use of diclofenac and dexketoprofen can increase the risk of hyponatraemia.","Concurrent use of diclofenac and dexketoprofen can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and dexketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and dexketoprofen can increase the risk of bleeding.","Both diclofenac and dipyridamole can increase the risk of bleeding.","Concurrent use of diclofenac and dosulepin can increase the risk of hyponatraemia.","Concurrent use of diclofenac and doxepin can increase the risk of hyponatraemia.","Concurrent use of diclofenac and drospirenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and duloxetine can increase the risk of hyponatraemia.","Both diclofenac and duloxetine can increase the risk of bleeding.","Edoxaban is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and enalapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and enoxaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and eplerenone can increase the risk of hyponatraemia.","Concurrent use of diclofenac and eplerenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and epoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and epoetin beta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and epoetin zeta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and epoprostenol can increase the risk of bleeding.","Concurrent use of diclofenac and eprosartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and eptifibatide can increase the risk of bleeding.","Erlotinib is predicted to increase the risk of gastrointestinal perforation when given with diclofenac.","Concurrent use of diclofenac and escitalopram can increase the risk of hyponatraemia.","Both diclofenac and escitalopram can increase the risk of bleeding.","Concurrent use of diclofenac and etodolac can increase the risk of hyponatraemia.","Concurrent use of diclofenac and etodolac can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and etodolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and etodolac can increase the risk of bleeding.","Concurrent use of diclofenac and etoricoxib can increase the risk of hyponatraemia.","Concurrent use of diclofenac and etoricoxib can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and etoricoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and etoricoxib can increase the risk of bleeding.","Concurrent use of diclofenac and felbinac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and fenoprofen can increase the risk of hyponatraemia.","Concurrent use of diclofenac and fenoprofen can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and fenoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and fenoprofen can increase the risk of bleeding.","Diclofenac increases the risk of gastrointestinal bleeding when given with fludrocortisone.","Concurrent use of diclofenac and fluoxetine can increase the risk of hyponatraemia.","Both diclofenac and fluoxetine can increase the risk of bleeding.","Concurrent use of diclofenac and flurbiprofen can increase the risk of hyponatraemia.","Concurrent use of diclofenac and flurbiprofen can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and flurbiprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and flurbiprofen can increase the risk of bleeding.","Diclofenac increases the risk of gastrointestinal bleeding when given with fluticasone.","Concurrent use of diclofenac and fluvoxamine can increase the risk of hyponatraemia.","Both diclofenac and fluvoxamine can increase the risk of bleeding.","Fondaparinux is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and foscarnet can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and furosemide can increase the risk of hyponatraemia.","Concurrent use of diclofenac and ganciclovir can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and gentamicin can increase the risk of nephrotoxicity.","Glucose is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and heparin (unfractionated) can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Heparin (unfractionated) is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and hydrochlorothiazide can increase the risk of hyponatraemia.","Diclofenac increases the risk of acute renal failure when given with hydrochlorothiazide.","Diclofenac increases the risk of gastrointestinal bleeding when given with hydrocortisone.","Concurrent use of diclofenac and hydroflumethiazide can increase the risk of hyponatraemia.","Diclofenac increases the risk of acute renal failure when given with hydroflumethiazide.","Diclofenac is predicted to increase the risk of gastrointestinal irritation when given with ibandronic acid.","Both diclofenac and ibrutinib can increase the risk of bleeding.","Concurrent use of diclofenac and ibuprofen can increase the risk of hyponatraemia.","Concurrent use of diclofenac and ibuprofen can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and ibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and ibuprofen can increase the risk of bleeding.","Concurrent use of diclofenac and ifosfamide can increase the risk of nephrotoxicity.","Both diclofenac and iloprost can increase the risk of bleeding.","Concurrent use of diclofenac and imidapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and imipramine can increase the risk of hyponatraemia.","Concurrent use of diclofenac and indapamide can increase the risk of hyponatraemia.","Diclofenac increases the risk of acute renal failure when given with indapamide.","Concurrent use of diclofenac and indometacin can increase the risk of hyponatraemia.","Concurrent use of diclofenac and indometacin can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and indometacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and indometacin can increase the risk of bleeding.","Concurrent use of diclofenac and irbesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and ketoprofen can increase the risk of hyponatraemia.","Concurrent use of diclofenac and ketoprofen can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and ketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and ketoprofen can increase the risk of bleeding.","Concurrent use of diclofenac and ketorolac can increase the risk of hyponatraemia.","Concurrent use of diclofenac and ketorolac can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and ketorolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and ketorolac can increase the risk of bleeding.","Diclofenac potentially increases the risk of seizures when given with levofloxacin.","Concurrent use of diclofenac and lisinopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Diclofenac increases the concentration of lithium. Manufacturer advises monitor and adjust dose.","Concurrent use of diclofenac and losartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and mefenamic acid can increase the risk of hyponatraemia.","Concurrent use of diclofenac and mefenamic acid can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and mefenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and mefenamic acid can increase the risk of bleeding.","Concurrent use of diclofenac and meloxicam can increase the risk of hyponatraemia.","Concurrent use of diclofenac and meloxicam can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and meloxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and meloxicam can increase the risk of bleeding.","Concurrent use of diclofenac and methotrexate can increase the risk of nephrotoxicity.","Diclofenac is predicted to increase the risk of toxicity when given with methotrexate. Manufacturer advises monitor and adjust dose.","Diclofenac increases the risk of gastrointestinal bleeding when given with methylprednisolone.","Concurrent use of diclofenac and metolazone can increase the risk of hyponatraemia.","Diclofenac increases the risk of acute renal failure when given with metolazone.","Diclofenac (high-dose) is predicted to decrease the efficacy of mifamurtide. Manufacturer advises avoid.","Concurrent use of diclofenac and moexipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Diclofenac increases the risk of gastrointestinal bleeding when given with mometasone.","Diclofenac potentially increases the risk of seizures when given with moxifloxacin.","Concurrent use of diclofenac and nabumetone can increase the risk of hyponatraemia.","Concurrent use of diclofenac and nabumetone can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and nabumetone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and nabumetone can increase the risk of bleeding.","Diclofenac potentially increases the risk of seizures when given with nalidixic acid.","Concurrent use of diclofenac and naproxen can increase the risk of hyponatraemia.","Concurrent use of diclofenac and naproxen can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and naproxen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and naproxen can increase the risk of bleeding.","Concurrent use of diclofenac and neomycin can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and nepafenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Nicorandil is predicted to increase the risk of gastrointestinal perforation when given with diclofenac.","Nicotinic acid is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Diclofenac potentially increases the risk of seizures when given with norfloxacin.","Concurrent use of diclofenac and nortriptyline can increase the risk of hyponatraemia.","Diclofenac potentially increases the risk of seizures when given with ofloxacin.","Concurrent use of diclofenac and olmesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Omega-3-acid ethyl esters is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and oxaliplatin can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and parecoxib can increase the risk of hyponatraemia.","Concurrent use of diclofenac and parecoxib can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and parecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and parecoxib can increase the risk of bleeding.","Concurrent use of diclofenac and paroxetine can increase the risk of hyponatraemia.","Both diclofenac and paroxetine can increase the risk of bleeding.","Concurrent use of diclofenac and pemetrexed can increase the risk of nephrotoxicity.","Diclofenac is predicted to increase the exposure to pemetrexed. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and penicillamine can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and pentamidine can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and perindopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Phenindione is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and piroxicam can increase the risk of hyponatraemia.","Concurrent use of diclofenac and piroxicam can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and piroxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and piroxicam can increase the risk of bleeding.","Concurrent use of diclofenac and polymyxins can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and potassium canrenoate can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and potassium chloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and prasugrel can increase the risk of bleeding.","Diclofenac increases the risk of gastrointestinal bleeding when given with prednisolone.","Diclofenac increases the risk of gastrointestinal bleeding when given with prednisone.","Concurrent use of diclofenac and quinapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and ramipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and regorafenib can increase the risk of bleeding.","Reteplase is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Rifampicin moderately decreases the exposure to diclofenac.","Rivaroxaban is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and sertraline can increase the risk of hyponatraemia.","Both diclofenac and sertraline can increase the risk of bleeding.","Diclofenac is predicted to increase the risk of renal impairment when given with sodium clodronate.","Concurrent use of diclofenac and sodium picosulfate can increase the risk of hyponatraemia.","Concurrent use of diclofenac and spironolactone can increase the risk of hyponatraemia.","Concurrent use of diclofenac and spironolactone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Streptokinase is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and streptomycin can increase the risk of nephrotoxicity.","Both diclofenac and sulfinpyrazone can increase the risk of bleeding.","Concurrent use of diclofenac and sulindac can increase the risk of hyponatraemia.","Concurrent use of diclofenac and sulindac can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and sulindac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and sulindac can increase the risk of bleeding.","Concurrent use of diclofenac and tacrolimus can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and tacrolimus can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and telavancin can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and telmisartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Tenecteplase is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and tenofovir can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and tenoxicam can increase the risk of hyponatraemia.","Concurrent use of diclofenac and tenoxicam can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and tenoxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and tenoxicam can increase the risk of bleeding.","Concurrent use of diclofenac and tiaprofenic acid can increase the risk of hyponatraemia.","Concurrent use of diclofenac and tiaprofenic acid can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and tiaprofenic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and tiaprofenic acid can increase the risk of bleeding.","Both diclofenac and ticagrelor can increase the risk of bleeding.","Concurrent use of diclofenac and tinzaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Tinzaparin is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Both diclofenac and tirofiban can increase the risk of bleeding.","Concurrent use of diclofenac and tobramycin can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and tolfenamic acid can increase the risk of hyponatraemia.","Concurrent use of diclofenac and tolfenamic acid can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and tolfenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and tolfenamic acid can increase the risk of bleeding.","Concurrent use of diclofenac and tolvaptan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and torasemide can increase the risk of hyponatraemia.","Concurrent use of diclofenac and trandolapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both diclofenac and trastuzumab can increase the risk of bleeding.","Both diclofenac and trastuzumab emtansine can increase the risk of bleeding.","Diclofenac increases the risk of gastrointestinal bleeding when given with triamcinolone.","Concurrent use of diclofenac and triamterene can increase the risk of hyponatraemia.","Concurrent use of diclofenac and triamterene can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and trimethoprim can increase the risk of hyponatraemia.","Concurrent use of diclofenac and trimethoprim can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and trimethoprim can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and trimipramine can increase the risk of hyponatraemia.","Urokinase is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and valaciclovir can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and valganciclovir can increase the risk of nephrotoxicity.","Concurrent use of diclofenac and valsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of diclofenac and vancomycin can increase the risk of nephrotoxicity.","Both diclofenac and venlafaxine can increase the risk of bleeding.","Voriconazole slightly increases the exposure to diclofenac. Manufacturer advises monitor and adjust dose.","Both diclofenac and vortioxetine can increase the risk of bleeding.","Warfarin is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of diclofenac and xipamide can increase the risk of hyponatraemia.","Diclofenac increases the risk of acute renal failure when given with xipamide.","Concurrent use of diclofenac and zidovudine can increase the risk of nephrotoxicity.","Zidovudine increases the risk of haematological toxicity when given with diclofenac.","Concurrent use of diclofenac and zoledronic acid can increase the risk of nephrotoxicity."]},{"name":"BNF.Digoxin.Digoxin","imports":["BNF.Amiodarone.Amiodarone","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisacodyl.Bisacodyl","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Clarithromycin.Clarithromycin","BNF.Diltiazem.Diltiazem","BNF.Fentanyl.Fentanyl","BNF.Furosemide.Furosemide","BNF.Indapamide.Indapamide","BNF.Levothyroxine.Levothyroxine","BNF.Phenytoin.Phenytoin","BNF.Quinine.Quinine","BNF.Salbutamol.Salbutamol","BNF.Senna.Senna","BNF.Spironolactone.Spironolactone","BNF.Theophylline.Theophylline","BNF.Trimethoprim.Trimethoprim"],"interactioninfo":["Acarbose decreases the concentration of digoxin.","Both digoxin and acebutolol can increase the risk of bradycardia.","Both digoxin and alectinib can increase the risk of bradycardia.","Alfacalcidol is predicted to increase the risk of toxicity when given with digoxin.","Both digoxin and alfentanil can increase the risk of bradycardia.","Aluminium hydroxide decreases the absorption of digoxin. Manufacturer advises separate administration by 2 hours.","Amikacin potentially increases the concentration of digoxin. Manufacturer advises monitor and adjust dose.","Aminophylline is predicted to increase the risk of digoxin toxicity when given with digoxin.","Both digoxin and amiodarone can increase the risk of bradycardia.","Amiodarone is predicted to moderately increase the exposure to digoxin. Manufacturer advises monitor and adjust digoxin dose.","Amphotericin is predicted to increase the risk of digoxin toxicity when given with digoxin.","Both digoxin and apraclonidine can increase the risk of bradycardia.","Both digoxin and atenolol can increase the risk of bradycardia.","Azithromycin increases the concentration of digoxin.","Balsalazide is predicted to decrease the concentration of digoxin.","Bambuterol is predicted to increase the risk of digoxin toxicity when given with digoxin.","Beclometasone is predicted to increase the risk of digoxin toxicity when given with digoxin.","Bendroflumethiazide is predicted to increase the risk of digoxin toxicity when given with digoxin.","Betamethasone is predicted to increase the risk of digoxin toxicity when given with digoxin.","Both digoxin and betaxolol can increase the risk of bradycardia.","Bisacodyl is predicted to increase the risk of digoxin toxicity when given with digoxin.","Both digoxin and bisoprolol can increase the risk of bradycardia.","Both digoxin and brimonidine can increase the risk of bradycardia.","Budesonide is predicted to increase the risk of digoxin toxicity when given with digoxin.","Bumetanide is predicted to increase the risk of digoxin toxicity when given with digoxin.","Calcipotriol is predicted to increase the risk of toxicity when given with digoxin.","Calcitriol is predicted to increase the risk of toxicity when given with digoxin.","Intravenous calcium acetate increases the concentration of digoxin. Manufacturer advises avoid.","Intravenous calcium carbonate increases the concentration of digoxin. Manufacturer advises avoid.","Intravenous calcium chloride increases the concentration of digoxin. Manufacturer advises avoid.","Intravenous calcium gluconate increases the concentration of digoxin. Manufacturer advises avoid.","Intravenous calcium lactate increases the concentration of digoxin. Manufacturer advises avoid.","Intravenous calcium phosphate increases the concentration of digoxin. Manufacturer advises avoid.","Carbimazole affects the concentration of digoxin. Manufacturer advises monitor and adjust dose.","Both digoxin and carteolol can increase the risk of bradycardia.","Both digoxin and carvedilol can increase the risk of bradycardia.","Both digoxin and celiprolol can increase the risk of bradycardia.","Ceritinib is predicted to increase the risk of bradycardia when given with digoxin. Manufacturer advises avoid.","Chlorothiazide is predicted to increase the risk of digoxin toxicity when given with digoxin.","Chlortalidone is predicted to increase the risk of digoxin toxicity when given with digoxin.","Ciclosporin increases the concentration of digoxin. Manufacturer advises monitor and adjust dose.","Both digoxin and cisatracurium can increase the risk of bradycardia.","Clarithromycin increases the concentration of digoxin.","Both digoxin and clonidine can increase the risk of bradycardia.","Clopamide is predicted to increase the risk of digoxin toxicity when given with digoxin.","Colecalciferol is predicted to increase the risk of toxicity when given with digoxin.","Both digoxin and crizotinib can increase the risk of bradycardia.","Cyclopenthiazide is predicted to increase the risk of digoxin toxicity when given with digoxin.","Daclatasvir slightly increases the concentration of digoxin.","Dantron is predicted to increase the risk of digoxin toxicity when given with digoxin.","Deflazacort is predicted to increase the risk of digoxin toxicity when given with digoxin.","Dexamethasone is predicted to increase the risk of digoxin toxicity when given with digoxin.","Dihydrotachysterol is predicted to increase the risk of toxicity when given with digoxin.","Both digoxin and diltiazem can increase the risk of bradycardia.","Diltiazem increases the concentration of digoxin. Manufacturer advises monitor and adjust dose.","Docusate sodium is predicted to increase the risk of digoxin toxicity when given with digoxin.","Both digoxin and donepezil can increase the risk of bradycardia.","Dronedarone is predicted to moderately increase the exposure to digoxin. Manufacturer advises monitor and adjust digoxin dose.","Eliglustat increases the exposure to digoxin. Manufacturer advises adjust dose.","Eplerenone very slightly increases the exposure to digoxin.","Ergocalciferol is predicted to increase the risk of toxicity when given with digoxin.","Erythromycin increases the concentration of digoxin.","Both digoxin and esmolol can increase the risk of bradycardia.","Both digoxin and fentanyl can increase the risk of bradycardia.","Both digoxin and fingolimod can increase the risk of bradycardia.","Both digoxin and flecainide can increase the risk of bradycardia.","Fludrocortisone is predicted to increase the risk of digoxin toxicity when given with digoxin.","Formoterol is predicted to increase the risk of digoxin toxicity when given with digoxin.","Fosphenytoin is predicted to decrease the concentration of digoxin.","Furosemide is predicted to increase the risk of digoxin toxicity when given with digoxin.","Both digoxin and galantamine can increase the risk of bradycardia.","Gentamicin potentially increases the concentration of digoxin. Manufacturer advises monitor and adjust dose.","Glycerol is predicted to increase the risk of digoxin toxicity when given with digoxin.","Hydrochlorothiazide is predicted to increase the risk of digoxin toxicity when given with digoxin.","Hydrocortisone is predicted to increase the risk of digoxin toxicity when given with digoxin.","Hydroflumethiazide is predicted to increase the risk of digoxin toxicity when given with digoxin.","Indacaterol is predicted to increase the risk of digoxin toxicity when given with digoxin.","Indapamide is predicted to increase the risk of digoxin toxicity when given with digoxin.","Indometacin increases the concentration of digoxin.","Itraconazole is predicted to markedly increase the concentration of digoxin. Manufacturer advises monitor and adjust dose.","Both digoxin and ivabradine can increase the risk of bradycardia.","Ketoconazole is predicted to markedly increase the concentration of digoxin.","Both digoxin and labetalol can increase the risk of bradycardia.","Lapatinib is predicted to increase the exposure to digoxin.","Both digoxin and levobunolol can increase the risk of bradycardia.","Levothyroxine is predicted to affect the concentration of digoxin. Manufacturer advises monitor and adjust dose.","Liothyronine is predicted to affect the concentration of digoxin. Manufacturer advises monitor and adjust dose.","Lumacaftor is predicted to affect the exposure to digoxin. Manufacturer advises monitor and adjust dose.","Magnesium carbonate decreases the absorption of digoxin. Manufacturer advises separate administration by 2 hours.","Magnesium trisilicate decreases the absorption of digoxin. Manufacturer advises separate administration by 2 hours.","Mefloquine is predicted to increase the risk of bradycardia when given with digoxin.","Both digoxin and methadone can increase the risk of bradycardia.","Methylprednisolone is predicted to increase the risk of digoxin toxicity when given with digoxin.","Metolazone is predicted to increase the risk of digoxin toxicity when given with digoxin.","Both digoxin and metoprolol can increase the risk of bradycardia.","Mirabegron slightly increases the exposure to digoxin. Manufacturer advises monitor concentration and adjust dose.","Both digoxin and nadolol can increase the risk of bradycardia.","Both digoxin and nebivolol can increase the risk of bradycardia.","Neomycin decreases the absorption of digoxin.","Both digoxin and neostigmine can increase the risk of bradycardia.","Olodaterol is predicted to increase the risk of digoxin toxicity when given with digoxin.","Both digoxin and oxprenolol can increase the risk of bradycardia.","Pancuronium is predicted to increase the risk of cardiovascular side-effects when given with digoxin.","Paricalcitol is predicted to increase the risk of toxicity when given with digoxin.","Both digoxin and pasireotide can increase the risk of bradycardia.","Penicillamine potentially decreases the concentration of digoxin. Manufacturer advises separate administration by 2 hours.","Phenytoin is predicted to decrease the concentration of digoxin.","Both digoxin and pindolol can increase the risk of bradycardia.","Pitolisant is predicted to decrease the exposure to digoxin.","Posaconazole is predicted to increase the concentration of digoxin.","Prednisolone is predicted to increase the risk of digoxin toxicity when given with digoxin.","Prednisone is predicted to increase the risk of digoxin toxicity when given with digoxin.","Propafenone increases the concentration of digoxin. Manufacturer advises monitor and adjust dose.","Both digoxin and propranolol can increase the risk of bradycardia.","Both digoxin and pyridostigmine can increase the risk of bradycardia.","Quinine increases the concentration of digoxin. Manufacturer advises monitor and adjust digoxin dose.","Ranolazine increases the concentration of digoxin.","Both digoxin and remifentanil can increase the risk of bradycardia.","Rifampicin decreases the concentration of digoxin.","Ritonavir increases the concentration of digoxin. Manufacturer advises adjust dose and monitor concentration.","Both digoxin and rivastigmine can increase the risk of bradycardia.","Rolapitant slightly increases the exposure to digoxin.","Salbutamol is predicted to increase the risk of digoxin toxicity when given with digoxin.","Salmeterol is predicted to increase the risk of digoxin toxicity when given with digoxin.","Both digoxin and selegiline can increase the risk of bradycardia.","Senna is predicted to increase the risk of digoxin toxicity when given with digoxin.","Sodium picosulfate is predicted to increase the risk of digoxin toxicity when given with digoxin.","Both digoxin and sotalol can increase the risk of bradycardia.","Spironolactone increases the concentration of digoxin. Manufacturer advises monitor and adjust dose.","St John's Wort decreases the concentration of digoxin. Manufacturer advises avoid.","Streptomycin potentially increases the concentration of digoxin. Manufacturer advises monitor and adjust dose.","Sucralfate decreases the absorption of digoxin. Manufacturer advises separate administration by 2 hours.","Both digoxin and sufentanil can increase the risk of bradycardia.","Sulfasalazine decreases the concentration of digoxin.","Suxamethonium is predicted to increase the risk of cardiovascular side-effects when given with digoxin.","Tacalcitol is predicted to increase the risk of toxicity when given with digoxin.","Terbutaline is predicted to increase the risk of digoxin toxicity when given with digoxin.","Both digoxin and thalidomide can increase the risk of bradycardia.","Theophylline is predicted to increase the risk of digoxin toxicity when given with digoxin.","Ticagrelor increases the concentration of digoxin.","Both digoxin and timolol can increase the risk of bradycardia.","Both digoxin and tizanidine can increase the risk of bradycardia.","Tobramycin potentially increases the concentration of digoxin. Manufacturer advises monitor and adjust dose.","Tolvaptan increases the concentration of digoxin.","Torasemide is predicted to increase the risk of digoxin toxicity when given with digoxin.","Triamcinolone is predicted to increase the risk of digoxin toxicity when given with digoxin.","Trimethoprim increases the concentration of digoxin.","Vandetanib slightly increases the exposure to digoxin. Manufacturer advises monitor ECG and adjust dose.","Velpatasvir is predicted to increase the exposure to digoxin.","Both digoxin and verapamil can increase the risk of bradycardia.","Verapamil increases the concentration of digoxin. Manufacturer advises monitor and adjust dose.","Vilanterol is predicted to increase the risk of digoxin toxicity when given with digoxin.","Xipamide is predicted to increase the risk of digoxin toxicity when given with digoxin."]},{"name":"BNF.Dihydrocodeine.Dihydrocodeine","imports":["BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Fentanyl.Fentanyl","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Oxycodone.Oxycodone","BNF.Prochlorperazine.Prochlorperazine","BNF.Temazepam.Temazepam","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of dihydrocodeine and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Buprenorphine is predicted to increase the risk of opiate withdrawal when given with dihydrocodeine.","Concurrent use of dihydrocodeine and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Dihydrocodeine is predicted to increase the risk of CNS excitation or depression when given with isocarboxazid. Manufacturer advises avoid.","Concurrent use of dihydrocodeine and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Nalmefene is predicted to decrease the efficacy of dihydrocodeine. Manufacturer advises avoid.","Concurrent use of dihydrocodeine and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Pentazocine is predicted to increase the risk of opiate withdrawal when given with dihydrocodeine.","Concurrent use of dihydrocodeine and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Dihydrocodeine is predicted to increase the risk of CNS excitation or depression when given with phenelzine. Manufacturer advises avoid.","Concurrent use of dihydrocodeine and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Dihydrocodeine is predicted to increase the risk of CNS excitation or depression when given with tranylcypromine. Manufacturer advises avoid.","Concurrent use of dihydrocodeine and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of dihydrocodeine and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Diltiazem.Diltiazem","imports":["BNF.Amiodarone.Amiodarone","BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Atorvastatin.Atorvastatin","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Carbamazepine.Carbamazepine","BNF.Clarithromycin.Clarithromycin","BNF.Digoxin.Digoxin","BNF.Doxazosin.Doxazosin","BNF.Fentanyl.Fentanyl","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Midazolam.Midazolam","BNF.Nifedipine.Nifedipine","BNF.Oxycodone.Oxycodone","BNF.Phenytoin.Phenytoin","BNF.Prochlorperazine.Prochlorperazine","BNF.Ramipril.Ramipril","BNF.Simvastatin.Simvastatin","BNF.Spironolactone.Spironolactone","BNF.Trazodone.Trazodone","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Both diltiazem and acebutolol can increase the risk of bradycardia.","Concurrent use of diltiazem and acebutolol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with acebutolol.","Concurrent use of diltiazem and alcohol (beverage) can increase the risk of hypotension.","Both diltiazem and alectinib can increase the risk of bradycardia.","Both diltiazem and alfentanil can increase the risk of bradycardia.","Diltiazem is predicted to increase the exposure to alfentanil. Manufacturer advises monitor and adjust dose.","Concurrent use of diltiazem and alfuzosin can increase the risk of hypotension.","Concurrent use of diltiazem and aliskiren can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to alprazolam.","Concurrent use of diltiazem and alprostadil can increase the risk of hypotension.","Concurrent use of diltiazem and amantadine can increase the risk of hypotension.","Both diltiazem and amiodarone can increase the risk of bradycardia.","Amiodarone is predicted to increase the risk of cardiodepression when given with diltiazem. Manufacturer advises avoid.","Concurrent use of diltiazem and amitriptyline can increase the risk of hypotension.","Concurrent use of diltiazem and amlodipine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of diltiazem and apomorphine can increase the risk of hypotension.","Both diltiazem and apraclonidine can increase the risk of bradycardia.","Concurrent use of diltiazem and apraclonidine can increase the risk of hypotension.","Diltiazem increases the exposure to aprepitant and aprepitant increases the exposure to diltiazem.","Concurrent use of diltiazem and aripiprazole can increase the risk of hypotension.","Concurrent use of diltiazem and asenapine can increase the risk of hypotension.","Atazanavir is predicted to increase the exposure to diltiazem.","Both diltiazem and atenolol can increase the risk of bradycardia.","Concurrent use of diltiazem and atenolol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with atenolol.","Diltiazem is predicted to increase the exposure to atorvastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of diltiazem and avanafil can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to avanafil. Manufacturer advises adjust avanafil dose.","Diltiazem is predicted to increase the exposure to axitinib.","Concurrent use of diltiazem and azilsartan can increase the risk of hypotension.","Concurrent use of diltiazem and baclofen can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to bedaquiline. Manufacturer advises avoid prolonged use.","Concurrent use of diltiazem and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of diltiazem and benperidol can increase the risk of hypotension.","Both diltiazem and betaxolol can increase the risk of bradycardia.","Concurrent use of diltiazem and betaxolol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with betaxolol.","Both diltiazem and bisoprolol can increase the risk of bradycardia.","Concurrent use of diltiazem and bisoprolol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with bisoprolol.","Concurrent use of diltiazem and bortezomib can increase the risk of hypotension.","Bosentan is predicted to decrease the exposure to diltiazem.","Diltiazem is predicted to increase the exposure to bosutinib. Manufacturer advises avoid or adjust dose.","Both diltiazem and brimonidine can increase the risk of bradycardia.","Concurrent use of diltiazem and brimonidine can increase the risk of hypotension.","Concurrent use of diltiazem and bromocriptine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to bromocriptine.","Concurrent use of diltiazem and bumetanide can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to buprenorphine. Manufacturer advises monitor and adjust dose.","Diltiazem is predicted to increase the exposure to buspirone. Manufacturer advises use with caution and adjust dose.","Diltiazem is predicted to increase the exposure to cabazitaxel.","Concurrent use of diltiazem and cabergoline can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to cabergoline.","Diltiazem is predicted to increase the exposure to cabozantinib.","Concurrent use of diltiazem and canagliflozin can increase the risk of hypotension.","Concurrent use of diltiazem and candesartan can increase the risk of hypotension.","Concurrent use of diltiazem and captopril can increase the risk of hypotension.","Diltiazem increases the concentration of carbamazepine. Manufacturer advises monitor concentration and adjust dose.","Carbamazepine decreases the exposure to diltiazem.","Both diltiazem and carteolol can increase the risk of bradycardia.","Concurrent use of diltiazem and carteolol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with carteolol.","Both diltiazem and carvedilol can increase the risk of bradycardia.","Concurrent use of diltiazem and carvedilol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with carvedilol.","Both diltiazem and celiprolol can increase the risk of bradycardia.","Concurrent use of diltiazem and celiprolol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with celiprolol.","Diltiazem is predicted to increase the exposure to ceritinib.","Concurrent use of diltiazem and chlorothiazide can increase the risk of hypotension.","Concurrent use of diltiazem and chlorpromazine can increase the risk of hypotension.","Concurrent use of diltiazem and chlortalidone can increase the risk of hypotension.","Diltiazem increases the concentration of ciclosporin.","Cimetidine slightly increases the exposure to diltiazem. Manufacturer advises monitor and adjust dose.","Both diltiazem and cisatracurium can increase the risk of bradycardia.","Clarithromycin is predicted to increase the exposure to diltiazem.","Concurrent use of diltiazem and clevidipine can increase the risk of hypotension.","Concurrent use of diltiazem and clomipramine can increase the risk of hypotension.","Both diltiazem and clonidine can increase the risk of bradycardia.","Concurrent use of diltiazem and clonidine can increase the risk of hypotension.","Concurrent use of diltiazem and clopamide can increase the risk of hypotension.","Concurrent use of diltiazem and clozapine can increase the risk of hypotension.","Cobicistat is predicted to increase the exposure to diltiazem.","Diltiazem is predicted to increase the exposure to cobimetinib.","Diltiazem is predicted to increase the exposure to colchicine. Manufacturer advises adjust colchicine dose.","Both diltiazem and crizotinib can increase the risk of bradycardia.","Diltiazem is predicted to increase the exposure to crizotinib.","Concurrent use of diltiazem and cyclopenthiazide can increase the risk of hypotension.","Intravenous dantrolene potentially increases the risk of acute hyperkalaemia and cardiovascular collapse when given with diltiazem. Manufacturer advises avoid.","Concurrent use of diltiazem and dapagliflozin can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to dapoxetine. Manufacturer advises adjust dapoxetine dose.","Diltiazem is predicted to slightly increase the exposure to darifenacin.","Darunavir is predicted to increase the exposure to diltiazem.","Diltiazem is predicted to increase the exposure to dasatinib.","Concurrent use of diltiazem and desflurane can increase the risk of hypotension.","Concurrent use of diltiazem and diazoxide can increase the risk of hypotension.","Both diltiazem and digoxin can increase the risk of bradycardia.","Diltiazem increases the concentration of digoxin. Manufacturer advises monitor and adjust dose.","Concurrent use of diltiazem and dipyridamole can increase the risk of hypotension.","Diltiazem increases the risk of QT-prolongation when given with domperidone. Manufacturer advises avoid.","Both diltiazem and donepezil can increase the risk of bradycardia.","Diltiazem increases the risk of bradycardia when given with donepezil.","Concurrent use of diltiazem and dosulepin can increase the risk of hypotension.","Concurrent use of diltiazem and doxazosin can increase the risk of hypotension.","Concurrent use of diltiazem and doxepin can increase the risk of hypotension.","Diltiazem increases the exposure to dronedarone and dronedarone increases the exposure to diltiazem.","Concurrent use of diltiazem and droperidol can increase the risk of hypotension.","Diltiazem is predicted to moderately increase the exposure to dutasteride.","Efavirenz is predicted to decrease the exposure to diltiazem.","Diltiazem is predicted to increase the exposure to eliglustat. Manufacturer advises avoid or adjust doseconsult product literature.","Concurrent use of diltiazem and empagliflozin can increase the risk of hypotension.","Concurrent use of diltiazem and enalapril can increase the risk of hypotension.","Enzalutamide decreases the exposure to diltiazem.","Concurrent use of diltiazem and eplerenone can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to eplerenone. Manufacturer advises adjust eplerenone dose.","Concurrent use of diltiazem and eprosartan can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of ergotism when given with ergometrine.","Diltiazem is predicted to increase the risk of ergotism when given with ergotamine.","Diltiazem is predicted to increase the exposure to erlotinib.","Erythromycin is predicted to increase the exposure to diltiazem.","Both diltiazem and esmolol can increase the risk of bradycardia.","Concurrent use of diltiazem and esmolol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with esmolol.","Concurrent use of diltiazem and etomidate can increase the risk of hypotension.","Diltiazem is predicted to increase the concentration of everolimus. Manufacturer advises avoid or adjust dose.","Concurrent use of diltiazem and felodipine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to felodipine. Manufacturer advises monitor and adjust dose.","Both diltiazem and fentanyl can increase the risk of bradycardia.","Diltiazem is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Diltiazem is predicted to increase the exposure to fesoterodine. Manufacturer advises adjust fesoterodine dose in hepatic and renal impairment.","Both diltiazem and fingolimod can increase the risk of bradycardia.","Diltiazem is predicted to increase the exposure to fingolimod. Manufacturer advises avoid.","Both diltiazem and flecainide can increase the risk of bradycardia.","Fluconazole (high-dose) is predicted to increase the exposure to diltiazem.","Concurrent use of diltiazem and flupentixol can increase the risk of hypotension.","Concurrent use of diltiazem and fluphenazine can increase the risk of hypotension.","Fosamprenavir is predicted to increase the exposure to diltiazem.","Concurrent use of diltiazem and fosinopril can increase the risk of hypotension.","Fosphenytoin decreases the exposure to diltiazem.","Concurrent use of diltiazem and furosemide can increase the risk of hypotension.","Both diltiazem and galantamine can increase the risk of bradycardia.","Diltiazem increases the risk of bradycardia when given with galantamine.","Diltiazem is predicted to increase the exposure to gefitinib.","Concurrent use of diltiazem and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of diltiazem and guanethidine can increase the risk of hypotension.","Concurrent use of diltiazem and guanfacine can increase the risk of hypotension.","Diltiazem is predicted to increase the concentration of guanfacine. Manufacturer advises adjust guanfacine dose.","Concurrent use of diltiazem and haloperidol can increase the risk of hypotension.","Concurrent use of diltiazem and histamine can increase the risk of hypotension.","Concurrent use of diltiazem and hydralazine can increase the risk of hypotension.","Concurrent use of diltiazem and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of diltiazem and hydroflumethiazide can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to ibrutinib. Manufacturer advises avoid or adjust ibrutinib dose.","Idelalisib is predicted to increase the exposure to diltiazem.","Diltiazem is predicted to increase the exposure to imatinib.","Concurrent use of diltiazem and imidapril can increase the risk of hypotension.","Concurrent use of diltiazem and imipramine can increase the risk of hypotension.","Concurrent use of diltiazem and indapamide can increase the risk of hypotension.","Concurrent use of diltiazem and indoramin can increase the risk of hypotension.","Concurrent use of diltiazem and irbesartan can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to isavuconazole.","Concurrent use of diltiazem and isocarboxazid can increase the risk of hypotension.","Concurrent use of diltiazem and isoflurane can increase the risk of hypotension.","Concurrent use of diltiazem and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of diltiazem and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of diltiazem and isradipine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to isradipine. Manufacturer advises monitor and adjust dose.","Itraconazole is predicted to increase the exposure to diltiazem.","Both diltiazem and ivabradine can increase the risk of bradycardia.","Diltiazem is predicted to increase the exposure to ivabradine. Manufacturer advises avoid.","Diltiazem is predicted to increase the exposure to ivacaftor. Manufacturer advises adjust ivacaftor dose.","Concurrent use of diltiazem and ketamine can increase the risk of hypotension.","Ketoconazole is predicted to increase the exposure to diltiazem.","Both diltiazem and labetalol can increase the risk of bradycardia.","Concurrent use of diltiazem and labetalol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with labetalol.","Concurrent use of diltiazem and lacidipine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to lacidipine. Manufacturer advises monitor and adjust dose.","Diltiazem is predicted to increase the exposure to lapatinib.","Concurrent use of diltiazem and lercanidipine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to lercanidipine. Manufacturer advises monitor and adjust dose.","Both diltiazem and levobunolol can increase the risk of bradycardia.","Concurrent use of diltiazem and levobunolol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with levobunolol.","Concurrent use of diltiazem and levodopa can increase the risk of hypotension.","Concurrent use of diltiazem and levomepromazine can increase the risk of hypotension.","Concurrent use of diltiazem and lisinopril can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of neurotoxicity when given with lithium.","Concurrent use of diltiazem and lofepramine can increase the risk of hypotension.","Concurrent use of diltiazem and lofexidine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to lomitapide. Manufacturer advises avoid.","Lopinavir is predicted to increase the exposure to diltiazem.","Concurrent use of diltiazem and losartan can increase the risk of hypotension.","Concurrent use of diltiazem and loxapine can increase the risk of hypotension.","Concurrent use of diltiazem and lurasidone can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to lurasidone.","Mefloquine is predicted to increase the risk of bradycardia when given with diltiazem.","Both diltiazem and methadone can increase the risk of bradycardia.","Diltiazem is predicted to increase the exposure to methadone.","Concurrent use of diltiazem and methyldopa can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to methylprednisolone. Manufacturer advises monitor and adjust dose.","Concurrent use of diltiazem and metolazone can increase the risk of hypotension.","Both diltiazem and metoprolol can increase the risk of bradycardia.","Concurrent use of diltiazem and metoprolol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with metoprolol.","Diltiazem is predicted to increase the exposure to midazolam. Manufacturer advises monitor side effects and adjust dose.","Concurrent use of diltiazem and minoxidil can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to mizolastine.","Concurrent use of diltiazem and moexipril can increase the risk of hypotension.","Concurrent use of diltiazem and moxisylyte can increase the risk of hypotension.","Concurrent use of diltiazem and moxonidine can increase the risk of hypotension.","Both diltiazem and nadolol can increase the risk of bradycardia.","Concurrent use of diltiazem and nadolol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with nadolol.","Diltiazem is predicted to increase the exposure to naloxegol. Manufacturer advises adjust naloxegol dose and monitor side effects.","Both diltiazem and nebivolol can increase the risk of bradycardia.","Concurrent use of diltiazem and nebivolol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with nebivolol.","Both diltiazem and neostigmine can increase the risk of bradycardia.","Nevirapine is predicted to decrease the exposure to diltiazem.","Concurrent use of diltiazem and nicardipine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to nicardipine. Manufacturer advises monitor and adjust dose.","Concurrent use of diltiazem and nicorandil can increase the risk of hypotension.","Concurrent use of diltiazem and nifedipine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Diltiazem is predicted to increase the exposure to nilotinib.","Concurrent use of diltiazem and nimodipine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to nimodipine. Manufacturer advises monitor and adjust dose.","Concurrent use of diltiazem and nitrous oxide can increase the risk of hypotension.","Concurrent use of diltiazem and nortriptyline can increase the risk of hypotension.","Concurrent use of diltiazem and olanzapine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to olaparib. Manufacturer advises avoid or adjust olaparib dose.","Concurrent use of diltiazem and olmesartan can increase the risk of hypotension.","Both diltiazem and oxprenolol can increase the risk of bradycardia.","Concurrent use of diltiazem and oxprenolol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with oxprenolol.","Diltiazem is predicted to increase the exposure to oxybutynin.","Diltiazem is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of diltiazem and paliperidone can increase the risk of hypotension.","Both diltiazem and pasireotide can increase the risk of bradycardia.","Diltiazem is predicted to increase the exposure to pazopanib.","Concurrent use of diltiazem and pergolide can increase the risk of hypotension.","Concurrent use of diltiazem and pericyazine can increase the risk of hypotension.","Concurrent use of diltiazem and perindopril can increase the risk of hypotension.","Concurrent use of diltiazem and perphenazine can increase the risk of hypotension.","Concurrent use of diltiazem and phenelzine can increase the risk of hypotension.","Phenobarbital decreases the exposure to diltiazem.","Phenytoin decreases the exposure to diltiazem.","Concurrent use of diltiazem and pimozide can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to pimozide. Manufacturer advises avoid.","Both diltiazem and pindolol can increase the risk of bradycardia.","Concurrent use of diltiazem and pindolol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with pindolol.","Diltiazem is predicted to increase the concentration of piperaquine.","Posaconazole is predicted to increase the exposure to diltiazem.","Concurrent use of diltiazem and pramipexole can increase the risk of hypotension.","Concurrent use of diltiazem and prazosin can increase the risk of hypotension.","Primidone decreases the exposure to diltiazem.","Concurrent use of diltiazem and prochlorperazine can increase the risk of hypotension.","Concurrent use of diltiazem and promazine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to propafenone. Manufacturer advises monitor and adjust dose.","Concurrent use of diltiazem and propofol can increase the risk of hypotension.","Both diltiazem and propranolol can increase the risk of bradycardia.","Concurrent use of diltiazem and propranolol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with propranolol.","Both diltiazem and pyridostigmine can increase the risk of bradycardia.","Concurrent use of diltiazem and quetiapine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to quetiapine. Manufacturer advises avoid.","Concurrent use of diltiazem and quinagolide can increase the risk of hypotension.","Concurrent use of diltiazem and quinapril can increase the risk of hypotension.","Concurrent use of diltiazem and ramipril can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to ranolazine.","Both diltiazem and remifentanil can increase the risk of bradycardia.","Rifampicin decreases the exposure to diltiazem.","Concurrent use of diltiazem and riociguat can increase the risk of hypotension.","Concurrent use of diltiazem and risperidone can increase the risk of hypotension.","Ritonavir is predicted to increase the exposure to diltiazem.","Both diltiazem and rivastigmine can increase the risk of bradycardia.","Diltiazem increases the risk of bradycardia when given with rivastigmine.","Concurrent use of diltiazem and ropinirole can increase the risk of hypotension.","Concurrent use of diltiazem and rotigotine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to rupatadine. Manufacturer advises avoid.","Diltiazem is predicted to increase the exposure to ruxolitinib.","Concurrent use of diltiazem and sacubitril can increase the risk of hypotension.","Concurrent use of diltiazem and sapropterin can increase the risk of hypotension.","Saquinavir is predicted to increase the exposure to diltiazem.","Diltiazem is predicted to increase the exposure to saxagliptin.","Both diltiazem and selegiline can increase the risk of bradycardia.","Concurrent use of diltiazem and selegiline can increase the risk of hypotension.","Concurrent use of diltiazem and sevoflurane can increase the risk of hypotension.","Concurrent use of diltiazem and sildenafil can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to sildenafil. Manufacturer advises monitor and adjust sildenafil dose.","Diltiazem is predicted to increase the exposure to simeprevir. Manufacturer advises avoid.","Diltiazem is predicted to increase the exposure to simvastatin. Manufacturer advises use with caution and adjust simvastatin dose.","Diltiazem increases the concentration of sirolimus. Manufacturer advises monitor and adjust dose.","Concurrent use of diltiazem and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of diltiazem and sodium oxybate can increase the risk of hypotension.","Both diltiazem and sotalol can increase the risk of bradycardia.","Concurrent use of diltiazem and sotalol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with sotalol.","Concurrent use of diltiazem and spironolactone can increase the risk of hypotension.","St John's Wort is predicted to decrease the exposure to diltiazem.","Both diltiazem and sufentanil can increase the risk of bradycardia.","Diltiazem is predicted to increase the exposure to sufentanil.","Concurrent use of diltiazem and sulpiride can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to sunitinib.","Diltiazem is predicted to increase the concentration of tacrolimus.","Concurrent use of diltiazem and tadalafil can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to tadalafil.","Concurrent use of diltiazem and tamsulosin can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to tamsulosin.","Concurrent use of diltiazem and telmisartan can increase the risk of hypotension.","Diltiazem is predicted to increase the concentration of temsirolimus.","Concurrent use of diltiazem and terazosin can increase the risk of hypotension.","Both diltiazem and thalidomide can increase the risk of bradycardia.","Concurrent use of diltiazem and thiopental can increase the risk of hypotension.","Both diltiazem and timolol can increase the risk of bradycardia.","Concurrent use of diltiazem and timolol can increase the risk of hypotension.","Diltiazem is predicted to increase the risk of cardiodepression when given with timolol.","Tipranavir is predicted to increase the exposure to diltiazem.","Both diltiazem and tizanidine can increase the risk of bradycardia.","Concurrent use of diltiazem and tizanidine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to tofacitinib.","Diltiazem is predicted to increase the exposure to tolterodine.","Diltiazem is predicted to increase the exposure to tolvaptan. Manufacturer advises adjust dose.","Concurrent use of diltiazem and torasemide can increase the risk of hypotension.","Concurrent use of diltiazem and trandolapril can increase the risk of hypotension.","Concurrent use of diltiazem and tranylcypromine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to trazodone.","Concurrent use of diltiazem and trifluoperazine can increase the risk of hypotension.","Concurrent use of diltiazem and trimipramine can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to ulipristal. Manufacturer advises avoid if used for uterine fibroids.","Concurrent use of diltiazem and valsartan can increase the risk of hypotension.","Concurrent use of diltiazem and vardenafil can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to vardenafil. Manufacturer advises adjust dose.","Diltiazem is predicted to increase the exposure to venetoclax. Manufacturer advises avoid or adjust venetoclax dose.","Both diltiazem and verapamil can increase the risk of bradycardia.","Concurrent use of diltiazem and verapamil can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to vinblastine.","Diltiazem is predicted to increase the exposure to vincristine.","Diltiazem is predicted to increase the exposure to vindesine.","Diltiazem is predicted to increase the exposure to vinflunine.","Diltiazem is predicted to increase the exposure to vinorelbine.","Voriconazole is predicted to increase the exposure to diltiazem.","Concurrent use of diltiazem and xipamide can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of diltiazem and zuclopenthixol can increase the risk of hypotension."]},{"name":"BNF.Doxazosin.Doxazosin","imports":["BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Clarithromycin.Clarithromycin","BNF.Diltiazem.Diltiazem","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Nifedipine.Nifedipine","BNF.Prochlorperazine.Prochlorperazine","BNF.Ramipril.Ramipril","BNF.Spironolactone.Spironolactone"],"interactioninfo":["Concurrent use of doxazosin and acebutolol can increase the risk of hypotension.","Concurrent use of doxazosin and alcohol (beverage) can increase the risk of hypotension.","Concurrent use of doxazosin and alfuzosin can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and alfuzosin can increase the risk of hypotension.","Concurrent use of doxazosin and aliskiren can increase the risk of hypotension.","Concurrent use of doxazosin and alprostadil can increase the risk of hypotension.","Concurrent use of doxazosin and amantadine can increase the risk of hypotension.","Concurrent use of doxazosin and amitriptyline can increase the risk of hypotension.","Concurrent use of doxazosin and amlodipine can increase the risk of hypotension.","Concurrent use of doxazosin and apomorphine can increase the risk of hypotension.","Concurrent use of doxazosin and apraclonidine can increase the risk of hypotension.","Concurrent use of doxazosin and aripiprazole can increase the risk of hypotension.","Concurrent use of doxazosin and asenapine can increase the risk of hypotension.","Atazanavir is predicted to increase the exposure to doxazosin.","Concurrent use of doxazosin and atenolol can increase the risk of hypotension.","Concurrent use of doxazosin and avanafil can increase the risk of hypotension.","Doxazosin causes significant hypotensive effects when given with avanafil. Manufacturer advises patient should be stabilised on first drug then second drug should be added at the lowest recommended dose.","Concurrent use of doxazosin and azilsartan can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and azilsartan can increase the risk of hypotension.","Concurrent use of doxazosin and baclofen can increase the risk of hypotension.","Concurrent use of doxazosin and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of doxazosin and benperidol can increase the risk of hypotension.","Concurrent use of doxazosin and betaxolol can increase the risk of hypotension.","Concurrent use of doxazosin and bisoprolol can increase the risk of hypotension.","Concurrent use of doxazosin and bortezomib can increase the risk of hypotension.","Concurrent use of doxazosin and brimonidine can increase the risk of hypotension.","Concurrent use of doxazosin and bromocriptine can increase the risk of hypotension.","Concurrent use of doxazosin and bumetanide can increase the risk of hypotension.","Concurrent use of doxazosin and cabergoline can increase the risk of hypotension.","Concurrent use of doxazosin and canagliflozin can increase the risk of hypotension.","Concurrent use of doxazosin and candesartan can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and candesartan can increase the risk of hypotension.","Concurrent use of doxazosin and captopril can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and captopril can increase the risk of hypotension.","Concurrent use of doxazosin and carteolol can increase the risk of hypotension.","Concurrent use of doxazosin and carvedilol can increase the risk of hypotension.","Concurrent use of doxazosin and celiprolol can increase the risk of hypotension.","Concurrent use of doxazosin and chlorothiazide can increase the risk of hypotension.","Concurrent use of doxazosin and chlorpromazine can increase the risk of hypotension.","Concurrent use of doxazosin and chlortalidone can increase the risk of hypotension.","Clarithromycin is predicted to increase the exposure to doxazosin.","Concurrent use of doxazosin and clevidipine can increase the risk of hypotension.","Concurrent use of doxazosin and clomipramine can increase the risk of hypotension.","Concurrent use of doxazosin and clonidine can increase the risk of hypotension.","Concurrent use of doxazosin and clopamide can increase the risk of hypotension.","Concurrent use of doxazosin and clozapine can increase the risk of hypotension.","Cobicistat is predicted to increase the exposure to doxazosin.","Concurrent use of doxazosin and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of doxazosin and dapagliflozin can increase the risk of hypotension.","Darunavir is predicted to increase the exposure to doxazosin.","Concurrent use of doxazosin and desflurane can increase the risk of hypotension.","Concurrent use of doxazosin and diazoxide can increase the risk of hypotension.","Concurrent use of doxazosin and diltiazem can increase the risk of hypotension.","Concurrent use of doxazosin and dipyridamole can increase the risk of hypotension.","Concurrent use of doxazosin and dosulepin can increase the risk of hypotension.","Concurrent use of doxazosin and doxepin can increase the risk of hypotension.","Concurrent use of doxazosin and droperidol can increase the risk of hypotension.","Concurrent use of doxazosin and empagliflozin can increase the risk of hypotension.","Concurrent use of doxazosin and enalapril can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and enalapril can increase the risk of hypotension.","Concurrent use of doxazosin and eplerenone can increase the risk of hypotension.","Concurrent use of doxazosin and eprosartan can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and eprosartan can increase the risk of hypotension.","Concurrent use of doxazosin and esmolol can increase the risk of hypotension.","Concurrent use of doxazosin and etomidate can increase the risk of hypotension.","Concurrent use of doxazosin and felodipine can increase the risk of hypotension.","Concurrent use of doxazosin and flupentixol can increase the risk of hypotension.","Concurrent use of doxazosin and fluphenazine can increase the risk of hypotension.","Fosamprenavir is predicted to increase the exposure to doxazosin.","Concurrent use of doxazosin and fosinopril can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and fosinopril can increase the risk of hypotension.","Concurrent use of doxazosin and furosemide can increase the risk of hypotension.","Concurrent use of doxazosin and glyceryl trinitrate can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of doxazosin and guanethidine can increase the risk of hypotension.","Concurrent use of doxazosin and guanfacine can increase the risk of hypotension.","Concurrent use of doxazosin and haloperidol can increase the risk of hypotension.","Concurrent use of doxazosin and histamine can increase the risk of hypotension.","Concurrent use of doxazosin and hydralazine can increase the risk of hypotension.","Concurrent use of doxazosin and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of doxazosin and hydroflumethiazide can increase the risk of hypotension.","Idelalisib is predicted to increase the exposure to doxazosin.","Concurrent use of doxazosin and imidapril can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and imidapril can increase the risk of hypotension.","Concurrent use of doxazosin and imipramine can increase the risk of hypotension.","Concurrent use of doxazosin and indapamide can increase the risk of hypotension.","Concurrent use of doxazosin and indoramin can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and indoramin can increase the risk of hypotension.","Concurrent use of doxazosin and irbesartan can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and irbesartan can increase the risk of hypotension.","Concurrent use of doxazosin and isocarboxazid can increase the risk of hypotension.","Concurrent use of doxazosin and isoflurane can increase the risk of hypotension.","Concurrent use of doxazosin and isosorbide dinitrate can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of doxazosin and isosorbide mononitrate can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of doxazosin and isradipine can increase the risk of hypotension.","Itraconazole is predicted to increase the exposure to doxazosin.","Concurrent use of doxazosin and ketamine can increase the risk of hypotension.","Ketoconazole is predicted to increase the exposure to doxazosin.","Concurrent use of doxazosin and labetalol can increase the risk of hypotension.","Concurrent use of doxazosin and lacidipine can increase the risk of hypotension.","Concurrent use of doxazosin and lercanidipine can increase the risk of hypotension.","Concurrent use of doxazosin and levobunolol can increase the risk of hypotension.","Concurrent use of doxazosin and levodopa can increase the risk of hypotension.","Concurrent use of doxazosin and levomepromazine can increase the risk of hypotension.","Concurrent use of doxazosin and lisinopril can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and lisinopril can increase the risk of hypotension.","Concurrent use of doxazosin and lofepramine can increase the risk of hypotension.","Concurrent use of doxazosin and lofexidine can increase the risk of hypotension.","Lopinavir is predicted to increase the exposure to doxazosin.","Concurrent use of doxazosin and losartan can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and losartan can increase the risk of hypotension.","Concurrent use of doxazosin and loxapine can increase the risk of hypotension.","Concurrent use of doxazosin and lurasidone can increase the risk of hypotension.","Concurrent use of doxazosin and methyldopa can increase the risk of hypotension.","Concurrent use of doxazosin and metolazone can increase the risk of hypotension.","Concurrent use of doxazosin and metoprolol can increase the risk of hypotension.","Concurrent use of doxazosin and minoxidil can increase the risk of hypotension.","Concurrent use of doxazosin and moexipril can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and moexipril can increase the risk of hypotension.","Concurrent use of doxazosin and moxisylyte can increase the risk of hypotension.","Concurrent use of doxazosin and moxonidine can increase the risk of hypotension.","Concurrent use of doxazosin and nadolol can increase the risk of hypotension.","Concurrent use of doxazosin and nebivolol can increase the risk of hypotension.","Concurrent use of doxazosin and nicardipine can increase the risk of hypotension.","Concurrent use of doxazosin and nicorandil can increase the risk of hypotension.","Concurrent use of doxazosin and nifedipine can increase the risk of hypotension.","Concurrent use of doxazosin and nimodipine can increase the risk of hypotension.","Concurrent use of doxazosin and nitrous oxide can increase the risk of hypotension.","Concurrent use of doxazosin and nortriptyline can increase the risk of hypotension.","Concurrent use of doxazosin and olanzapine can increase the risk of hypotension.","Concurrent use of doxazosin and olmesartan can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and olmesartan can increase the risk of hypotension.","Concurrent use of doxazosin and oxprenolol can increase the risk of hypotension.","Concurrent use of doxazosin and paliperidone can increase the risk of hypotension.","Concurrent use of doxazosin and pergolide can increase the risk of hypotension.","Concurrent use of doxazosin and pericyazine can increase the risk of hypotension.","Concurrent use of doxazosin and perindopril can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and perindopril can increase the risk of hypotension.","Concurrent use of doxazosin and perphenazine can increase the risk of hypotension.","Concurrent use of doxazosin and phenelzine can increase the risk of hypotension.","Concurrent use of doxazosin and pimozide can increase the risk of hypotension.","Concurrent use of doxazosin and pindolol can increase the risk of hypotension.","Concurrent use of doxazosin and pramipexole can increase the risk of hypotension.","Concurrent use of doxazosin and prazosin can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and prazosin can increase the risk of hypotension.","Concurrent use of doxazosin and prochlorperazine can increase the risk of hypotension.","Concurrent use of doxazosin and promazine can increase the risk of hypotension.","Concurrent use of doxazosin and propofol can increase the risk of hypotension.","Concurrent use of doxazosin and propranolol can increase the risk of hypotension.","Concurrent use of doxazosin and quetiapine can increase the risk of hypotension.","Concurrent use of doxazosin and quinagolide can increase the risk of hypotension.","Concurrent use of doxazosin and quinapril can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and quinapril can increase the risk of hypotension.","Concurrent use of doxazosin and ramipril can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and ramipril can increase the risk of hypotension.","Concurrent use of doxazosin and riociguat can increase the risk of hypotension.","Concurrent use of doxazosin and risperidone can increase the risk of hypotension.","Ritonavir is predicted to increase the exposure to doxazosin.","Concurrent use of doxazosin and ropinirole can increase the risk of hypotension.","Concurrent use of doxazosin and rotigotine can increase the risk of hypotension.","Concurrent use of doxazosin and sacubitril can increase the risk of hypotension.","Concurrent use of doxazosin and sapropterin can increase the risk of hypotension.","Saquinavir is predicted to increase the exposure to doxazosin.","Concurrent use of doxazosin and selegiline can increase the risk of hypotension.","Concurrent use of doxazosin and sevoflurane can increase the risk of hypotension.","Concurrent use of doxazosin and sildenafil can increase the risk of hypotension.","Doxazosin causes significant hypotensive effects when given with sildenafil. Manufacturer advises patient should be stabilised on first drug then second drug should be added at the lowest recommended dose.","Concurrent use of doxazosin and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of doxazosin and sodium oxybate can increase the risk of hypotension.","Concurrent use of doxazosin and sotalol can increase the risk of hypotension.","Concurrent use of doxazosin and spironolactone can increase the risk of hypotension.","Concurrent use of doxazosin and sulpiride can increase the risk of hypotension.","Concurrent use of doxazosin and tadalafil can increase the risk of hypotension.","Doxazosin causes significant hypotensive effects when given with tadalafil. Manufacturer advises patient should be stabilised on first drug then second drug should be added at the lowest recommended dose.","Concurrent use of doxazosin and tamsulosin can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and tamsulosin can increase the risk of hypotension.","Concurrent use of doxazosin and telmisartan can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and telmisartan can increase the risk of hypotension.","Concurrent use of doxazosin and terazosin can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and terazosin can increase the risk of hypotension.","Concurrent use of doxazosin and thiopental can increase the risk of hypotension.","Concurrent use of doxazosin and timolol can increase the risk of hypotension.","Tipranavir is predicted to increase the exposure to doxazosin.","Concurrent use of doxazosin and tizanidine can increase the risk of hypotension.","Concurrent use of doxazosin and torasemide can increase the risk of hypotension.","Concurrent use of doxazosin and trandolapril can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and trandolapril can increase the risk of hypotension.","Concurrent use of doxazosin and tranylcypromine can increase the risk of hypotension.","Concurrent use of doxazosin and trifluoperazine can increase the risk of hypotension.","Concurrent use of doxazosin and trimipramine can increase the risk of hypotension.","Concurrent use of doxazosin and valsartan can increase the risk of first-dose hypotension.","Concurrent use of doxazosin and valsartan can increase the risk of hypotension.","Concurrent use of doxazosin and vardenafil can increase the risk of hypotension.","Doxazosin causes significant hypotensive effects when given with vardenafil. Manufacturer advises patient should be stabilised on first drug then second drug should be added at the lowest recommended dose.","Concurrent use of doxazosin and verapamil can increase the risk of hypotension.","Voriconazole is predicted to increase the exposure to doxazosin.","Concurrent use of doxazosin and xipamide can increase the risk of hypotension.","Concurrent use of doxazosin and zuclopenthixol can increase the risk of hypotension."]},{"name":"BNF.Doxycycline.Doxycycline","imports":["BNF.Atorvastatin.Atorvastatin","BNF.Carbamazepine.Carbamazepine","BNF.Paracetamol.Paracetamol","BNF.Phenytoin.Phenytoin","BNF.Pravastatin.Pravastatin","BNF.Simvastatin.Simvastatin","BNF.Warfarin.Warfarin"],"interactioninfo":["Doxycycline increases the risk of bleeding events when given with acenocoumarol.","Acitretin increases the risk of benign intracranial hypertension when given with doxycycline. Manufacturer advises avoid.","Concurrent use of doxycycline and alcohol (beverage) can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and alectinib can increase the risk of hepatotoxicity.","Alitretinoin increases the risk of benign intracranial hypertension when given with doxycycline. Manufacturer advises avoid.","Aluminium hydroxide decreases the absorption of doxycycline. Manufacturer advises separate administration by 2 to 3 hours.","Concurrent use of doxycycline and asparaginase can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and atorvastatin can increase the risk of hepatotoxicity.","Calcium carbonate is predicted to decrease the absorption of doxycycline. Manufacturer advises separate administration by 2 to 3 hours.","Concurrent use of doxycycline and carbamazepine can increase the risk of hepatotoxicity.","Carbamazepine decreases the exposure to doxycycline. Manufacturer advises monitor and adjust dose.","Concurrent use of doxycycline and crisantaspase can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and daclizumab can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and dactinomycin can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and dantrolene can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and demeclocycline can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and didanosine can increase the risk of hepatotoxicity.","Enzalutamide decreases the exposure to doxycycline. Manufacturer advises monitor and adjust dose.","Ferric maltol decreases the absorption of doxycycline. Manufacturer advises doxycycline should be taken 2 to 3 hours after ferric maltol.","Ferrous fumarate decreases the absorption of doxycycline. Manufacturer advises doxycycline should be taken 2 to 3 hours after ferrous fumarate.","Ferrous gluconate decreases the absorption of doxycycline. Manufacturer advises doxycycline should be taken 2 to 3 hours after ferrous gluconate.","Ferrous sulfate decreases the absorption of doxycycline. Manufacturer advises doxycycline should be taken 2 to 3 hours after ferrous sulfate.","Concurrent use of doxycycline and fluconazole can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and fluvastatin can increase the risk of hepatotoxicity.","Fosphenytoin decreases the exposure to doxycycline. Manufacturer advises monitor and adjust dose.","Concurrent use of doxycycline and isoniazid can increase the risk of hepatotoxicity.","Isotretinoin increases the risk of benign intracranial hypertension when given with doxycycline. Manufacturer advises avoid.","Concurrent use of doxycycline and itraconazole can increase the risk of hepatotoxicity.","Kaolin is predicted to decrease the absorption of doxycycline.","Lanthanum is predicted to decrease the absorption of doxycycline. Manufacturer advises separate administration by 2 hours.","Concurrent use of doxycycline and leflunomide can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and lenalidomide can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and lomitapide can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and lymecycline can increase the risk of hepatotoxicity.","Magnesium carbonate decreases the absorption of doxycycline. Manufacturer advises separate administration by 2 to 3 hours.","Magnesium trisilicate decreases the absorption of doxycycline. Manufacturer advises separate administration by 2 to 3 hours.","Concurrent use of doxycycline and mercaptopurine can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and methotrexate can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and micafungin can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and minocycline can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and oxytetracycline can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and paracetamol can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and pegaspargase can increase the risk of hepatotoxicity.","Phenobarbital decreases the exposure to doxycycline. Manufacturer advises monitor and adjust dose.","Phenytoin decreases the exposure to doxycycline. Manufacturer advises monitor and adjust dose.","Polysaccharide-iron complex decreases the absorption of doxycycline. Manufacturer advises doxycycline should be taken 2 to 3 hours after polysaccharide-iron complex.","Concurrent use of doxycycline and pravastatin can increase the risk of hepatotoxicity.","Primidone decreases the exposure to doxycycline. Manufacturer advises monitor and adjust dose.","Rifampicin decreases the exposure to doxycycline. Manufacturer advises monitor and adjust dose.","Concurrent use of doxycycline and rosuvastatin can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and simvastatin can increase the risk of hepatotoxicity.","Sodium feredetate decreases the absorption of doxycycline. Manufacturer advises doxycycline should be taken 2 to 3 hours after sodium feredetate.","Strontium ranelate is predicted to decrease the absorption of doxycycline. Manufacturer advises avoid.","Concurrent use of doxycycline and sulfasalazine can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and tetracycline can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and tigecycline can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and trabectedin can increase the risk of hepatotoxicity.","Tretinoin increases the risk of benign intracranial hypertension when given with doxycycline. Manufacturer advises avoid.","Concurrent use of doxycycline and valproate can increase the risk of hepatotoxicity.","Concurrent use of doxycycline and vincristine can increase the risk of hepatotoxicity.","Doxycycline increases the risk of bleeding events when given with warfarin.","Oral zinc is predicted to decrease the absorption of doxycycline. Manufacturer advises separate administration by 2 to 3 hours."]},{"name":"BNF.Enoxaparin.Enoxaparin","imports":["BNF.Amiloride.Amiloride","BNF.Apixaban.Apixaban","BNF.Candesartan.Candesartan","BNF.Citalopram.Citalopram","BNF.Diclofenac.Diclofenac","BNF.Fluoxetine.Fluoxetine","BNF.Glucose.Glucose","BNF.Ibuprofen.Ibuprofen","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Naproxen.Naproxen","BNF.Ramipril.Ramipril","BNF.Rivaroxaban.Rivaroxaban","BNF.Sertraline.Sertraline","BNF.Spironolactone.Spironolactone","BNF.Trimethoprim.Trimethoprim","BNF.Venlafaxine.Venlafaxine","BNF.Warfarin.Warfarin"],"interactioninfo":["Enoxaparin is predicted to increase the risk of bleeding events when given with abciximab. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and aceclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with aceclofenac. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and acemetacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with acemetacin. Manufacturer advises use with caution or avoid.","Both enoxaparin and acenocoumarol can increase the risk of bleeding.","Concurrent use of enoxaparin and aliskiren can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both enoxaparin and alteplase can increase the risk of bleeding.","Concurrent use of enoxaparin and amiloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with anagrelide. Manufacturer advises use with caution or avoid.","Both enoxaparin and apixaban can increase the risk of bleeding.","Both enoxaparin and argatroban can increase the risk of bleeding.","Enoxaparin is predicted to increase the risk of bleeding events when given with aspirin. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and azilsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and benzydamine can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with bevacizumab. Manufacturer advises use with caution or avoid.","Both enoxaparin and bivalirudin can increase the risk of bleeding.","Concurrent use of enoxaparin and bromfenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and candesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with cangrelor. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and captopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and celecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with celecoxib. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and ciclosporin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with cilostazol. Manufacturer advises use with caution or avoid.","Enoxaparin is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Enoxaparin is predicted to increase the risk of bleeding events when given with clopidogrel. Manufacturer advises use with caution or avoid.","Both enoxaparin and dabigatran can increase the risk of bleeding.","Concurrent use of enoxaparin and dalteparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both enoxaparin and dalteparin can increase the risk of bleeding.","Both enoxaparin and danaparoid can increase the risk of bleeding.","Enoxaparin is predicted to increase the risk of bleeding events when given with dapoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and darbepoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with dasatinib. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and dexibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with dexibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and dexketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with dexketoprofen. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and diclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Enoxaparin is predicted to increase the risk of bleeding events when given with dipyridamole. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and drospirenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with duloxetine. Manufacturer advises use with caution or avoid.","Both enoxaparin and edoxaban can increase the risk of bleeding.","Concurrent use of enoxaparin and enalapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and eplerenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and epoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and epoetin beta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and epoetin zeta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with epoprostenol. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and eprosartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with eptifibatide. Manufacturer advises use with caution or avoid.","Enoxaparin is predicted to increase the risk of bleeding events when given with escitalopram. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and etodolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with etodolac. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and etoricoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with etoricoxib. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and felbinac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and fenoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with fenoprofen. Manufacturer advises use with caution or avoid.","Enoxaparin is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and flurbiprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with flurbiprofen. Manufacturer advises use with caution or avoid.","Enoxaparin is predicted to increase the risk of bleeding events when given with fluvoxamine. Manufacturer advises use with caution or avoid.","Both enoxaparin and fondaparinux can increase the risk of bleeding.","Both enoxaparin and glucose can increase the risk of bleeding.","Concurrent use of enoxaparin and heparin (unfractionated) can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both enoxaparin and heparin (unfractionated) can increase the risk of bleeding.","Enoxaparin is predicted to increase the risk of bleeding events when given with ibrutinib. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and ibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Enoxaparin is predicted to increase the risk of bleeding events when given with iloprost. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and imidapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and indometacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with indometacin. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and irbesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and ketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with ketoprofen. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and ketorolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with ketorolac. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and lisinopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and losartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and mefenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with mefenamic acid. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and meloxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with meloxicam. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and moexipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and nabumetone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with nabumetone. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and naproxen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and nepafenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both enoxaparin and nicotinic acid can increase the risk of bleeding.","Concurrent use of enoxaparin and olmesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both enoxaparin and omega-3-acid ethyl esters can increase the risk of bleeding.","Concurrent use of enoxaparin and parecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with parecoxib. Manufacturer advises use with caution or avoid.","Enoxaparin is predicted to increase the risk of bleeding events when given with paroxetine. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and perindopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both enoxaparin and phenindione can increase the risk of bleeding.","Concurrent use of enoxaparin and piroxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with piroxicam. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and potassium canrenoate can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and potassium chloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with prasugrel. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and quinapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and ramipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Ranibizumab increases the risk of bleeding events when given with enoxaparin.","Enoxaparin is predicted to increase the risk of bleeding events when given with regorafenib. Manufacturer advises use with caution or avoid.","Both enoxaparin and reteplase can increase the risk of bleeding.","Both enoxaparin and rivaroxaban can increase the risk of bleeding.","Enoxaparin is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and spironolactone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both enoxaparin and streptokinase can increase the risk of bleeding.","Enoxaparin is predicted to increase the risk of bleeding events when given with sulfinpyrazone. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and sulindac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with sulindac. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and tacrolimus can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and telmisartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both enoxaparin and tenecteplase can increase the risk of bleeding.","Concurrent use of enoxaparin and tenoxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with tenoxicam. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and tiaprofenic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with tiaprofenic acid. Manufacturer advises use with caution or avoid.","Enoxaparin is predicted to increase the risk of bleeding events when given with ticagrelor. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and tinzaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both enoxaparin and tinzaparin can increase the risk of bleeding.","Enoxaparin is predicted to increase the risk of bleeding events when given with tirofiban. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and tolfenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with tolfenamic acid. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and tolvaptan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and trandolapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with trastuzumab. Manufacturer advises use with caution or avoid.","Enoxaparin is predicted to increase the risk of bleeding events when given with trastuzumab emtansine. Manufacturer advises use with caution or avoid.","Concurrent use of enoxaparin and triamterene can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of enoxaparin and trimethoprim can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both enoxaparin and urokinase can increase the risk of bleeding.","Concurrent use of enoxaparin and valsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Enoxaparin is predicted to increase the risk of bleeding events when given with vortioxetine. Manufacturer advises use with caution or avoid.","Both enoxaparin and warfarin can increase the risk of bleeding."]},{"name":"BNF.Esomeprazole.Esomeprazole","imports":["BNF.Citalopram.Citalopram"],"interactioninfo":["Esomeprazole decreases the exposure to atazanavir. Manufacturer advises avoid or adjust dose.","Esomeprazole is predicted to decrease the absorption of bosutinib.","Esomeprazole is predicted to decrease the absorption of ceritinib.","Esomeprazole is predicted to increase the exposure to cilostazol.","Esomeprazole is predicted to slightly to moderately increase the exposure to citalopram. Manufacturer advises monitor and adjust dose.","Esomeprazole is predicted to decrease the efficacy of clopidogrel. Manufacturer advises avoid.","Esomeprazole is predicted to decrease the exposure to dabrafenib. Manufacturer advises avoid.","Esomeprazole is predicted to slightly to moderately decrease the exposure to dasatinib. Manufacturer advises avoid.","Esomeprazole is predicted to decrease the absorption of dipyridamole (immediate release tablets).","Esomeprazole is predicted to slightly decrease the exposure to erlotinib. Manufacturer advises avoid.","Esomeprazole is predicted to slightly to moderately increase the exposure to escitalopram. Manufacturer advises monitor and adjust dose.","Fluconazole is predicted to increase the exposure to esomeprazole.","Fluvoxamine is predicted to increase the exposure to esomeprazole.","Esomeprazole is predicted to decrease the exposure to gefitinib.","Esomeprazole decreases the absorption of itraconazole. Manufacturer advises administer itraconazole capsules with an acidic beverage.","Esomeprazole decreases the absorption of ketoconazole. Manufacturer advises administer ketoconazole with an acidic beverage.","Esomeprazole is predicted to decrease the exposure to ledipasvir. Manufacturer advises adjust dose, see sofosbuvir with ledipasvir.","Lumacaftor is predicted to decrease the exposure to esomeprazole. Manufacturer advises adjust dose.","Esomeprazole decreases the clearance of methotrexate. Manufacturer advises use with caution or avoid.","Esomeprazole is predicted to decrease the exposure to pazopanib. Manufacturer advises avoid or administer concurrently without food.","Esomeprazole decreases the absorption of posaconazole (oral suspension). Manufacturer advises avoid.","Esomeprazole is predicted to decrease the exposure to rilpivirine. Manufacturer advises avoid.","Esomeprazole increases the exposure to saquinavir. Manufacturer advises avoid.","Esomeprazole potentially decreases the exposure to sofosbuvir. Manufacturer advises adjust dose, see sofosbuvir with ledipasvir and sofosbuvir with velpatasvir.","Tipranavir decreases the exposure to esomeprazole. Manufacturer advises avoid.","Esomeprazole is predicted to decrease the concentration of velpatasvir. Manufacturer advises adjust dose, see sofosbuvir with velpatasvir.","Voriconazole increases the exposure to esomeprazole. Manufacturer advises adjust dose."]},{"name":"BNF.Fentanyl.Fentanyl","imports":["BNF.Amiodarone.Amiodarone","BNF.Atenolol.Atenolol","BNF.Bisoprolol.Bisoprolol","BNF.Carbamazepine.Carbamazepine","BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Digoxin.Digoxin","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Diltiazem.Diltiazem","BNF.Fluoxetine.Fluoxetine","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Ondansetron.Ondansetron","BNF.Oxycodone.Oxycodone","BNF.Phenytoin.Phenytoin","BNF.Prochlorperazine.Prochlorperazine","BNF.Sertraline.Sertraline","BNF.Temazepam.Temazepam","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of fentanyl and St John's Wort can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fentanyl and acebutolol can increase the risk of bradycardia.","Concurrent use of fentanyl and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and alectinib can increase the risk of bradycardia.","Both fentanyl and alfentanil can increase the risk of bradycardia.","Concurrent use of fentanyl and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and almotriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and amiodarone can increase the risk of bradycardia.","Amiodarone is predicted to increase the concentration of fentanyl.","Concurrent use of fentanyl and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and apraclonidine can increase the risk of bradycardia.","Concurrent use of fentanyl and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Aprepitant is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Atazanavir is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Both fentanyl and atenolol can increase the risk of bradycardia.","Concurrent use of fentanyl and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and betaxolol can increase the risk of bradycardia.","Both fentanyl and bisoprolol can increase the risk of bradycardia.","Both fentanyl and brimonidine can increase the risk of bradycardia.","Concurrent use of fentanyl and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Buprenorphine is predicted to increase the risk of opiate withdrawal when given with fentanyl.","Concurrent use of fentanyl and bupropion can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and buspirone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Carbamazepine is predicted to decrease the exposure to fentanyl.","Both fentanyl and carteolol can increase the risk of bradycardia.","Both fentanyl and carvedilol can increase the risk of bradycardia.","Both fentanyl and celiprolol can increase the risk of bradycardia.","Ceritinib is predicted to increase the exposure to fentanyl. Manufacturer advises avoid.","Concurrent use of fentanyl and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Cimetidine increases the exposure to fentanyl.","Concurrent use of fentanyl and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and cisatracurium can increase the risk of bradycardia.","Concurrent use of fentanyl and citalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Clarithromycin is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and clomipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and clonidine can increase the risk of bradycardia.","Concurrent use of fentanyl and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Cobicistat is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and crizotinib can increase the risk of bradycardia.","Crizotinib is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and dapoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Darunavir is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and dexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and digoxin can increase the risk of bradycardia.","Concurrent use of fentanyl and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and diltiazem can increase the risk of bradycardia.","Diltiazem is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and donepezil can increase the risk of bradycardia.","Dronedarone is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and duloxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and eletriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Enzalutamide is predicted to decrease the exposure to fentanyl.","Erythromycin is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and escitalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fentanyl and esmolol can increase the risk of bradycardia.","Concurrent use of fentanyl and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and fingolimod can increase the risk of bradycardia.","Both fentanyl and flecainide can increase the risk of bradycardia.","Fluconazole is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and fluoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and fluvoxamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fosamprenavir is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Fosphenytoin is predicted to decrease the exposure to fentanyl.","Concurrent use of fentanyl and frovatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and galantamine can increase the risk of bradycardia.","Concurrent use of fentanyl and granisetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Idelalisib is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Imatinib is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and imipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Indinavir is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Isavuconazole is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and isocarboxazid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fentanyl is predicted to increase the risk of CNS excitation or depression when given with isocarboxazid. Manufacturer advises avoid.","Concurrent use of fentanyl and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Itraconazole is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Both fentanyl and ivabradine can increase the risk of bradycardia.","Concurrent use of fentanyl and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ketoconazole is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and labetalol can increase the risk of bradycardia.","Concurrent use of fentanyl and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and levobunolol can increase the risk of bradycardia.","Concurrent use of fentanyl and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and linezolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and lisdexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and lithium can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Lopinavir is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and methadone can increase the risk of bradycardia.","Concurrent use of fentanyl and methadone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and methylthioninium chloride can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fentanyl and metoprolol can increase the risk of bradycardia.","Concurrent use of fentanyl and mianserin can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and mirtazapine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and moclobemide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and nadolol can increase the risk of bradycardia.","Nalmefene is predicted to decrease the efficacy of fentanyl. Manufacturer advises avoid.","Concurrent use of fentanyl and naratriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fentanyl and nebivolol can increase the risk of bradycardia.","Both fentanyl and neostigmine can increase the risk of bradycardia.","Netupitant is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Nilotinib is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and ondansetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and oxprenolol can increase the risk of bradycardia.","Concurrent use of fentanyl and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Palbociclib is predicted to increase the exposure to fentanyl. Manufacturer advises adjust dose.","Concurrent use of fentanyl and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and palonosetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and paroxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fentanyl and pasireotide can increase the risk of bradycardia.","Concurrent use of fentanyl and pentazocine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Pentazocine is predicted to increase the risk of opiate withdrawal when given with fentanyl.","Concurrent use of fentanyl and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and pethidine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and phenelzine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fentanyl is predicted to increase the risk of CNS excitation or depression when given with phenelzine. Manufacturer advises avoid.","Concurrent use of fentanyl and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Phenobarbital is predicted to decrease the exposure to fentanyl.","Phenytoin is predicted to decrease the exposure to fentanyl.","Concurrent use of fentanyl and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and pindolol can increase the risk of bradycardia.","Concurrent use of fentanyl and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Posaconazole is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Primidone is predicted to decrease the exposure to fentanyl.","Concurrent use of fentanyl and procarbazine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and propranolol can increase the risk of bradycardia.","Both fentanyl and pyridostigmine can increase the risk of bradycardia.","Concurrent use of fentanyl and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and rasagiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fentanyl and remifentanil can increase the risk of bradycardia.","Concurrent use of fentanyl and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Rifampicin is predicted to decrease the exposure to fentanyl.","Concurrent use of fentanyl and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ritonavir is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Both fentanyl and rivastigmine can increase the risk of bradycardia.","Concurrent use of fentanyl and rizatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and safinamide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Saquinavir is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Both fentanyl and selegiline can increase the risk of bradycardia.","Concurrent use of fentanyl and selegiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and sertraline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and sotalol can increase the risk of bradycardia.","Both fentanyl and sufentanil can increase the risk of bradycardia.","Concurrent use of fentanyl and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and sumatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and tapentadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and tedizolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and thalidomide can increase the risk of bradycardia.","Concurrent use of fentanyl and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and timolol can increase the risk of bradycardia.","Tipranavir is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Both fentanyl and tizanidine can increase the risk of bradycardia.","Concurrent use of fentanyl and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and tramadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and tranylcypromine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fentanyl is predicted to increase the risk of CNS excitation or depression when given with tranylcypromine. Manufacturer advises avoid.","Concurrent use of fentanyl and trazodone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and venlafaxine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both fentanyl and verapamil can increase the risk of bradycardia.","Verapamil is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Voriconazole is predicted to increase the exposure to fentanyl. Manufacturer advises monitor and adjust dose.","Concurrent use of fentanyl and vortioxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and zolmitriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fentanyl and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of fentanyl and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Flucloxacillin.Flucloxacillin","imports":["BNF.Warfarin.Warfarin"],"interactioninfo":["Flucloxacillin potentially alters the anticoagulant effect of acenocoumarol. Manufacturer advises monitor INR and adjust dose.","Flucloxacillin is predicted to increase the risk of toxicity when given with methotrexate.","Flucloxacillin is predicted to increase the risk of bleeding events when given with phenindione.","Flucloxacillin potentially alters the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose."]},{"name":"BNF.Fluoxetine.Fluoxetine","imports":["BNF.Amiloride.Amiloride","BNF.Amitriptyline.Amitriptyline","BNF.Apixaban.Apixaban","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bumetanide.Bumetanide","BNF.Carbamazepine.Carbamazepine","BNF.Citalopram.Citalopram","BNF.Codeine.Codeine","BNF.Diclofenac.Diclofenac","BNF.Enoxaparin.Enoxaparin","BNF.Fentanyl.Fentanyl","BNF.Furosemide.Furosemide","BNF.Glucose.Glucose","BNF.Haloperidol.Haloperidol","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Mirtazapine.Mirtazapine","BNF.Naproxen.Naproxen","BNF.Ondansetron.Ondansetron","BNF.Phenytoin.Phenytoin","BNF.Rivaroxaban.Rivaroxaban","BNF.Sertraline.Sertraline","BNF.Spironolactone.Spironolactone","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Trimethoprim.Trimethoprim","BNF.Venlafaxine.Venlafaxine","BNF.Warfarin.Warfarin"],"interactioninfo":["Concurrent use of fluoxetine and St John's Wort can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fluoxetine and abciximab can increase the risk of bleeding.","Concurrent use of fluoxetine and aceclofenac can increase the risk of hyponatraemia.","Both fluoxetine and aceclofenac can increase the risk of bleeding.","Concurrent use of fluoxetine and acemetacin can increase the risk of hyponatraemia.","Both fluoxetine and acemetacin can increase the risk of bleeding.","Acenocoumarol is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of fluoxetine and almotriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Alteplase is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of fluoxetine and amiloride can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and amitriptyline can increase the risk of hyponatraemia.","Fluoxetine is predicted to increase the exposure to amitriptyline. Manufacturer advises monitor for toxicity and adjust dose.","Both fluoxetine and anagrelide can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Argatroban is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Fluoxetine is predicted to moderately increase the exposure to aripiprazole. Manufacturer advises adjust aripiprazole dose.","Both fluoxetine and aspirin can increase the risk of bleeding.","Fluoxetine is predicted to markedly increase the exposure to atomoxetine. Manufacturer advises adjust dose.","Concurrent use of fluoxetine and bendroflumethiazide can increase the risk of hyponatraemia.","Both fluoxetine and bevacizumab can increase the risk of bleeding.","Bivalirudin is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of fluoxetine and bumetanide can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and bupropion can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and buspirone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fluoxetine and cangrelor can increase the risk of bleeding.","Concurrent use of fluoxetine and carbamazepine can increase the risk of hyponatraemia.","Fluoxetine is predicted to increase the exposure to carvedilol.","Concurrent use of fluoxetine and celecoxib can increase the risk of hyponatraemia.","Both fluoxetine and celecoxib can increase the risk of bleeding.","Concurrent use of fluoxetine and chlorothiazide can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and chlortalidone can increase the risk of hyponatraemia.","Both fluoxetine and cilostazol can increase the risk of bleeding.","Concurrent use of fluoxetine and citalopram can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and citalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fluoxetine and citalopram can increase the risk of bleeding.","Concurrent use of fluoxetine and clomipramine can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and clomipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fluoxetine is predicted to increase the exposure to clomipramine. Manufacturer advises monitor for toxicity and adjust dose.","Concurrent use of fluoxetine and clopamide can increase the risk of hyponatraemia.","Both fluoxetine and clopidogrel can increase the risk of bleeding.","Fluoxetine is predicted to decrease the efficacy of codeine.","Concurrent use of fluoxetine and cyclopenthiazide can increase the risk of hyponatraemia.","Cyproheptadine potentially decreases the effects of fluoxetine.","Dabigatran is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Dalteparin is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Danaparoid is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of fluoxetine and dapoxetine can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and dapoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fluoxetine and dapoxetine can increase the risk of bleeding.","Fluoxetine is predicted to increase the exposure to dapoxetine.","Fluoxetine is predicted to slightly increase the exposure to darifenacin.","Both fluoxetine and dasatinib can increase the risk of bleeding.","Concurrent use of fluoxetine and desmopressin can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and dexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fluoxetine is predicted to increase the exposure to dexamfetamine.","Concurrent use of fluoxetine and dexibuprofen can increase the risk of hyponatraemia.","Both fluoxetine and dexibuprofen can increase the risk of bleeding.","Concurrent use of fluoxetine and dexketoprofen can increase the risk of hyponatraemia.","Both fluoxetine and dexketoprofen can increase the risk of bleeding.","Concurrent use of fluoxetine and diclofenac can increase the risk of hyponatraemia.","Both fluoxetine and diclofenac can increase the risk of bleeding.","Both fluoxetine and dipyridamole can increase the risk of bleeding.","Fluoxetine is predicted to increase the exposure to donepezil.","Concurrent use of fluoxetine and dosulepin can increase the risk of hyponatraemia.","Fluoxetine is predicted to increase the exposure to dosulepin. Manufacturer advises monitor for toxicity and adjust dose.","Concurrent use of fluoxetine and doxepin can increase the risk of hyponatraemia.","Fluoxetine is predicted to increase the exposure to doxepin. Manufacturer advises monitor for toxicity and adjust dose.","Dronedarone is predicted to increase the exposure to fluoxetine.","Concurrent use of fluoxetine and duloxetine can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and duloxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fluoxetine and duloxetine can increase the risk of bleeding.","Edoxaban is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of fluoxetine and eletriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fluoxetine is predicted to increase the exposure to eliglustat. Manufacturer advises avoid or adjust doseconsult product literature.","Enoxaparin is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of fluoxetine and eplerenone can increase the risk of hyponatraemia.","Both fluoxetine and epoprostenol can increase the risk of bleeding.","Both fluoxetine and eptifibatide can increase the risk of bleeding.","Concurrent use of fluoxetine and escitalopram can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and escitalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fluoxetine and escitalopram can increase the risk of bleeding.","Concurrent use of fluoxetine and etodolac can increase the risk of hyponatraemia.","Both fluoxetine and etodolac can increase the risk of bleeding.","Concurrent use of fluoxetine and etoricoxib can increase the risk of hyponatraemia.","Both fluoxetine and etoricoxib can increase the risk of bleeding.","Concurrent use of fluoxetine and fenoprofen can increase the risk of hyponatraemia.","Both fluoxetine and fenoprofen can increase the risk of bleeding.","Concurrent use of fluoxetine and fentanyl can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fluoxetine is predicted to increase the exposure to flecainide.","Concurrent use of fluoxetine and flurbiprofen can increase the risk of hyponatraemia.","Both fluoxetine and flurbiprofen can increase the risk of bleeding.","Concurrent use of fluoxetine and fluvoxamine can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and fluvoxamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fluoxetine and fluvoxamine can increase the risk of bleeding.","Fondaparinux is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Fluoxetine is predicted to increase the concentration of fosphenytoin. Manufacturer advises monitor and adjust dose.","Concurrent use of fluoxetine and frovatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and furosemide can increase the risk of hyponatraemia.","Fluoxetine is predicted to increase the exposure to galantamine. Manufacturer advises monitor and adjust dose.","Glucose is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of fluoxetine and granisetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fluoxetine increases the concentration of haloperidol. Manufacturer advises adjust dose.","Heparin (unfractionated) is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of fluoxetine and hydrochlorothiazide can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and hydroflumethiazide can increase the risk of hyponatraemia.","Both fluoxetine and ibrutinib can increase the risk of bleeding.","Concurrent use of fluoxetine and ibuprofen can increase the risk of hyponatraemia.","Both fluoxetine and ibuprofen can increase the risk of bleeding.","Both fluoxetine and iloprost can increase the risk of bleeding.","Concurrent use of fluoxetine and imipramine can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and imipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fluoxetine is predicted to increase the exposure to imipramine. Manufacturer advises monitor for toxicity and adjust dose.","Concurrent use of fluoxetine and indapamide can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and indometacin can increase the risk of hyponatraemia.","Both fluoxetine and indometacin can increase the risk of bleeding.","Concurrent use of fluoxetine and isocarboxazid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and ketoprofen can increase the risk of hyponatraemia.","Both fluoxetine and ketoprofen can increase the risk of bleeding.","Concurrent use of fluoxetine and ketorolac can increase the risk of hyponatraemia.","Both fluoxetine and ketorolac can increase the risk of bleeding.","Concurrent use of fluoxetine and linezolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and lisdexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fluoxetine is predicted to increase the exposure to lisdexamfetamine.","Concurrent use of fluoxetine and lithium can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fluoxetine is predicted to increase the exposure to lofepramine. Manufacturer advises monitor for toxicity and adjust dose.","Fluoxetine is predicted to increase the exposure to lomitapide. Manufacturer advises separate administration by 12 hours.","Concurrent use of fluoxetine and mefenamic acid can increase the risk of hyponatraemia.","Both fluoxetine and mefenamic acid can increase the risk of bleeding.","Concurrent use of fluoxetine and meloxicam can increase the risk of hyponatraemia.","Both fluoxetine and meloxicam can increase the risk of bleeding.","Concurrent use of fluoxetine and methadone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and methylthioninium chloride can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and metolazone can increase the risk of hyponatraemia.","Fluoxetine is predicted to increase the exposure to metoprolol.","Concurrent use of fluoxetine and mianserin can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and mirtazapine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fluoxetine potentially increases the risk of prolonged neuromuscular blockade when given with mivacurium.","Concurrent use of fluoxetine and moclobemide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and nabumetone can increase the risk of hyponatraemia.","Both fluoxetine and nabumetone can increase the risk of bleeding.","Concurrent use of fluoxetine and naproxen can increase the risk of hyponatraemia.","Both fluoxetine and naproxen can increase the risk of bleeding.","Concurrent use of fluoxetine and naratriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fluoxetine is predicted to increase the exposure to nebivolol.","Nicotinic acid is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of fluoxetine and nortriptyline can increase the risk of hyponatraemia.","Fluoxetine is predicted to increase the exposure to nortriptyline. Manufacturer advises monitor for toxicity and adjust dose.","Omega-3-acid ethyl esters is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of fluoxetine and ondansetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and palonosetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and parecoxib can increase the risk of hyponatraemia.","Both fluoxetine and parecoxib can increase the risk of bleeding.","Concurrent use of fluoxetine and paroxetine can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and paroxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fluoxetine and paroxetine can increase the risk of bleeding.","Concurrent use of fluoxetine and pentazocine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and pethidine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and phenelzine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Phenindione is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Fluoxetine is predicted to increase the concentration of phenytoin. Manufacturer advises monitor and adjust dose.","Concurrent use of fluoxetine and piroxicam can increase the risk of hyponatraemia.","Both fluoxetine and piroxicam can increase the risk of bleeding.","Fluoxetine is predicted to moderately increase the exposure to pitolisant. Manufacturer advises use with caution and adjust dose.","Both fluoxetine and prasugrel can increase the risk of bleeding.","Concurrent use of fluoxetine and procarbazine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fluoxetine is predicted to increase the exposure to propafenone. Manufacturer advises monitor and adjust dose.","Concurrent use of fluoxetine and rasagiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fluoxetine and regorafenib can increase the risk of bleeding.","Reteplase is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Fluoxetine is predicted to increase the exposure to risperidone. Manufacturer advises adjust dose.","Rivaroxaban is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of fluoxetine and rizatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and safinamide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and selegiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and sertraline can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and sertraline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fluoxetine and sertraline can increase the risk of bleeding.","Concurrent use of fluoxetine and sodium picosulfate can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and spironolactone can increase the risk of hyponatraemia.","Streptokinase is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Both fluoxetine and sulfinpyrazone can increase the risk of bleeding.","Concurrent use of fluoxetine and sulindac can increase the risk of hyponatraemia.","Both fluoxetine and sulindac can increase the risk of bleeding.","Concurrent use of fluoxetine and sumatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fluoxetine potentially increases the risk of prolonged neuromuscular blockade when given with suxamethonium.","Fluoxetine is predicted to decrease the efficacy of tamoxifen. Manufacturer advises avoid.","Concurrent use of fluoxetine and tapentadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and tedizolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Tenecteplase is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of fluoxetine and tenoxicam can increase the risk of hyponatraemia.","Both fluoxetine and tenoxicam can increase the risk of bleeding.","Terbinafine is predicted to increase the exposure to fluoxetine. Manufacturer advises adjust dose.","Concurrent use of fluoxetine and tiaprofenic acid can increase the risk of hyponatraemia.","Both fluoxetine and tiaprofenic acid can increase the risk of bleeding.","Both fluoxetine and ticagrelor can increase the risk of bleeding.","Fluoxetine is predicted to increase the exposure to timolol.","Tinzaparin is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Both fluoxetine and tirofiban can increase the risk of bleeding.","Concurrent use of fluoxetine and tolfenamic acid can increase the risk of hyponatraemia.","Both fluoxetine and tolfenamic acid can increase the risk of bleeding.","Concurrent use of fluoxetine and torasemide can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and tramadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fluoxetine is predicted to decrease the efficacy of tramadol.","Concurrent use of fluoxetine and tranylcypromine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fluoxetine and trastuzumab can increase the risk of bleeding.","Both fluoxetine and trastuzumab emtansine can increase the risk of bleeding.","Concurrent use of fluoxetine and trazodone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of fluoxetine and triamterene can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and trimethoprim can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and trimipramine can increase the risk of hyponatraemia.","Fluoxetine is predicted to increase the exposure to trimipramine. Manufacturer advises monitor for toxicity and adjust dose.","Urokinase is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of fluoxetine and venlafaxine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fluoxetine and venlafaxine can increase the risk of bleeding.","Concurrent use of fluoxetine and vortioxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both fluoxetine and vortioxetine can increase the risk of bleeding.","Fluoxetine is predicted to increase the exposure to vortioxetine. Manufacturer advises monitor and adjust dose.","Warfarin is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Concurrent use of fluoxetine and xipamide can increase the risk of hyponatraemia.","Concurrent use of fluoxetine and zolmitriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs."]},{"name":"BNF.Furosemide.Furosemide","imports":["BNF.Amiloride.Amiloride","BNF.Amiodarone.Amiodarone","BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisacodyl.Bisacodyl","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Carbamazepine.Carbamazepine","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Diclofenac.Diclofenac","BNF.Digoxin.Digoxin","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Fluoxetine.Fluoxetine","BNF.Haloperidol.Haloperidol","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Naproxen.Naproxen","BNF.Nifedipine.Nifedipine","BNF.Ondansetron.Ondansetron","BNF.Phenytoin.Phenytoin","BNF.Prochlorperazine.Prochlorperazine","BNF.Quinine.Quinine","BNF.Ramipril.Ramipril","BNF.Salbutamol.Salbutamol","BNF.Senna.Senna","BNF.Sertraline.Sertraline","BNF.Spironolactone.Spironolactone","BNF.Theophylline.Theophylline","BNF.Trimethoprim.Trimethoprim","BNF.Vancomycin.Vancomycin","BNF.Venlafaxine.Venlafaxine"],"interactioninfo":["Concurrent use of furosemide and acebutolol can increase the risk of hypotension.","Concurrent use of furosemide and aceclofenac can increase the risk of hyponatraemia.","Concurrent use of furosemide and acemetacin can increase the risk of hyponatraemia.","Concurrent use of furosemide and alcohol (beverage) can increase the risk of hypotension.","Concurrent use of furosemide and alfuzosin can increase the risk of hypotension.","Concurrent use of furosemide and aliskiren can increase the risk of hypotension.","Aliskiren slightly decreases the exposure to furosemide.","Concurrent use of furosemide and alprostadil can increase the risk of hypotension.","Concurrent use of furosemide and amantadine can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with amifampridine. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and amikacin can increase the risk of ototoxicity.","Furosemide increases the risk of nephrotoxicity when given with amikacin. Manufacturer advises avoid.","Concurrent use of furosemide and amiloride can increase the risk of hyponatraemia.","Concurrent use of furosemide and aminophylline can increase the risk of hypokalaemia.","Furosemide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Furosemide is predicted to increase the risk of torsade de pointes when given with amisulpride. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and amitriptyline can increase the risk of hyponatraemia.","Concurrent use of furosemide and amitriptyline can increase the risk of hypotension.","Concurrent use of furosemide and amlodipine can increase the risk of hypotension.","Concurrent use of furosemide and amphotericin can increase the risk of hypokalaemia.","Concurrent use of furosemide and apomorphine can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with apomorphine. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and apraclonidine can increase the risk of hypotension.","Concurrent use of furosemide and aripiprazole can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with arsenic trioxide. Manufacturer advises use with caution or avoid.","Furosemide is predicted to increase the risk of torsade de pointes when given with artemether. Manufacturer advises use with caution or avoid.","Furosemide is predicted to increase the risk of torsade de pointes when given with artenimol. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and asenapine can increase the risk of hypotension.","Concurrent use of furosemide and atenolol can increase the risk of hypotension.","Concurrent use of furosemide and avanafil can increase the risk of hypotension.","Concurrent use of furosemide and azilsartan can increase the risk of hypotension.","Concurrent use of furosemide and baclofen can increase the risk of hypotension.","Concurrent use of furosemide and bambuterol can increase the risk of hypokalaemia.","Concurrent use of furosemide and beclometasone can increase the risk of hypokalaemia.","Furosemide is predicted to increase the risk of torsade de pointes when given with bedaquiline. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and bendroflumethiazide can increase the risk of hyponatraemia.","Concurrent use of furosemide and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of furosemide and bendroflumethiazide can increase the risk of hypokalaemia.","Concurrent use of furosemide and benperidol can increase the risk of hypotension.","Concurrent use of furosemide and betamethasone can increase the risk of hypokalaemia.","Concurrent use of furosemide and betaxolol can increase the risk of hypotension.","Concurrent use of furosemide and bisacodyl can increase the risk of hypokalaemia.","Concurrent use of furosemide and bisoprolol can increase the risk of hypotension.","Concurrent use of furosemide and bortezomib can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with bosutinib. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and brimonidine can increase the risk of hypotension.","Concurrent use of furosemide and bromocriptine can increase the risk of hypotension.","Concurrent use of furosemide and budesonide can increase the risk of hypokalaemia.","Concurrent use of furosemide and bumetanide can increase the risk of hyponatraemia.","Concurrent use of furosemide and bumetanide can increase the risk of hypotension.","Concurrent use of furosemide and bumetanide can increase the risk of ototoxicity.","Concurrent use of furosemide and bumetanide can increase the risk of hypokalaemia.","Concurrent use of furosemide and cabergoline can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with cabozantinib. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and canagliflozin can increase the risk of hypotension.","Concurrent use of furosemide and candesartan can increase the risk of hypotension.","Concurrent use of furosemide and capreomycin can increase the risk of ototoxicity.","Concurrent use of furosemide and captopril can increase the risk of hypotension.","Concurrent use of furosemide and carbamazepine can increase the risk of hyponatraemia.","Concurrent use of furosemide and carboplatin can increase the risk of ototoxicity.","Concurrent use of furosemide and carteolol can increase the risk of hypotension.","Concurrent use of furosemide and carvedilol can increase the risk of hypotension.","Concurrent use of furosemide and celecoxib can increase the risk of hyponatraemia.","Concurrent use of furosemide and celiprolol can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with ceritinib. Manufacturer advises use with caution or avoid.","Intravenous furosemide potentially increases the risk of sweating, variable blood pressure, and tachycardia when given after chloral hydrate.","Concurrent use of furosemide and chlorothiazide can increase the risk of hyponatraemia.","Concurrent use of furosemide and chlorothiazide can increase the risk of hypotension.","Concurrent use of furosemide and chlorothiazide can increase the risk of hypokalaemia.","Concurrent use of furosemide and chlorpromazine can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with chlorpromazine. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and chlortalidone can increase the risk of hyponatraemia.","Concurrent use of furosemide and chlortalidone can increase the risk of hypotension.","Concurrent use of furosemide and chlortalidone can increase the risk of hypokalaemia.","Concurrent use of furosemide and cisplatin can increase the risk of ototoxicity.","Concurrent use of furosemide and citalopram can increase the risk of hyponatraemia.","Furosemide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Furosemide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and clevidipine can increase the risk of hypotension.","Concurrent use of furosemide and clomipramine can increase the risk of hyponatraemia.","Concurrent use of furosemide and clomipramine can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with clomipramine. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and clonidine can increase the risk of hypotension.","Concurrent use of furosemide and clopamide can increase the risk of hyponatraemia.","Concurrent use of furosemide and clopamide can increase the risk of hypotension.","Concurrent use of furosemide and clopamide can increase the risk of hypokalaemia.","Concurrent use of furosemide and clozapine can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with crizotinib. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and cyclopenthiazide can increase the risk of hyponatraemia.","Concurrent use of furosemide and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of furosemide and cyclopenthiazide can increase the risk of hypokalaemia.","Concurrent use of furosemide and dantron can increase the risk of hypokalaemia.","Concurrent use of furosemide and dapagliflozin can increase the risk of hypotension.","Concurrent use of furosemide and dapoxetine can increase the risk of hyponatraemia.","Dasabuvir (with ombitasvir, paritaprevir and ritonavir) increases the concentration of furosemide. Manufacturer advises adjust dose.","Furosemide is predicted to increase the risk of torsade de pointes when given with dasatinib. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and deflazacort can increase the risk of hypokalaemia.","Furosemide is predicted to increase the risk of torsade de pointes when given with delamanid. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and desflurane can increase the risk of hypotension.","Concurrent use of furosemide and desmopressin can increase the risk of hyponatraemia.","Concurrent use of furosemide and dexamethasone can increase the risk of hypokalaemia.","Concurrent use of furosemide and dexibuprofen can increase the risk of hyponatraemia.","Concurrent use of furosemide and dexketoprofen can increase the risk of hyponatraemia.","Concurrent use of furosemide and diazoxide can increase the risk of hypotension.","Concurrent use of furosemide and diclofenac can increase the risk of hyponatraemia.","Furosemide is predicted to increase the risk of digoxin toxicity when given with digoxin.","Concurrent use of furosemide and diltiazem can increase the risk of hypotension.","Concurrent use of furosemide and dipyridamole can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with disopyramide. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and docusate sodium can increase the risk of hypokalaemia.","Concurrent use of furosemide and dosulepin can increase the risk of hyponatraemia.","Concurrent use of furosemide and dosulepin can increase the risk of hypotension.","Concurrent use of furosemide and doxazosin can increase the risk of hypotension.","Concurrent use of furosemide and doxepin can increase the risk of hyponatraemia.","Concurrent use of furosemide and doxepin can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with dronedarone. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and droperidol can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with droperidol. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and duloxetine can increase the risk of hyponatraemia.","Concurrent use of furosemide and empagliflozin can increase the risk of hypotension.","Concurrent use of furosemide and enalapril can increase the risk of hypotension.","Concurrent use of furosemide and eplerenone can increase the risk of hyponatraemia.","Concurrent use of furosemide and eplerenone can increase the risk of hypotension.","Concurrent use of furosemide and eprosartan can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with eribulin. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and escitalopram can increase the risk of hyponatraemia.","Furosemide is predicted to increase the risk of torsade de pointes when given with escitalopram. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and esmolol can increase the risk of hypotension.","Concurrent use of furosemide and etodolac can increase the risk of hyponatraemia.","Concurrent use of furosemide and etomidate can increase the risk of hypotension.","Concurrent use of furosemide and etoricoxib can increase the risk of hyponatraemia.","Concurrent use of furosemide and felodipine can increase the risk of hypotension.","Concurrent use of furosemide and fenoprofen can increase the risk of hyponatraemia.","Furosemide is predicted to increase the risk of torsade de pointes when given with flecainide. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and fludrocortisone can increase the risk of hypokalaemia.","Concurrent use of furosemide and fluoxetine can increase the risk of hyponatraemia.","Concurrent use of furosemide and flupentixol can increase the risk of hypotension.","Concurrent use of furosemide and fluphenazine can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with fluphenazine. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and flurbiprofen can increase the risk of hyponatraemia.","Concurrent use of furosemide and fluvoxamine can increase the risk of hyponatraemia.","Concurrent use of furosemide and formoterol can increase the risk of hypokalaemia.","Concurrent use of furosemide and fosinopril can increase the risk of hypotension.","Fosphenytoin decreases the effects of furosemide.","Concurrent use of furosemide and gentamicin can increase the risk of ototoxicity.","Furosemide increases the risk of nephrotoxicity when given with gentamicin. Manufacturer advises avoid.","Concurrent use of furosemide and glycerol can increase the risk of hypokalaemia.","Concurrent use of furosemide and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of furosemide and guanethidine can increase the risk of hypotension.","Concurrent use of furosemide and guanfacine can increase the risk of hypotension.","Concurrent use of furosemide and haloperidol can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and histamine can increase the risk of hypotension.","Concurrent use of furosemide and hydralazine can increase the risk of hypotension.","Concurrent use of furosemide and hydrochlorothiazide can increase the risk of hyponatraemia.","Concurrent use of furosemide and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of furosemide and hydrochlorothiazide can increase the risk of hypokalaemia.","Concurrent use of furosemide and hydrocortisone can increase the risk of hypokalaemia.","Concurrent use of furosemide and hydroflumethiazide can increase the risk of hyponatraemia.","Concurrent use of furosemide and hydroflumethiazide can increase the risk of hypotension.","Concurrent use of furosemide and hydroflumethiazide can increase the risk of hypokalaemia.","Furosemide is predicted to increase the risk of torsade de pointes when given with hydroxyzine. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and ibuprofen can increase the risk of hyponatraemia.","Concurrent use of furosemide and imidapril can increase the risk of hypotension.","Concurrent use of furosemide and imipramine can increase the risk of hyponatraemia.","Concurrent use of furosemide and imipramine can increase the risk of hypotension.","Concurrent use of furosemide and indacaterol can increase the risk of hypokalaemia.","Concurrent use of furosemide and indapamide can increase the risk of hyponatraemia.","Concurrent use of furosemide and indapamide can increase the risk of hypotension.","Concurrent use of furosemide and indapamide can increase the risk of hypokalaemia.","Concurrent use of furosemide and indometacin can increase the risk of hyponatraemia.","Concurrent use of furosemide and indoramin can increase the risk of hypotension.","Concurrent use of furosemide and irbesartan can increase the risk of hypotension.","Concurrent use of furosemide and isocarboxazid can increase the risk of hypotension.","Concurrent use of furosemide and isoflurane can increase the risk of hypotension.","Concurrent use of furosemide and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of furosemide and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of furosemide and isradipine can increase the risk of hypotension.","Concurrent use of furosemide and ketamine can increase the risk of hypotension.","Concurrent use of furosemide and ketoprofen can increase the risk of hyponatraemia.","Concurrent use of furosemide and ketorolac can increase the risk of hyponatraemia.","Concurrent use of furosemide and labetalol can increase the risk of hypotension.","Concurrent use of furosemide and lacidipine can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with lapatinib. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and lercanidipine can increase the risk of hypotension.","Concurrent use of furosemide and levobunolol can increase the risk of hypotension.","Concurrent use of furosemide and levodopa can increase the risk of hypotension.","Concurrent use of furosemide and levomepromazine can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and lisinopril can increase the risk of hypotension.","Furosemide increases the concentration of lithium. Manufacturer advises monitor and adjust dose.","Concurrent use of furosemide and lofepramine can increase the risk of hypotension.","Concurrent use of furosemide and lofexidine can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with lofexidine. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and losartan can increase the risk of hypotension.","Concurrent use of furosemide and loxapine can increase the risk of hypotension.","Concurrent use of furosemide and lurasidone can increase the risk of hypotension.","Concurrent use of furosemide and mefenamic acid can increase the risk of hyponatraemia.","Concurrent use of furosemide and meloxicam can increase the risk of hyponatraemia.","Furosemide is predicted to increase the risk of torsade de pointes when given with methadone. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and methyldopa can increase the risk of hypotension.","Concurrent use of furosemide and methylprednisolone can increase the risk of hypokalaemia.","Concurrent use of furosemide and metolazone can increase the risk of hyponatraemia.","Concurrent use of furosemide and metolazone can increase the risk of hypotension.","Concurrent use of furosemide and metolazone can increase the risk of hypokalaemia.","Concurrent use of furosemide and metoprolol can increase the risk of hypotension.","Concurrent use of furosemide and minoxidil can increase the risk of hypotension.","Concurrent use of furosemide and moexipril can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with moxifloxacin. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and moxisylyte can increase the risk of hypotension.","Concurrent use of furosemide and moxonidine can increase the risk of hypotension.","Concurrent use of furosemide and nabumetone can increase the risk of hyponatraemia.","Concurrent use of furosemide and nadolol can increase the risk of hypotension.","Concurrent use of furosemide and naproxen can increase the risk of hyponatraemia.","Concurrent use of furosemide and nebivolol can increase the risk of hypotension.","Concurrent use of furosemide and neomycin can increase the risk of ototoxicity.","Concurrent use of furosemide and nicardipine can increase the risk of hypotension.","Concurrent use of furosemide and nicorandil can increase the risk of hypotension.","Concurrent use of furosemide and nifedipine can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with nilotinib. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and nimodipine can increase the risk of hypotension.","Concurrent use of furosemide and nitrous oxide can increase the risk of hypotension.","Concurrent use of furosemide and nortriptyline can increase the risk of hyponatraemia.","Concurrent use of furosemide and nortriptyline can increase the risk of hypotension.","Concurrent use of furosemide and olanzapine can increase the risk of hypotension.","Concurrent use of furosemide and olmesartan can increase the risk of hypotension.","Concurrent use of furosemide and olodaterol can increase the risk of hypokalaemia.","Furosemide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Furosemide is predicted to increase the risk of torsade de pointes when given with osimertinib. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and oxaliplatin can increase the risk of ototoxicity.","Concurrent use of furosemide and oxprenolol can increase the risk of hypotension.","Concurrent use of furosemide and paliperidone can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with paliperidone. Manufacturer advises use with caution or avoid.","Furosemide is predicted to increase the risk of torsade de pointes when given with panobinostat. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and parecoxib can increase the risk of hyponatraemia.","Paritaprevir (with ritonavir and ombitasvir) is predicted to increase the exposure to furosemide. Manufacturer advises adjust dose.","Concurrent use of furosemide and paroxetine can increase the risk of hyponatraemia.","Furosemide is predicted to increase the risk of torsade de pointes when given with pasireotide. Manufacturer advises use with caution or avoid.","Furosemide is predicted to increase the risk of torsade de pointes when given with pazopanib. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and pergolide can increase the risk of hypotension.","Concurrent use of furosemide and pericyazine can increase the risk of hypotension.","Concurrent use of furosemide and perindopril can increase the risk of hypotension.","Concurrent use of furosemide and perphenazine can increase the risk of hypotension.","Concurrent use of furosemide and phenelzine can increase the risk of hypotension.","Phenytoin decreases the effects of furosemide.","Concurrent use of furosemide and pimozide can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with pimozide. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and pindolol can increase the risk of hypotension.","Concurrent use of furosemide and piroxicam can increase the risk of hyponatraemia.","Concurrent use of furosemide and pramipexole can increase the risk of hypotension.","Concurrent use of furosemide and prazosin can increase the risk of hypotension.","Concurrent use of furosemide and prednisolone can increase the risk of hypokalaemia.","Concurrent use of furosemide and prednisone can increase the risk of hypokalaemia.","Concurrent use of furosemide and prochlorperazine can increase the risk of hypotension.","Concurrent use of furosemide and promazine can increase the risk of hypotension.","Concurrent use of furosemide and propofol can increase the risk of hypotension.","Concurrent use of furosemide and propranolol can increase the risk of hypotension.","Concurrent use of furosemide and quetiapine can increase the risk of hypotension.","Concurrent use of furosemide and quinagolide can increase the risk of hypotension.","Concurrent use of furosemide and quinapril can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and ramipril can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with ranolazine. Manufacturer advises use with caution or avoid.","Reboxetine is predicted to increase the risk of hypokalaemia when given with furosemide.","Concurrent use of furosemide and riociguat can increase the risk of hypotension.","Concurrent use of furosemide and risperidone can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with risperidone. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and ropinirole can increase the risk of hypotension.","Concurrent use of furosemide and rotigotine can increase the risk of hypotension.","Concurrent use of furosemide and sacubitril can increase the risk of hypotension.","Concurrent use of furosemide and salbutamol can increase the risk of hypokalaemia.","Concurrent use of furosemide and salmeterol can increase the risk of hypokalaemia.","Concurrent use of furosemide and sapropterin can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with saquinavir. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and selegiline can increase the risk of hypotension.","Concurrent use of furosemide and senna can increase the risk of hypokalaemia.","Concurrent use of furosemide and sertraline can increase the risk of hyponatraemia.","Concurrent use of furosemide and sevoflurane can increase the risk of hypotension.","Concurrent use of furosemide and sildenafil can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with sildenafil. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of furosemide and sodium oxybate can increase the risk of hypotension.","Concurrent use of furosemide and sodium picosulfate can increase the risk of hyponatraemia.","Concurrent use of furosemide and sodium picosulfate can increase the risk of hypokalaemia.","Furosemide is predicted to increase the risk of torsade de pointes when given with sorafenib. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and sotalol can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with sotalol. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and spironolactone can increase the risk of hyponatraemia.","Concurrent use of furosemide and spironolactone can increase the risk of hypotension.","Concurrent use of furosemide and streptomycin can increase the risk of ototoxicity.","Furosemide increases the risk of nephrotoxicity when given with streptomycin. Manufacturer advises avoid.","Concurrent use of furosemide and sulindac can increase the risk of hyponatraemia.","Concurrent use of furosemide and sulpiride can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with sulpiride. Manufacturer advises use with caution or avoid.","Furosemide is predicted to increase the risk of torsade de pointes when given with sunitinib. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and tadalafil can increase the risk of hypotension.","Concurrent use of furosemide and tamsulosin can increase the risk of hypotension.","Concurrent use of furosemide and telavancin can increase the risk of ototoxicity.","Furosemide is predicted to increase the risk of torsade de pointes when given with telavancin. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and telmisartan can increase the risk of hypotension.","Concurrent use of furosemide and tenoxicam can increase the risk of hyponatraemia.","Concurrent use of furosemide and terazosin can increase the risk of hypotension.","Concurrent use of furosemide and terbutaline can increase the risk of hypokalaemia.","Furosemide is predicted to increase the risk of torsade de pointes when given with tetrabenazine. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and theophylline can increase the risk of hypokalaemia.","Concurrent use of furosemide and thiopental can increase the risk of hypotension.","Concurrent use of furosemide and tiaprofenic acid can increase the risk of hyponatraemia.","Concurrent use of furosemide and timolol can increase the risk of hypotension.","Concurrent use of furosemide and tizanidine can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with tizanidine. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and tobramycin can increase the risk of ototoxicity.","Furosemide increases the risk of nephrotoxicity when given with tobramycin. Manufacturer advises avoid.","Concurrent use of furosemide and tolfenamic acid can increase the risk of hyponatraemia.","Furosemide is predicted to increase the risk of torsade de pointes when given with tolterodine. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and torasemide can increase the risk of hyponatraemia.","Concurrent use of furosemide and torasemide can increase the risk of hypotension.","Concurrent use of furosemide and torasemide can increase the risk of ototoxicity.","Concurrent use of furosemide and torasemide can increase the risk of hypokalaemia.","Furosemide is predicted to increase the risk of torsade de pointes when given with toremifene. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and trandolapril can increase the risk of hypotension.","Concurrent use of furosemide and tranylcypromine can increase the risk of hypotension.","Concurrent use of furosemide and triamcinolone can increase the risk of hypokalaemia.","Concurrent use of furosemide and triamterene can increase the risk of hyponatraemia.","Concurrent use of furosemide and trifluoperazine can increase the risk of hypotension.","Concurrent use of furosemide and trimethoprim can increase the risk of hyponatraemia.","Concurrent use of furosemide and trimipramine can increase the risk of hyponatraemia.","Concurrent use of furosemide and trimipramine can increase the risk of hypotension.","Concurrent use of furosemide and valsartan can increase the risk of hypotension.","Concurrent use of furosemide and vancomycin can increase the risk of ototoxicity.","Furosemide is predicted to increase the risk of torsade de pointes when given with vandetanib. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and vardenafil can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with vardenafil. Manufacturer advises use with caution or avoid.","Furosemide is predicted to increase the risk of torsade de pointes when given with vemurafenib. Manufacturer advises use with caution or avoid.","Furosemide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and verapamil can increase the risk of hypotension.","Concurrent use of furosemide and vilanterol can increase the risk of hypokalaemia.","Concurrent use of furosemide and vinblastine can increase the risk of ototoxicity.","Concurrent use of furosemide and vincristine can increase the risk of ototoxicity.","Concurrent use of furosemide and vindesine can increase the risk of ototoxicity.","Concurrent use of furosemide and vinflunine can increase the risk of ototoxicity.","Furosemide is predicted to increase the risk of torsade de pointes when given with vinflunine. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and vinorelbine can increase the risk of ototoxicity.","Furosemide is predicted to increase the risk of torsade de pointes when given with voriconazole. Manufacturer advises use with caution or avoid.","Concurrent use of furosemide and xipamide can increase the risk of hyponatraemia.","Concurrent use of furosemide and xipamide can increase the risk of hypotension.","Concurrent use of furosemide and xipamide can increase the risk of hypokalaemia.","Concurrent use of furosemide and zuclopenthixol can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with zuclopenthixol. Manufacturer advises use with caution or avoid."]},{"name":"BNF.Gabapentin.Gabapentin","imports":["BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Fentanyl.Fentanyl","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Oxycodone.Oxycodone","BNF.Prochlorperazine.Prochlorperazine","BNF.Temazepam.Temazepam","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of gabapentin and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Aluminium hydroxide decreases the absorption of gabapentin. Manufacturer advises gabapentin should be taken 2 hours after aluminium hydroxide.","Concurrent use of gabapentin and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Magnesium carbonate decreases the absorption of gabapentin. Manufacturer advises gabapentin should be taken 2 hours after magnesium carbonate.","Magnesium trisilicate decreases the absorption of gabapentin. Manufacturer advises gabapentin should be taken 2 hours after magnesium trisilicate.","Concurrent use of gabapentin and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of gabapentin and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Gliclazide.Gliclazide","imports":["BNF.Amiodarone.Amiodarone","BNF.Clarithromycin.Clarithromycin","BNF.Insulin.Insulin","BNF.Metformin.Metformin"],"interactioninfo":["Concurrent use of gliclazide and acarbose can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and albiglutide can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and alogliptin can increase the risk of hypoglycaemia.","Amiodarone is predicted to increase the exposure to gliclazide. Manufacturer advises use with caution and adjust dose.","Bezafibrate is predicted to increase the risk of hypoglycaemia when given with gliclazide.","Concurrent use of gliclazide and biphasic insulin aspart can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and biphasic insulin lispro can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and biphasic isophane insulin can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and canagliflozin can increase the risk of hypoglycaemia.","Chloramphenicol is predicted to increase the exposure to gliclazide.","Ciprofibrate is predicted to increase the risk of hypoglycaemia when given with gliclazide.","Clarithromycin is predicted to slightly increase the exposure to gliclazide.","Co-trimoxazole is predicted to increase the exposure to gliclazide.","Concurrent use of gliclazide and dapagliflozin can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and dulaglutide can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and empagliflozin can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and exenatide can increase the risk of hypoglycaemia.","Fenofibrate is predicted to increase the risk of hypoglycaemia when given with gliclazide.","Fluconazole is predicted to increase the exposure to gliclazide. Manufacturer advises use with caution and adjust dose.","Gemfibrozil is predicted to increase the risk of hypoglycaemia when given with gliclazide.","Concurrent use of gliclazide and glibenclamide can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and glimepiride can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and glipizide can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and insulin can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and insulin aspart can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and insulin degludec can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and insulin detemir can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and insulin glargine can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and insulin glulisine can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and insulin lispro can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and insulin zinc suspension can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and isophane insulin can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and linagliptin can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and liraglutide can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and lixisenatide can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and metformin can increase the risk of hypoglycaemia.","Miconazole is predicted to increase the exposure to gliclazide. Manufacturer advises use with caution and adjust dose.","Concurrent use of gliclazide and nateglinide can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and pioglitazone can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and protamine zinc insulin can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and repaglinide can increase the risk of hypoglycaemia.","Rifampicin is predicted to decrease the exposure to gliclazide.","Concurrent use of gliclazide and saxagliptin can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and sitagliptin can increase the risk of hypoglycaemia.","Sulfadiazine is predicted to increase the exposure to gliclazide.","Sulfadoxine is predicted to increase the exposure to gliclazide.","Sulfamethoxazole is predicted to increase the exposure to gliclazide.","Sulfinpyrazone is predicted to increase the exposure to gliclazide. Manufacturer advises use with caution and adjust dose.","Concurrent use of gliclazide and tolbutamide can increase the risk of hypoglycaemia.","Concurrent use of gliclazide and vildagliptin can increase the risk of hypoglycaemia.","Voriconazole is predicted to increase the concentration of gliclazide. Manufacturer advises use with caution and adjust dose."]},{"name":"BNF.Glucose.Glucose","imports":["BNF.Apixaban.Apixaban","BNF.Citalopram.Citalopram","BNF.Diclofenac.Diclofenac","BNF.Enoxaparin.Enoxaparin","BNF.Fluoxetine.Fluoxetine","BNF.Ibuprofen.Ibuprofen","BNF.Naproxen.Naproxen","BNF.Rivaroxaban.Rivaroxaban","BNF.Sertraline.Sertraline","BNF.Venlafaxine.Venlafaxine","BNF.Warfarin.Warfarin"],"interactioninfo":["Glucose is predicted to increase the risk of bleeding events when given with abciximab. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with aceclofenac. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with acemetacin. Manufacturer advises use with caution or avoid.","Both glucose and acenocoumarol can increase the risk of bleeding.","Both glucose and alteplase can increase the risk of bleeding.","Glucose is predicted to increase the risk of bleeding events when given with anagrelide. Manufacturer advises use with caution or avoid.","Both glucose and apixaban can increase the risk of bleeding.","Both glucose and argatroban can increase the risk of bleeding.","Glucose is predicted to increase the risk of bleeding events when given with aspirin. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with bevacizumab. Manufacturer advises use with caution or avoid.","Both glucose and bivalirudin can increase the risk of bleeding.","Glucose is predicted to increase the risk of bleeding events when given with cangrelor. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with celecoxib. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with cilostazol. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with clopidogrel. Manufacturer advises use with caution or avoid.","Both glucose and dabigatran can increase the risk of bleeding.","Both glucose and dalteparin can increase the risk of bleeding.","Both glucose and danaparoid can increase the risk of bleeding.","Glucose is predicted to increase the risk of bleeding events when given with dapoxetine. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with dasatinib. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with dexibuprofen. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with dexketoprofen. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with dipyridamole. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with duloxetine. Manufacturer advises use with caution or avoid.","Both glucose and edoxaban can increase the risk of bleeding.","Both glucose and enoxaparin can increase the risk of bleeding.","Glucose is predicted to increase the risk of bleeding events when given with epoprostenol. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with eptifibatide. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with escitalopram. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with etodolac. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with etoricoxib. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with fenoprofen. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with flurbiprofen. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with fluvoxamine. Manufacturer advises use with caution or avoid.","Both glucose and fondaparinux can increase the risk of bleeding.","Both glucose and heparin (unfractionated) can increase the risk of bleeding.","Glucose is predicted to increase the risk of bleeding events when given with ibrutinib. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with iloprost. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with indometacin. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with ketoprofen. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with ketorolac. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with mefenamic acid. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with meloxicam. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with nabumetone. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Both glucose and nicotinic acid can increase the risk of bleeding.","Both glucose and omega-3-acid ethyl esters can increase the risk of bleeding.","Glucose is predicted to increase the risk of bleeding events when given with parecoxib. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with paroxetine. Manufacturer advises use with caution or avoid.","Both glucose and phenindione can increase the risk of bleeding.","Glucose is predicted to increase the risk of bleeding events when given with piroxicam. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with prasugrel. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with regorafenib. Manufacturer advises use with caution or avoid.","Both glucose and reteplase can increase the risk of bleeding.","Both glucose and rivaroxaban can increase the risk of bleeding.","Glucose is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Both glucose and streptokinase can increase the risk of bleeding.","Glucose is predicted to increase the risk of bleeding events when given with sulfinpyrazone. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with sulindac. Manufacturer advises use with caution or avoid.","Both glucose and tenecteplase can increase the risk of bleeding.","Glucose is predicted to increase the risk of bleeding events when given with tenoxicam. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with tiaprofenic acid. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with ticagrelor. Manufacturer advises use with caution or avoid.","Both glucose and tinzaparin can increase the risk of bleeding.","Glucose is predicted to increase the risk of bleeding events when given with tirofiban. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with tolfenamic acid. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with trastuzumab. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with trastuzumab emtansine. Manufacturer advises use with caution or avoid.","Both glucose and urokinase can increase the risk of bleeding.","Glucose is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Glucose is predicted to increase the risk of bleeding events when given with vortioxetine. Manufacturer advises use with caution or avoid.","Both glucose and warfarin can increase the risk of bleeding."]},{"name":"BNF.Haloperidol.Haloperidol","imports":["BNF.Amiodarone.Amiodarone","BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisacodyl.Bisacodyl","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Carbamazepine.Carbamazepine","BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Fentanyl.Fentanyl","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Gabapentin.Gabapentin","BNF.Indapamide.Indapamide","BNF.Ipratropium.Ipratropium","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Lorazepam.Lorazepam","BNF.Losartan.Losartan","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Nefopam.Nefopam","BNF.Nifedipine.Nifedipine","BNF.Ondansetron.Ondansetron","BNF.Oxycodone.Oxycodone","BNF.Phenytoin.Phenytoin","BNF.Prochlorperazine.Prochlorperazine","BNF.Quinine.Quinine","BNF.Ramipril.Ramipril","BNF.Salbutamol.Salbutamol","BNF.Senna.Senna","BNF.Spironolactone.Spironolactone","BNF.Temazepam.Temazepam","BNF.Theophylline.Theophylline","BNF.Tiotropium.Tiotropium","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of haloperidol and acebutolol can increase the risk of hypotension.","Concurrent use of haloperidol and aclidinium can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and alcohol (beverage) can increase the risk of hypotension.","Concurrent use of haloperidol and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and alfuzosin can increase the risk of hypotension.","Concurrent use of haloperidol and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and aliskiren can increase the risk of hypotension.","Concurrent use of haloperidol and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and alprostadil can increase the risk of hypotension.","Concurrent use of haloperidol and amantadine can increase the risk of hypotension.","Concurrent use of haloperidol and amantadine can increase the risk of antimuscarinic effects.","Haloperidol is predicted to decrease the effects of amantadine. Manufacturer advises avoid.","Both haloperidol and amifampridine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Aminophylline is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Both haloperidol and amiodarone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both haloperidol and amisulpride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and amitriptyline can increase the risk of hypotension.","Concurrent use of haloperidol and amitriptyline can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and amlodipine can increase the risk of hypotension.","Amphotericin is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and apomorphine can increase the risk of hypotension.","Both haloperidol and apomorphine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Haloperidol is predicted to decrease the effects of apomorphine. Manufacturer advises avoid.","Concurrent use of haloperidol and apraclonidine can increase the risk of hypotension.","Concurrent use of haloperidol and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and aripiprazole can increase the risk of hypotension.","Concurrent use of haloperidol and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both haloperidol and arsenic trioxide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both haloperidol and artemether prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both haloperidol and artenimol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and asenapine can increase the risk of hypotension.","Concurrent use of haloperidol and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and atenolol can increase the risk of hypotension.","Concurrent use of haloperidol and atropine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and avanafil can increase the risk of hypotension.","Concurrent use of haloperidol and azilsartan can increase the risk of hypotension.","Concurrent use of haloperidol and baclofen can increase the risk of hypotension.","Concurrent use of haloperidol and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and baclofen can increase the risk of antimuscarinic effects.","Bambuterol is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Beclometasone is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Both haloperidol and bedaquiline prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and bendroflumethiazide can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and benperidol can increase the risk of hypotension.","Concurrent use of haloperidol and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Betamethasone is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and betaxolol can increase the risk of hypotension.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and bisoprolol can increase the risk of hypotension.","Concurrent use of haloperidol and bortezomib can increase the risk of hypotension.","Both haloperidol and bosutinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and brimonidine can increase the risk of hypotension.","Concurrent use of haloperidol and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and bromocriptine can increase the risk of hypotension.","Haloperidol is predicted to decrease the effects of bromocriptine. Manufacturer advises avoid.","Concurrent use of haloperidol and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Budesonide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and bumetanide can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and cabergoline can increase the risk of hypotension.","Haloperidol is predicted to decrease the effects of cabergoline. Manufacturer advises avoid.","Both haloperidol and cabozantinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and canagliflozin can increase the risk of hypotension.","Concurrent use of haloperidol and candesartan can increase the risk of hypotension.","Concurrent use of haloperidol and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and captopril can increase the risk of hypotension.","Carbamazepine decreases the concentration of haloperidol. Manufacturer advises adjust dose.","Concurrent use of haloperidol and carteolol can increase the risk of hypotension.","Concurrent use of haloperidol and carvedilol can increase the risk of hypotension.","Concurrent use of haloperidol and celiprolol can increase the risk of hypotension.","Both haloperidol and ceritinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and chlorothiazide can increase the risk of hypotension.","Chlorothiazide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and chlorphenamine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and chlorpromazine can increase the risk of hypotension.","Both haloperidol and chlorpromazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and chlorpromazine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and chlortalidone can increase the risk of hypotension.","Chlortalidone is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both haloperidol and citalopram prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both haloperidol and clarithromycin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and clemastine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and clevidipine can increase the risk of hypotension.","Concurrent use of haloperidol and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and clomipramine can increase the risk of hypotension.","Both haloperidol and clomipramine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and clomipramine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and clonidine can increase the risk of hypotension.","Concurrent use of haloperidol and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and clopamide can increase the risk of hypotension.","Clopamide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and clozapine can increase the risk of hypotension.","Concurrent use of haloperidol and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and clozapine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both haloperidol and crizotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and cyclizine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and cyclopenthiazide can increase the risk of hypotension.","Cyclopenthiazide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and cyclopentolate can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and cyproheptadine can increase the risk of antimuscarinic effects.","Dantron is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and dapagliflozin can increase the risk of hypotension.","Concurrent use of haloperidol and darifenacin can increase the risk of antimuscarinic effects.","Both haloperidol and dasatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Deflazacort is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Both haloperidol and delamanid prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and desflurane can increase the risk of hypotension.","Concurrent use of haloperidol and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Dexamethasone is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and diazoxide can increase the risk of hypotension.","Concurrent use of haloperidol and dicycloverine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and diltiazem can increase the risk of hypotension.","Concurrent use of haloperidol and dimenhydrinate can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and dipyridamole can increase the risk of hypotension.","Both haloperidol and disopyramide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and disopyramide can increase the risk of antimuscarinic effects.","Docusate sodium is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Domperidone increases the risk of QT-prolongation when given with haloperidol. Manufacturer advises avoid.","Concurrent use of haloperidol and dosulepin can increase the risk of hypotension.","Concurrent use of haloperidol and dosulepin can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and doxazosin can increase the risk of hypotension.","Concurrent use of haloperidol and doxepin can increase the risk of hypotension.","Concurrent use of haloperidol and doxepin can increase the risk of antimuscarinic effects.","Both haloperidol and dronedarone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and droperidol can increase the risk of hypotension.","Both haloperidol and droperidol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and empagliflozin can increase the risk of hypotension.","Concurrent use of haloperidol and enalapril can increase the risk of hypotension.","Enzalutamide decreases the concentration of haloperidol. Manufacturer advises adjust dose.","Concurrent use of haloperidol and eplerenone can increase the risk of hypotension.","Concurrent use of haloperidol and eprosartan can increase the risk of hypotension.","Both haloperidol and eribulin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Intravenous erythromycin increases the risk of QT-prolongation when given with haloperidol. Manufacturer advises avoid or monitor.","Both haloperidol and escitalopram prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and esmolol can increase the risk of hypotension.","Concurrent use of haloperidol and etomidate can increase the risk of hypotension.","Concurrent use of haloperidol and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and felodipine can increase the risk of hypotension.","Concurrent use of haloperidol and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and fesoterodine can increase the risk of antimuscarinic effects.","Fingolimod increases the risk of QT-prolongation when given with haloperidol. Manufacturer advises avoid.","Concurrent use of haloperidol and flavoxate can increase the risk of antimuscarinic effects.","Both haloperidol and flecainide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Fludrocortisone is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Fluoxetine increases the concentration of haloperidol. Manufacturer advises adjust dose.","Concurrent use of haloperidol and flupentixol can increase the risk of hypotension.","Concurrent use of haloperidol and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and fluphenazine can increase the risk of hypotension.","Both haloperidol and fluphenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Fluvoxamine increases the concentration of haloperidol. Manufacturer advises adjust dose.","Formoterol is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and fosinopril can increase the risk of hypotension.","Fosphenytoin decreases the concentration of haloperidol. Manufacturer advises adjust dose.","Concurrent use of haloperidol and furosemide can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Glycerol is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of haloperidol and glycopyrronium can increase the risk of antimuscarinic effects.","Granisetron is predicted to increase the risk of QT-prolongation when given with haloperidol.","Concurrent use of haloperidol and guanethidine can increase the risk of hypotension.","Haloperidol is predicted to decrease the antihypertensive effects of guanethidine. Manufacturer advises monitor and adjust dose.","Concurrent use of haloperidol and guanfacine can increase the risk of hypotension.","Concurrent use of haloperidol and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and histamine can increase the risk of hypotension.","Concurrent use of haloperidol and homatropine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and hydralazine can increase the risk of hypotension.","Concurrent use of haloperidol and hydrochlorothiazide can increase the risk of hypotension.","Hydrochlorothiazide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Hydrocortisone is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and hydroflumethiazide can increase the risk of hypotension.","Hydroflumethiazide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both haloperidol and hydroxyzine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and hydroxyzine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and hyoscine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and imidapril can increase the risk of hypotension.","Concurrent use of haloperidol and imipramine can increase the risk of hypotension.","Concurrent use of haloperidol and imipramine can increase the risk of antimuscarinic effects.","Indacaterol is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and indapamide can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and indoramin can increase the risk of hypotension.","Concurrent use of haloperidol and ipratropium can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and irbesartan can increase the risk of hypotension.","Concurrent use of haloperidol and isocarboxazid can increase the risk of hypotension.","Concurrent use of haloperidol and isoflurane can increase the risk of hypotension.","Concurrent use of haloperidol and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of haloperidol and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of haloperidol and isradipine can increase the risk of hypotension.","Itraconazole increases the concentration of haloperidol.","Ivabradine is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises avoid.","Concurrent use of haloperidol and ketamine can increase the risk of hypotension.","Concurrent use of haloperidol and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and labetalol can increase the risk of hypotension.","Concurrent use of haloperidol and lacidipine can increase the risk of hypotension.","Concurrent use of haloperidol and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both haloperidol and lapatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and lercanidipine can increase the risk of hypotension.","Concurrent use of haloperidol and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and levobunolol can increase the risk of hypotension.","Concurrent use of haloperidol and levodopa can increase the risk of hypotension.","Haloperidol decreases the effects of levodopa.","Concurrent use of haloperidol and levomepromazine can increase the risk of hypotension.","Both haloperidol and levomepromazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and levomepromazine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and lisinopril can increase the risk of hypotension.","Both haloperidol and lithium prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and lofepramine can increase the risk of hypotension.","Concurrent use of haloperidol and lofepramine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and lofexidine can increase the risk of hypotension.","Both haloperidol and lofexidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and losartan can increase the risk of hypotension.","Concurrent use of haloperidol and loxapine can increase the risk of hypotension.","Concurrent use of haloperidol and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and loxapine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and lurasidone can increase the risk of hypotension.","Concurrent use of haloperidol and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Mefloquine is predicted to increase the risk of QT-prolongation when given with haloperidol.","Concurrent use of haloperidol and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both haloperidol and methadone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and methyldopa can increase the risk of hypotension.","Methylprednisolone is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and metolazone can increase the risk of hypotension.","Metolazone is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and metoprolol can increase the risk of hypotension.","Concurrent use of haloperidol and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and minoxidil can increase the risk of hypotension.","Concurrent use of haloperidol and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Mizolastine is predicted to increase the risk of QT-prolongation when given with haloperidol. Manufacturer advises avoid.","Concurrent use of haloperidol and moexipril can increase the risk of hypotension.","Concurrent use of haloperidol and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both haloperidol and moxifloxacin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and moxisylyte can increase the risk of hypotension.","Concurrent use of haloperidol and moxonidine can increase the risk of hypotension.","Concurrent use of haloperidol and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and nadolol can increase the risk of hypotension.","Concurrent use of haloperidol and nebivolol can increase the risk of hypotension.","Concurrent use of haloperidol and nefopam can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and nicardipine can increase the risk of hypotension.","Concurrent use of haloperidol and nicorandil can increase the risk of hypotension.","Concurrent use of haloperidol and nifedipine can increase the risk of hypotension.","Both haloperidol and nilotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and nimodipine can increase the risk of hypotension.","Concurrent use of haloperidol and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and nitrous oxide can increase the risk of hypotension.","Concurrent use of haloperidol and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and nortriptyline can increase the risk of hypotension.","Concurrent use of haloperidol and nortriptyline can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and olanzapine can increase the risk of hypotension.","Concurrent use of haloperidol and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and olmesartan can increase the risk of hypotension.","Olodaterol is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Both haloperidol and ondansetron prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and orphenadrine can increase the risk of antimuscarinic effects.","Both haloperidol and osimertinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and oxprenolol can increase the risk of hypotension.","Concurrent use of haloperidol and oxybutynin can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and paliperidone can increase the risk of hypotension.","Both haloperidol and paliperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Palonosetron is predicted to increase the risk of QT-prolongation when given with haloperidol.","Both haloperidol and panobinostat prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both haloperidol and pasireotide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both haloperidol and pazopanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Intravenous pentamidine potentially increases the risk of QT-prolongation when given with haloperidol.","Concurrent use of haloperidol and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and pergolide can increase the risk of hypotension.","Haloperidol is predicted to decrease the effects of pergolide. Manufacturer advises avoid.","Concurrent use of haloperidol and pericyazine can increase the risk of hypotension.","Concurrent use of haloperidol and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and perindopril can increase the risk of hypotension.","Concurrent use of haloperidol and perphenazine can increase the risk of hypotension.","Concurrent use of haloperidol and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and perphenazine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and phenelzine can increase the risk of hypotension.","Concurrent use of haloperidol and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Phenobarbital decreases the concentration of haloperidol. Manufacturer advises adjust dose.","Phenytoin decreases the concentration of haloperidol. Manufacturer advises adjust dose.","Concurrent use of haloperidol and pimozide can increase the risk of hypotension.","Both haloperidol and pimozide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and pimozide can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and pindolol can increase the risk of hypotension.","Concurrent use of haloperidol and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and pramipexole can increase the risk of hypotension.","Haloperidol is predicted to decrease the effects of pramipexole. Manufacturer advises avoid.","Concurrent use of haloperidol and prazosin can increase the risk of hypotension.","Prednisolone is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Prednisone is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Primidone decreases the concentration of haloperidol. Manufacturer advises adjust dose.","Concurrent use of haloperidol and prochlorperazine can increase the risk of hypotension.","Concurrent use of haloperidol and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and prochlorperazine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and procyclidine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and promazine can increase the risk of hypotension.","Concurrent use of haloperidol and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and promethazine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and propafenone can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and propantheline can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and propiverine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and propofol can increase the risk of hypotension.","Concurrent use of haloperidol and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and propranolol can increase the risk of hypotension.","Concurrent use of haloperidol and quetiapine can increase the risk of hypotension.","Concurrent use of haloperidol and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and quinagolide can increase the risk of hypotension.","Haloperidol is predicted to decrease the effects of quinagolide. Manufacturer advises avoid.","Concurrent use of haloperidol and quinapril can increase the risk of hypotension.","Both haloperidol and quinine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and ramipril can increase the risk of hypotension.","Both haloperidol and ranolazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Rifampicin decreases the concentration of haloperidol. Manufacturer advises adjust dose.","Concurrent use of haloperidol and riociguat can increase the risk of hypotension.","Concurrent use of haloperidol and risperidone can increase the risk of hypotension.","Both haloperidol and risperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ritonavir is predicted to increase the exposure to haloperidol.","Concurrent use of haloperidol and ropinirole can increase the risk of hypotension.","Haloperidol is predicted to decrease the effects of ropinirole. Manufacturer advises avoid.","Concurrent use of haloperidol and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and rotigotine can increase the risk of hypotension.","Haloperidol is predicted to decrease the effects of rotigotine. Manufacturer advises avoid.","Concurrent use of haloperidol and sacubitril can increase the risk of hypotension.","Salbutamol is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Salmeterol is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and sapropterin can increase the risk of hypotension.","Both haloperidol and saquinavir prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and selegiline can increase the risk of hypotension.","Senna is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and sevoflurane can increase the risk of hypotension.","Concurrent use of haloperidol and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and sildenafil can increase the risk of hypotension.","Both haloperidol and sildenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of haloperidol and sodium oxybate can increase the risk of hypotension.","Concurrent use of haloperidol and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Haloperidol potentially decreases the effects of sodium phenylbutyrate.","Sodium picosulfate is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and solifenacin can increase the risk of antimuscarinic effects.","Both haloperidol and sorafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and sotalol can increase the risk of hypotension.","Both haloperidol and sotalol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and spironolactone can increase the risk of hypotension.","Concurrent use of haloperidol and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and sulpiride can increase the risk of hypotension.","Both haloperidol and sulpiride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both haloperidol and sunitinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and tadalafil can increase the risk of hypotension.","Concurrent use of haloperidol and tamsulosin can increase the risk of hypotension.","Concurrent use of haloperidol and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both haloperidol and telavancin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and telmisartan can increase the risk of hypotension.","Concurrent use of haloperidol and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and terazosin can increase the risk of hypotension.","Terbutaline is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Both haloperidol and tetrabenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Theophylline is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and thiopental can increase the risk of hypotension.","Concurrent use of haloperidol and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and timolol can increase the risk of hypotension.","Concurrent use of haloperidol and tiotropium can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and tizanidine can increase the risk of hypotension.","Both haloperidol and tizanidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both haloperidol and tolterodine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and tolterodine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and torasemide can increase the risk of hypotension.","Torasemide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Both haloperidol and toremifene prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and trandolapril can increase the risk of hypotension.","Concurrent use of haloperidol and tranylcypromine can increase the risk of hypotension.","Concurrent use of haloperidol and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Triamcinolone is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and trifluoperazine can increase the risk of hypotension.","Concurrent use of haloperidol and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and trifluoperazine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and trihexyphenidyl can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and trimipramine can increase the risk of hypotension.","Concurrent use of haloperidol and trimipramine can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and tropicamide can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and trospium can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and umeclidinium can increase the risk of antimuscarinic effects.","Concurrent use of haloperidol and valsartan can increase the risk of hypotension.","Both haloperidol and vandetanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and vardenafil can increase the risk of hypotension.","Both haloperidol and vardenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both haloperidol and vemurafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both haloperidol and venlafaxine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Venlafaxine slightly increases the exposure to haloperidol.","Concurrent use of haloperidol and verapamil can increase the risk of hypotension.","Vilanterol is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Both haloperidol and vinflunine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both haloperidol and voriconazole prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and xipamide can increase the risk of hypotension.","Xipamide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of haloperidol and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Haloperidol potentially increases the risk of overheating and dehydration when given with zonisamide. Manufacturer advises avoid in children.","Concurrent use of haloperidol and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of haloperidol and zuclopenthixol can increase the risk of hypotension.","Both haloperidol and zuclopenthixol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of haloperidol and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Ibuprofen.Ibuprofen","imports":["BNF.Amiloride.Amiloride","BNF.Amitriptyline.Amitriptyline","BNF.Apixaban.Apixaban","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Carbamazepine.Carbamazepine","BNF.Ceftazidime.Ceftazidime","BNF.Cefuroxime.Cefuroxime","BNF.Ciprofloxacin.Ciprofloxacin","BNF.Citalopram.Citalopram","BNF.Diclofenac.Diclofenac","BNF.Enoxaparin.Enoxaparin","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Glucose.Glucose","BNF.Indapamide.Indapamide","BNF.Levofloxacin.Levofloxacin","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Naproxen.Naproxen","BNF.Ramipril.Ramipril","BNF.Rivaroxaban.Rivaroxaban","BNF.Sertraline.Sertraline","BNF.Spironolactone.Spironolactone","BNF.Trimethoprim.Trimethoprim","BNF.Vancomycin.Vancomycin","BNF.Venlafaxine.Venlafaxine","BNF.Warfarin.Warfarin"],"interactioninfo":["Both ibuprofen and abciximab can increase the risk of bleeding.","Concurrent use of ibuprofen and aceclofenac can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and aceclofenac can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and aceclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and aceclofenac can increase the risk of bleeding.","Concurrent use of ibuprofen and acemetacin can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and acemetacin can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and acemetacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and acemetacin can increase the risk of bleeding.","Acenocoumarol is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and aciclovir can increase the risk of nephrotoxicity.","Ibuprofen is predicted to increase the risk of gastrointestinal irritation when given with alendronic acid.","Concurrent use of ibuprofen and aliskiren can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Alteplase is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and amikacin can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and amiloride can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and amiloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and amitriptyline can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and amphotericin can increase the risk of nephrotoxicity.","Both ibuprofen and anagrelide can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Argatroban is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Both ibuprofen and aspirin can increase the risk of bleeding.","Concurrent use of ibuprofen and azilsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and bacitracin can increase the risk of nephrotoxicity.","Ibuprofen increases the risk of gastrointestinal bleeding when given with beclometasone.","Concurrent use of ibuprofen and bendroflumethiazide can increase the risk of hyponatraemia.","Ibuprofen increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of ibuprofen and benzydamine can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Ibuprofen increases the risk of gastrointestinal bleeding when given with betamethasone.","Both ibuprofen and bevacizumab can increase the risk of bleeding.","Bivalirudin is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and bromfenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Ibuprofen increases the risk of gastrointestinal bleeding when given with budesonide.","Concurrent use of ibuprofen and bumetanide can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and candesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and cangrelor can increase the risk of bleeding.","Concurrent use of ibuprofen and capreomycin can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and captopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and carbamazepine can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and carboplatin can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and cefaclor can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and cefadroxil can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and cefalexin can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and cefixime can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and cefotaxime can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and cefradine can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and ceftaroline can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and ceftazidime can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and ceftobiprole can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and ceftolozane can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and ceftriaxone can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and cefuroxime can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and celecoxib can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and celecoxib can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and celecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and celecoxib can increase the risk of bleeding.","Concurrent use of ibuprofen and chlorothiazide can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and chlortalidone can increase the risk of hyponatraemia.","Ibuprofen increases the risk of acute renal failure when given with chlortalidone.","Ibuprofen increases the risk of gastrointestinal bleeding when given with ciclesonide.","Concurrent use of ibuprofen and ciclosporin can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and ciclosporin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and cilostazol can increase the risk of bleeding.","Ibuprofen potentially increases the risk of seizures when given with ciprofloxacin.","Concurrent use of ibuprofen and cisplatin can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and citalopram can increase the risk of hyponatraemia.","Both ibuprofen and citalopram can increase the risk of bleeding.","Concurrent use of ibuprofen and clomipramine can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and clopamide can increase the risk of hyponatraemia.","Ibuprofen increases the risk of acute renal failure when given with clopamide.","Both ibuprofen and clopidogrel can increase the risk of bleeding.","Concurrent use of ibuprofen and colistimethate can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and cyclopenthiazide can increase the risk of hyponatraemia.","Ibuprofen increases the risk of acute renal failure when given with cyclopenthiazide.","Dabigatran is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and dalteparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Dalteparin is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Danaparoid is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and dapoxetine can increase the risk of hyponatraemia.","Both ibuprofen and dapoxetine can increase the risk of bleeding.","Ibuprofen increases the risk of renal impairment when given with daptomycin.","Concurrent use of ibuprofen and darbepoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and dasatinib can increase the risk of bleeding.","Ibuprofen is predicted to increase the risk of gastrointestinal bleeding when given with deferasirox.","Ibuprofen increases the risk of gastrointestinal bleeding when given with deflazacort.","Concurrent use of ibuprofen and desmopressin can increase the risk of hyponatraemia.","Ibuprofen increases the risk of gastrointestinal bleeding when given with dexamethasone.","Concurrent use of ibuprofen and dexibuprofen can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and dexibuprofen can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and dexibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and dexibuprofen can increase the risk of bleeding.","Concurrent use of ibuprofen and dexketoprofen can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and dexketoprofen can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and dexketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and dexketoprofen can increase the risk of bleeding.","Concurrent use of ibuprofen and diclofenac can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and diclofenac can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and diclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and diclofenac can increase the risk of bleeding.","Both ibuprofen and dipyridamole can increase the risk of bleeding.","Concurrent use of ibuprofen and dosulepin can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and doxepin can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and drospirenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and duloxetine can increase the risk of hyponatraemia.","Both ibuprofen and duloxetine can increase the risk of bleeding.","Edoxaban is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and enalapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and enoxaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and eplerenone can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and eplerenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and epoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and epoetin beta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and epoetin zeta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and epoprostenol can increase the risk of bleeding.","Concurrent use of ibuprofen and eprosartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and eptifibatide can increase the risk of bleeding.","Erlotinib is predicted to increase the risk of gastrointestinal perforation when given with ibuprofen.","Concurrent use of ibuprofen and escitalopram can increase the risk of hyponatraemia.","Both ibuprofen and escitalopram can increase the risk of bleeding.","Concurrent use of ibuprofen and etodolac can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and etodolac can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and etodolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and etodolac can increase the risk of bleeding.","Concurrent use of ibuprofen and etoricoxib can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and etoricoxib can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and etoricoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and etoricoxib can increase the risk of bleeding.","Concurrent use of ibuprofen and felbinac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and fenoprofen can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and fenoprofen can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and fenoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and fenoprofen can increase the risk of bleeding.","Ibuprofen increases the risk of gastrointestinal bleeding when given with fludrocortisone.","Concurrent use of ibuprofen and fluoxetine can increase the risk of hyponatraemia.","Both ibuprofen and fluoxetine can increase the risk of bleeding.","Concurrent use of ibuprofen and flurbiprofen can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and flurbiprofen can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and flurbiprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and flurbiprofen can increase the risk of bleeding.","Ibuprofen increases the risk of gastrointestinal bleeding when given with fluticasone.","Concurrent use of ibuprofen and fluvoxamine can increase the risk of hyponatraemia.","Both ibuprofen and fluvoxamine can increase the risk of bleeding.","Fondaparinux is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and foscarnet can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and furosemide can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and ganciclovir can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and gentamicin can increase the risk of nephrotoxicity.","Glucose is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and heparin (unfractionated) can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Heparin (unfractionated) is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and hydrochlorothiazide can increase the risk of hyponatraemia.","Ibuprofen increases the risk of acute renal failure when given with hydrochlorothiazide.","Ibuprofen increases the risk of gastrointestinal bleeding when given with hydrocortisone.","Concurrent use of ibuprofen and hydroflumethiazide can increase the risk of hyponatraemia.","Ibuprofen increases the risk of acute renal failure when given with hydroflumethiazide.","Ibuprofen is predicted to increase the risk of gastrointestinal irritation when given with ibandronic acid.","Both ibuprofen and ibrutinib can increase the risk of bleeding.","Concurrent use of ibuprofen and ifosfamide can increase the risk of nephrotoxicity.","Both ibuprofen and iloprost can increase the risk of bleeding.","Concurrent use of ibuprofen and imidapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and imipramine can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and indapamide can increase the risk of hyponatraemia.","Ibuprofen increases the risk of acute renal failure when given with indapamide.","Concurrent use of ibuprofen and indometacin can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and indometacin can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and indometacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and indometacin can increase the risk of bleeding.","Concurrent use of ibuprofen and irbesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and ketoprofen can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and ketoprofen can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and ketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and ketoprofen can increase the risk of bleeding.","Concurrent use of ibuprofen and ketorolac can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and ketorolac can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and ketorolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and ketorolac can increase the risk of bleeding.","Ibuprofen potentially increases the risk of seizures when given with levofloxacin.","Concurrent use of ibuprofen and lisinopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Ibuprofen increases the concentration of lithium. Manufacturer advises monitor and adjust dose.","Concurrent use of ibuprofen and losartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Lumacaftor is predicted to decrease the exposure to ibuprofen. Manufacturer advises adjust dose.","Concurrent use of ibuprofen and mefenamic acid can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and mefenamic acid can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and mefenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and mefenamic acid can increase the risk of bleeding.","Concurrent use of ibuprofen and meloxicam can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and meloxicam can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and meloxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and meloxicam can increase the risk of bleeding.","Concurrent use of ibuprofen and methotrexate can increase the risk of nephrotoxicity.","Ibuprofen is predicted to increase the risk of toxicity when given with methotrexate. Manufacturer advises monitor and adjust dose.","Ibuprofen increases the risk of gastrointestinal bleeding when given with methylprednisolone.","Concurrent use of ibuprofen and metolazone can increase the risk of hyponatraemia.","Ibuprofen increases the risk of acute renal failure when given with metolazone.","Ibuprofen (high-dose) is predicted to decrease the efficacy of mifamurtide. Manufacturer advises avoid.","Concurrent use of ibuprofen and moexipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Ibuprofen increases the risk of gastrointestinal bleeding when given with mometasone.","Ibuprofen potentially increases the risk of seizures when given with moxifloxacin.","Concurrent use of ibuprofen and nabumetone can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and nabumetone can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and nabumetone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and nabumetone can increase the risk of bleeding.","Ibuprofen potentially increases the risk of seizures when given with nalidixic acid.","Concurrent use of ibuprofen and naproxen can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and naproxen can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and naproxen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and naproxen can increase the risk of bleeding.","Concurrent use of ibuprofen and neomycin can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and nepafenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Nicorandil is predicted to increase the risk of gastrointestinal perforation when given with ibuprofen.","Nicotinic acid is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Ibuprofen potentially increases the risk of seizures when given with norfloxacin.","Concurrent use of ibuprofen and nortriptyline can increase the risk of hyponatraemia.","Ibuprofen potentially increases the risk of seizures when given with ofloxacin.","Concurrent use of ibuprofen and olmesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Omega-3-acid ethyl esters is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and oxaliplatin can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and parecoxib can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and parecoxib can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and parecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and parecoxib can increase the risk of bleeding.","Concurrent use of ibuprofen and paroxetine can increase the risk of hyponatraemia.","Both ibuprofen and paroxetine can increase the risk of bleeding.","Concurrent use of ibuprofen and pemetrexed can increase the risk of nephrotoxicity.","Ibuprofen is predicted to increase the exposure to pemetrexed. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and penicillamine can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and pentamidine can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and perindopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Phenindione is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and piroxicam can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and piroxicam can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and piroxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and piroxicam can increase the risk of bleeding.","Concurrent use of ibuprofen and polymyxins can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and potassium canrenoate can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and potassium chloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and prasugrel can increase the risk of bleeding.","Ibuprofen increases the risk of gastrointestinal bleeding when given with prednisolone.","Ibuprofen increases the risk of gastrointestinal bleeding when given with prednisone.","Concurrent use of ibuprofen and quinapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and ramipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and regorafenib can increase the risk of bleeding.","Reteplase is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and sertraline can increase the risk of hyponatraemia.","Both ibuprofen and sertraline can increase the risk of bleeding.","Ibuprofen is predicted to increase the risk of renal impairment when given with sodium clodronate.","Concurrent use of ibuprofen and sodium picosulfate can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and spironolactone can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and spironolactone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Streptokinase is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and streptomycin can increase the risk of nephrotoxicity.","Both ibuprofen and sulfinpyrazone can increase the risk of bleeding.","Concurrent use of ibuprofen and sulindac can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and sulindac can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and sulindac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and sulindac can increase the risk of bleeding.","Concurrent use of ibuprofen and tacrolimus can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and tacrolimus can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and telavancin can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and telmisartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Tenecteplase is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and tenofovir can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and tenoxicam can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and tenoxicam can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and tenoxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and tenoxicam can increase the risk of bleeding.","Concurrent use of ibuprofen and tiaprofenic acid can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and tiaprofenic acid can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and tiaprofenic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and tiaprofenic acid can increase the risk of bleeding.","Both ibuprofen and ticagrelor can increase the risk of bleeding.","Concurrent use of ibuprofen and tinzaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Tinzaparin is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Both ibuprofen and tirofiban can increase the risk of bleeding.","Concurrent use of ibuprofen and tobramycin can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and tolfenamic acid can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and tolfenamic acid can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and tolfenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and tolfenamic acid can increase the risk of bleeding.","Concurrent use of ibuprofen and tolvaptan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and torasemide can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and trandolapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both ibuprofen and trastuzumab can increase the risk of bleeding.","Both ibuprofen and trastuzumab emtansine can increase the risk of bleeding.","Ibuprofen increases the risk of gastrointestinal bleeding when given with triamcinolone.","Concurrent use of ibuprofen and triamterene can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and triamterene can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and trimethoprim can increase the risk of hyponatraemia.","Concurrent use of ibuprofen and trimethoprim can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and trimethoprim can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and trimipramine can increase the risk of hyponatraemia.","Urokinase is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and valaciclovir can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and valganciclovir can increase the risk of nephrotoxicity.","Concurrent use of ibuprofen and valsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ibuprofen and vancomycin can increase the risk of nephrotoxicity.","Both ibuprofen and venlafaxine can increase the risk of bleeding.","Voriconazole moderately increases the exposure to ibuprofen. Manufacturer advises adjust dose.","Both ibuprofen and vortioxetine can increase the risk of bleeding.","Warfarin is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Concurrent use of ibuprofen and xipamide can increase the risk of hyponatraemia.","Ibuprofen increases the risk of acute renal failure when given with xipamide.","Concurrent use of ibuprofen and zidovudine can increase the risk of nephrotoxicity.","Zidovudine increases the risk of haematological toxicity when given with ibuprofen.","Concurrent use of ibuprofen and zoledronic acid can increase the risk of nephrotoxicity."]},{"name":"BNF.Indapamide.Indapamide","imports":["BNF.Amiloride.Amiloride","BNF.Amiodarone.Amiodarone","BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisacodyl.Bisacodyl","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Carbamazepine.Carbamazepine","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Diclofenac.Diclofenac","BNF.Digoxin.Digoxin","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Ibuprofen.Ibuprofen","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Naproxen.Naproxen","BNF.Nifedipine.Nifedipine","BNF.Ondansetron.Ondansetron","BNF.Prochlorperazine.Prochlorperazine","BNF.Quinine.Quinine","BNF.Ramipril.Ramipril","BNF.Salbutamol.Salbutamol","BNF.Senna.Senna","BNF.Sertraline.Sertraline","BNF.Spironolactone.Spironolactone","BNF.Theophylline.Theophylline","BNF.Trimethoprim.Trimethoprim","BNF.Venlafaxine.Venlafaxine"],"interactioninfo":["Concurrent use of indapamide and acebutolol can increase the risk of hypotension.","Concurrent use of indapamide and aceclofenac can increase the risk of hyponatraemia.","Aceclofenac increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and acemetacin can increase the risk of hyponatraemia.","Acemetacin increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and alcohol (beverage) can increase the risk of hypotension.","Indapamide increases the risk of hypercalcaemia when given with alfacalcidol.","Concurrent use of indapamide and alfuzosin can increase the risk of hypotension.","Concurrent use of indapamide and aliskiren can increase the risk of hypotension.","Indapamide is predicted to increase the risk of hypersensitivity reactions when given with allopurinol.","Concurrent use of indapamide and alprostadil can increase the risk of hypotension.","Concurrent use of indapamide and amantadine can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with amifampridine. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and amiloride can increase the risk of hyponatraemia.","Concurrent use of indapamide and aminophylline can increase the risk of hypokalaemia.","Indapamide is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with amisulpride. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and amitriptyline can increase the risk of hyponatraemia.","Concurrent use of indapamide and amitriptyline can increase the risk of hypotension.","Concurrent use of indapamide and amlodipine can increase the risk of hypotension.","Concurrent use of indapamide and amphotericin can increase the risk of hypokalaemia.","Concurrent use of indapamide and apomorphine can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with apomorphine. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and apraclonidine can increase the risk of hypotension.","Concurrent use of indapamide and aripiprazole can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with arsenic trioxide. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with artemether. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with artenimol. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and asenapine can increase the risk of hypotension.","Aspirin (high-dose) increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and atenolol can increase the risk of hypotension.","Concurrent use of indapamide and avanafil can increase the risk of hypotension.","Concurrent use of indapamide and azilsartan can increase the risk of hypotension.","Concurrent use of indapamide and baclofen can increase the risk of hypotension.","Concurrent use of indapamide and bambuterol can increase the risk of hypokalaemia.","Concurrent use of indapamide and beclometasone can increase the risk of hypokalaemia.","Indapamide is predicted to increase the risk of torsade de pointes when given with bedaquiline. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and bendroflumethiazide can increase the risk of hyponatraemia.","Concurrent use of indapamide and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of indapamide and bendroflumethiazide can increase the risk of hypokalaemia.","Concurrent use of indapamide and benperidol can increase the risk of hypotension.","Benzydamine increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and betamethasone can increase the risk of hypokalaemia.","Concurrent use of indapamide and betaxolol can increase the risk of hypotension.","Concurrent use of indapamide and bisacodyl can increase the risk of hypokalaemia.","Concurrent use of indapamide and bisoprolol can increase the risk of hypotension.","Concurrent use of indapamide and bortezomib can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with bosutinib. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and brimonidine can increase the risk of hypotension.","Bromfenac increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and bromocriptine can increase the risk of hypotension.","Concurrent use of indapamide and budesonide can increase the risk of hypokalaemia.","Concurrent use of indapamide and bumetanide can increase the risk of hyponatraemia.","Concurrent use of indapamide and bumetanide can increase the risk of hypotension.","Concurrent use of indapamide and bumetanide can increase the risk of hypokalaemia.","Concurrent use of indapamide and cabergoline can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with cabozantinib. Manufacturer advises use with caution or avoid.","Indapamide increases the risk of hypercalcaemia when given with calcipotriol.","Indapamide increases the risk of hypercalcaemia when given with calcitriol.","Indapamide increases the risk of hypercalcaemia when given with calcium acetate.","Indapamide increases the risk of hypercalcaemia when given with calcium carbonate.","Indapamide increases the risk of hypercalcaemia when given with calcium chloride.","Indapamide increases the risk of hypercalcaemia when given with calcium gluconate.","Indapamide increases the risk of hypercalcaemia when given with calcium lactate.","Indapamide increases the risk of hypercalcaemia when given with calcium phosphate.","Concurrent use of indapamide and canagliflozin can increase the risk of hypotension.","Concurrent use of indapamide and candesartan can increase the risk of hypotension.","Concurrent use of indapamide and captopril can increase the risk of hypotension.","Concurrent use of indapamide and carbamazepine can increase the risk of hyponatraemia.","Concurrent use of indapamide and carteolol can increase the risk of hypotension.","Concurrent use of indapamide and carvedilol can increase the risk of hypotension.","Concurrent use of indapamide and celecoxib can increase the risk of hyponatraemia.","Celecoxib increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and celiprolol can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with ceritinib. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and chlorothiazide can increase the risk of hyponatraemia.","Concurrent use of indapamide and chlorothiazide can increase the risk of hypotension.","Concurrent use of indapamide and chlorothiazide can increase the risk of hypokalaemia.","Concurrent use of indapamide and chlorpromazine can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with chlorpromazine. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and chlortalidone can increase the risk of hyponatraemia.","Concurrent use of indapamide and chlortalidone can increase the risk of hypotension.","Concurrent use of indapamide and chlortalidone can increase the risk of hypokalaemia.","Concurrent use of indapamide and citalopram can increase the risk of hyponatraemia.","Indapamide is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and clevidipine can increase the risk of hypotension.","Concurrent use of indapamide and clomipramine can increase the risk of hyponatraemia.","Concurrent use of indapamide and clomipramine can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with clomipramine. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and clonidine can increase the risk of hypotension.","Concurrent use of indapamide and clopamide can increase the risk of hyponatraemia.","Concurrent use of indapamide and clopamide can increase the risk of hypotension.","Concurrent use of indapamide and clopamide can increase the risk of hypokalaemia.","Concurrent use of indapamide and clozapine can increase the risk of hypotension.","Indapamide increases the risk of hypercalcaemia when given with colecalciferol.","Indapamide is predicted to increase the risk of torsade de pointes when given with crizotinib. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and cyclopenthiazide can increase the risk of hyponatraemia.","Concurrent use of indapamide and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of indapamide and cyclopenthiazide can increase the risk of hypokalaemia.","Concurrent use of indapamide and dantron can increase the risk of hypokalaemia.","Concurrent use of indapamide and dapagliflozin can increase the risk of hypotension.","Concurrent use of indapamide and dapoxetine can increase the risk of hyponatraemia.","Indapamide is predicted to increase the risk of torsade de pointes when given with dasatinib. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and deflazacort can increase the risk of hypokalaemia.","Indapamide is predicted to increase the risk of torsade de pointes when given with delamanid. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and desflurane can increase the risk of hypotension.","Concurrent use of indapamide and desmopressin can increase the risk of hyponatraemia.","Concurrent use of indapamide and dexamethasone can increase the risk of hypokalaemia.","Concurrent use of indapamide and dexibuprofen can increase the risk of hyponatraemia.","Dexibuprofen increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and dexketoprofen can increase the risk of hyponatraemia.","Dexketoprofen increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and diazoxide can increase the risk of hypotension.","Concurrent use of indapamide and diclofenac can increase the risk of hyponatraemia.","Diclofenac increases the risk of acute renal failure when given with indapamide.","Indapamide is predicted to increase the risk of digoxin toxicity when given with digoxin.","Indapamide increases the risk of hypercalcaemia when given with dihydrotachysterol.","Concurrent use of indapamide and diltiazem can increase the risk of hypotension.","Concurrent use of indapamide and dipyridamole can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with disopyramide. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and docusate sodium can increase the risk of hypokalaemia.","Concurrent use of indapamide and dosulepin can increase the risk of hyponatraemia.","Concurrent use of indapamide and dosulepin can increase the risk of hypotension.","Concurrent use of indapamide and doxazosin can increase the risk of hypotension.","Concurrent use of indapamide and doxepin can increase the risk of hyponatraemia.","Concurrent use of indapamide and doxepin can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with dronedarone. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and droperidol can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with droperidol. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and duloxetine can increase the risk of hyponatraemia.","Concurrent use of indapamide and empagliflozin can increase the risk of hypotension.","Concurrent use of indapamide and enalapril can increase the risk of hypotension.","Concurrent use of indapamide and eplerenone can increase the risk of hyponatraemia.","Concurrent use of indapamide and eplerenone can increase the risk of hypotension.","Concurrent use of indapamide and eprosartan can increase the risk of hypotension.","Indapamide increases the risk of hypercalcaemia when given with ergocalciferol.","Indapamide is predicted to increase the risk of torsade de pointes when given with eribulin. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and escitalopram can increase the risk of hyponatraemia.","Indapamide is predicted to increase the risk of torsade de pointes when given with escitalopram. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and esmolol can increase the risk of hypotension.","Concurrent use of indapamide and etodolac can increase the risk of hyponatraemia.","Etodolac increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and etomidate can increase the risk of hypotension.","Concurrent use of indapamide and etoricoxib can increase the risk of hyponatraemia.","Etoricoxib increases the risk of acute renal failure when given with indapamide.","Felbinac increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and felodipine can increase the risk of hypotension.","Concurrent use of indapamide and fenoprofen can increase the risk of hyponatraemia.","Fenoprofen increases the risk of acute renal failure when given with indapamide.","Indapamide is predicted to increase the risk of torsade de pointes when given with flecainide. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and fludrocortisone can increase the risk of hypokalaemia.","Concurrent use of indapamide and fluoxetine can increase the risk of hyponatraemia.","Concurrent use of indapamide and flupentixol can increase the risk of hypotension.","Concurrent use of indapamide and fluphenazine can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with fluphenazine. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and flurbiprofen can increase the risk of hyponatraemia.","Flurbiprofen increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and fluvoxamine can increase the risk of hyponatraemia.","Concurrent use of indapamide and formoterol can increase the risk of hypokalaemia.","Concurrent use of indapamide and fosinopril can increase the risk of hypotension.","Concurrent use of indapamide and furosemide can increase the risk of hyponatraemia.","Concurrent use of indapamide and furosemide can increase the risk of hypotension.","Concurrent use of indapamide and furosemide can increase the risk of hypokalaemia.","Concurrent use of indapamide and glycerol can increase the risk of hypokalaemia.","Concurrent use of indapamide and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of indapamide and guanethidine can increase the risk of hypotension.","Concurrent use of indapamide and guanfacine can increase the risk of hypotension.","Concurrent use of indapamide and haloperidol can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and histamine can increase the risk of hypotension.","Concurrent use of indapamide and hydralazine can increase the risk of hypotension.","Concurrent use of indapamide and hydrochlorothiazide can increase the risk of hyponatraemia.","Concurrent use of indapamide and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of indapamide and hydrochlorothiazide can increase the risk of hypokalaemia.","Concurrent use of indapamide and hydrocortisone can increase the risk of hypokalaemia.","Concurrent use of indapamide and hydroflumethiazide can increase the risk of hyponatraemia.","Concurrent use of indapamide and hydroflumethiazide can increase the risk of hypotension.","Concurrent use of indapamide and hydroflumethiazide can increase the risk of hypokalaemia.","Indapamide is predicted to increase the risk of torsade de pointes when given with hydroxyzine. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and ibuprofen can increase the risk of hyponatraemia.","Ibuprofen increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and imidapril can increase the risk of hypotension.","Concurrent use of indapamide and imipramine can increase the risk of hyponatraemia.","Concurrent use of indapamide and imipramine can increase the risk of hypotension.","Concurrent use of indapamide and indacaterol can increase the risk of hypokalaemia.","Concurrent use of indapamide and indometacin can increase the risk of hyponatraemia.","Indometacin increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and indoramin can increase the risk of hypotension.","Concurrent use of indapamide and irbesartan can increase the risk of hypotension.","Concurrent use of indapamide and isocarboxazid can increase the risk of hypotension.","Concurrent use of indapamide and isoflurane can increase the risk of hypotension.","Concurrent use of indapamide and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of indapamide and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of indapamide and isradipine can increase the risk of hypotension.","Concurrent use of indapamide and ketamine can increase the risk of hypotension.","Concurrent use of indapamide and ketoprofen can increase the risk of hyponatraemia.","Ketoprofen increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and ketorolac can increase the risk of hyponatraemia.","Ketorolac increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and labetalol can increase the risk of hypotension.","Concurrent use of indapamide and lacidipine can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with lapatinib. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and lercanidipine can increase the risk of hypotension.","Concurrent use of indapamide and levobunolol can increase the risk of hypotension.","Concurrent use of indapamide and levodopa can increase the risk of hypotension.","Concurrent use of indapamide and levomepromazine can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and lisinopril can increase the risk of hypotension.","Indapamide increases the concentration of lithium. Manufacturer advises avoid or adjust dose and monitor concentration.","Concurrent use of indapamide and lofepramine can increase the risk of hypotension.","Concurrent use of indapamide and lofexidine can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with lofexidine. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and losartan can increase the risk of hypotension.","Concurrent use of indapamide and loxapine can increase the risk of hypotension.","Concurrent use of indapamide and lurasidone can increase the risk of hypotension.","Concurrent use of indapamide and mefenamic acid can increase the risk of hyponatraemia.","Mefenamic acid increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and meloxicam can increase the risk of hyponatraemia.","Meloxicam increases the risk of acute renal failure when given with indapamide.","Indapamide is predicted to increase the risk of torsade de pointes when given with methadone. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and methyldopa can increase the risk of hypotension.","Concurrent use of indapamide and methylprednisolone can increase the risk of hypokalaemia.","Concurrent use of indapamide and metolazone can increase the risk of hyponatraemia.","Concurrent use of indapamide and metolazone can increase the risk of hypotension.","Concurrent use of indapamide and metolazone can increase the risk of hypokalaemia.","Concurrent use of indapamide and metoprolol can increase the risk of hypotension.","Concurrent use of indapamide and minoxidil can increase the risk of hypotension.","Concurrent use of indapamide and moexipril can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with moxifloxacin. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and moxisylyte can increase the risk of hypotension.","Concurrent use of indapamide and moxonidine can increase the risk of hypotension.","Concurrent use of indapamide and nabumetone can increase the risk of hyponatraemia.","Nabumetone increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and nadolol can increase the risk of hypotension.","Concurrent use of indapamide and naproxen can increase the risk of hyponatraemia.","Naproxen increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and nebivolol can increase the risk of hypotension.","Nepafenac increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and nicardipine can increase the risk of hypotension.","Concurrent use of indapamide and nicorandil can increase the risk of hypotension.","Concurrent use of indapamide and nifedipine can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with nilotinib. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and nimodipine can increase the risk of hypotension.","Concurrent use of indapamide and nitrous oxide can increase the risk of hypotension.","Concurrent use of indapamide and nortriptyline can increase the risk of hyponatraemia.","Concurrent use of indapamide and nortriptyline can increase the risk of hypotension.","Concurrent use of indapamide and olanzapine can increase the risk of hypotension.","Concurrent use of indapamide and olmesartan can increase the risk of hypotension.","Concurrent use of indapamide and olodaterol can increase the risk of hypokalaemia.","Indapamide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with osimertinib. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and oxprenolol can increase the risk of hypotension.","Concurrent use of indapamide and paliperidone can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with paliperidone. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with panobinostat. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and parecoxib can increase the risk of hyponatraemia.","Parecoxib increases the risk of acute renal failure when given with indapamide.","Indapamide increases the risk of hypercalcaemia when given with paricalcitol.","Concurrent use of indapamide and paroxetine can increase the risk of hyponatraemia.","Indapamide is predicted to increase the risk of torsade de pointes when given with pasireotide. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with pazopanib. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and pergolide can increase the risk of hypotension.","Concurrent use of indapamide and pericyazine can increase the risk of hypotension.","Concurrent use of indapamide and perindopril can increase the risk of hypotension.","Concurrent use of indapamide and perphenazine can increase the risk of hypotension.","Concurrent use of indapamide and phenelzine can increase the risk of hypotension.","Concurrent use of indapamide and pimozide can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with pimozide. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and pindolol can increase the risk of hypotension.","Concurrent use of indapamide and piroxicam can increase the risk of hyponatraemia.","Piroxicam increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and pramipexole can increase the risk of hypotension.","Concurrent use of indapamide and prazosin can increase the risk of hypotension.","Concurrent use of indapamide and prednisolone can increase the risk of hypokalaemia.","Concurrent use of indapamide and prednisone can increase the risk of hypokalaemia.","Concurrent use of indapamide and prochlorperazine can increase the risk of hypotension.","Concurrent use of indapamide and promazine can increase the risk of hypotension.","Concurrent use of indapamide and propofol can increase the risk of hypotension.","Concurrent use of indapamide and propranolol can increase the risk of hypotension.","Concurrent use of indapamide and quetiapine can increase the risk of hypotension.","Concurrent use of indapamide and quinagolide can increase the risk of hypotension.","Concurrent use of indapamide and quinapril can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and ramipril can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with ranolazine. Manufacturer advises use with caution or avoid.","Reboxetine is predicted to increase the risk of hypokalaemia when given with indapamide.","Concurrent use of indapamide and riociguat can increase the risk of hypotension.","Concurrent use of indapamide and risperidone can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with risperidone. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and ropinirole can increase the risk of hypotension.","Concurrent use of indapamide and rotigotine can increase the risk of hypotension.","Concurrent use of indapamide and sacubitril can increase the risk of hypotension.","Concurrent use of indapamide and salbutamol can increase the risk of hypokalaemia.","Concurrent use of indapamide and salmeterol can increase the risk of hypokalaemia.","Concurrent use of indapamide and sapropterin can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with saquinavir. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and selegiline can increase the risk of hypotension.","Concurrent use of indapamide and senna can increase the risk of hypokalaemia.","Concurrent use of indapamide and sertraline can increase the risk of hyponatraemia.","Concurrent use of indapamide and sevoflurane can increase the risk of hypotension.","Concurrent use of indapamide and sildenafil can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with sildenafil. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of indapamide and sodium oxybate can increase the risk of hypotension.","Concurrent use of indapamide and sodium picosulfate can increase the risk of hyponatraemia.","Concurrent use of indapamide and sodium picosulfate can increase the risk of hypokalaemia.","Indapamide is predicted to increase the risk of torsade de pointes when given with sorafenib. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and sotalol can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with sotalol. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and spironolactone can increase the risk of hyponatraemia.","Concurrent use of indapamide and spironolactone can increase the risk of hypotension.","Concurrent use of indapamide and sulindac can increase the risk of hyponatraemia.","Sulindac increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and sulpiride can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with sulpiride. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with sunitinib. Manufacturer advises use with caution or avoid.","Indapamide increases the risk of hypercalcaemia when given with tacalcitol.","Concurrent use of indapamide and tadalafil can increase the risk of hypotension.","Concurrent use of indapamide and tamsulosin can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with telavancin. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and telmisartan can increase the risk of hypotension.","Concurrent use of indapamide and tenoxicam can increase the risk of hyponatraemia.","Tenoxicam increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and terazosin can increase the risk of hypotension.","Concurrent use of indapamide and terbutaline can increase the risk of hypokalaemia.","Indapamide is predicted to increase the risk of torsade de pointes when given with tetrabenazine. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and theophylline can increase the risk of hypokalaemia.","Concurrent use of indapamide and thiopental can increase the risk of hypotension.","Concurrent use of indapamide and tiaprofenic acid can increase the risk of hyponatraemia.","Tiaprofenic acid increases the risk of acute renal failure when given with indapamide.","Concurrent use of indapamide and timolol can increase the risk of hypotension.","Concurrent use of indapamide and tizanidine can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with tizanidine. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and tolfenamic acid can increase the risk of hyponatraemia.","Tolfenamic acid increases the risk of acute renal failure when given with indapamide.","Indapamide is predicted to increase the risk of torsade de pointes when given with tolterodine. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and torasemide can increase the risk of hyponatraemia.","Concurrent use of indapamide and torasemide can increase the risk of hypotension.","Concurrent use of indapamide and torasemide can increase the risk of hypokalaemia.","Indapamide is predicted to increase the risk of torsade de pointes when given with toremifene. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and trandolapril can increase the risk of hypotension.","Concurrent use of indapamide and tranylcypromine can increase the risk of hypotension.","Concurrent use of indapamide and triamcinolone can increase the risk of hypokalaemia.","Concurrent use of indapamide and triamterene can increase the risk of hyponatraemia.","Concurrent use of indapamide and trifluoperazine can increase the risk of hypotension.","Concurrent use of indapamide and trimethoprim can increase the risk of hyponatraemia.","Concurrent use of indapamide and trimipramine can increase the risk of hyponatraemia.","Concurrent use of indapamide and trimipramine can increase the risk of hypotension.","Concurrent use of indapamide and valsartan can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with vandetanib. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and vardenafil can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with vardenafil. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with vemurafenib. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and verapamil can increase the risk of hypotension.","Concurrent use of indapamide and vilanterol can increase the risk of hypokalaemia.","Indapamide is predicted to increase the risk of torsade de pointes when given with vinflunine. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with voriconazole. Manufacturer advises use with caution or avoid.","Concurrent use of indapamide and xipamide can increase the risk of hyponatraemia.","Concurrent use of indapamide and xipamide can increase the risk of hypotension.","Concurrent use of indapamide and xipamide can increase the risk of hypokalaemia.","Concurrent use of indapamide and zuclopenthixol can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with zuclopenthixol. Manufacturer advises use with caution or avoid."]},{"name":"BNF.Insulin.Insulin","imports":["BNF.Gliclazide.Gliclazide","BNF.Metformin.Metformin"],"interactioninfo":["Concurrent use of insulin and acarbose can increase the risk of hypoglycaemia.","Concurrent use of insulin and albiglutide can increase the risk of hypoglycaemia.","Concurrent use of insulin and alogliptin can increase the risk of hypoglycaemia.","Bezafibrate is predicted to increase the risk of hypoglycaemia when given with insulin.","Concurrent use of insulin and biphasic insulin aspart can increase the risk of hypoglycaemia.","Concurrent use of insulin and biphasic insulin lispro can increase the risk of hypoglycaemia.","Concurrent use of insulin and biphasic isophane insulin can increase the risk of hypoglycaemia.","Concurrent use of insulin and canagliflozin can increase the risk of hypoglycaemia.","Ciprofibrate is predicted to increase the risk of hypoglycaemia when given with insulin.","Concurrent use of insulin and dapagliflozin can increase the risk of hypoglycaemia.","Concurrent use of insulin and dulaglutide can increase the risk of hypoglycaemia.","Concurrent use of insulin and empagliflozin can increase the risk of hypoglycaemia.","Concurrent use of insulin and exenatide can increase the risk of hypoglycaemia.","Fenofibrate is predicted to increase the risk of hypoglycaemia when given with insulin.","Gemfibrozil is predicted to increase the risk of hypoglycaemia when given with insulin.","Concurrent use of insulin and glibenclamide can increase the risk of hypoglycaemia.","Concurrent use of insulin and gliclazide can increase the risk of hypoglycaemia.","Concurrent use of insulin and glimepiride can increase the risk of hypoglycaemia.","Concurrent use of insulin and glipizide can increase the risk of hypoglycaemia.","Concurrent use of insulin and insulin aspart can increase the risk of hypoglycaemia.","Concurrent use of insulin and insulin degludec can increase the risk of hypoglycaemia.","Concurrent use of insulin and insulin detemir can increase the risk of hypoglycaemia.","Concurrent use of insulin and insulin glargine can increase the risk of hypoglycaemia.","Concurrent use of insulin and insulin glulisine can increase the risk of hypoglycaemia.","Concurrent use of insulin and insulin lispro can increase the risk of hypoglycaemia.","Concurrent use of insulin and insulin zinc suspension can increase the risk of hypoglycaemia.","Concurrent use of insulin and isophane insulin can increase the risk of hypoglycaemia.","Concurrent use of insulin and linagliptin can increase the risk of hypoglycaemia.","Concurrent use of insulin and liraglutide can increase the risk of hypoglycaemia.","Concurrent use of insulin and lixisenatide can increase the risk of hypoglycaemia.","Concurrent use of insulin and metformin can increase the risk of hypoglycaemia.","Concurrent use of insulin and nateglinide can increase the risk of hypoglycaemia.","Concurrent use of insulin and pioglitazone can increase the risk of hypoglycaemia.","Concurrent use of insulin and protamine zinc insulin can increase the risk of hypoglycaemia.","Concurrent use of insulin and repaglinide can increase the risk of hypoglycaemia.","Concurrent use of insulin and saxagliptin can increase the risk of hypoglycaemia.","Concurrent use of insulin and sitagliptin can increase the risk of hypoglycaemia.","Concurrent use of insulin and tolbutamide can increase the risk of hypoglycaemia.","Concurrent use of insulin and vildagliptin can increase the risk of hypoglycaemia."]},{"name":"BNF.Ipratropium.Ipratropium","imports":["BNF.Amitriptyline.Amitriptyline","BNF.Cyclizine.Cyclizine","BNF.Haloperidol.Haloperidol","BNF.Levomepromazine.Levomepromazine","BNF.Nefopam.Nefopam","BNF.Prochlorperazine.Prochlorperazine","BNF.Salbutamol.Salbutamol","BNF.Tiotropium.Tiotropium"],"interactioninfo":["Concurrent use of ipratropium and aclidinium can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and amantadine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and amitriptyline can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and atropine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and baclofen can increase the risk of antimuscarinic effects.","Bambuterol is predicted to increase the risk of glaucoma when given with ipratropium.","Concurrent use of ipratropium and chlorphenamine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and chlorpromazine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and clemastine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and clomipramine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and clozapine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and cyclizine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and cyclopentolate can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and cyproheptadine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and darifenacin can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and dicycloverine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and dimenhydrinate can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and disopyramide can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and dosulepin can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and doxepin can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and fesoterodine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and flavoxate can increase the risk of antimuscarinic effects.","Formoterol is predicted to increase the risk of glaucoma when given with ipratropium.","Concurrent use of ipratropium and glycopyrronium can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and haloperidol can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and homatropine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and hydroxyzine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and hyoscine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and imipramine can increase the risk of antimuscarinic effects.","Indacaterol is predicted to increase the risk of glaucoma when given with ipratropium.","Ipratropium decreases the absorption of levodopa.","Concurrent use of ipratropium and levomepromazine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and lofepramine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and loxapine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and nefopam can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and nortriptyline can increase the risk of antimuscarinic effects.","Olodaterol is predicted to increase the risk of glaucoma when given with ipratropium.","Concurrent use of ipratropium and orphenadrine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and oxybutynin can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and perphenazine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and pimozide can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and prochlorperazine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and procyclidine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and promethazine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and propafenone can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and propantheline can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and propiverine can increase the risk of antimuscarinic effects.","Salbutamol is predicted to increase the risk of glaucoma when given with ipratropium.","Salmeterol is predicted to increase the risk of glaucoma when given with ipratropium.","Concurrent use of ipratropium and solifenacin can increase the risk of antimuscarinic effects.","Terbutaline is predicted to increase the risk of glaucoma when given with ipratropium.","Concurrent use of ipratropium and tiotropium can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and tolterodine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and trifluoperazine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and trihexyphenidyl can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and trimipramine can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and tropicamide can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and trospium can increase the risk of antimuscarinic effects.","Concurrent use of ipratropium and umeclidinium can increase the risk of antimuscarinic effects.","Vilanterol is predicted to increase the risk of glaucoma when given with ipratropium."]},{"name":"BNF.Ketamine.Ketamine","imports":["BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Fentanyl.Fentanyl","BNF.Furosemide.Furosemide","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Lorazepam.Lorazepam","BNF.Losartan.Losartan","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Nifedipine.Nifedipine","BNF.Oxycodone.Oxycodone","BNF.Prochlorperazine.Prochlorperazine","BNF.Ramipril.Ramipril","BNF.Spironolactone.Spironolactone","BNF.Temazepam.Temazepam","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of ketamine and acebutolol can increase the risk of hypotension.","Concurrent use of ketamine and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and alcohol (beverage) can increase the risk of hypotension.","Concurrent use of ketamine and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and alfuzosin can increase the risk of hypotension.","Concurrent use of ketamine and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and aliskiren can increase the risk of hypotension.","Concurrent use of ketamine and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and alprostadil can increase the risk of hypotension.","Concurrent use of ketamine and amantadine can increase the risk of hypotension.","Concurrent use of ketamine and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and amitriptyline can increase the risk of hypotension.","Concurrent use of ketamine and amlodipine can increase the risk of hypotension.","Concurrent use of ketamine and apomorphine can increase the risk of hypotension.","Concurrent use of ketamine and apraclonidine can increase the risk of hypotension.","Concurrent use of ketamine and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and aripiprazole can increase the risk of hypotension.","Concurrent use of ketamine and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and asenapine can increase the risk of hypotension.","Concurrent use of ketamine and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and atenolol can increase the risk of hypotension.","Concurrent use of ketamine and avanafil can increase the risk of hypotension.","Concurrent use of ketamine and azilsartan can increase the risk of hypotension.","Concurrent use of ketamine and baclofen can increase the risk of hypotension.","Concurrent use of ketamine and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of ketamine and benperidol can increase the risk of hypotension.","Concurrent use of ketamine and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and betaxolol can increase the risk of hypotension.","Concurrent use of ketamine and bisoprolol can increase the risk of hypotension.","Concurrent use of ketamine and bortezomib can increase the risk of hypotension.","Concurrent use of ketamine and brimonidine can increase the risk of hypotension.","Concurrent use of ketamine and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and bromocriptine can increase the risk of hypotension.","Concurrent use of ketamine and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and bumetanide can increase the risk of hypotension.","Concurrent use of ketamine and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and cabergoline can increase the risk of hypotension.","Concurrent use of ketamine and canagliflozin can increase the risk of hypotension.","Concurrent use of ketamine and candesartan can increase the risk of hypotension.","Concurrent use of ketamine and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and captopril can increase the risk of hypotension.","Concurrent use of ketamine and carteolol can increase the risk of hypotension.","Concurrent use of ketamine and carvedilol can increase the risk of hypotension.","Concurrent use of ketamine and celiprolol can increase the risk of hypotension.","Concurrent use of ketamine and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and chlorothiazide can increase the risk of hypotension.","Concurrent use of ketamine and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and chlorpromazine can increase the risk of hypotension.","Concurrent use of ketamine and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and chlortalidone can increase the risk of hypotension.","Concurrent use of ketamine and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and clevidipine can increase the risk of hypotension.","Concurrent use of ketamine and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and clomipramine can increase the risk of hypotension.","Concurrent use of ketamine and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and clonidine can increase the risk of hypotension.","Concurrent use of ketamine and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and clopamide can increase the risk of hypotension.","Concurrent use of ketamine and clozapine can increase the risk of hypotension.","Concurrent use of ketamine and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of ketamine and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and dapagliflozin can increase the risk of hypotension.","Concurrent use of ketamine and desflurane can increase the risk of hypotension.","Concurrent use of ketamine and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and diazoxide can increase the risk of hypotension.","Concurrent use of ketamine and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and diltiazem can increase the risk of hypotension.","Concurrent use of ketamine and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and dipyridamole can increase the risk of hypotension.","Concurrent use of ketamine and dosulepin can increase the risk of hypotension.","Concurrent use of ketamine and doxazosin can increase the risk of hypotension.","Concurrent use of ketamine and doxepin can increase the risk of hypotension.","Concurrent use of ketamine and droperidol can increase the risk of hypotension.","Concurrent use of ketamine and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and empagliflozin can increase the risk of hypotension.","Concurrent use of ketamine and enalapril can increase the risk of hypotension.","Concurrent use of ketamine and eplerenone can increase the risk of hypotension.","Concurrent use of ketamine and eprosartan can increase the risk of hypotension.","Concurrent use of ketamine and esmolol can increase the risk of hypotension.","Concurrent use of ketamine and etomidate can increase the risk of hypotension.","Concurrent use of ketamine and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and felodipine can increase the risk of hypotension.","Concurrent use of ketamine and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and flupentixol can increase the risk of hypotension.","Concurrent use of ketamine and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and fluphenazine can increase the risk of hypotension.","Concurrent use of ketamine and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and fosinopril can increase the risk of hypotension.","Concurrent use of ketamine and furosemide can increase the risk of hypotension.","Concurrent use of ketamine and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of ketamine and guanethidine can increase the risk of hypotension.","Concurrent use of ketamine and guanfacine can increase the risk of hypotension.","Concurrent use of ketamine and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and haloperidol can increase the risk of hypotension.","Concurrent use of ketamine and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and histamine can increase the risk of hypotension.","Concurrent use of ketamine and hydralazine can increase the risk of hypotension.","Concurrent use of ketamine and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of ketamine and hydroflumethiazide can increase the risk of hypotension.","Concurrent use of ketamine and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and imidapril can increase the risk of hypotension.","Concurrent use of ketamine and imipramine can increase the risk of hypotension.","Concurrent use of ketamine and indapamide can increase the risk of hypotension.","Concurrent use of ketamine and indoramin can increase the risk of hypotension.","Concurrent use of ketamine and irbesartan can increase the risk of hypotension.","Concurrent use of ketamine and isocarboxazid can increase the risk of hypotension.","Concurrent use of ketamine and isoflurane can increase the risk of hypotension.","Concurrent use of ketamine and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of ketamine and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of ketamine and isradipine can increase the risk of hypotension.","Concurrent use of ketamine and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and labetalol can increase the risk of hypotension.","Concurrent use of ketamine and lacidipine can increase the risk of hypotension.","Concurrent use of ketamine and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and lercanidipine can increase the risk of hypotension.","Concurrent use of ketamine and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and levobunolol can increase the risk of hypotension.","Concurrent use of ketamine and levodopa can increase the risk of hypotension.","Concurrent use of ketamine and levomepromazine can increase the risk of hypotension.","Concurrent use of ketamine and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and lisinopril can increase the risk of hypotension.","Concurrent use of ketamine and lofepramine can increase the risk of hypotension.","Concurrent use of ketamine and lofexidine can increase the risk of hypotension.","Concurrent use of ketamine and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and losartan can increase the risk of hypotension.","Concurrent use of ketamine and loxapine can increase the risk of hypotension.","Concurrent use of ketamine and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and lurasidone can increase the risk of hypotension.","Concurrent use of ketamine and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Memantine is predicted to increase the risk of CNS side-effects when given with ketamine. Manufacturer advises avoid.","Concurrent use of ketamine and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and methyldopa can increase the risk of hypotension.","Concurrent use of ketamine and metolazone can increase the risk of hypotension.","Concurrent use of ketamine and metoprolol can increase the risk of hypotension.","Concurrent use of ketamine and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and minoxidil can increase the risk of hypotension.","Concurrent use of ketamine and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and moexipril can increase the risk of hypotension.","Concurrent use of ketamine and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and moxisylyte can increase the risk of hypotension.","Concurrent use of ketamine and moxonidine can increase the risk of hypotension.","Concurrent use of ketamine and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and nadolol can increase the risk of hypotension.","Concurrent use of ketamine and nebivolol can increase the risk of hypotension.","Concurrent use of ketamine and nicardipine can increase the risk of hypotension.","Concurrent use of ketamine and nicorandil can increase the risk of hypotension.","Concurrent use of ketamine and nifedipine can increase the risk of hypotension.","Concurrent use of ketamine and nimodipine can increase the risk of hypotension.","Concurrent use of ketamine and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and nitrous oxide can increase the risk of hypotension.","Concurrent use of ketamine and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and nortriptyline can increase the risk of hypotension.","Concurrent use of ketamine and olanzapine can increase the risk of hypotension.","Concurrent use of ketamine and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and olmesartan can increase the risk of hypotension.","Concurrent use of ketamine and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and oxprenolol can increase the risk of hypotension.","Concurrent use of ketamine and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and paliperidone can increase the risk of hypotension.","Concurrent use of ketamine and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and pergolide can increase the risk of hypotension.","Concurrent use of ketamine and pericyazine can increase the risk of hypotension.","Concurrent use of ketamine and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and perindopril can increase the risk of hypotension.","Concurrent use of ketamine and perphenazine can increase the risk of hypotension.","Concurrent use of ketamine and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and phenelzine can increase the risk of hypotension.","Concurrent use of ketamine and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and pimozide can increase the risk of hypotension.","Concurrent use of ketamine and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and pindolol can increase the risk of hypotension.","Concurrent use of ketamine and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and pramipexole can increase the risk of hypotension.","Concurrent use of ketamine and prazosin can increase the risk of hypotension.","Concurrent use of ketamine and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and prochlorperazine can increase the risk of hypotension.","Concurrent use of ketamine and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and promazine can increase the risk of hypotension.","Concurrent use of ketamine and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and propofol can increase the risk of hypotension.","Concurrent use of ketamine and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and propranolol can increase the risk of hypotension.","Concurrent use of ketamine and quetiapine can increase the risk of hypotension.","Concurrent use of ketamine and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and quinagolide can increase the risk of hypotension.","Concurrent use of ketamine and quinapril can increase the risk of hypotension.","Concurrent use of ketamine and ramipril can increase the risk of hypotension.","Concurrent use of ketamine and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and riociguat can increase the risk of hypotension.","Concurrent use of ketamine and risperidone can increase the risk of hypotension.","Concurrent use of ketamine and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and ropinirole can increase the risk of hypotension.","Concurrent use of ketamine and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and rotigotine can increase the risk of hypotension.","Concurrent use of ketamine and sacubitril can increase the risk of hypotension.","Concurrent use of ketamine and sapropterin can increase the risk of hypotension.","Concurrent use of ketamine and selegiline can increase the risk of hypotension.","Concurrent use of ketamine and sevoflurane can increase the risk of hypotension.","Concurrent use of ketamine and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and sildenafil can increase the risk of hypotension.","Concurrent use of ketamine and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of ketamine and sodium oxybate can increase the risk of hypotension.","Concurrent use of ketamine and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and sotalol can increase the risk of hypotension.","Concurrent use of ketamine and spironolactone can increase the risk of hypotension.","Concurrent use of ketamine and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and sulpiride can increase the risk of hypotension.","Concurrent use of ketamine and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and tadalafil can increase the risk of hypotension.","Concurrent use of ketamine and tamsulosin can increase the risk of hypotension.","Concurrent use of ketamine and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and telmisartan can increase the risk of hypotension.","Concurrent use of ketamine and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and terazosin can increase the risk of hypotension.","Concurrent use of ketamine and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and thiopental can increase the risk of hypotension.","Concurrent use of ketamine and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and timolol can increase the risk of hypotension.","Concurrent use of ketamine and tizanidine can increase the risk of hypotension.","Concurrent use of ketamine and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and torasemide can increase the risk of hypotension.","Concurrent use of ketamine and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and trandolapril can increase the risk of hypotension.","Concurrent use of ketamine and tranylcypromine can increase the risk of hypotension.","Concurrent use of ketamine and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and trifluoperazine can increase the risk of hypotension.","Concurrent use of ketamine and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and trimipramine can increase the risk of hypotension.","Concurrent use of ketamine and valsartan can increase the risk of hypotension.","Concurrent use of ketamine and vardenafil can increase the risk of hypotension.","Concurrent use of ketamine and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and verapamil can increase the risk of hypotension.","Concurrent use of ketamine and xipamide can increase the risk of hypotension.","Concurrent use of ketamine and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of ketamine and zuclopenthixol can increase the risk of hypotension.","Concurrent use of ketamine and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Lansoprazole.Lansoprazole","imports":[""],"interactioninfo":["Lansoprazole decreases the exposure to atazanavir. Manufacturer advises avoid or adjust dose.","Lansoprazole is predicted to decrease the absorption of bosutinib.","Lansoprazole is predicted to decrease the absorption of ceritinib.","Lansoprazole is predicted to decrease the exposure to dabrafenib. Manufacturer advises avoid.","Lansoprazole is predicted to slightly to moderately decrease the exposure to dasatinib. Manufacturer advises avoid.","Lansoprazole is predicted to decrease the absorption of dipyridamole (immediate release tablets).","Lansoprazole is predicted to slightly decrease the exposure to erlotinib. Manufacturer advises avoid.","Fluconazole is predicted to increase the exposure to lansoprazole.","Fluvoxamine is predicted to increase the exposure to lansoprazole.","Lansoprazole is predicted to decrease the exposure to gefitinib.","Lansoprazole decreases the absorption of itraconazole. Manufacturer advises administer itraconazole capsules with an acidic beverage.","Lansoprazole decreases the absorption of ketoconazole. Manufacturer advises administer ketoconazole with an acidic beverage.","Lansoprazole is predicted to decrease the exposure to ledipasvir. Manufacturer advises adjust dose, see sofosbuvir with ledipasvir.","Lumacaftor is predicted to decrease the exposure to lansoprazole. Manufacturer advises adjust dose.","Lansoprazole decreases the clearance of methotrexate. Manufacturer advises use with caution or avoid.","Lansoprazole is predicted to decrease the exposure to pazopanib. Manufacturer advises avoid or administer concurrently without food.","Lansoprazole decreases the absorption of posaconazole (oral suspension). Manufacturer advises avoid.","Lansoprazole is predicted to decrease the exposure to rilpivirine. Manufacturer advises avoid.","Lansoprazole increases the exposure to saquinavir. Manufacturer advises avoid.","Lansoprazole potentially decreases the exposure to sofosbuvir. Manufacturer advises adjust dose, see sofosbuvir with ledipasvir and sofosbuvir with velpatasvir.","Tipranavir decreases the exposure to lansoprazole. Manufacturer advises avoid.","Lansoprazole is predicted to decrease the concentration of velpatasvir. Manufacturer advises adjust dose, see sofosbuvir with velpatasvir."]},{"name":"BNF.Levofloxacin.Levofloxacin","imports":["BNF.Diclofenac.Diclofenac","BNF.Ibuprofen.Ibuprofen","BNF.Naproxen.Naproxen","BNF.Warfarin.Warfarin"],"interactioninfo":["Aceclofenac potentially increases the risk of seizures when given with levofloxacin.","Acemetacin potentially increases the risk of seizures when given with levofloxacin.","Levofloxacin increases the anticoagulant effect of acenocoumarol.","Aluminium hydroxide decreases the absorption of levofloxacin. Manufacturer advises levofloxacin should be taken 2 hours before or 4 hours after aluminium hydroxide.","Benzydamine potentially increases the risk of seizures when given with levofloxacin.","Bromfenac potentially increases the risk of seizures when given with levofloxacin.","Celecoxib potentially increases the risk of seizures when given with levofloxacin.","Dexibuprofen potentially increases the risk of seizures when given with levofloxacin.","Dexketoprofen potentially increases the risk of seizures when given with levofloxacin.","Diclofenac potentially increases the risk of seizures when given with levofloxacin.","Didanosine (buffered) is predicted to greatly decrease the exposure to oral levofloxacin. Manufacturer advises didanosine should be taken 2 hours after quinolones.","Etodolac potentially increases the risk of seizures when given with levofloxacin.","Etoricoxib potentially increases the risk of seizures when given with levofloxacin.","Felbinac potentially increases the risk of seizures when given with levofloxacin.","Fenoprofen potentially increases the risk of seizures when given with levofloxacin.","Ferric maltol decreases the exposure to levofloxacin. Manufacturer advises separate administration by at least 2 hours.","Ferrous fumarate decreases the exposure to levofloxacin. Manufacturer advises separate administration by at least 2 hours.","Ferrous gluconate decreases the exposure to levofloxacin. Manufacturer advises separate administration by at least 2 hours.","Ferrous sulfate decreases the exposure to levofloxacin. Manufacturer advises separate administration by at least 2 hours.","Flurbiprofen potentially increases the risk of seizures when given with levofloxacin.","Ibuprofen potentially increases the risk of seizures when given with levofloxacin.","Indometacin potentially increases the risk of seizures when given with levofloxacin.","Ketoprofen potentially increases the risk of seizures when given with levofloxacin.","Ketorolac potentially increases the risk of seizures when given with levofloxacin.","Lanthanum moderately decreases the exposure to levofloxacin. Manufacturer advises levofloxacin should be taken 2 hours before or 4 hours after lanthanum.","Magnesium carbonate decreases the absorption of levofloxacin. Manufacturer advises levofloxacin should be taken 2 hours before or 4 hours after magnesium carbonate.","Magnesium trisilicate decreases the absorption of levofloxacin. Manufacturer advises levofloxacin should be taken 2 hours before or 4 hours after magnesium trisilicate.","Mefenamic acid potentially increases the risk of seizures when given with levofloxacin.","Meloxicam potentially increases the risk of seizures when given with levofloxacin.","Nabumetone potentially increases the risk of seizures when given with levofloxacin.","Naproxen potentially increases the risk of seizures when given with levofloxacin.","Nepafenac potentially increases the risk of seizures when given with levofloxacin.","Parecoxib potentially increases the risk of seizures when given with levofloxacin.","Piroxicam potentially increases the risk of seizures when given with levofloxacin.","Polysaccharide-iron complex decreases the exposure to levofloxacin. Manufacturer advises separate administration by at least 2 hours.","Sodium feredetate decreases the exposure to levofloxacin. Manufacturer advises separate administration by at least 2 hours.","Strontium ranelate is predicted to decrease the absorption of levofloxacin. Manufacturer advises avoid.","Sucralfate decreases the exposure to levofloxacin. Manufacturer advises separate administration by 2 hours.","Sulindac potentially increases the risk of seizures when given with levofloxacin.","Tenoxicam potentially increases the risk of seizures when given with levofloxacin.","Tiaprofenic acid potentially increases the risk of seizures when given with levofloxacin.","Tolfenamic acid potentially increases the risk of seizures when given with levofloxacin.","Levofloxacin increases the anticoagulant effect of warfarin.","Zinc is predicted to decrease the exposure to levofloxacin. Manufacturer advises separate administration by 2 hours."]},{"name":"BNF.Levomepromazine.Levomepromazine","imports":["BNF.Amiodarone.Amiodarone","BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisacodyl.Bisacodyl","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Fentanyl.Fentanyl","BNF.Furosemide.Furosemide","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Ipratropium.Ipratropium","BNF.Ketamine.Ketamine","BNF.Lisinopril.Lisinopril","BNF.Lorazepam.Lorazepam","BNF.Losartan.Losartan","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Nefopam.Nefopam","BNF.Nifedipine.Nifedipine","BNF.Ondansetron.Ondansetron","BNF.Oxycodone.Oxycodone","BNF.Prochlorperazine.Prochlorperazine","BNF.Quinine.Quinine","BNF.Ramipril.Ramipril","BNF.Salbutamol.Salbutamol","BNF.Senna.Senna","BNF.Spironolactone.Spironolactone","BNF.Temazepam.Temazepam","BNF.Theophylline.Theophylline","BNF.Tiotropium.Tiotropium","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of levomepromazine and acebutolol can increase the risk of hypotension.","Concurrent use of levomepromazine and aclidinium can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and alcohol (beverage) can increase the risk of hypotension.","Concurrent use of levomepromazine and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and alfuzosin can increase the risk of hypotension.","Concurrent use of levomepromazine and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and aliskiren can increase the risk of hypotension.","Concurrent use of levomepromazine and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and alprostadil can increase the risk of hypotension.","Aluminium hydroxide decreases the absorption of levomepromazine.","Concurrent use of levomepromazine and amantadine can increase the risk of hypotension.","Concurrent use of levomepromazine and amantadine can increase the risk of antimuscarinic effects.","Levomepromazine is predicted to decrease the effects of amantadine. Manufacturer advises avoid.","Both levomepromazine and amifampridine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Aminophylline is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Both levomepromazine and amiodarone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both levomepromazine and amisulpride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and amitriptyline can increase the risk of hypotension.","Concurrent use of levomepromazine and amitriptyline can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and amlodipine can increase the risk of hypotension.","Amphotericin is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and apomorphine can increase the risk of hypotension.","Both levomepromazine and apomorphine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Levomepromazine is predicted to decrease the effects of apomorphine. Manufacturer advises avoid.","Concurrent use of levomepromazine and apraclonidine can increase the risk of hypotension.","Concurrent use of levomepromazine and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and aripiprazole can increase the risk of hypotension.","Concurrent use of levomepromazine and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both levomepromazine and arsenic trioxide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both levomepromazine and artemether prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both levomepromazine and artenimol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and asenapine can increase the risk of hypotension.","Concurrent use of levomepromazine and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and atenolol can increase the risk of hypotension.","Concurrent use of levomepromazine and atropine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and avanafil can increase the risk of hypotension.","Concurrent use of levomepromazine and azilsartan can increase the risk of hypotension.","Concurrent use of levomepromazine and baclofen can increase the risk of hypotension.","Concurrent use of levomepromazine and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and baclofen can increase the risk of antimuscarinic effects.","Bambuterol is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Beclometasone is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Both levomepromazine and bedaquiline prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and bendroflumethiazide can increase the risk of hypotension.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and benperidol can increase the risk of hypotension.","Concurrent use of levomepromazine and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Betamethasone is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and betaxolol can increase the risk of hypotension.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and bisoprolol can increase the risk of hypotension.","Concurrent use of levomepromazine and bortezomib can increase the risk of hypotension.","Both levomepromazine and bosutinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and brimonidine can increase the risk of hypotension.","Concurrent use of levomepromazine and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and bromocriptine can increase the risk of hypotension.","Levomepromazine is predicted to decrease the effects of bromocriptine. Manufacturer advises avoid.","Concurrent use of levomepromazine and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Budesonide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and bumetanide can increase the risk of hypotension.","Bumetanide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and cabergoline can increase the risk of hypotension.","Levomepromazine is predicted to decrease the effects of cabergoline. Manufacturer advises avoid.","Both levomepromazine and cabozantinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and canagliflozin can increase the risk of hypotension.","Concurrent use of levomepromazine and candesartan can increase the risk of hypotension.","Concurrent use of levomepromazine and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and captopril can increase the risk of hypotension.","Concurrent use of levomepromazine and carteolol can increase the risk of hypotension.","Concurrent use of levomepromazine and carvedilol can increase the risk of hypotension.","Concurrent use of levomepromazine and celiprolol can increase the risk of hypotension.","Both levomepromazine and ceritinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and chlorothiazide can increase the risk of hypotension.","Chlorothiazide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and chlorphenamine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and chlorpromazine can increase the risk of hypotension.","Both levomepromazine and chlorpromazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and chlorpromazine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and chlortalidone can increase the risk of hypotension.","Chlortalidone is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both levomepromazine and citalopram prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both levomepromazine and clarithromycin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and clemastine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and clevidipine can increase the risk of hypotension.","Concurrent use of levomepromazine and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and clomipramine can increase the risk of hypotension.","Both levomepromazine and clomipramine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and clomipramine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and clonidine can increase the risk of hypotension.","Concurrent use of levomepromazine and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and clopamide can increase the risk of hypotension.","Clopamide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and clozapine can increase the risk of hypotension.","Concurrent use of levomepromazine and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and clozapine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both levomepromazine and crizotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and cyclizine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and cyclopenthiazide can increase the risk of hypotension.","Cyclopenthiazide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and cyclopentolate can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and cyproheptadine can increase the risk of antimuscarinic effects.","Dantron is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and dapagliflozin can increase the risk of hypotension.","Concurrent use of levomepromazine and darifenacin can increase the risk of antimuscarinic effects.","Both levomepromazine and dasatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Deflazacort is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Both levomepromazine and delamanid prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and desflurane can increase the risk of hypotension.","Concurrent use of levomepromazine and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Dexamethasone is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Levomepromazine is predicted to decrease the effects of dexamfetamine.","Concurrent use of levomepromazine and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and diazoxide can increase the risk of hypotension.","Concurrent use of levomepromazine and dicycloverine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and diltiazem can increase the risk of hypotension.","Concurrent use of levomepromazine and dimenhydrinate can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and dipyridamole can increase the risk of hypotension.","Both levomepromazine and disopyramide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and disopyramide can increase the risk of antimuscarinic effects.","Docusate sodium is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Domperidone increases the risk of QT-prolongation when given with levomepromazine. Manufacturer advises avoid.","Concurrent use of levomepromazine and dosulepin can increase the risk of hypotension.","Concurrent use of levomepromazine and dosulepin can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and doxazosin can increase the risk of hypotension.","Concurrent use of levomepromazine and doxepin can increase the risk of hypotension.","Concurrent use of levomepromazine and doxepin can increase the risk of antimuscarinic effects.","Both levomepromazine and dronedarone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and droperidol can increase the risk of hypotension.","Both levomepromazine and droperidol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and empagliflozin can increase the risk of hypotension.","Concurrent use of levomepromazine and enalapril can increase the risk of hypotension.","Concurrent use of levomepromazine and eplerenone can increase the risk of hypotension.","Concurrent use of levomepromazine and eprosartan can increase the risk of hypotension.","Both levomepromazine and eribulin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Intravenous erythromycin increases the risk of QT-prolongation when given with levomepromazine. Manufacturer advises avoid or monitor.","Both levomepromazine and escitalopram prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and esmolol can increase the risk of hypotension.","Concurrent use of levomepromazine and etomidate can increase the risk of hypotension.","Concurrent use of levomepromazine and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and felodipine can increase the risk of hypotension.","Concurrent use of levomepromazine and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and fesoterodine can increase the risk of antimuscarinic effects.","Fingolimod increases the risk of QT-prolongation when given with levomepromazine. Manufacturer advises avoid.","Concurrent use of levomepromazine and flavoxate can increase the risk of antimuscarinic effects.","Both levomepromazine and flecainide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Fludrocortisone is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and flupentixol can increase the risk of hypotension.","Concurrent use of levomepromazine and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and fluphenazine can increase the risk of hypotension.","Both levomepromazine and fluphenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Formoterol is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and fosinopril can increase the risk of hypotension.","Concurrent use of levomepromazine and furosemide can increase the risk of hypotension.","Furosemide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Glycerol is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of levomepromazine and glycopyrronium can increase the risk of antimuscarinic effects.","Granisetron is predicted to increase the risk of QT-prolongation when given with levomepromazine.","Concurrent use of levomepromazine and guanethidine can increase the risk of hypotension.","Levomepromazine is predicted to decrease the antihypertensive effects of guanethidine.","Concurrent use of levomepromazine and guanfacine can increase the risk of hypotension.","Concurrent use of levomepromazine and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and haloperidol can increase the risk of hypotension.","Both levomepromazine and haloperidol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and haloperidol can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and histamine can increase the risk of hypotension.","Levomepromazine is predicted to decrease the effects of histamine. Manufacturer advises avoid.","Concurrent use of levomepromazine and homatropine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and hydralazine can increase the risk of hypotension.","Concurrent use of levomepromazine and hydrochlorothiazide can increase the risk of hypotension.","Hydrochlorothiazide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Hydrocortisone is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and hydroflumethiazide can increase the risk of hypotension.","Hydroflumethiazide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both levomepromazine and hydroxyzine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and hydroxyzine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and hyoscine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and imidapril can increase the risk of hypotension.","Concurrent use of levomepromazine and imipramine can increase the risk of hypotension.","Concurrent use of levomepromazine and imipramine can increase the risk of antimuscarinic effects.","Indacaterol is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and indapamide can increase the risk of hypotension.","Indapamide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and indoramin can increase the risk of hypotension.","Concurrent use of levomepromazine and ipratropium can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and irbesartan can increase the risk of hypotension.","Concurrent use of levomepromazine and isocarboxazid can increase the risk of hypotension.","Isocarboxazid is predicted to increase the risk of neuroleptic malignant syndrome when given with levomepromazine.","Concurrent use of levomepromazine and isoflurane can increase the risk of hypotension.","Concurrent use of levomepromazine and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of levomepromazine and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of levomepromazine and isradipine can increase the risk of hypotension.","Ivabradine is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises avoid.","Concurrent use of levomepromazine and ketamine can increase the risk of hypotension.","Concurrent use of levomepromazine and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and labetalol can increase the risk of hypotension.","Concurrent use of levomepromazine and lacidipine can increase the risk of hypotension.","Concurrent use of levomepromazine and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both levomepromazine and lapatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and lercanidipine can increase the risk of hypotension.","Concurrent use of levomepromazine and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and levobunolol can increase the risk of hypotension.","Concurrent use of levomepromazine and levodopa can increase the risk of hypotension.","Levomepromazine decreases the effects of levodopa. Manufacturer advises avoid or monitor worsening parkinsonian symptoms.","Concurrent use of levomepromazine and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Levomepromazine is predicted to decrease the effects of lisdexamfetamine.","Concurrent use of levomepromazine and lisinopril can increase the risk of hypotension.","Both levomepromazine and lithium prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Levomepromazine potentially increases the risk of neurotoxicity when given with lithium.","Concurrent use of levomepromazine and lofepramine can increase the risk of hypotension.","Concurrent use of levomepromazine and lofepramine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and lofexidine can increase the risk of hypotension.","Both levomepromazine and lofexidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and losartan can increase the risk of hypotension.","Concurrent use of levomepromazine and loxapine can increase the risk of hypotension.","Concurrent use of levomepromazine and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and loxapine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and lurasidone can increase the risk of hypotension.","Concurrent use of levomepromazine and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Magnesium carbonate decreases the absorption of levomepromazine.","Magnesium trisilicate decreases the absorption of levomepromazine.","Mefloquine is predicted to increase the risk of QT-prolongation when given with levomepromazine.","Concurrent use of levomepromazine and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both levomepromazine and methadone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and methyldopa can increase the risk of hypotension.","Methylprednisolone is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and metolazone can increase the risk of hypotension.","Metolazone is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and metoprolol can increase the risk of hypotension.","Concurrent use of levomepromazine and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and minoxidil can increase the risk of hypotension.","Concurrent use of levomepromazine and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Mizolastine is predicted to increase the risk of QT-prolongation when given with levomepromazine. Manufacturer advises avoid.","Moclobemide increases the risk of side-effects when given with levomepromazine.","Concurrent use of levomepromazine and moexipril can increase the risk of hypotension.","Concurrent use of levomepromazine and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both levomepromazine and moxifloxacin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and moxisylyte can increase the risk of hypotension.","Concurrent use of levomepromazine and moxonidine can increase the risk of hypotension.","Concurrent use of levomepromazine and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and nadolol can increase the risk of hypotension.","Concurrent use of levomepromazine and nebivolol can increase the risk of hypotension.","Concurrent use of levomepromazine and nefopam can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and nicardipine can increase the risk of hypotension.","Concurrent use of levomepromazine and nicorandil can increase the risk of hypotension.","Concurrent use of levomepromazine and nifedipine can increase the risk of hypotension.","Both levomepromazine and nilotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and nimodipine can increase the risk of hypotension.","Concurrent use of levomepromazine and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and nitrous oxide can increase the risk of hypotension.","Concurrent use of levomepromazine and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and nortriptyline can increase the risk of hypotension.","Concurrent use of levomepromazine and nortriptyline can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and olanzapine can increase the risk of hypotension.","Concurrent use of levomepromazine and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and olmesartan can increase the risk of hypotension.","Olodaterol is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Both levomepromazine and ondansetron prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and orphenadrine can increase the risk of antimuscarinic effects.","Both levomepromazine and osimertinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and oxprenolol can increase the risk of hypotension.","Concurrent use of levomepromazine and oxybutynin can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and paliperidone can increase the risk of hypotension.","Both levomepromazine and paliperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Palonosetron is predicted to increase the risk of QT-prolongation when given with levomepromazine.","Both levomepromazine and panobinostat prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both levomepromazine and pasireotide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both levomepromazine and pazopanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Intravenous pentamidine potentially increases the risk of QT-prolongation when given with levomepromazine.","Concurrent use of levomepromazine and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and pergolide can increase the risk of hypotension.","Levomepromazine is predicted to decrease the effects of pergolide. Manufacturer advises avoid.","Concurrent use of levomepromazine and pericyazine can increase the risk of hypotension.","Concurrent use of levomepromazine and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and perindopril can increase the risk of hypotension.","Concurrent use of levomepromazine and perphenazine can increase the risk of hypotension.","Concurrent use of levomepromazine and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and perphenazine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and phenelzine can increase the risk of hypotension.","Phenelzine is predicted to increase the risk of neuroleptic malignant syndrome when given with levomepromazine.","Concurrent use of levomepromazine and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and pimozide can increase the risk of hypotension.","Both levomepromazine and pimozide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and pimozide can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and pindolol can increase the risk of hypotension.","Concurrent use of levomepromazine and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and pramipexole can increase the risk of hypotension.","Levomepromazine is predicted to decrease the effects of pramipexole. Manufacturer advises avoid.","Concurrent use of levomepromazine and prazosin can increase the risk of hypotension.","Prednisolone is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Prednisone is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and prochlorperazine can increase the risk of hypotension.","Concurrent use of levomepromazine and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and prochlorperazine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and procyclidine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and promazine can increase the risk of hypotension.","Concurrent use of levomepromazine and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and promethazine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and propafenone can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and propantheline can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and propiverine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and propofol can increase the risk of hypotension.","Concurrent use of levomepromazine and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and propranolol can increase the risk of hypotension.","Concurrent use of levomepromazine and quetiapine can increase the risk of hypotension.","Concurrent use of levomepromazine and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and quinagolide can increase the risk of hypotension.","Levomepromazine is predicted to decrease the effects of quinagolide. Manufacturer advises avoid.","Concurrent use of levomepromazine and quinapril can increase the risk of hypotension.","Both levomepromazine and quinine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and ramipril can increase the risk of hypotension.","Both levomepromazine and ranolazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and riociguat can increase the risk of hypotension.","Concurrent use of levomepromazine and risperidone can increase the risk of hypotension.","Both levomepromazine and risperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and ropinirole can increase the risk of hypotension.","Levomepromazine is predicted to decrease the effects of ropinirole. Manufacturer advises avoid.","Concurrent use of levomepromazine and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and rotigotine can increase the risk of hypotension.","Levomepromazine is predicted to decrease the effects of rotigotine. Manufacturer advises avoid.","Concurrent use of levomepromazine and sacubitril can increase the risk of hypotension.","Salbutamol is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Salmeterol is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and sapropterin can increase the risk of hypotension.","Both levomepromazine and saquinavir prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and selegiline can increase the risk of hypotension.","Senna is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and sevoflurane can increase the risk of hypotension.","Concurrent use of levomepromazine and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and sildenafil can increase the risk of hypotension.","Both levomepromazine and sildenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of levomepromazine and sodium oxybate can increase the risk of hypotension.","Concurrent use of levomepromazine and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Sodium picosulfate is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and solifenacin can increase the risk of antimuscarinic effects.","Both levomepromazine and sorafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and sotalol can increase the risk of hypotension.","Both levomepromazine and sotalol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and spironolactone can increase the risk of hypotension.","Concurrent use of levomepromazine and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and sulpiride can increase the risk of hypotension.","Both levomepromazine and sulpiride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both levomepromazine and sunitinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and tadalafil can increase the risk of hypotension.","Concurrent use of levomepromazine and tamsulosin can increase the risk of hypotension.","Concurrent use of levomepromazine and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both levomepromazine and telavancin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and telmisartan can increase the risk of hypotension.","Concurrent use of levomepromazine and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and terazosin can increase the risk of hypotension.","Terbutaline is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Both levomepromazine and tetrabenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Theophylline is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and thiopental can increase the risk of hypotension.","Concurrent use of levomepromazine and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and timolol can increase the risk of hypotension.","Concurrent use of levomepromazine and tiotropium can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and tizanidine can increase the risk of hypotension.","Both levomepromazine and tizanidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both levomepromazine and tolterodine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and tolterodine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and torasemide can increase the risk of hypotension.","Torasemide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Both levomepromazine and toremifene prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and trandolapril can increase the risk of hypotension.","Concurrent use of levomepromazine and tranylcypromine can increase the risk of hypotension.","Tranylcypromine is predicted to increase the risk of neuroleptic malignant syndrome when given with levomepromazine.","Concurrent use of levomepromazine and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Triamcinolone is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and trifluoperazine can increase the risk of hypotension.","Concurrent use of levomepromazine and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and trifluoperazine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and trihexyphenidyl can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and trimipramine can increase the risk of hypotension.","Concurrent use of levomepromazine and trimipramine can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and tropicamide can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and trospium can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and umeclidinium can increase the risk of antimuscarinic effects.","Concurrent use of levomepromazine and valsartan can increase the risk of hypotension.","Both levomepromazine and vandetanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and vardenafil can increase the risk of hypotension.","Both levomepromazine and vardenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both levomepromazine and vemurafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both levomepromazine and venlafaxine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and verapamil can increase the risk of hypotension.","Vilanterol is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Both levomepromazine and vinflunine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both levomepromazine and voriconazole prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and xipamide can increase the risk of hypotension.","Xipamide is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Concurrent use of levomepromazine and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of levomepromazine and zuclopenthixol can increase the risk of hypotension.","Both levomepromazine and zuclopenthixol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of levomepromazine and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Levothyroxine.Levothyroxine","imports":["BNF.Amiodarone.Amiodarone","BNF.Carbamazepine.Carbamazepine","BNF.Digoxin.Digoxin","BNF.Phenytoin.Phenytoin"],"interactioninfo":["Aluminium hydroxide is predicted to decrease the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Amiodarone is predicted to increase the risk of thyroid dysfunction when given with levothyroxine. Manufacturer advises avoid.","Oral calcium acetate is predicted to decrease the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Oral calcium carbonate is predicted to decrease the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Oral calcium chloride is predicted to decrease the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Oral calcium gluconate is predicted to decrease the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Oral calcium lactate is predicted to decrease the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Oral calcium phosphate is predicted to decrease the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Carbamazepine is predicted to increase the risk of hypothyroidism when given with levothyroxine.","Levothyroxine is predicted to affect the concentration of digoxin. Manufacturer advises monitor and adjust dose.","Ferric maltol decreases the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Ferrous fumarate decreases the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Ferrous gluconate decreases the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Ferrous sulfate decreases the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Fosphenytoin is predicted to increase the risk of hypothyroidism when given with levothyroxine.","Oral Hormone replacement therapy is predicted to decrease the effects of levothyroxine.","Lanthanum decreases the absorption of levothyroxine. Manufacturer advises separate administration by 2 hours.","Magnesium carbonate is predicted to decrease the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Magnesium trisilicate is predicted to decrease the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Phenobarbital is predicted to decrease the effects of levothyroxine.","Phenytoin is predicted to increase the risk of hypothyroidism when given with levothyroxine.","Polysaccharide-iron complex decreases the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Polystyrene sulfonate is predicted to decrease the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Primidone is predicted to decrease the effects of levothyroxine.","Sodium feredetate decreases the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours.","Sucralfate decreases the absorption of levothyroxine. Manufacturer advises separate administration by at least 4 hours."]},{"name":"BNF.Lisinopril.Lisinopril","imports":["BNF.Amiloride.Amiloride","BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Diclofenac.Diclofenac","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Enoxaparin.Enoxaparin","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Losartan.Losartan","BNF.Naproxen.Naproxen","BNF.Nifedipine.Nifedipine","BNF.Prochlorperazine.Prochlorperazine","BNF.Ramipril.Ramipril","BNF.Spironolactone.Spironolactone","BNF.Trimethoprim.Trimethoprim"],"interactioninfo":["Concurrent use of lisinopril and acebutolol can increase the risk of hypotension.","Concurrent use of lisinopril and aceclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and acemetacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and alcohol (beverage) can increase the risk of hypotension.","Concurrent use of lisinopril and alfuzosin can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and alfuzosin can increase the risk of hypotension.","Concurrent use of lisinopril and aliskiren can increase the risk of hypotension.","Concurrent use of lisinopril and aliskiren can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Lisinopril increases the risk of renal impairment when given with aliskiren. Manufacturer advises use with caution or avoid aliskiren in selected patients.","Lisinopril is predicted to increase the risk of hypersensitivity and haematological reactions when given with allopurinol.","Concurrent use of lisinopril and alprostadil can increase the risk of hypotension.","Concurrent use of lisinopril and amantadine can increase the risk of hypotension.","Concurrent use of lisinopril and amiloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and amitriptyline can increase the risk of hypotension.","Concurrent use of lisinopril and amlodipine can increase the risk of hypotension.","Concurrent use of lisinopril and apomorphine can increase the risk of hypotension.","Concurrent use of lisinopril and apraclonidine can increase the risk of hypotension.","Concurrent use of lisinopril and aripiprazole can increase the risk of hypotension.","Concurrent use of lisinopril and asenapine can increase the risk of hypotension.","Concurrent use of lisinopril and atenolol can increase the risk of hypotension.","Concurrent use of lisinopril and avanafil can increase the risk of hypotension.","Lisinopril is predicted to increase the risk of anaemia and/or leucopenia when given with azathioprine.","Concurrent use of lisinopril and azilsartan can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and azilsartan can increase the risk of hypotension.","Concurrent use of lisinopril and azilsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and baclofen can increase the risk of hypotension.","Concurrent use of lisinopril and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of lisinopril and benperidol can increase the risk of hypotension.","Concurrent use of lisinopril and benzydamine can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and betaxolol can increase the risk of hypotension.","Concurrent use of lisinopril and bisoprolol can increase the risk of hypotension.","Concurrent use of lisinopril and bortezomib can increase the risk of hypotension.","Concurrent use of lisinopril and brimonidine can increase the risk of hypotension.","Concurrent use of lisinopril and bromfenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and bromocriptine can increase the risk of hypotension.","Concurrent use of lisinopril and bumetanide can increase the risk of hypotension.","Concurrent use of lisinopril and cabergoline can increase the risk of hypotension.","Concurrent use of lisinopril and canagliflozin can increase the risk of hypotension.","Concurrent use of lisinopril and candesartan can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and candesartan can increase the risk of hypotension.","Concurrent use of lisinopril and candesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and captopril can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and captopril can increase the risk of hypotension.","Concurrent use of lisinopril and captopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and carteolol can increase the risk of hypotension.","Concurrent use of lisinopril and carvedilol can increase the risk of hypotension.","Concurrent use of lisinopril and celecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and celiprolol can increase the risk of hypotension.","Concurrent use of lisinopril and chlorothiazide can increase the risk of hypotension.","Concurrent use of lisinopril and chlorpromazine can increase the risk of hypotension.","Concurrent use of lisinopril and chlortalidone can increase the risk of hypotension.","Concurrent use of lisinopril and ciclosporin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and clevidipine can increase the risk of hypotension.","Concurrent use of lisinopril and clomipramine can increase the risk of hypotension.","Concurrent use of lisinopril and clonidine can increase the risk of hypotension.","Concurrent use of lisinopril and clopamide can increase the risk of hypotension.","Concurrent use of lisinopril and clozapine can increase the risk of hypotension.","Concurrent use of lisinopril and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of lisinopril and dalteparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and dapagliflozin can increase the risk of hypotension.","Concurrent use of lisinopril and darbepoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and desflurane can increase the risk of hypotension.","Concurrent use of lisinopril and dexibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and dexketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and diazoxide can increase the risk of hypotension.","Concurrent use of lisinopril and diclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and diltiazem can increase the risk of hypotension.","Concurrent use of lisinopril and dipyridamole can increase the risk of hypotension.","Concurrent use of lisinopril and dosulepin can increase the risk of hypotension.","Concurrent use of lisinopril and doxazosin can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and doxazosin can increase the risk of hypotension.","Concurrent use of lisinopril and doxepin can increase the risk of hypotension.","Concurrent use of lisinopril and droperidol can increase the risk of hypotension.","Concurrent use of lisinopril and drospirenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and empagliflozin can increase the risk of hypotension.","Concurrent use of lisinopril and enalapril can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and enalapril can increase the risk of hypotension.","Concurrent use of lisinopril and enalapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and enoxaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and eplerenone can increase the risk of hypotension.","Concurrent use of lisinopril and eplerenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and epoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and epoetin beta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and epoetin zeta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and eprosartan can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and eprosartan can increase the risk of hypotension.","Concurrent use of lisinopril and eprosartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and esmolol can increase the risk of hypotension.","Concurrent use of lisinopril and etodolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and etomidate can increase the risk of hypotension.","Concurrent use of lisinopril and etoricoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and felbinac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and felodipine can increase the risk of hypotension.","Concurrent use of lisinopril and fenoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and flupentixol can increase the risk of hypotension.","Concurrent use of lisinopril and fluphenazine can increase the risk of hypotension.","Concurrent use of lisinopril and flurbiprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and fosinopril can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and fosinopril can increase the risk of hypotension.","Concurrent use of lisinopril and furosemide can increase the risk of hypotension.","Concurrent use of lisinopril and glyceryl trinitrate can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of lisinopril and guanethidine can increase the risk of hypotension.","Concurrent use of lisinopril and guanfacine can increase the risk of hypotension.","Concurrent use of lisinopril and haloperidol can increase the risk of hypotension.","Concurrent use of lisinopril and heparin (unfractionated) can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and histamine can increase the risk of hypotension.","Concurrent use of lisinopril and hydralazine can increase the risk of hypotension.","Concurrent use of lisinopril and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of lisinopril and hydroflumethiazide can increase the risk of hypotension.","Concurrent use of lisinopril and ibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Lisinopril is predicted to decrease the efficacy of icatibant and icatibant is predicted to decrease the efficacy of lisinopril. Manufacturer advises avoid.","Concurrent use of lisinopril and imidapril can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and imidapril can increase the risk of hypotension.","Concurrent use of lisinopril and imidapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and imipramine can increase the risk of hypotension.","Concurrent use of lisinopril and indapamide can increase the risk of hypotension.","Concurrent use of lisinopril and indometacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and indoramin can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and indoramin can increase the risk of hypotension.","Concurrent use of lisinopril and irbesartan can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and irbesartan can increase the risk of hypotension.","Concurrent use of lisinopril and irbesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and isocarboxazid can increase the risk of hypotension.","Concurrent use of lisinopril and isoflurane can increase the risk of hypotension.","Concurrent use of lisinopril and isosorbide dinitrate can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of lisinopril and isosorbide mononitrate can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of lisinopril and isradipine can increase the risk of hypotension.","Concurrent use of lisinopril and ketamine can increase the risk of hypotension.","Concurrent use of lisinopril and ketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and ketorolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and labetalol can increase the risk of hypotension.","Concurrent use of lisinopril and lacidipine can increase the risk of hypotension.","Concurrent use of lisinopril and lercanidipine can increase the risk of hypotension.","Concurrent use of lisinopril and levobunolol can increase the risk of hypotension.","Concurrent use of lisinopril and levodopa can increase the risk of hypotension.","Concurrent use of lisinopril and levomepromazine can increase the risk of hypotension.","Lisinopril is predicted to increase the concentration of lithium. Manufacturer advises monitor and adjust dose.","Concurrent use of lisinopril and lofepramine can increase the risk of hypotension.","Concurrent use of lisinopril and lofexidine can increase the risk of hypotension.","Concurrent use of lisinopril and losartan can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and losartan can increase the risk of hypotension.","Concurrent use of lisinopril and losartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and loxapine can increase the risk of hypotension.","Concurrent use of lisinopril and lurasidone can increase the risk of hypotension.","Concurrent use of lisinopril and mefenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and meloxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and methyldopa can increase the risk of hypotension.","Concurrent use of lisinopril and metolazone can increase the risk of hypotension.","Concurrent use of lisinopril and metoprolol can increase the risk of hypotension.","Concurrent use of lisinopril and minoxidil can increase the risk of hypotension.","Concurrent use of lisinopril and moexipril can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and moexipril can increase the risk of hypotension.","Concurrent use of lisinopril and moexipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and moxisylyte can increase the risk of hypotension.","Concurrent use of lisinopril and moxonidine can increase the risk of hypotension.","Concurrent use of lisinopril and nabumetone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and nadolol can increase the risk of hypotension.","Concurrent use of lisinopril and naproxen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and nebivolol can increase the risk of hypotension.","Concurrent use of lisinopril and nepafenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and nicardipine can increase the risk of hypotension.","Concurrent use of lisinopril and nicorandil can increase the risk of hypotension.","Concurrent use of lisinopril and nifedipine can increase the risk of hypotension.","Concurrent use of lisinopril and nimodipine can increase the risk of hypotension.","Concurrent use of lisinopril and nitrous oxide can increase the risk of hypotension.","Concurrent use of lisinopril and nortriptyline can increase the risk of hypotension.","Concurrent use of lisinopril and olanzapine can increase the risk of hypotension.","Concurrent use of lisinopril and olmesartan can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and olmesartan can increase the risk of hypotension.","Concurrent use of lisinopril and olmesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and oxprenolol can increase the risk of hypotension.","Concurrent use of lisinopril and paliperidone can increase the risk of hypotension.","Concurrent use of lisinopril and parecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and pergolide can increase the risk of hypotension.","Concurrent use of lisinopril and pericyazine can increase the risk of hypotension.","Concurrent use of lisinopril and perindopril can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and perindopril can increase the risk of hypotension.","Concurrent use of lisinopril and perindopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and perphenazine can increase the risk of hypotension.","Concurrent use of lisinopril and phenelzine can increase the risk of hypotension.","Concurrent use of lisinopril and pimozide can increase the risk of hypotension.","Concurrent use of lisinopril and pindolol can increase the risk of hypotension.","Concurrent use of lisinopril and piroxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and potassium canrenoate can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and potassium chloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and pramipexole can increase the risk of hypotension.","Concurrent use of lisinopril and prazosin can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and prazosin can increase the risk of hypotension.","Concurrent use of lisinopril and prochlorperazine can increase the risk of hypotension.","Concurrent use of lisinopril and promazine can increase the risk of hypotension.","Concurrent use of lisinopril and propofol can increase the risk of hypotension.","Concurrent use of lisinopril and propranolol can increase the risk of hypotension.","Concurrent use of lisinopril and quetiapine can increase the risk of hypotension.","Concurrent use of lisinopril and quinagolide can increase the risk of hypotension.","Concurrent use of lisinopril and quinapril can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and quinapril can increase the risk of hypotension.","Concurrent use of lisinopril and quinapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and ramipril can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and ramipril can increase the risk of hypotension.","Concurrent use of lisinopril and ramipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and riociguat can increase the risk of hypotension.","Concurrent use of lisinopril and risperidone can increase the risk of hypotension.","Concurrent use of lisinopril and ropinirole can increase the risk of hypotension.","Concurrent use of lisinopril and rotigotine can increase the risk of hypotension.","Concurrent use of lisinopril and sacubitril can increase the risk of hypotension.","Concurrent use of lisinopril and sapropterin can increase the risk of hypotension.","Concurrent use of lisinopril and selegiline can increase the risk of hypotension.","Concurrent use of lisinopril and sevoflurane can increase the risk of hypotension.","Concurrent use of lisinopril and sildenafil can increase the risk of hypotension.","Lisinopril is predicted to increase the risk of hypersensitivity when given with sodium aurothiomalate.","Concurrent use of lisinopril and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of lisinopril and sodium oxybate can increase the risk of hypotension.","Concurrent use of lisinopril and sotalol can increase the risk of hypotension.","Concurrent use of lisinopril and spironolactone can increase the risk of hypotension.","Concurrent use of lisinopril and spironolactone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and sulindac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and sulpiride can increase the risk of hypotension.","Concurrent use of lisinopril and tacrolimus can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and tadalafil can increase the risk of hypotension.","Concurrent use of lisinopril and tamsulosin can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and tamsulosin can increase the risk of hypotension.","Concurrent use of lisinopril and telmisartan can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and telmisartan can increase the risk of hypotension.","Concurrent use of lisinopril and telmisartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and tenoxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and terazosin can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and terazosin can increase the risk of hypotension.","Concurrent use of lisinopril and thiopental can increase the risk of hypotension.","Concurrent use of lisinopril and tiaprofenic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and timolol can increase the risk of hypotension.","Concurrent use of lisinopril and tinzaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and tizanidine can increase the risk of hypotension.","Concurrent use of lisinopril and tolfenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and tolvaptan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and torasemide can increase the risk of hypotension.","Concurrent use of lisinopril and trandolapril can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and trandolapril can increase the risk of hypotension.","Concurrent use of lisinopril and trandolapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and tranylcypromine can increase the risk of hypotension.","Concurrent use of lisinopril and triamterene can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and trifluoperazine can increase the risk of hypotension.","Concurrent use of lisinopril and trimethoprim can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and trimipramine can increase the risk of hypotension.","Concurrent use of lisinopril and valsartan can increase the risk of first-dose hypotension.","Concurrent use of lisinopril and valsartan can increase the risk of hypotension.","Concurrent use of lisinopril and valsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of lisinopril and vardenafil can increase the risk of hypotension.","Concurrent use of lisinopril and verapamil can increase the risk of hypotension.","Concurrent use of lisinopril and xipamide can increase the risk of hypotension.","Concurrent use of lisinopril and zuclopenthixol can increase the risk of hypotension."]},{"name":"BNF.Lorazepam.Lorazepam","imports":["BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Fentanyl.Fentanyl","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Oxycodone.Oxycodone","BNF.Prochlorperazine.Prochlorperazine","BNF.Temazepam.Temazepam","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of lorazepam and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Rifampicin increases the clearance of lorazepam.","Concurrent use of lorazepam and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of lorazepam and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Losartan.Losartan","imports":["BNF.Amiloride.Amiloride","BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Diclofenac.Diclofenac","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Enoxaparin.Enoxaparin","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Naproxen.Naproxen","BNF.Nifedipine.Nifedipine","BNF.Prochlorperazine.Prochlorperazine","BNF.Ramipril.Ramipril","BNF.Spironolactone.Spironolactone","BNF.Trimethoprim.Trimethoprim"],"interactioninfo":["Concurrent use of losartan and acebutolol can increase the risk of hypotension.","Concurrent use of losartan and aceclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and acemetacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and alcohol (beverage) can increase the risk of hypotension.","Concurrent use of losartan and alfuzosin can increase the risk of first-dose hypotension.","Concurrent use of losartan and alfuzosin can increase the risk of hypotension.","Concurrent use of losartan and aliskiren can increase the risk of hypotension.","Concurrent use of losartan and aliskiren can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Losartan increases the risk of renal impairment when given with aliskiren. Manufacturer advises use with caution or avoid aliskiren in selected patients.","Concurrent use of losartan and alprostadil can increase the risk of hypotension.","Concurrent use of losartan and amantadine can increase the risk of hypotension.","Concurrent use of losartan and amiloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and amitriptyline can increase the risk of hypotension.","Concurrent use of losartan and amlodipine can increase the risk of hypotension.","Concurrent use of losartan and apomorphine can increase the risk of hypotension.","Concurrent use of losartan and apraclonidine can increase the risk of hypotension.","Concurrent use of losartan and aripiprazole can increase the risk of hypotension.","Concurrent use of losartan and asenapine can increase the risk of hypotension.","Concurrent use of losartan and atenolol can increase the risk of hypotension.","Concurrent use of losartan and avanafil can increase the risk of hypotension.","Concurrent use of losartan and azilsartan can increase the risk of first-dose hypotension.","Concurrent use of losartan and azilsartan can increase the risk of hypotension.","Concurrent use of losartan and azilsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and baclofen can increase the risk of hypotension.","Concurrent use of losartan and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of losartan and benperidol can increase the risk of hypotension.","Concurrent use of losartan and benzydamine can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and betaxolol can increase the risk of hypotension.","Concurrent use of losartan and bisoprolol can increase the risk of hypotension.","Concurrent use of losartan and bortezomib can increase the risk of hypotension.","Concurrent use of losartan and brimonidine can increase the risk of hypotension.","Concurrent use of losartan and bromfenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and bromocriptine can increase the risk of hypotension.","Concurrent use of losartan and bumetanide can increase the risk of hypotension.","Concurrent use of losartan and cabergoline can increase the risk of hypotension.","Concurrent use of losartan and canagliflozin can increase the risk of hypotension.","Concurrent use of losartan and candesartan can increase the risk of first-dose hypotension.","Concurrent use of losartan and candesartan can increase the risk of hypotension.","Concurrent use of losartan and candesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and captopril can increase the risk of first-dose hypotension.","Concurrent use of losartan and captopril can increase the risk of hypotension.","Concurrent use of losartan and captopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and carteolol can increase the risk of hypotension.","Concurrent use of losartan and carvedilol can increase the risk of hypotension.","Concurrent use of losartan and celecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and celiprolol can increase the risk of hypotension.","Concurrent use of losartan and chlorothiazide can increase the risk of hypotension.","Concurrent use of losartan and chlorpromazine can increase the risk of hypotension.","Concurrent use of losartan and chlortalidone can increase the risk of hypotension.","Concurrent use of losartan and ciclosporin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and clevidipine can increase the risk of hypotension.","Concurrent use of losartan and clomipramine can increase the risk of hypotension.","Concurrent use of losartan and clonidine can increase the risk of hypotension.","Concurrent use of losartan and clopamide can increase the risk of hypotension.","Concurrent use of losartan and clozapine can increase the risk of hypotension.","Concurrent use of losartan and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of losartan and dalteparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and dapagliflozin can increase the risk of hypotension.","Concurrent use of losartan and darbepoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and desflurane can increase the risk of hypotension.","Concurrent use of losartan and dexibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and dexketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and diazoxide can increase the risk of hypotension.","Concurrent use of losartan and diclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and diltiazem can increase the risk of hypotension.","Concurrent use of losartan and dipyridamole can increase the risk of hypotension.","Concurrent use of losartan and dosulepin can increase the risk of hypotension.","Concurrent use of losartan and doxazosin can increase the risk of first-dose hypotension.","Concurrent use of losartan and doxazosin can increase the risk of hypotension.","Concurrent use of losartan and doxepin can increase the risk of hypotension.","Concurrent use of losartan and droperidol can increase the risk of hypotension.","Concurrent use of losartan and drospirenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and empagliflozin can increase the risk of hypotension.","Concurrent use of losartan and enalapril can increase the risk of first-dose hypotension.","Concurrent use of losartan and enalapril can increase the risk of hypotension.","Concurrent use of losartan and enalapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and enoxaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and eplerenone can increase the risk of hypotension.","Concurrent use of losartan and eplerenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and epoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and epoetin beta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and epoetin zeta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and eprosartan can increase the risk of first-dose hypotension.","Concurrent use of losartan and eprosartan can increase the risk of hypotension.","Concurrent use of losartan and eprosartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and esmolol can increase the risk of hypotension.","Concurrent use of losartan and etodolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and etomidate can increase the risk of hypotension.","Concurrent use of losartan and etoricoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and felbinac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and felodipine can increase the risk of hypotension.","Concurrent use of losartan and fenoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and flupentixol can increase the risk of hypotension.","Concurrent use of losartan and fluphenazine can increase the risk of hypotension.","Concurrent use of losartan and flurbiprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and fosinopril can increase the risk of first-dose hypotension.","Concurrent use of losartan and fosinopril can increase the risk of hypotension.","Concurrent use of losartan and furosemide can increase the risk of hypotension.","Concurrent use of losartan and glyceryl trinitrate can increase the risk of first-dose hypotension.","Concurrent use of losartan and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of losartan and guanethidine can increase the risk of hypotension.","Concurrent use of losartan and guanfacine can increase the risk of hypotension.","Concurrent use of losartan and haloperidol can increase the risk of hypotension.","Concurrent use of losartan and heparin (unfractionated) can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and histamine can increase the risk of hypotension.","Concurrent use of losartan and hydralazine can increase the risk of hypotension.","Concurrent use of losartan and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of losartan and hydroflumethiazide can increase the risk of hypotension.","Concurrent use of losartan and ibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and imidapril can increase the risk of first-dose hypotension.","Concurrent use of losartan and imidapril can increase the risk of hypotension.","Concurrent use of losartan and imidapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and imipramine can increase the risk of hypotension.","Concurrent use of losartan and indapamide can increase the risk of hypotension.","Concurrent use of losartan and indometacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and indoramin can increase the risk of first-dose hypotension.","Concurrent use of losartan and indoramin can increase the risk of hypotension.","Concurrent use of losartan and irbesartan can increase the risk of first-dose hypotension.","Concurrent use of losartan and irbesartan can increase the risk of hypotension.","Concurrent use of losartan and irbesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and isocarboxazid can increase the risk of hypotension.","Concurrent use of losartan and isoflurane can increase the risk of hypotension.","Concurrent use of losartan and isosorbide dinitrate can increase the risk of first-dose hypotension.","Concurrent use of losartan and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of losartan and isosorbide mononitrate can increase the risk of first-dose hypotension.","Concurrent use of losartan and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of losartan and isradipine can increase the risk of hypotension.","Concurrent use of losartan and ketamine can increase the risk of hypotension.","Concurrent use of losartan and ketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and ketorolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and labetalol can increase the risk of hypotension.","Concurrent use of losartan and lacidipine can increase the risk of hypotension.","Concurrent use of losartan and lercanidipine can increase the risk of hypotension.","Concurrent use of losartan and levobunolol can increase the risk of hypotension.","Concurrent use of losartan and levodopa can increase the risk of hypotension.","Concurrent use of losartan and levomepromazine can increase the risk of hypotension.","Concurrent use of losartan and lisinopril can increase the risk of first-dose hypotension.","Concurrent use of losartan and lisinopril can increase the risk of hypotension.","Concurrent use of losartan and lisinopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Losartan potentially increases the concentration of lithium. Manufacturer advises monitor concentration and adjust dose.","Concurrent use of losartan and lofepramine can increase the risk of hypotension.","Concurrent use of losartan and lofexidine can increase the risk of hypotension.","Concurrent use of losartan and loxapine can increase the risk of hypotension.","Concurrent use of losartan and lurasidone can increase the risk of hypotension.","Concurrent use of losartan and mefenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and meloxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and methyldopa can increase the risk of hypotension.","Concurrent use of losartan and metolazone can increase the risk of hypotension.","Concurrent use of losartan and metoprolol can increase the risk of hypotension.","Concurrent use of losartan and minoxidil can increase the risk of hypotension.","Concurrent use of losartan and moexipril can increase the risk of first-dose hypotension.","Concurrent use of losartan and moexipril can increase the risk of hypotension.","Concurrent use of losartan and moexipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and moxisylyte can increase the risk of hypotension.","Concurrent use of losartan and moxonidine can increase the risk of hypotension.","Concurrent use of losartan and nabumetone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and nadolol can increase the risk of hypotension.","Concurrent use of losartan and naproxen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and nebivolol can increase the risk of hypotension.","Concurrent use of losartan and nepafenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and nicardipine can increase the risk of hypotension.","Concurrent use of losartan and nicorandil can increase the risk of hypotension.","Concurrent use of losartan and nifedipine can increase the risk of hypotension.","Concurrent use of losartan and nimodipine can increase the risk of hypotension.","Concurrent use of losartan and nitrous oxide can increase the risk of hypotension.","Concurrent use of losartan and nortriptyline can increase the risk of hypotension.","Concurrent use of losartan and olanzapine can increase the risk of hypotension.","Concurrent use of losartan and olmesartan can increase the risk of first-dose hypotension.","Concurrent use of losartan and olmesartan can increase the risk of hypotension.","Concurrent use of losartan and olmesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and oxprenolol can increase the risk of hypotension.","Concurrent use of losartan and paliperidone can increase the risk of hypotension.","Concurrent use of losartan and parecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and pergolide can increase the risk of hypotension.","Concurrent use of losartan and pericyazine can increase the risk of hypotension.","Concurrent use of losartan and perindopril can increase the risk of first-dose hypotension.","Concurrent use of losartan and perindopril can increase the risk of hypotension.","Concurrent use of losartan and perindopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and perphenazine can increase the risk of hypotension.","Concurrent use of losartan and phenelzine can increase the risk of hypotension.","Concurrent use of losartan and pimozide can increase the risk of hypotension.","Concurrent use of losartan and pindolol can increase the risk of hypotension.","Concurrent use of losartan and piroxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and potassium canrenoate can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and potassium chloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and pramipexole can increase the risk of hypotension.","Concurrent use of losartan and prazosin can increase the risk of first-dose hypotension.","Concurrent use of losartan and prazosin can increase the risk of hypotension.","Concurrent use of losartan and prochlorperazine can increase the risk of hypotension.","Concurrent use of losartan and promazine can increase the risk of hypotension.","Concurrent use of losartan and propofol can increase the risk of hypotension.","Concurrent use of losartan and propranolol can increase the risk of hypotension.","Concurrent use of losartan and quetiapine can increase the risk of hypotension.","Concurrent use of losartan and quinagolide can increase the risk of hypotension.","Concurrent use of losartan and quinapril can increase the risk of first-dose hypotension.","Concurrent use of losartan and quinapril can increase the risk of hypotension.","Concurrent use of losartan and quinapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and ramipril can increase the risk of first-dose hypotension.","Concurrent use of losartan and ramipril can increase the risk of hypotension.","Concurrent use of losartan and ramipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and riociguat can increase the risk of hypotension.","Concurrent use of losartan and risperidone can increase the risk of hypotension.","Concurrent use of losartan and ropinirole can increase the risk of hypotension.","Concurrent use of losartan and rotigotine can increase the risk of hypotension.","Concurrent use of losartan and sacubitril can increase the risk of hypotension.","Concurrent use of losartan and sapropterin can increase the risk of hypotension.","Concurrent use of losartan and selegiline can increase the risk of hypotension.","Concurrent use of losartan and sevoflurane can increase the risk of hypotension.","Concurrent use of losartan and sildenafil can increase the risk of hypotension.","Concurrent use of losartan and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of losartan and sodium oxybate can increase the risk of hypotension.","Concurrent use of losartan and sotalol can increase the risk of hypotension.","Concurrent use of losartan and spironolactone can increase the risk of hypotension.","Concurrent use of losartan and spironolactone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and sulindac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and sulpiride can increase the risk of hypotension.","Concurrent use of losartan and tacrolimus can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and tadalafil can increase the risk of hypotension.","Concurrent use of losartan and tamsulosin can increase the risk of first-dose hypotension.","Concurrent use of losartan and tamsulosin can increase the risk of hypotension.","Concurrent use of losartan and telmisartan can increase the risk of first-dose hypotension.","Concurrent use of losartan and telmisartan can increase the risk of hypotension.","Concurrent use of losartan and telmisartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and tenoxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and terazosin can increase the risk of first-dose hypotension.","Concurrent use of losartan and terazosin can increase the risk of hypotension.","Concurrent use of losartan and thiopental can increase the risk of hypotension.","Concurrent use of losartan and tiaprofenic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and timolol can increase the risk of hypotension.","Concurrent use of losartan and tinzaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and tizanidine can increase the risk of hypotension.","Concurrent use of losartan and tolfenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and tolvaptan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and torasemide can increase the risk of hypotension.","Concurrent use of losartan and trandolapril can increase the risk of first-dose hypotension.","Concurrent use of losartan and trandolapril can increase the risk of hypotension.","Concurrent use of losartan and trandolapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and tranylcypromine can increase the risk of hypotension.","Concurrent use of losartan and triamterene can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and trifluoperazine can increase the risk of hypotension.","Concurrent use of losartan and trimethoprim can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and trimipramine can increase the risk of hypotension.","Concurrent use of losartan and valsartan can increase the risk of first-dose hypotension.","Concurrent use of losartan and valsartan can increase the risk of hypotension.","Concurrent use of losartan and valsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of losartan and vardenafil can increase the risk of hypotension.","Concurrent use of losartan and verapamil can increase the risk of hypotension.","Concurrent use of losartan and xipamide can increase the risk of hypotension.","Concurrent use of losartan and zuclopenthixol can increase the risk of hypotension."]},{"name":"BNF.Meropenem.Meropenem","imports":[""],"interactioninfo":["Meropenem decreases the concentration of valproate. Manufacturer advises avoid."]},{"name":"BNF.Metformin.Metformin","imports":["BNF.Gliclazide.Gliclazide","BNF.Insulin.Insulin"],"interactioninfo":["Concurrent use of metformin and acarbose can increase the risk of hypoglycaemia.","Concurrent use of metformin and albiglutide can increase the risk of hypoglycaemia.","Concurrent use of metformin and alogliptin can increase the risk of hypoglycaemia.","Concurrent use of metformin and biphasic insulin aspart can increase the risk of hypoglycaemia.","Concurrent use of metformin and biphasic insulin lispro can increase the risk of hypoglycaemia.","Concurrent use of metformin and biphasic isophane insulin can increase the risk of hypoglycaemia.","Concurrent use of metformin and canagliflozin can increase the risk of hypoglycaemia.","Cimetidine slightly increases the exposure to metformin. Manufacturer advises monitor and adjust dose.","Concurrent use of metformin and dapagliflozin can increase the risk of hypoglycaemia.","Dolutegravir slightly to moderately increases the exposure to metformin. Manufacturer advises use with caution and adjust dose.","Concurrent use of metformin and dulaglutide can increase the risk of hypoglycaemia.","Concurrent use of metformin and empagliflozin can increase the risk of hypoglycaemia.","Concurrent use of metformin and exenatide can increase the risk of hypoglycaemia.","Concurrent use of metformin and glibenclamide can increase the risk of hypoglycaemia.","Concurrent use of metformin and gliclazide can increase the risk of hypoglycaemia.","Concurrent use of metformin and glimepiride can increase the risk of hypoglycaemia.","Concurrent use of metformin and glipizide can increase the risk of hypoglycaemia.","Concurrent use of metformin and insulin can increase the risk of hypoglycaemia.","Concurrent use of metformin and insulin aspart can increase the risk of hypoglycaemia.","Concurrent use of metformin and insulin degludec can increase the risk of hypoglycaemia.","Concurrent use of metformin and insulin detemir can increase the risk of hypoglycaemia.","Concurrent use of metformin and insulin glargine can increase the risk of hypoglycaemia.","Concurrent use of metformin and insulin glulisine can increase the risk of hypoglycaemia.","Concurrent use of metformin and insulin lispro can increase the risk of hypoglycaemia.","Concurrent use of metformin and insulin zinc suspension can increase the risk of hypoglycaemia.","Concurrent use of metformin and isophane insulin can increase the risk of hypoglycaemia.","Concurrent use of metformin and linagliptin can increase the risk of hypoglycaemia.","Concurrent use of metformin and liraglutide can increase the risk of hypoglycaemia.","Concurrent use of metformin and lixisenatide can increase the risk of hypoglycaemia.","Concurrent use of metformin and nateglinide can increase the risk of hypoglycaemia.","Concurrent use of metformin and pioglitazone can increase the risk of hypoglycaemia.","Pitolisant is predicted to increase the exposure to metformin.","Concurrent use of metformin and protamine zinc insulin can increase the risk of hypoglycaemia.","Concurrent use of metformin and repaglinide can increase the risk of hypoglycaemia.","Concurrent use of metformin and saxagliptin can increase the risk of hypoglycaemia.","Concurrent use of metformin and sitagliptin can increase the risk of hypoglycaemia.","Concurrent use of metformin and tolbutamide can increase the risk of hypoglycaemia.","Vandetanib slightly increases the exposure to metformin. Manufacturer advises monitor and adjust dose.","Concurrent use of metformin and vildagliptin can increase the risk of hypoglycaemia."]},{"name":"BNF.Metoclopramide.Metoclopramide","imports":[""],"interactioninfo":["Metoclopramide is predicted to decrease the effects of apomorphine. Manufacturer advises avoid.","Metoclopramide decreases the concentration of atovaquone. Manufacturer advises avoid.","Metoclopramide is predicted to increase the effects of atracurium.","Metoclopramide is predicted to decrease the effects of bromocriptine. Manufacturer advises avoid.","Metoclopramide is predicted to decrease the effects of cabergoline. Manufacturer advises avoid.","Metoclopramide is predicted to increase the effects of cisatracurium.","Metoclopramide decreases the effects of levodopa. Manufacturer advises avoid.","Metoclopramide is predicted to increase the effects of mivacurium.","Metoclopramide is predicted to increase the effects of pancuronium.","Metoclopramide is predicted to decrease the effects of pergolide. Manufacturer advises avoid.","Metoclopramide is predicted to decrease the effects of pramipexole. Manufacturer advises avoid.","Metoclopramide is predicted to increase the risk of methaemoglobinaemia when given with topical prilocaine. Manufacturer advises avoid.","Metoclopramide is predicted to decrease the effects of quinagolide. Manufacturer advises avoid.","Metoclopramide is predicted to increase the effects of rocuronium.","Metoclopramide is predicted to decrease the effects of ropinirole. Manufacturer advises avoid.","Metoclopramide is predicted to decrease the effects of rotigotine. Manufacturer advises avoid.","Metoclopramide increases the effects of suxamethonium.","Metoclopramide is predicted to increase the effects of vecuronium."]},{"name":"BNF.Midazolam.Midazolam","imports":["BNF.Carbamazepine.Carbamazepine","BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Clarithromycin.Clarithromycin","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Diltiazem.Diltiazem","BNF.Fentanyl.Fentanyl","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Oxycodone.Oxycodone","BNF.Phenytoin.Phenytoin","BNF.Prochlorperazine.Prochlorperazine","BNF.Temazepam.Temazepam","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of midazolam and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Aprepitant is predicted to increase the exposure to midazolam. Manufacturer advises monitor side effects and adjust dose.","Concurrent use of midazolam and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Atazanavir is predicted to markedly to very markedly increase the exposure to midazolam. Manufacturer advises avoid or adjust dose.","Concurrent use of midazolam and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Bosentan is predicted to decrease the concentration of midazolam. Manufacturer advises monitor and adjust dose.","Concurrent use of midazolam and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Carbamazepine is predicted to decrease the exposure to midazolam. Manufacturer advises monitor and adjust dose.","Concurrent use of midazolam and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Clarithromycin is predicted to markedly to very markedly increase the exposure to midazolam. Manufacturer advises avoid or adjust dose.","Concurrent use of midazolam and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Cobicistat is predicted to markedly to very markedly increase the exposure to midazolam. Manufacturer advises avoid or adjust dose.","Concurrent use of midazolam and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Crizotinib is predicted to increase the exposure to midazolam. Manufacturer advises monitor side effects and adjust dose.","Concurrent use of midazolam and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Dabrafenib decreases the exposure to midazolam. Manufacturer advises monitor and adjust dose.","Darunavir is predicted to markedly to very markedly increase the exposure to midazolam. Manufacturer advises avoid or adjust dose.","Concurrent use of midazolam and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Diltiazem is predicted to increase the exposure to midazolam. Manufacturer advises monitor side effects and adjust dose.","Concurrent use of midazolam and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Dronedarone is predicted to increase the exposure to midazolam. Manufacturer advises monitor side effects and adjust dose.","Concurrent use of midazolam and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Efavirenz is predicted to alter the effects of midazolam. Manufacturer advises avoid.","Enzalutamide is predicted to decrease the exposure to midazolam. Manufacturer advises monitor and adjust dose.","Erythromycin is predicted to increase the exposure to midazolam. Manufacturer advises monitor side effects and adjust dose.","Concurrent use of midazolam and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Fluconazole is predicted to increase the exposure to midazolam. Manufacturer advises monitor side effects and adjust dose.","Concurrent use of midazolam and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Fosamprenavir is predicted to markedly to very markedly increase the exposure to midazolam. Manufacturer advises avoid or adjust dose.","Fosaprepitant slightly increases the exposure to midazolam.","Fosphenytoin is predicted to decrease the exposure to midazolam. Manufacturer advises monitor and adjust dose.","Concurrent use of midazolam and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Idelalisib is predicted to markedly to very markedly increase the exposure to midazolam. Manufacturer advises avoid or adjust dose.","Imatinib is predicted to increase the exposure to midazolam. Manufacturer advises monitor side effects and adjust dose.","Indinavir is predicted to increase the exposure to midazolam. Manufacturer advises monitor side effects and adjust dose.","Isavuconazole is predicted to increase the exposure to midazolam. Manufacturer advises monitor side effects and adjust dose.","Concurrent use of midazolam and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Itraconazole is predicted to markedly to very markedly increase the exposure to midazolam. Manufacturer advises avoid or adjust dose.","Concurrent use of midazolam and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ketoconazole is predicted to markedly to very markedly increase the exposure to midazolam. Manufacturer advises avoid or adjust dose.","Concurrent use of midazolam and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Lopinavir is predicted to markedly to very markedly increase the exposure to midazolam. Manufacturer advises avoid or adjust dose.","Concurrent use of midazolam and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Lumacaftor is predicted to decrease the exposure to midazolam. Manufacturer advises avoid.","Concurrent use of midazolam and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Miconazole is predicted to increase the exposure to intravenous midazolam. Manufacturer advises use with caution and adjust dose.","Miconazole is predicted to increase the exposure to oral midazolam. Manufacturer advises avoid.","Concurrent use of midazolam and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Netupitant is predicted to increase the exposure to midazolam. Manufacturer advises monitor side effects and adjust dose.","Nevirapine decreases the concentration of midazolam. Manufacturer advises monitor and adjust dose.","Nilotinib is predicted to increase the exposure to midazolam. Manufacturer advises monitor side effects and adjust dose.","Concurrent use of midazolam and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Palbociclib increases the exposure to midazolam.","Concurrent use of midazolam and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Phenobarbital is predicted to decrease the exposure to midazolam. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to midazolam. Manufacturer advises monitor and adjust dose.","Concurrent use of midazolam and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Posaconazole is predicted to increase the exposure to midazolam. Manufacturer advises monitor side effects and adjust dose.","Concurrent use of midazolam and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Primidone is predicted to decrease the exposure to midazolam. Manufacturer advises monitor and adjust dose.","Concurrent use of midazolam and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Rifampicin is predicted to decrease the exposure to midazolam. Manufacturer advises monitor and adjust dose.","Concurrent use of midazolam and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ritonavir is predicted to markedly to very markedly increase the exposure to midazolam. Manufacturer advises avoid or adjust dose.","Concurrent use of midazolam and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Saquinavir is predicted to markedly to very markedly increase the exposure to midazolam. Manufacturer advises avoid or adjust dose.","Concurrent use of midazolam and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","St John's Wort moderately decreases the exposure to midazolam. Manufacturer advises monitor and adjust dose.","Concurrent use of midazolam and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Tipranavir is predicted to markedly to very markedly increase the exposure to midazolam. Manufacturer advises avoid or adjust dose.","Concurrent use of midazolam and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Verapamil is predicted to increase the exposure to midazolam. Manufacturer advises monitor side effects and adjust dose.","Voriconazole is predicted to markedly to very markedly increase the exposure to midazolam. Manufacturer advises avoid or adjust dose.","Concurrent use of midazolam and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of midazolam and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Mirtazapine.Mirtazapine","imports":["BNF.Carbamazepine.Carbamazepine","BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Fentanyl.Fentanyl","BNF.Fluoxetine.Fluoxetine","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Morphine.Morphine","BNF.Ondansetron.Ondansetron","BNF.Oxycodone.Oxycodone","BNF.Phenytoin.Phenytoin","BNF.Prochlorperazine.Prochlorperazine","BNF.Sertraline.Sertraline","BNF.Temazepam.Temazepam","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of mirtazapine and St John's Wort can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and almotriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Atazanavir is predicted to increase the exposure to mirtazapine.","Concurrent use of mirtazapine and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and bupropion can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and buspirone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Carbamazepine is predicted to decrease the exposure to mirtazapine. Manufacturer advises adjust dose.","Concurrent use of mirtazapine and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Cimetidine slightly increases the exposure to mirtazapine. Manufacturer advises use with caution and adjust dose.","Concurrent use of mirtazapine and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and citalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Clarithromycin is predicted to increase the exposure to mirtazapine.","Concurrent use of mirtazapine and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and clomipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Cobicistat is predicted to increase the exposure to mirtazapine.","Concurrent use of mirtazapine and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and dapoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Darunavir is predicted to increase the exposure to mirtazapine.","Concurrent use of mirtazapine and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and dexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and duloxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and eletriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Enzalutamide is predicted to decrease the exposure to mirtazapine. Manufacturer advises adjust dose.","Concurrent use of mirtazapine and escitalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and fentanyl can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and fluoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and fluvoxamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fosamprenavir is predicted to increase the exposure to mirtazapine.","Fosphenytoin is predicted to decrease the exposure to mirtazapine. Manufacturer advises adjust dose.","Concurrent use of mirtazapine and frovatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and granisetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Idelalisib is predicted to increase the exposure to mirtazapine.","Concurrent use of mirtazapine and imipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and isocarboxazid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Itraconazole is predicted to increase the exposure to mirtazapine.","Concurrent use of mirtazapine and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ketoconazole is predicted to increase the exposure to mirtazapine.","Concurrent use of mirtazapine and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and linezolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and lisdexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and lithium can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Lopinavir is predicted to increase the exposure to mirtazapine.","Concurrent use of mirtazapine and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and methadone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and methylthioninium chloride can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and mianserin can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and moclobemide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and naratriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and ondansetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and palonosetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and paroxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and pentazocine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and pethidine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and phenelzine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Phenobarbital is predicted to decrease the exposure to mirtazapine. Manufacturer advises adjust dose.","Phenytoin is predicted to decrease the exposure to mirtazapine. Manufacturer advises adjust dose.","Concurrent use of mirtazapine and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Mirtazapine is predicted to decrease the efficacy of pitolisant.","Concurrent use of mirtazapine and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Primidone is predicted to decrease the exposure to mirtazapine. Manufacturer advises adjust dose.","Concurrent use of mirtazapine and procarbazine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and rasagiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Rifampicin is predicted to decrease the exposure to mirtazapine. Manufacturer advises adjust dose.","Concurrent use of mirtazapine and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ritonavir is predicted to increase the exposure to mirtazapine.","Concurrent use of mirtazapine and rizatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and safinamide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Saquinavir is predicted to increase the exposure to mirtazapine.","Concurrent use of mirtazapine and selegiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and sertraline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and sumatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and tapentadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and tedizolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Tipranavir is predicted to increase the exposure to mirtazapine.","Concurrent use of mirtazapine and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and tramadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and tranylcypromine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and trazodone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and venlafaxine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Voriconazole is predicted to increase the exposure to mirtazapine.","Concurrent use of mirtazapine and vortioxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and zolmitriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of mirtazapine and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of mirtazapine and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Morphine.Morphine","imports":["BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Fentanyl.Fentanyl","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Oxycodone.Oxycodone","BNF.Prochlorperazine.Prochlorperazine","BNF.Temazepam.Temazepam","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of morphine and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Buprenorphine is predicted to increase the risk of opiate withdrawal when given with morphine.","Concurrent use of morphine and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Morphine is predicted to increase the risk of CNS excitation or depression when given with isocarboxazid. Manufacturer advises avoid.","Concurrent use of morphine and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Nalmefene is predicted to decrease the efficacy of morphine. Manufacturer advises avoid.","Concurrent use of morphine and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Pentazocine is predicted to increase the risk of opiate withdrawal when given with morphine.","Concurrent use of morphine and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Morphine is predicted to increase the risk of CNS excitation or depression when given with phenelzine. Manufacturer advises avoid.","Concurrent use of morphine and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Pitolisant is predicted to decrease the exposure to morphine.","Concurrent use of morphine and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Rifampicin decreases the exposure to morphine.","Concurrent use of morphine and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ritonavir is predicted to decrease the concentration of morphine.","Concurrent use of morphine and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Morphine is predicted to increase the risk of CNS excitation or depression when given with tranylcypromine. Manufacturer advises avoid.","Concurrent use of morphine and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of morphine and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Naproxen.Naproxen","imports":["BNF.Amiloride.Amiloride","BNF.Amitriptyline.Amitriptyline","BNF.Apixaban.Apixaban","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Carbamazepine.Carbamazepine","BNF.Ceftazidime.Ceftazidime","BNF.Cefuroxime.Cefuroxime","BNF.Ciprofloxacin.Ciprofloxacin","BNF.Citalopram.Citalopram","BNF.Diclofenac.Diclofenac","BNF.Enoxaparin.Enoxaparin","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Glucose.Glucose","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Levofloxacin.Levofloxacin","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Ramipril.Ramipril","BNF.Rivaroxaban.Rivaroxaban","BNF.Sertraline.Sertraline","BNF.Spironolactone.Spironolactone","BNF.Trimethoprim.Trimethoprim","BNF.Vancomycin.Vancomycin","BNF.Venlafaxine.Venlafaxine","BNF.Warfarin.Warfarin"],"interactioninfo":["Both naproxen and abciximab can increase the risk of bleeding.","Concurrent use of naproxen and aceclofenac can increase the risk of hyponatraemia.","Concurrent use of naproxen and aceclofenac can increase the risk of nephrotoxicity.","Concurrent use of naproxen and aceclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and aceclofenac can increase the risk of bleeding.","Concurrent use of naproxen and acemetacin can increase the risk of hyponatraemia.","Concurrent use of naproxen and acemetacin can increase the risk of nephrotoxicity.","Concurrent use of naproxen and acemetacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and acemetacin can increase the risk of bleeding.","Acenocoumarol is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and aciclovir can increase the risk of nephrotoxicity.","Naproxen is predicted to increase the risk of gastrointestinal irritation when given with alendronic acid.","Concurrent use of naproxen and aliskiren can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Alteplase is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and amikacin can increase the risk of nephrotoxicity.","Concurrent use of naproxen and amiloride can increase the risk of hyponatraemia.","Concurrent use of naproxen and amiloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and amitriptyline can increase the risk of hyponatraemia.","Concurrent use of naproxen and amphotericin can increase the risk of nephrotoxicity.","Both naproxen and anagrelide can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Argatroban is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Both naproxen and aspirin can increase the risk of bleeding.","Concurrent use of naproxen and azilsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and bacitracin can increase the risk of nephrotoxicity.","Naproxen increases the risk of gastrointestinal bleeding when given with beclometasone.","Concurrent use of naproxen and bendroflumethiazide can increase the risk of hyponatraemia.","Naproxen increases the risk of acute renal failure when given with bendroflumethiazide.","Concurrent use of naproxen and benzydamine can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Naproxen increases the risk of gastrointestinal bleeding when given with betamethasone.","Both naproxen and bevacizumab can increase the risk of bleeding.","Bivalirudin is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and bromfenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Naproxen increases the risk of gastrointestinal bleeding when given with budesonide.","Concurrent use of naproxen and bumetanide can increase the risk of hyponatraemia.","Concurrent use of naproxen and candesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and cangrelor can increase the risk of bleeding.","Concurrent use of naproxen and capreomycin can increase the risk of nephrotoxicity.","Concurrent use of naproxen and captopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and carbamazepine can increase the risk of hyponatraemia.","Concurrent use of naproxen and carboplatin can increase the risk of nephrotoxicity.","Concurrent use of naproxen and cefaclor can increase the risk of nephrotoxicity.","Concurrent use of naproxen and cefadroxil can increase the risk of nephrotoxicity.","Concurrent use of naproxen and cefalexin can increase the risk of nephrotoxicity.","Concurrent use of naproxen and cefixime can increase the risk of nephrotoxicity.","Concurrent use of naproxen and cefotaxime can increase the risk of nephrotoxicity.","Concurrent use of naproxen and cefradine can increase the risk of nephrotoxicity.","Concurrent use of naproxen and ceftaroline can increase the risk of nephrotoxicity.","Concurrent use of naproxen and ceftazidime can increase the risk of nephrotoxicity.","Concurrent use of naproxen and ceftobiprole can increase the risk of nephrotoxicity.","Concurrent use of naproxen and ceftolozane can increase the risk of nephrotoxicity.","Concurrent use of naproxen and ceftriaxone can increase the risk of nephrotoxicity.","Concurrent use of naproxen and cefuroxime can increase the risk of nephrotoxicity.","Concurrent use of naproxen and celecoxib can increase the risk of hyponatraemia.","Concurrent use of naproxen and celecoxib can increase the risk of nephrotoxicity.","Concurrent use of naproxen and celecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and celecoxib can increase the risk of bleeding.","Concurrent use of naproxen and chlorothiazide can increase the risk of hyponatraemia.","Concurrent use of naproxen and chlortalidone can increase the risk of hyponatraemia.","Naproxen increases the risk of acute renal failure when given with chlortalidone.","Naproxen increases the risk of gastrointestinal bleeding when given with ciclesonide.","Concurrent use of naproxen and ciclosporin can increase the risk of nephrotoxicity.","Concurrent use of naproxen and ciclosporin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and cilostazol can increase the risk of bleeding.","Naproxen potentially increases the risk of seizures when given with ciprofloxacin.","Concurrent use of naproxen and cisplatin can increase the risk of nephrotoxicity.","Concurrent use of naproxen and citalopram can increase the risk of hyponatraemia.","Both naproxen and citalopram can increase the risk of bleeding.","Concurrent use of naproxen and clomipramine can increase the risk of hyponatraemia.","Concurrent use of naproxen and clopamide can increase the risk of hyponatraemia.","Naproxen increases the risk of acute renal failure when given with clopamide.","Both naproxen and clopidogrel can increase the risk of bleeding.","Concurrent use of naproxen and colistimethate can increase the risk of nephrotoxicity.","Concurrent use of naproxen and cyclopenthiazide can increase the risk of hyponatraemia.","Naproxen increases the risk of acute renal failure when given with cyclopenthiazide.","Dabigatran is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and dalteparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Dalteparin is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Danaparoid is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and dapoxetine can increase the risk of hyponatraemia.","Both naproxen and dapoxetine can increase the risk of bleeding.","Naproxen increases the risk of renal impairment when given with daptomycin.","Concurrent use of naproxen and darbepoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and dasatinib can increase the risk of bleeding.","Naproxen is predicted to increase the risk of gastrointestinal bleeding when given with deferasirox.","Naproxen increases the risk of gastrointestinal bleeding when given with deflazacort.","Concurrent use of naproxen and desmopressin can increase the risk of hyponatraemia.","Naproxen increases the risk of gastrointestinal bleeding when given with dexamethasone.","Concurrent use of naproxen and dexibuprofen can increase the risk of hyponatraemia.","Concurrent use of naproxen and dexibuprofen can increase the risk of nephrotoxicity.","Concurrent use of naproxen and dexibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and dexibuprofen can increase the risk of bleeding.","Concurrent use of naproxen and dexketoprofen can increase the risk of hyponatraemia.","Concurrent use of naproxen and dexketoprofen can increase the risk of nephrotoxicity.","Concurrent use of naproxen and dexketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and dexketoprofen can increase the risk of bleeding.","Concurrent use of naproxen and diclofenac can increase the risk of hyponatraemia.","Concurrent use of naproxen and diclofenac can increase the risk of nephrotoxicity.","Concurrent use of naproxen and diclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and diclofenac can increase the risk of bleeding.","Both naproxen and dipyridamole can increase the risk of bleeding.","Concurrent use of naproxen and dosulepin can increase the risk of hyponatraemia.","Concurrent use of naproxen and doxepin can increase the risk of hyponatraemia.","Concurrent use of naproxen and drospirenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and duloxetine can increase the risk of hyponatraemia.","Both naproxen and duloxetine can increase the risk of bleeding.","Edoxaban is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and enalapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and enoxaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Enoxaparin is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and eplerenone can increase the risk of hyponatraemia.","Concurrent use of naproxen and eplerenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and epoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and epoetin beta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and epoetin zeta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and epoprostenol can increase the risk of bleeding.","Concurrent use of naproxen and eprosartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and eptifibatide can increase the risk of bleeding.","Erlotinib is predicted to increase the risk of gastrointestinal perforation when given with naproxen.","Concurrent use of naproxen and escitalopram can increase the risk of hyponatraemia.","Both naproxen and escitalopram can increase the risk of bleeding.","Concurrent use of naproxen and etodolac can increase the risk of hyponatraemia.","Concurrent use of naproxen and etodolac can increase the risk of nephrotoxicity.","Concurrent use of naproxen and etodolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and etodolac can increase the risk of bleeding.","Concurrent use of naproxen and etoricoxib can increase the risk of hyponatraemia.","Concurrent use of naproxen and etoricoxib can increase the risk of nephrotoxicity.","Concurrent use of naproxen and etoricoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and etoricoxib can increase the risk of bleeding.","Concurrent use of naproxen and felbinac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and fenoprofen can increase the risk of hyponatraemia.","Concurrent use of naproxen and fenoprofen can increase the risk of nephrotoxicity.","Concurrent use of naproxen and fenoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and fenoprofen can increase the risk of bleeding.","Naproxen increases the risk of gastrointestinal bleeding when given with fludrocortisone.","Concurrent use of naproxen and fluoxetine can increase the risk of hyponatraemia.","Both naproxen and fluoxetine can increase the risk of bleeding.","Concurrent use of naproxen and flurbiprofen can increase the risk of hyponatraemia.","Concurrent use of naproxen and flurbiprofen can increase the risk of nephrotoxicity.","Concurrent use of naproxen and flurbiprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and flurbiprofen can increase the risk of bleeding.","Naproxen increases the risk of gastrointestinal bleeding when given with fluticasone.","Concurrent use of naproxen and fluvoxamine can increase the risk of hyponatraemia.","Both naproxen and fluvoxamine can increase the risk of bleeding.","Fondaparinux is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and foscarnet can increase the risk of nephrotoxicity.","Concurrent use of naproxen and furosemide can increase the risk of hyponatraemia.","Concurrent use of naproxen and ganciclovir can increase the risk of nephrotoxicity.","Concurrent use of naproxen and gentamicin can increase the risk of nephrotoxicity.","Glucose is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and heparin (unfractionated) can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Heparin (unfractionated) is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and hydrochlorothiazide can increase the risk of hyponatraemia.","Naproxen increases the risk of acute renal failure when given with hydrochlorothiazide.","Naproxen increases the risk of gastrointestinal bleeding when given with hydrocortisone.","Concurrent use of naproxen and hydroflumethiazide can increase the risk of hyponatraemia.","Naproxen increases the risk of acute renal failure when given with hydroflumethiazide.","Naproxen is predicted to increase the risk of gastrointestinal irritation when given with ibandronic acid.","Both naproxen and ibrutinib can increase the risk of bleeding.","Concurrent use of naproxen and ibuprofen can increase the risk of hyponatraemia.","Concurrent use of naproxen and ibuprofen can increase the risk of nephrotoxicity.","Concurrent use of naproxen and ibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and ibuprofen can increase the risk of bleeding.","Concurrent use of naproxen and ifosfamide can increase the risk of nephrotoxicity.","Both naproxen and iloprost can increase the risk of bleeding.","Concurrent use of naproxen and imidapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and imipramine can increase the risk of hyponatraemia.","Concurrent use of naproxen and indapamide can increase the risk of hyponatraemia.","Naproxen increases the risk of acute renal failure when given with indapamide.","Concurrent use of naproxen and indometacin can increase the risk of hyponatraemia.","Concurrent use of naproxen and indometacin can increase the risk of nephrotoxicity.","Concurrent use of naproxen and indometacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and indometacin can increase the risk of bleeding.","Concurrent use of naproxen and irbesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and ketoprofen can increase the risk of hyponatraemia.","Concurrent use of naproxen and ketoprofen can increase the risk of nephrotoxicity.","Concurrent use of naproxen and ketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and ketoprofen can increase the risk of bleeding.","Concurrent use of naproxen and ketorolac can increase the risk of hyponatraemia.","Concurrent use of naproxen and ketorolac can increase the risk of nephrotoxicity.","Concurrent use of naproxen and ketorolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and ketorolac can increase the risk of bleeding.","Naproxen potentially increases the risk of seizures when given with levofloxacin.","Concurrent use of naproxen and lisinopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Naproxen increases the concentration of lithium. Manufacturer advises monitor and adjust dose.","Concurrent use of naproxen and losartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and mefenamic acid can increase the risk of hyponatraemia.","Concurrent use of naproxen and mefenamic acid can increase the risk of nephrotoxicity.","Concurrent use of naproxen and mefenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and mefenamic acid can increase the risk of bleeding.","Concurrent use of naproxen and meloxicam can increase the risk of hyponatraemia.","Concurrent use of naproxen and meloxicam can increase the risk of nephrotoxicity.","Concurrent use of naproxen and meloxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and meloxicam can increase the risk of bleeding.","Concurrent use of naproxen and methotrexate can increase the risk of nephrotoxicity.","Naproxen is predicted to increase the risk of toxicity when given with methotrexate. Manufacturer advises monitor and adjust dose.","Naproxen increases the risk of gastrointestinal bleeding when given with methylprednisolone.","Concurrent use of naproxen and metolazone can increase the risk of hyponatraemia.","Naproxen increases the risk of acute renal failure when given with metolazone.","Naproxen (high-dose) is predicted to decrease the efficacy of mifamurtide. Manufacturer advises avoid.","Concurrent use of naproxen and moexipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Naproxen increases the risk of gastrointestinal bleeding when given with mometasone.","Naproxen potentially increases the risk of seizures when given with moxifloxacin.","Concurrent use of naproxen and nabumetone can increase the risk of hyponatraemia.","Concurrent use of naproxen and nabumetone can increase the risk of nephrotoxicity.","Concurrent use of naproxen and nabumetone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and nabumetone can increase the risk of bleeding.","Naproxen potentially increases the risk of seizures when given with nalidixic acid.","Concurrent use of naproxen and neomycin can increase the risk of nephrotoxicity.","Concurrent use of naproxen and nepafenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Nicorandil is predicted to increase the risk of gastrointestinal perforation when given with naproxen.","Nicotinic acid is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Naproxen potentially increases the risk of seizures when given with norfloxacin.","Concurrent use of naproxen and nortriptyline can increase the risk of hyponatraemia.","Naproxen potentially increases the risk of seizures when given with ofloxacin.","Concurrent use of naproxen and olmesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Omega-3-acid ethyl esters is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and oxaliplatin can increase the risk of nephrotoxicity.","Concurrent use of naproxen and parecoxib can increase the risk of hyponatraemia.","Concurrent use of naproxen and parecoxib can increase the risk of nephrotoxicity.","Concurrent use of naproxen and parecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and parecoxib can increase the risk of bleeding.","Concurrent use of naproxen and paroxetine can increase the risk of hyponatraemia.","Both naproxen and paroxetine can increase the risk of bleeding.","Concurrent use of naproxen and pemetrexed can increase the risk of nephrotoxicity.","Naproxen is predicted to increase the exposure to pemetrexed. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and penicillamine can increase the risk of nephrotoxicity.","Concurrent use of naproxen and pentamidine can increase the risk of nephrotoxicity.","Concurrent use of naproxen and perindopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Phenindione is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and piroxicam can increase the risk of hyponatraemia.","Concurrent use of naproxen and piroxicam can increase the risk of nephrotoxicity.","Concurrent use of naproxen and piroxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and piroxicam can increase the risk of bleeding.","Concurrent use of naproxen and polymyxins can increase the risk of nephrotoxicity.","Concurrent use of naproxen and potassium canrenoate can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and potassium chloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and prasugrel can increase the risk of bleeding.","Naproxen increases the risk of gastrointestinal bleeding when given with prednisolone.","Naproxen increases the risk of gastrointestinal bleeding when given with prednisone.","Concurrent use of naproxen and quinapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and ramipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and regorafenib can increase the risk of bleeding.","Reteplase is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and sertraline can increase the risk of hyponatraemia.","Both naproxen and sertraline can increase the risk of bleeding.","Naproxen is predicted to increase the risk of renal impairment when given with sodium clodronate.","Concurrent use of naproxen and sodium picosulfate can increase the risk of hyponatraemia.","Concurrent use of naproxen and spironolactone can increase the risk of hyponatraemia.","Concurrent use of naproxen and spironolactone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Streptokinase is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and streptomycin can increase the risk of nephrotoxicity.","Both naproxen and sulfinpyrazone can increase the risk of bleeding.","Concurrent use of naproxen and sulindac can increase the risk of hyponatraemia.","Concurrent use of naproxen and sulindac can increase the risk of nephrotoxicity.","Concurrent use of naproxen and sulindac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and sulindac can increase the risk of bleeding.","Concurrent use of naproxen and tacrolimus can increase the risk of nephrotoxicity.","Concurrent use of naproxen and tacrolimus can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and telavancin can increase the risk of nephrotoxicity.","Concurrent use of naproxen and telmisartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Tenecteplase is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and tenofovir can increase the risk of nephrotoxicity.","Concurrent use of naproxen and tenoxicam can increase the risk of hyponatraemia.","Concurrent use of naproxen and tenoxicam can increase the risk of nephrotoxicity.","Concurrent use of naproxen and tenoxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and tenoxicam can increase the risk of bleeding.","Concurrent use of naproxen and tiaprofenic acid can increase the risk of hyponatraemia.","Concurrent use of naproxen and tiaprofenic acid can increase the risk of nephrotoxicity.","Concurrent use of naproxen and tiaprofenic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and tiaprofenic acid can increase the risk of bleeding.","Both naproxen and ticagrelor can increase the risk of bleeding.","Concurrent use of naproxen and tinzaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Tinzaparin is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Both naproxen and tirofiban can increase the risk of bleeding.","Concurrent use of naproxen and tobramycin can increase the risk of nephrotoxicity.","Concurrent use of naproxen and tolfenamic acid can increase the risk of hyponatraemia.","Concurrent use of naproxen and tolfenamic acid can increase the risk of nephrotoxicity.","Concurrent use of naproxen and tolfenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and tolfenamic acid can increase the risk of bleeding.","Concurrent use of naproxen and tolvaptan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and torasemide can increase the risk of hyponatraemia.","Concurrent use of naproxen and trandolapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Both naproxen and trastuzumab can increase the risk of bleeding.","Both naproxen and trastuzumab emtansine can increase the risk of bleeding.","Naproxen increases the risk of gastrointestinal bleeding when given with triamcinolone.","Concurrent use of naproxen and triamterene can increase the risk of hyponatraemia.","Concurrent use of naproxen and triamterene can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and trimethoprim can increase the risk of hyponatraemia.","Concurrent use of naproxen and trimethoprim can increase the risk of nephrotoxicity.","Concurrent use of naproxen and trimethoprim can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and trimipramine can increase the risk of hyponatraemia.","Urokinase is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and valaciclovir can increase the risk of nephrotoxicity.","Concurrent use of naproxen and valganciclovir can increase the risk of nephrotoxicity.","Concurrent use of naproxen and valsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of naproxen and vancomycin can increase the risk of nephrotoxicity.","Both naproxen and venlafaxine can increase the risk of bleeding.","Both naproxen and vortioxetine can increase the risk of bleeding.","Warfarin is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Concurrent use of naproxen and xipamide can increase the risk of hyponatraemia.","Naproxen increases the risk of acute renal failure when given with xipamide.","Concurrent use of naproxen and zidovudine can increase the risk of nephrotoxicity.","Zidovudine increases the risk of haematological toxicity when given with naproxen.","Concurrent use of naproxen and zoledronic acid can increase the risk of nephrotoxicity."]},{"name":"BNF.Nefopam.Nefopam","imports":["BNF.Amitriptyline.Amitriptyline","BNF.Cyclizine.Cyclizine","BNF.Haloperidol.Haloperidol","BNF.Ipratropium.Ipratropium","BNF.Levomepromazine.Levomepromazine","BNF.Prochlorperazine.Prochlorperazine","BNF.Tiotropium.Tiotropium"],"interactioninfo":["Concurrent use of nefopam and aclidinium can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and amantadine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and amitriptyline can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and atropine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and baclofen can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and chlorphenamine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and chlorpromazine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and clemastine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and clomipramine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and clozapine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and cyclizine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and cyclopentolate can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and cyproheptadine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and darifenacin can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and dicycloverine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and dimenhydrinate can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and disopyramide can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and dosulepin can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and doxepin can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and fesoterodine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and flavoxate can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and glycopyrronium can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and haloperidol can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and homatropine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and hydroxyzine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and hyoscine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and imipramine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and ipratropium can increase the risk of antimuscarinic effects.","Nefopam is predicted to increase the risk of serious elevations in blood pressure when given with isocarboxazid. Manufacturer advises avoid.","Nefopam decreases the absorption of levodopa.","Concurrent use of nefopam and levomepromazine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and lofepramine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and loxapine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and nortriptyline can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and orphenadrine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and oxybutynin can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and perphenazine can increase the risk of antimuscarinic effects.","Nefopam is predicted to increase the risk of serious elevations in blood pressure when given with phenelzine. Manufacturer advises avoid.","Concurrent use of nefopam and pimozide can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and prochlorperazine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and procyclidine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and promethazine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and propafenone can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and propantheline can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and propiverine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and solifenacin can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and tiotropium can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and tolterodine can increase the risk of antimuscarinic effects.","Nefopam is predicted to increase the risk of serious elevations in blood pressure when given with tranylcypromine. Manufacturer advises avoid.","Concurrent use of nefopam and trifluoperazine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and trihexyphenidyl can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and trimipramine can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and tropicamide can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and trospium can increase the risk of antimuscarinic effects.","Concurrent use of nefopam and umeclidinium can increase the risk of antimuscarinic effects."]},{"name":"BNF.Nifedipine.Nifedipine","imports":["BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Carbamazepine.Carbamazepine","BNF.Clarithromycin.Clarithromycin","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Phenytoin.Phenytoin","BNF.Prochlorperazine.Prochlorperazine","BNF.Ramipril.Ramipril","BNF.Spironolactone.Spironolactone"],"interactioninfo":["Concurrent use of nifedipine and acebutolol can increase the risk of hypotension.","Concurrent use of nifedipine and alcohol (beverage) can increase the risk of hypotension.","Concurrent use of nifedipine and alfuzosin can increase the risk of hypotension.","Concurrent use of nifedipine and aliskiren can increase the risk of hypotension.","Concurrent use of nifedipine and alprostadil can increase the risk of hypotension.","Concurrent use of nifedipine and amantadine can increase the risk of hypotension.","Concurrent use of nifedipine and amitriptyline can increase the risk of hypotension.","Concurrent use of nifedipine and amlodipine can increase the risk of hypotension.","Concurrent use of nifedipine and apomorphine can increase the risk of hypotension.","Concurrent use of nifedipine and apraclonidine can increase the risk of hypotension.","Aprepitant is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and aripiprazole can increase the risk of hypotension.","Concurrent use of nifedipine and asenapine can increase the risk of hypotension.","Atazanavir is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and atenolol can increase the risk of hypotension.","Concurrent use of nifedipine and avanafil can increase the risk of hypotension.","Concurrent use of nifedipine and azilsartan can increase the risk of hypotension.","Concurrent use of nifedipine and baclofen can increase the risk of hypotension.","Concurrent use of nifedipine and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of nifedipine and benperidol can increase the risk of hypotension.","Concurrent use of nifedipine and betaxolol can increase the risk of hypotension.","Concurrent use of nifedipine and bisoprolol can increase the risk of hypotension.","Concurrent use of nifedipine and bortezomib can increase the risk of hypotension.","Bosentan is predicted to decrease the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and brimonidine can increase the risk of hypotension.","Concurrent use of nifedipine and bromocriptine can increase the risk of hypotension.","Concurrent use of nifedipine and bumetanide can increase the risk of hypotension.","Concurrent use of nifedipine and cabergoline can increase the risk of hypotension.","Concurrent use of nifedipine and canagliflozin can increase the risk of hypotension.","Concurrent use of nifedipine and candesartan can increase the risk of hypotension.","Concurrent use of nifedipine and captopril can increase the risk of hypotension.","Carbamazepine is predicted to decrease the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and carteolol can increase the risk of hypotension.","Concurrent use of nifedipine and carvedilol can increase the risk of hypotension.","Concurrent use of nifedipine and celiprolol can increase the risk of hypotension.","Concurrent use of nifedipine and chlorothiazide can increase the risk of hypotension.","Concurrent use of nifedipine and chlorpromazine can increase the risk of hypotension.","Concurrent use of nifedipine and chlortalidone can increase the risk of hypotension.","Cimetidine moderately increases the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Clarithromycin is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and clevidipine can increase the risk of hypotension.","Concurrent use of nifedipine and clomipramine can increase the risk of hypotension.","Concurrent use of nifedipine and clonidine can increase the risk of hypotension.","Concurrent use of nifedipine and clopamide can increase the risk of hypotension.","Concurrent use of nifedipine and clozapine can increase the risk of hypotension.","Cobicistat is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Crizotinib is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of nifedipine and dapagliflozin can increase the risk of hypotension.","Darunavir is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and desflurane can increase the risk of hypotension.","Concurrent use of nifedipine and diazoxide can increase the risk of hypotension.","Concurrent use of nifedipine and diltiazem can increase the risk of hypotension.","Diltiazem is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and dipyridamole can increase the risk of hypotension.","Concurrent use of nifedipine and dosulepin can increase the risk of hypotension.","Concurrent use of nifedipine and doxazosin can increase the risk of hypotension.","Concurrent use of nifedipine and doxepin can increase the risk of hypotension.","Dronedarone is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and droperidol can increase the risk of hypotension.","Efavirenz is predicted to decrease the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and empagliflozin can increase the risk of hypotension.","Concurrent use of nifedipine and enalapril can increase the risk of hypotension.","Enzalutamide is predicted to decrease the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and eplerenone can increase the risk of hypotension.","Concurrent use of nifedipine and eprosartan can increase the risk of hypotension.","Erythromycin is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and esmolol can increase the risk of hypotension.","Concurrent use of nifedipine and etomidate can increase the risk of hypotension.","Concurrent use of nifedipine and felodipine can increase the risk of hypotension.","Fluconazole is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and flupentixol can increase the risk of hypotension.","Concurrent use of nifedipine and fluphenazine can increase the risk of hypotension.","Fosamprenavir is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and fosinopril can increase the risk of hypotension.","Fosphenytoin is predicted to decrease the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and furosemide can increase the risk of hypotension.","Concurrent use of nifedipine and glyceryl trinitrate can increase the risk of hypotension.","Grapefruit juice increases the exposure to nifedipine. Manufacturer advises avoid.","Concurrent use of nifedipine and guanethidine can increase the risk of hypotension.","Concurrent use of nifedipine and guanfacine can increase the risk of hypotension.","Concurrent use of nifedipine and haloperidol can increase the risk of hypotension.","Concurrent use of nifedipine and histamine can increase the risk of hypotension.","Concurrent use of nifedipine and hydralazine can increase the risk of hypotension.","Concurrent use of nifedipine and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of nifedipine and hydroflumethiazide can increase the risk of hypotension.","Idelalisib is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Imatinib is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and imidapril can increase the risk of hypotension.","Concurrent use of nifedipine and imipramine can increase the risk of hypotension.","Concurrent use of nifedipine and indapamide can increase the risk of hypotension.","Indinavir is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and indoramin can increase the risk of hypotension.","Concurrent use of nifedipine and irbesartan can increase the risk of hypotension.","Isavuconazole is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and isocarboxazid can increase the risk of hypotension.","Concurrent use of nifedipine and isoflurane can increase the risk of hypotension.","Concurrent use of nifedipine and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of nifedipine and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of nifedipine and isradipine can increase the risk of hypotension.","Itraconazole is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and ketamine can increase the risk of hypotension.","Ketoconazole is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and labetalol can increase the risk of hypotension.","Concurrent use of nifedipine and lacidipine can increase the risk of hypotension.","Concurrent use of nifedipine and lercanidipine can increase the risk of hypotension.","Concurrent use of nifedipine and levobunolol can increase the risk of hypotension.","Concurrent use of nifedipine and levodopa can increase the risk of hypotension.","Concurrent use of nifedipine and levomepromazine can increase the risk of hypotension.","Concurrent use of nifedipine and lisinopril can increase the risk of hypotension.","Concurrent use of nifedipine and lofepramine can increase the risk of hypotension.","Concurrent use of nifedipine and lofexidine can increase the risk of hypotension.","Lopinavir is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and losartan can increase the risk of hypotension.","Concurrent use of nifedipine and loxapine can increase the risk of hypotension.","Concurrent use of nifedipine and lurasidone can increase the risk of hypotension.","Intravenous magnesium potentially increases the risk of hypotension when given with nifedipine (in pregnant women).","Mefloquine is predicted to increase the risk of bradycardia when given with nifedipine.","Concurrent use of nifedipine and methyldopa can increase the risk of hypotension.","Concurrent use of nifedipine and metolazone can increase the risk of hypotension.","Concurrent use of nifedipine and metoprolol can increase the risk of hypotension.","Miconazole is predicted to increase the exposure to nifedipine. Manufacturer advises use with caution and adjust dose.","Concurrent use of nifedipine and minoxidil can increase the risk of hypotension.","Concurrent use of nifedipine and moexipril can increase the risk of hypotension.","Concurrent use of nifedipine and moxisylyte can increase the risk of hypotension.","Concurrent use of nifedipine and moxonidine can increase the risk of hypotension.","Concurrent use of nifedipine and nadolol can increase the risk of hypotension.","Concurrent use of nifedipine and nebivolol can increase the risk of hypotension.","Netupitant is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Nevirapine is predicted to decrease the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and nicardipine can increase the risk of hypotension.","Concurrent use of nifedipine and nicorandil can increase the risk of hypotension.","Nilotinib is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and nimodipine can increase the risk of hypotension.","Concurrent use of nifedipine and nitrous oxide can increase the risk of hypotension.","Concurrent use of nifedipine and nortriptyline can increase the risk of hypotension.","Concurrent use of nifedipine and olanzapine can increase the risk of hypotension.","Concurrent use of nifedipine and olmesartan can increase the risk of hypotension.","Concurrent use of nifedipine and oxprenolol can increase the risk of hypotension.","Concurrent use of nifedipine and paliperidone can increase the risk of hypotension.","Concurrent use of nifedipine and pergolide can increase the risk of hypotension.","Concurrent use of nifedipine and pericyazine can increase the risk of hypotension.","Concurrent use of nifedipine and perindopril can increase the risk of hypotension.","Concurrent use of nifedipine and perphenazine can increase the risk of hypotension.","Concurrent use of nifedipine and phenelzine can increase the risk of hypotension.","Phenobarbital is predicted to decrease the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and pimozide can increase the risk of hypotension.","Concurrent use of nifedipine and pindolol can increase the risk of hypotension.","Posaconazole is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and pramipexole can increase the risk of hypotension.","Concurrent use of nifedipine and prazosin can increase the risk of hypotension.","Primidone is predicted to decrease the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and prochlorperazine can increase the risk of hypotension.","Concurrent use of nifedipine and promazine can increase the risk of hypotension.","Concurrent use of nifedipine and propofol can increase the risk of hypotension.","Concurrent use of nifedipine and propranolol can increase the risk of hypotension.","Concurrent use of nifedipine and quetiapine can increase the risk of hypotension.","Concurrent use of nifedipine and quinagolide can increase the risk of hypotension.","Concurrent use of nifedipine and quinapril can increase the risk of hypotension.","Concurrent use of nifedipine and ramipril can increase the risk of hypotension.","Rifampicin moderately decreases the exposure to nifedipine. Manufacturer advises avoid.","Concurrent use of nifedipine and riociguat can increase the risk of hypotension.","Concurrent use of nifedipine and risperidone can increase the risk of hypotension.","Ritonavir is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and ropinirole can increase the risk of hypotension.","Concurrent use of nifedipine and rotigotine can increase the risk of hypotension.","Concurrent use of nifedipine and sacubitril can increase the risk of hypotension.","Concurrent use of nifedipine and sapropterin can increase the risk of hypotension.","Saquinavir is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and selegiline can increase the risk of hypotension.","Concurrent use of nifedipine and sevoflurane can increase the risk of hypotension.","Concurrent use of nifedipine and sildenafil can increase the risk of hypotension.","Concurrent use of nifedipine and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of nifedipine and sodium oxybate can increase the risk of hypotension.","Concurrent use of nifedipine and sotalol can increase the risk of hypotension.","Concurrent use of nifedipine and spironolactone can increase the risk of hypotension.","St John's Wort is predicted to decrease the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and sulpiride can increase the risk of hypotension.","Concurrent use of nifedipine and tadalafil can increase the risk of hypotension.","Concurrent use of nifedipine and tamsulosin can increase the risk of hypotension.","Concurrent use of nifedipine and telmisartan can increase the risk of hypotension.","Concurrent use of nifedipine and terazosin can increase the risk of hypotension.","Concurrent use of nifedipine and thiopental can increase the risk of hypotension.","Concurrent use of nifedipine and timolol can increase the risk of hypotension.","Tipranavir is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and tizanidine can increase the risk of hypotension.","Concurrent use of nifedipine and torasemide can increase the risk of hypotension.","Concurrent use of nifedipine and trandolapril can increase the risk of hypotension.","Concurrent use of nifedipine and tranylcypromine can increase the risk of hypotension.","Concurrent use of nifedipine and trifluoperazine can increase the risk of hypotension.","Concurrent use of nifedipine and trimipramine can increase the risk of hypotension.","Concurrent use of nifedipine and valsartan can increase the risk of hypotension.","Concurrent use of nifedipine and vardenafil can increase the risk of hypotension.","Concurrent use of nifedipine and verapamil can increase the risk of hypotension.","Verapamil is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Voriconazole is predicted to increase the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Concurrent use of nifedipine and xipamide can increase the risk of hypotension.","Concurrent use of nifedipine and zuclopenthixol can increase the risk of hypotension."]},{"name":"BNF.Nitrofurantoin.Nitrofurantoin","imports":[""],"interactioninfo":["Nitrofurantoin is predicted to increase the risk of methaemoglobinaemia when given with dapsone.","Magnesium trisilicate decreases the absorption of nitrofurantoin.","Nitrofurantoin is predicted to increase the risk of methaemoglobinaemia when given with topical prilocaine. Manufacturer advises use with caution or avoid."]},{"name":"BNF.Omeprazole.Omeprazole","imports":["BNF.Citalopram.Citalopram"],"interactioninfo":["Omeprazole decreases the exposure to atazanavir. Manufacturer advises avoid or adjust dose.","Omeprazole is predicted to decrease the absorption of bosutinib.","Omeprazole is predicted to decrease the absorption of ceritinib.","Omeprazole is predicted to increase the exposure to cilostazol. Manufacturer advises adjust cilostazol dose.","Omeprazole slightly to moderately increases the exposure to citalopram. Manufacturer advises monitor and adjust dose.","Omeprazole is predicted to decrease the efficacy of clopidogrel. Manufacturer advises avoid.","Omeprazole is predicted to decrease the exposure to dabrafenib. Manufacturer advises avoid.","Omeprazole is predicted to slightly to moderately decrease the exposure to dasatinib. Manufacturer advises avoid.","Omeprazole is predicted to decrease the absorption of dipyridamole (immediate release tablets).","Enzalutamide is predicted to moderately decrease the exposure to omeprazole.","Omeprazole is predicted to slightly decrease the exposure to erlotinib. Manufacturer advises avoid.","Omeprazole slightly to moderately increases the exposure to escitalopram. Manufacturer advises monitor and adjust dose.","Fluconazole is predicted to increase the exposure to omeprazole.","Fluvoxamine is predicted to increase the exposure to omeprazole.","Omeprazole is predicted to decrease the exposure to gefitinib.","Omeprazole decreases the absorption of itraconazole. Manufacturer advises administer itraconazole capsules with an acidic beverage.","Omeprazole decreases the absorption of ketoconazole. Manufacturer advises administer ketoconazole with an acidic beverage.","Omeprazole is predicted to decrease the exposure to ledipasvir. Manufacturer advises adjust dose, see sofosbuvir with ledipasvir.","Lumacaftor is predicted to decrease the exposure to omeprazole. Manufacturer advises adjust dose.","Omeprazole decreases the clearance of methotrexate. Manufacturer advises use with caution or avoid.","Omeprazole is predicted to decrease the exposure to pazopanib. Manufacturer advises avoid or administer concurrently without food.","Omeprazole decreases the absorption of posaconazole (oral suspension). Manufacturer advises avoid.","Rifampicin is predicted to moderately decrease the exposure to omeprazole.","Omeprazole is predicted to decrease the exposure to rilpivirine. Manufacturer advises avoid.","Omeprazole increases the exposure to saquinavir. Manufacturer advises avoid.","Omeprazole potentially decreases the exposure to sofosbuvir. Manufacturer advises adjust dose, see sofosbuvir with ledipasvir and sofosbuvir with velpatasvir.","Tipranavir decreases the exposure to omeprazole. Manufacturer advises avoid.","Omeprazole is predicted to decrease the concentration of velpatasvir. Manufacturer advises adjust dose, see sofosbuvir with velpatasvir.","Voriconazole increases the exposure to omeprazole. Manufacturer advises adjust dose."]},{"name":"BNF.Ondansetron.Ondansetron","imports":["BNF.Amiodarone.Amiodarone","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisacodyl.Bisacodyl","BNF.Bumetanide.Bumetanide","BNF.Carbamazepine.Carbamazepine","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Fentanyl.Fentanyl","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Levomepromazine.Levomepromazine","BNF.Mirtazapine.Mirtazapine","BNF.Phenytoin.Phenytoin","BNF.Quinine.Quinine","BNF.Salbutamol.Salbutamol","BNF.Senna.Senna","BNF.Sertraline.Sertraline","BNF.Theophylline.Theophylline","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine"],"interactioninfo":["Concurrent use of ondansetron and St John's Wort can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of ondansetron and almotriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and amifampridine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Aminophylline is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and amiodarone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and amisulpride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amphotericin is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and apomorphine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Apomorphine increases the risk of severe hypotension when given with ondansetron. Manufacturer advises avoid.","Both ondansetron and arsenic trioxide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and artemether prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and artenimol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Bambuterol is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Beclometasone is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and bedaquiline prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Betamethasone is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and bosutinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Budesonide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Bumetanide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Concurrent use of ondansetron and bupropion can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of ondansetron and buspirone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and cabozantinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Carbamazepine is predicted to decrease the exposure to ondansetron.","Both ondansetron and ceritinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Chlorothiazide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and chlorpromazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Chlortalidone is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Concurrent use of ondansetron and citalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and citalopram prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and clarithromycin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and clomipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and clomipramine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clopamide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and crizotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Cyclopenthiazide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Dantron is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Concurrent use of ondansetron and dapoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and dasatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Deflazacort is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and delamanid prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Dexamethasone is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Concurrent use of ondansetron and dexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and disopyramide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Docusate sodium is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Domperidone increases the risk of QT-prolongation when given with ondansetron. Manufacturer advises avoid.","Both ondansetron and dronedarone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and droperidol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and duloxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of ondansetron and eletriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Enzalutamide is predicted to decrease the exposure to ondansetron.","Both ondansetron and eribulin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Intravenous erythromycin increases the risk of QT-prolongation when given with ondansetron. Manufacturer advises avoid or monitor.","Concurrent use of ondansetron and escitalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and escitalopram prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and fentanyl can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fingolimod increases the risk of QT-prolongation when given with ondansetron. Manufacturer advises avoid.","Both ondansetron and flecainide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Fludrocortisone is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Concurrent use of ondansetron and fluoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and fluphenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and fluvoxamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Formoterol is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Fosphenytoin is predicted to decrease the exposure to ondansetron.","Concurrent use of ondansetron and frovatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Furosemide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Glycerol is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Concurrent use of ondansetron and granisetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Granisetron is predicted to increase the risk of QT-prolongation when given with ondansetron.","Both ondansetron and haloperidol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Hydrochlorothiazide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Hydrocortisone is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Hydroflumethiazide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and hydroxyzine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and imipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Indacaterol is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Concurrent use of ondansetron and isocarboxazid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Ivabradine is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises avoid.","Both ondansetron and lapatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and levomepromazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and linezolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of ondansetron and lisdexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of ondansetron and lithium can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and lithium prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and lofexidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Mefloquine is predicted to increase the risk of QT-prolongation when given with ondansetron.","Concurrent use of ondansetron and methadone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and methadone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Methylprednisolone is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Concurrent use of ondansetron and methylthioninium chloride can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Metolazone is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Concurrent use of ondansetron and mianserin can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of ondansetron and mirtazapine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Mizolastine is predicted to increase the risk of QT-prolongation when given with ondansetron. Manufacturer advises avoid.","Concurrent use of ondansetron and moclobemide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and moxifloxacin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and naratriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and nilotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Olodaterol is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and osimertinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and paliperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and palonosetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Palonosetron is predicted to increase the risk of QT-prolongation when given with ondansetron.","Both ondansetron and panobinostat prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and paroxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and pasireotide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and pazopanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Intravenous pentamidine potentially increases the risk of QT-prolongation when given with ondansetron.","Concurrent use of ondansetron and pentazocine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of ondansetron and pethidine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of ondansetron and phenelzine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Phenobarbital is predicted to decrease the exposure to ondansetron.","Phenytoin is predicted to decrease the exposure to ondansetron.","Both ondansetron and pimozide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Prednisolone is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Prednisone is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Primidone is predicted to decrease the exposure to ondansetron.","Concurrent use of ondansetron and procarbazine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and quinine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and ranolazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and rasagiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Rifampicin is predicted to decrease the exposure to ondansetron.","Both ondansetron and risperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and rizatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of ondansetron and safinamide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Salbutamol is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Salmeterol is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and saquinavir prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and selegiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Senna is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Concurrent use of ondansetron and sertraline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and sildenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Sodium picosulfate is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and sorafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and sotalol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and sulpiride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and sumatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and sunitinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and tapentadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of ondansetron and tedizolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and telavancin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Terbutaline is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and tetrabenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Theophylline is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and tizanidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and tolterodine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Torasemide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and toremifene prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and tramadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of ondansetron and tranylcypromine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of ondansetron and trazodone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Triamcinolone is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and vandetanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and vardenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and vemurafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and venlafaxine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and venlafaxine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Vilanterol is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Both ondansetron and vinflunine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both ondansetron and voriconazole prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of ondansetron and vortioxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Xipamide is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Concurrent use of ondansetron and zolmitriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both ondansetron and zuclopenthixol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation."]},{"name":"BNF.Oxycodone.Oxycodone","imports":["BNF.Carbamazepine.Carbamazepine","BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Clarithromycin.Clarithromycin","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Diltiazem.Diltiazem","BNF.Fentanyl.Fentanyl","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Phenytoin.Phenytoin","BNF.Prochlorperazine.Prochlorperazine","BNF.Temazepam.Temazepam","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of oxycodone and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Aprepitant is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Atazanavir is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Buprenorphine is predicted to increase the risk of opiate withdrawal when given with oxycodone.","Concurrent use of oxycodone and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Carbamazepine is predicted to decrease the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Clarithromycin is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Cobicistat is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Crizotinib is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Darunavir is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Diltiazem is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Dronedarone is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Enzalutamide is predicted to decrease the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Erythromycin is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Fluconazole is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Fosamprenavir is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Fosphenytoin is predicted to decrease the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Idelalisib is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Imatinib is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Indinavir is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Isavuconazole is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Oxycodone is predicted to increase the risk of CNS excitation or depression when given with isocarboxazid. Manufacturer advises avoid.","Concurrent use of oxycodone and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Itraconazole is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ketoconazole is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Lopinavir is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Nalmefene is predicted to decrease the efficacy of oxycodone. Manufacturer advises avoid.","Netupitant is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Nilotinib is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Pentazocine is predicted to increase the risk of opiate withdrawal when given with oxycodone.","Concurrent use of oxycodone and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Oxycodone is predicted to increase the risk of CNS excitation or depression when given with phenelzine. Manufacturer advises avoid.","Concurrent use of oxycodone and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Phenobarbital is predicted to decrease the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Posaconazole is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Primidone is predicted to decrease the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Rifampicin is predicted to decrease the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ritonavir is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Saquinavir is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","St John's Wort moderately decreases the exposure to oxycodone. Manufacturer advises adjust dose.","Concurrent use of oxycodone and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Tipranavir is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Oxycodone is predicted to increase the risk of CNS excitation or depression when given with tranylcypromine. Manufacturer advises avoid.","Concurrent use of oxycodone and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Verapamil is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Voriconazole is predicted to increase the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of oxycodone and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of oxycodone and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Paracetamol.Paracetamol","imports":["BNF.Atorvastatin.Atorvastatin","BNF.Carbamazepine.Carbamazepine","BNF.Doxycycline.Doxycycline","BNF.Phenytoin.Phenytoin","BNF.Pravastatin.Pravastatin","BNF.Simvastatin.Simvastatin","BNF.Warfarin.Warfarin"],"interactioninfo":["Paracetamol increases the anticoagulant effect of acenocoumarol.","Concurrent use of paracetamol and alcohol (beverage) can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and alectinib can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and asparaginase can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and atorvastatin can increase the risk of hepatotoxicity.","Paracetamol is predicted to decrease the clearance of busulfan.","Concurrent use of paracetamol and carbamazepine can increase the risk of hepatotoxicity.","Carbamazepine is predicted to decrease the exposure to paracetamol.","Concurrent use of paracetamol and crisantaspase can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and daclizumab can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and dactinomycin can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and dantrolene can increase the risk of hepatotoxicity.","Paracetamol is predicted to increase the risk of methaemoglobinaemia when given with dapsone.","Concurrent use of paracetamol and demeclocycline can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and didanosine can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and doxycycline can increase the risk of hepatotoxicity.","Enzalutamide is predicted to decrease the exposure to paracetamol.","Concurrent use of paracetamol and fluconazole can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and fluvastatin can increase the risk of hepatotoxicity.","Fosphenytoin is predicted to decrease the exposure to paracetamol.","Imatinib increases the risk of hepatotoxicity when given with paracetamol.","Concurrent use of paracetamol and isoniazid can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and itraconazole can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and leflunomide can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and lenalidomide can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and lomitapide can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and lymecycline can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and mercaptopurine can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and methotrexate can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and micafungin can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and minocycline can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and oxytetracycline can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and pegaspargase can increase the risk of hepatotoxicity.","Paracetamol is predicted to increase the anticoagulant effect of phenindione.","Phenobarbital is predicted to decrease the exposure to paracetamol.","Phenytoin is predicted to decrease the exposure to paracetamol.","Pitolisant is predicted to decrease the exposure to paracetamol.","Concurrent use of paracetamol and pravastatin can increase the risk of hepatotoxicity.","Paracetamol is predicted to increase the risk of methaemoglobinaemia when given with topical prilocaine. Manufacturer advises use with caution or avoid.","Primidone is predicted to decrease the exposure to paracetamol.","Rifampicin is predicted to decrease the exposure to paracetamol.","Concurrent use of paracetamol and rosuvastatin can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and simvastatin can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and sulfasalazine can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and tetracycline can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and tigecycline can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and trabectedin can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and valproate can increase the risk of hepatotoxicity.","Concurrent use of paracetamol and vincristine can increase the risk of hepatotoxicity.","Paracetamol increases the anticoagulant effect of warfarin."]},{"name":"BNF.Phenytoin.Phenytoin","imports":["BNF.Amiodarone.Amiodarone","BNF.Amlodipine.Amlodipine","BNF.Apixaban.Apixaban","BNF.Atorvastatin.Atorvastatin","BNF.Carbamazepine.Carbamazepine","BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Ciprofloxacin.Ciprofloxacin","BNF.Clonazepam.Clonazepam","BNF.Diazepam.Diazepam","BNF.Digoxin.Digoxin","BNF.Diltiazem.Diltiazem","BNF.Doxycycline.Doxycycline","BNF.Fentanyl.Fentanyl","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Levothyroxine.Levothyroxine","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Nifedipine.Nifedipine","BNF.Ondansetron.Ondansetron","BNF.Oxycodone.Oxycodone","BNF.Paracetamol.Paracetamol","BNF.Rivaroxaban.Rivaroxaban","BNF.Sertraline.Sertraline","BNF.Simvastatin.Simvastatin","BNF.Theophylline.Theophylline","BNF.Trimethoprim.Trimethoprim","BNF.Warfarin.Warfarin","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Phenytoin is predicted to decrease the exposure to abacavir.","Phenytoin is predicted to decrease the exposure to abiraterone. Manufacturer advises avoid.","Phenytoin is predicted to alter the anticoagulant effect of acenocoumarol.","Phenytoin is predicted to decrease the exposure to agomelatine.","Phenytoin decreases the concentration of albendazole.","Phenytoin decreases the effects of alfacalcidol.","Phenytoin is predicted to decrease the exposure to alfentanil.","Phenytoin is predicted to decrease the exposure to alprazolam. Manufacturer advises adjust dose.","Phenytoin decreases the exposure to aminophylline. Manufacturer advises adjust dose.","Concurrent use of phenytoin and amiodarone can increase the risk of peripheral neuropathy.","Amiodarone is predicted to slightly increase the concentration of phenytoin. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to amlodipine. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to moderately decrease the exposure to apixaban. Manufacturer advises use with caution or avoid.","Phenytoin moderately decreases the exposure to apremilast. Manufacturer advises avoid.","Phenytoin is predicted to markedly decrease the exposure to aprepitant. Manufacturer advises avoid.","Phenytoin is predicted to moderately decrease the exposure to aripiprazole. Manufacturer advises adjust aripiprazole dose.","Phenytoin is predicted to decrease the exposure to artemether (with lumafantrine). Manufacturer advises avoid.","Atazanavir is predicted to affect the exposure to phenytoin and phenytoin decreases the concentration of atazanavir.","Phenytoin potentially decreases the exposure to atorvastatin.","Phenytoin decreases the effects of (but acute use increases the effects of) atracurium.","Phenytoin is predicted to decrease the exposure to avanafil. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to axitinib. Manufacturer advises avoid or adjust dose.","Phenytoin is predicted to decrease the exposure to bazedoxifene.","Phenytoin decreases the exposure to bedaquiline. Manufacturer advises avoid.","Concurrent use of phenytoin and bortezomib can increase the risk of peripheral neuropathy.","Phenytoin slightly decreases the exposure to bortezomib. Manufacturer advises avoid.","Phenytoin affects the exposure to bosentan. Manufacturer advises avoid.","Phenytoin is predicted to very markedly decrease the exposure to bosutinib. Manufacturer advises avoid.","Concurrent use of phenytoin and brentuximab vedotin can increase the risk of peripheral neuropathy.","Phenytoin decreases the concentration of brivaracetam.","Phenytoin is predicted to decrease the exposure to budesonide. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to buprenorphine. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to markedly decrease the exposure to bupropion.","Phenytoin is predicted to decrease the exposure to buspirone. Manufacturer advises use with caution and adjust dose.","Concurrent use of phenytoin and cabazitaxel can increase the risk of peripheral neuropathy.","Phenytoin is predicted to decrease the exposure to cabazitaxel. Manufacturer advises avoid.","Phenytoin moderately decreases the exposure to cabozantinib. Manufacturer advises avoid.","Phenytoin is predicted to moderately increase the clearance of caffeine citrate. Manufacturer advises monitor and adjust dose.","Phenytoin decreases the effects of calcipotriol.","Phenytoin decreases the effects of calcitriol.","Phenytoin is predicted to decrease the exposure to cannabis extract. Manufacturer advises avoid.","Capecitabine increases the concentration of phenytoin.","Carbamazepine affects the concentration of phenytoin and phenytoin decreases the concentration of carbamazepine. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the concentration of caspofungin. Manufacturer advises adjust caspofungin dose.","Phenytoin is predicted to decrease the exposure to ceritinib. Manufacturer advises avoid.","Intravenous chloramphenicol increases the concentration of phenytoin and phenytoin affects the concentration of intravenous chloramphenicol. Manufacturer advises monitor concentration and adjust dose.","Chlordiazepoxide affects the concentration of phenytoin.","Phenytoin decreases the concentration of ciclosporin.","Phenytoin is predicted to alter the effects of cilostazol.","Cimetidine increases the concentration of phenytoin. Manufacturer advises monitor concentration and adjust dose.","Ciprofloxacin affects the concentration of phenytoin. Manufacturer advises monitor concentration and adjust dose.","Phenytoin decreases the effects of (but acute use increases the effects of) cisatracurium.","Concurrent use of phenytoin and cisplatin can increase the risk of peripheral neuropathy.","Clobazam potentially affects the concentration of phenytoin.","Phenytoin decreases the exposure to clomethiazole. Manufacturer advises monitor and adjust dose.","Clonazepam potentially affects the concentration of phenytoin.","Phenytoin is predicted to decrease the exposure to clozapine.","Phenytoin is predicted to decrease the exposure to cobicistat. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to cobimetinib. Manufacturer advises avoid.","Phenytoin decreases the effects of colecalciferol.","Phenytoin is predicted to decrease the efficacy of combined hormonal contraceptives. For FSRH guidance, see Contraceptives, interactions.","Phenytoin is predicted to markedly decrease the exposure to crizotinib. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to dabrafenib. Manufacturer advises avoid.","Phenytoin is predicted to moderately decrease the exposure to daclatasvir. Manufacturer advises avoid.","Phenytoin is predicted to increase the risk of methaemoglobinaemia when given with dapsone.","Phenytoin is predicted to decrease the exposure to darifenacin.","Darunavir is predicted to affect the exposure to phenytoin and phenytoin decreases the concentration of darunavir.","Phenytoin is predicted to decrease the exposure to dasabuvir. Manufacturer advises avoid.","Phenytoin is predicted to markedly decrease the exposure to dasatinib. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to deferasirox. Manufacturer advises monitor serum ferritin and adjust dose.","Phenytoin is predicted to slightly decrease the exposure to delamanid. Manufacturer advises avoid.","Phenytoin is predicted to decrease the efficacy of desogestrel. For FSRH guidance, see Contraceptives, interactions.","Phenytoin is predicted to decrease the exposure to dexamethasone. Manufacturer advises monitor and adjust dose.","Diazepam potentially affects the concentration of phenytoin. Manufacturer advises monitor concentration and adjust dose.","Diazoxide decreases the concentration of phenytoin and phenytoin is predicted to decrease the effects of diazoxide. Manufacturer advises monitor concentration and adjust dose.","Concurrent use of phenytoin and didanosine can increase the risk of peripheral neuropathy.","Phenytoin is predicted to decrease the concentration of digoxin.","Phenytoin decreases the effects of dihydrotachysterol.","Phenytoin decreases the exposure to diltiazem.","Phenytoin is predicted to decrease the exposure to disopyramide. Manufacturer advises avoid.","Concurrent use of phenytoin and disulfiram can increase the risk of peripheral neuropathy.","Disulfiram increases the concentration of phenytoin. Manufacturer advises monitor concentration and adjust dose.","Concurrent use of phenytoin and docetaxel can increase the risk of peripheral neuropathy.","Phenytoin is predicted to decrease the exposure to docetaxel.","Phenytoin decreases the exposure to dolutegravir. Manufacturer advises adjust dose.","Phenytoin is predicted to decrease the exposure to donepezil.","Phenytoin decreases the exposure to doxycycline. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to dronedarone. Manufacturer advises avoid.","Phenytoin slightly decreases the exposure to efavirenz and efavirenz affects the concentration of phenytoin.","Phenytoin is predicted to decrease the exposure to elbasvir. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to eliglustat. Manufacturer advises avoid.","Phenytoin is predicted to decrease the concentration of elvitegravir. Manufacturer advises avoid.","Enteral feeds decrease the absorption of phenytoin.","Phenytoin is predicted to decrease the exposure to eplerenone. Manufacturer advises avoid.","Phenytoin decreases the effects of ergocalciferol.","Phenytoin is predicted to decrease the effects of ergotamine.","Concurrent use of phenytoin and eribulin can increase the risk of peripheral neuropathy.","Phenytoin is predicted to decrease the exposure to erlotinib. Manufacturer advises avoid or adjust erlotinib dose.","Eslicarbazepine increases the exposure to phenytoin and phenytoin decreases the exposure to eslicarbazepine. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the efficacy of etonogestrel. For FSRH guidance, see Contraceptives, interactions.","Phenytoin is predicted to decrease the efficacy of etoposide.","Phenytoin is predicted to decrease the exposure to etravirine. Manufacturer advises avoid.","Phenytoin is predicted to decrease the concentration of everolimus. Manufacturer advises avoid or adjust dose.","Phenytoin moderately decreases the exposure to exemestane.","Phenytoin is predicted to decrease the exposure to felodipine. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to fentanyl.","Phenytoin is predicted to decrease the exposure to fesoterodine. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to fingolimod.","Fluconazole increases the concentration of phenytoin. Manufacturer advises monitor concentration and adjust dose.","Fluorouracil increases the concentration of phenytoin. Manufacturer advises monitor concentration and adjust dose.","Fluoxetine is predicted to increase the concentration of phenytoin. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to fluticasone.","Fluvoxamine is predicted to increase the concentration of phenytoin. Manufacturer advises monitor and adjust dose.","Folic acid is predicted to decrease the concentration of phenytoin. Manufacturer advises monitor concentration and adjust dose.","Folinic acid is predicted to decrease the concentration of phenytoin. Manufacturer advises monitor concentration and adjust dose.","Fosamprenavir is predicted to affect the exposure to phenytoin and phenytoin decreases the concentration of fosamprenavir.","Phenytoin is predicted to decrease the exposure to fosaprepitant. Manufacturer advises avoid.","Concurrent use of phenytoin and fosphenytoin can increase the risk of peripheral neuropathy.","Phenytoin decreases the effects of furosemide.","Phenytoin is predicted to decrease the exposure to gefitinib. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to grazoprevir. Manufacturer advises avoid.","Phenytoin is predicted to decrease the concentration of guanfacine. Manufacturer advises adjust guanfacine dose.","Phenytoin decreases the concentration of haloperidol. Manufacturer advises adjust dose.","Phenytoin is predicted to decrease the effects of Hormone replacement therapy.","Phenytoin is predicted to decrease the exposure to ibrutinib. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to idelalisib. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to imatinib. Manufacturer advises avoid.","Indinavir is predicted to affect the exposure to phenytoin and phenytoin decreases the concentration of indinavir.","Phenytoin is predicted to decrease the exposure to irinotecan. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to isavuconazole. Manufacturer advises avoid.","Concurrent use of phenytoin and isoniazid can increase the risk of peripheral neuropathy.","Isoniazid increases the concentration of phenytoin.","Phenytoin decreases the exposure to isradipine. Manufacturer advises avoid.","Phenytoin very markedly decreases the exposure to itraconazole. Manufacturer advises avoid phenytoin for 14 days before and during treatment with itraconazole.","Phenytoin is predicted to decrease the exposure to ivabradine. Manufacturer advises adjust dose.","Phenytoin markedly decreases the exposure to ivacaftor. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to ixazomib. Manufacturer advises avoid.","Phenytoin decreases the exposure to ketoconazole. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to lacidipine. Manufacturer advises monitor and adjust dose.","Concurrent use of phenytoin and lamivudine can increase the risk of peripheral neuropathy.","Phenytoin decreases the concentration of lamotrigine. Manufacturer advises monitor and adjust lamotrigine dose.","Phenytoin is predicted to decrease the exposure to lapatinib. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to lercanidipine. Manufacturer advises monitor and adjust dose.","Phenytoin decreases the effects of levodopa.","Levofolinic acid is predicted to decrease the concentration of phenytoin. Manufacturer advises monitor concentration and adjust dose.","Phenytoin is predicted to decrease the efficacy of levonorgestrel. For FSRH guidance, see Contraceptives, interactions.","Phenytoin is predicted to increase the risk of hypothyroidism when given with levothyroxine.","Phenytoin is predicted to decrease the exposure to lidocaine.","Phenytoin is predicted to decrease the exposure to linagliptin.","Phenytoin is predicted to increase the risk of hypothyroidism when given with liothyronine.","Phenytoin is predicted to decrease the exposure to lomitapide. Manufacturer advises monitor and adjust dose.","Lopinavir is predicted to affect the exposure to phenytoin and phenytoin decreases the concentration of lopinavir.","Lumacaftor is predicted to decrease the exposure to phenytoin. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to lurasidone. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to macitentan. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to maraviroc. Manufacturer advises adjust dose.","Phenytoin decreases the exposure to methadone. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to methylprednisolone. Manufacturer advises monitor and adjust dose.","Concurrent use of phenytoin and metronidazole can increase the risk of peripheral neuropathy.","Phenytoin is predicted to decrease the effects of metyrapone. Manufacturer advises avoid.","Miconazole increases the risk of phenytoin toxicity when given with phenytoin. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to midazolam. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to mirtazapine. Manufacturer advises adjust dose.","Phenytoin is predicted to decrease the exposure to modafinil and modafinil is predicted to increase the concentration of phenytoin. Manufacturer advises monitor concentration and adjust dose.","Phenytoin is predicted to decrease the exposure to montelukast.","Phenytoin is predicted to markedly decrease the exposure to naloxegol. Manufacturer advises avoid.","Phenytoin is predicted to slightly decrease the exposure to nateglinide.","Phenytoin is predicted to decrease the exposure to netupitant. Manufacturer advises avoid.","Nevirapine is predicted to decrease the concentration of phenytoin and phenytoin is predicted to decrease the concentration of nevirapine.","Phenytoin is predicted to decrease the exposure to nicardipine. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to nifedipine. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to moderately decrease the exposure to nilotinib. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to nimodipine. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to nitisinone. Manufacturer advises adjust dose.","Phenytoin is predicted to decrease the efficacy of norethisterone. For FSRH guidance, see Contraceptives, interactions.","Phenytoin is predicted to decrease the exposure to olaparib. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to ondansetron.","Phenytoin is predicted to moderately decrease the exposure to osimertinib. Manufacturer advises avoid.","Oxcarbazepine is predicted to increase the concentration of phenytoin. Manufacturer advises monitor concentration and adjust dose.","Phenytoin is predicted to decrease the exposure to oxycodone. Manufacturer advises monitor and adjust dose.","Concurrent use of phenytoin and paclitaxel can increase the risk of peripheral neuropathy.","Phenytoin is predicted to decrease the exposure to paclitaxel. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to palbociclib. Manufacturer advises avoid.","Phenytoin decreases the effects of (but acute use increases the effects of) pancuronium.","Phenytoin is predicted to decrease the exposure to panobinostat. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to paracetamol.","Phenytoin decreases the effects of paricalcitol.","Phenytoin is predicted to decrease the exposure to paritaprevir (with ritonavir and ombitasvir). Manufacturer advises avoid.","Phenytoin decreases the concentration of paroxetine.","Phenytoin is predicted to decrease the exposure to pazopanib. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to perampanel. Manufacturer advises monitor and adjust dose.","Phenytoin increases the concentration of phenobarbital and phenobarbital affects the concentration of phenytoin.","Phenytoin is predicted to decrease the concentration of piperaquine. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to pirfenidone. Manufacturer advises avoid.","Phenytoin is predicted to moderately decrease the exposure to pitolisant.","Phenytoin is predicted to decrease the exposure to ponatinib. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to posaconazole. Manufacturer advises avoid.","Phenytoin is predicted to markedly decrease the exposure to praziquantel. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to prednisolone. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to prednisone.","Phenytoin is predicted to increase the risk of methaemoglobinaemia when given with topical prilocaine. Manufacturer advises use with caution or avoid.","Phenytoin increases the concentration of primidone and primidone affects the concentration of phenytoin.","Phenytoin is predicted to increase the risk of hypersensitivity reactions when given with procarbazine.","Phenytoin is predicted to decrease the efficacy of propafenone.","Pyrimethamine increases the risk of haematological toxicity when given with phenytoin.","Phenytoin is predicted to decrease the exposure to quetiapine.","Phenytoin is predicted to decrease the exposure to ranolazine. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to reboxetine.","Phenytoin is predicted to decrease the exposure to regorafenib. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to repaglinide. Manufacturer advises monitor blood glucose and adjust dose.","Phenytoin is predicted to slightly increase the clearance of retigabine.","Rifampicin decreases the concentration of phenytoin. Manufacturer advises use with caution and adjust dose.","Phenytoin markedly decreases the exposure to rilpivirine. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to risperidone. Manufacturer advises adjust dose.","Ritonavir is predicted to affect the exposure to phenytoin and phenytoin decreases the concentration of ritonavir.","Phenytoin is predicted to moderately decrease the exposure to rivaroxaban. Manufacturer advises avoid unless patient can be monitored for signs of thrombosis.","Phenytoin decreases the effects of (but acute use increases the effects of) rocuronium.","Phenytoin is predicted to decrease the exposure to roflumilast. Manufacturer advises avoid.","Phenytoin is predicted to markedly decrease the exposure to rolapitant. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to ruxolitinib. Manufacturer advises monitor and adjust dose.","Saquinavir is predicted to affect the exposure to phenytoin and phenytoin decreases the concentration of saquinavir.","Phenytoin is predicted to moderately decrease the exposure to saxagliptin.","Phenytoin is predicted to decrease the exposure to the active metabolite of selexipag. Manufacturer advises adjust dose.","Sertraline potentially increases the risk of toxicity when given with phenytoin. Manufacturer advises monitor concentration and adjust dose.","Phenytoin is predicted to decrease the exposure to sildenafil.","Phenytoin is predicted to decrease the exposure to simeprevir. Manufacturer advises avoid.","Phenytoin potentially decreases the exposure to simvastatin.","Phenytoin is predicted to decrease the concentration of sirolimus. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to sofosbuvir. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to solifenacin.","Phenytoin is predicted to decrease the exposure to sorafenib.","St John's Wort is predicted to decrease the concentration of phenytoin. Manufacturer advises avoid.","Concurrent use of phenytoin and stavudine can increase the risk of peripheral neuropathy.","Stiripentol is predicted to increase the concentration of phenytoin. Manufacturer advises avoid in Dravet syndrome.","Sulfadiazine increases the concentration of phenytoin. Manufacturer advises monitor and adjust dose.","Sulfinpyrazone increases the concentration of phenytoin.","Phenytoin is predicted to decrease the exposure to sunitinib. Manufacturer advises avoid or adjust sunitinib dose.","Phenytoin increases the effects of suxamethonium.","Phenytoin decreases the effects of tacalcitol.","Phenytoin decreases the concentration of tacrolimus. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to tadalafil. Manufacturer advises avoid.","Tegafur potentially increases the concentration of phenytoin. Manufacturer advises monitor concentration and adjust dose.","Phenytoin is predicted to decrease the concentration of temsirolimus. Manufacturer advises avoid.","Concurrent use of phenytoin and thalidomide can increase the risk of peripheral neuropathy.","Phenytoin is predicted to decrease the exposure to theophylline. Manufacturer advises adjust dose.","Phenytoin decreases the exposure to tiagabine. Manufacturer advises monitor and adjust tiagabine dose.","Phenytoin is predicted to markedly decrease the exposure to ticagrelor. Manufacturer advises avoid.","Tipranavir is predicted to affect the exposure to phenytoin and phenytoin decreases the concentration of tipranavir.","Phenytoin moderately decreases the exposure to tizanidine.","Phenytoin is predicted to decrease the exposure to tofacitinib. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to tolvaptan. Manufacturer advises avoid.","Phenytoin decreases the concentration of topiramate and topiramate increases the concentration of phenytoin. Manufacturer advises monitor and adjust dose.","Phenytoin increases the clearance of topotecan.","Phenytoin is predicted to decrease the exposure to toremifene. Manufacturer advises adjust dose.","Phenytoin is predicted to decrease the exposure to trabectedin. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to trastuzumab emtansine.","Trimethoprim increases the concentration of phenytoin.","Phenytoin decreases the efficacy of ulipristal. For FSRH guidance, see Contraceptives, interactions.","Valproate affects the concentration of phenytoin and phenytoin decreases the concentration of valproate.","Phenytoin is predicted to decrease the exposure to vandetanib. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to vardenafil.","Phenytoin decreases the effects of (but acute use increases the effects of) vecuronium.","Phenytoin is predicted to moderately decrease the exposure to velpatasvir. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to vemurafenib. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to venetoclax. Manufacturer advises avoid.","Phenytoin is predicted to decrease the exposure to verapamil.","Vigabatrin decreases the concentration of phenytoin.","Concurrent use of phenytoin and vinblastine can increase the risk of peripheral neuropathy.","Phenytoin is predicted to decrease the exposure to vinblastine.","Concurrent use of phenytoin and vincristine can increase the risk of peripheral neuropathy.","Phenytoin is predicted to decrease the exposure to vincristine.","Concurrent use of phenytoin and vindesine can increase the risk of peripheral neuropathy.","Phenytoin is predicted to decrease the exposure to vindesine.","Concurrent use of phenytoin and vinflunine can increase the risk of peripheral neuropathy.","Phenytoin is predicted to decrease the exposure to vinflunine. Manufacturer advises avoid.","Concurrent use of phenytoin and vinorelbine can increase the risk of peripheral neuropathy.","Phenytoin is predicted to decrease the exposure to vinorelbine. Manufacturer advises use with caution or avoid.","Phenytoin is predicted to decrease the exposure to vismodegib. Manufacturer advises avoid.","Phenytoin decreases the exposure to voriconazole and voriconazole increases the exposure to phenytoin. Manufacturer advises avoid or adjust voriconazole dose and monitor phenytoin concentration.","Phenytoin is predicted to decrease the exposure to vortioxetine. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to alter the anticoagulant effect of warfarin.","Phenytoin slightly to moderately decreases the concentration of zonisamide. Manufacturer advises monitor and adjust dose.","Phenytoin is predicted to decrease the exposure to zopiclone. Manufacturer advises adjust dose."]},{"name":"BNF.Pravastatin.Pravastatin","imports":["BNF.Atorvastatin.Atorvastatin","BNF.Carbamazepine.Carbamazepine","BNF.Clarithromycin.Clarithromycin","BNF.Doxycycline.Doxycycline","BNF.Paracetamol.Paracetamol","BNF.Simvastatin.Simvastatin"],"interactioninfo":["Concurrent use of pravastatin and alcohol (beverage) can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and alectinib can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and asparaginase can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and atorvastatin can increase the risk of hepatotoxicity.","Bezafibrate increases the risk of rhabdomyolysis when given with pravastatin. Manufacturer advises avoid.","Concurrent use of pravastatin and carbamazepine can increase the risk of hepatotoxicity.","Ceftobiprole is predicted to increase the concentration of pravastatin.","Ciclosporin markedly to very markedly increases the exposure to pravastatin. Manufacturer advises adjust pravastatin dose.","Ciprofibrate increases the risk of rhabdomyolysis when given with pravastatin. Manufacturer advises avoid.","Clarithromycin moderately increases the exposure to pravastatin.","Colchicine increases the risk of rhabdomyolysis when given with pravastatin.","Concurrent use of pravastatin and crisantaspase can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and daclizumab can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and dactinomycin can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and dantrolene can increase the risk of hepatotoxicity.","Pravastatin is predicted to increase the risk of rhabdomyolysis when given with daptomycin.","Concurrent use of pravastatin and demeclocycline can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and didanosine can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and doxycycline can increase the risk of hepatotoxicity.","Eltrombopag is predicted to increase the exposure to pravastatin. Manufacturer advises monitor and adjust dose.","Eluxadoline is predicted to increase the exposure to pravastatin.","Erythromycin is predicted to increase the exposure to pravastatin.","Ezetimibe potentially increases the risk of rhabdomyolysis when given with pravastatin.","Fenofibrate is predicted to increase the risk of rhabdomyolysis when given with pravastatin. Manufacturer advises avoid.","Concurrent use of pravastatin and fluconazole can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and fluvastatin can increase the risk of hepatotoxicity.","Fusidic acid increases the risk of rhabdomyolysis when given with pravastatin. Manufacturer advises avoid.","Gemfibrozil increases the risk of rhabdomyolysis when given with pravastatin. Manufacturer advises avoid.","Concurrent use of pravastatin and isoniazid can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and itraconazole can increase the risk of hepatotoxicity.","Ledipasvir is predicted to increase the exposure to pravastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of pravastatin and leflunomide can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and lenalidomide can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and lomitapide can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and lymecycline can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and mercaptopurine can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and methotrexate can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and micafungin can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and minocycline can increase the risk of hepatotoxicity.","Nicotinic acid is predicted to increase the risk of rhabdomyolysis when given with pravastatin.","Concurrent use of pravastatin and oxytetracycline can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and paracetamol can increase the risk of hepatotoxicity.","Paritaprevir (with ritonavir and ombitasvir) increases the exposure to pravastatin. Manufacturer advises adjust pravastatin dose.","Concurrent use of pravastatin and pegaspargase can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and rosuvastatin can increase the risk of hepatotoxicity.","Sacubitril is predicted to increase the exposure to pravastatin.","Simeprevir is predicted to increase the exposure to pravastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of pravastatin and simvastatin can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and sulfasalazine can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and tetracycline can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and tigecycline can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and trabectedin can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and valproate can increase the risk of hepatotoxicity.","Concurrent use of pravastatin and vincristine can increase the risk of hepatotoxicity."]},{"name":"BNF.Prochlorperazine.Prochlorperazine","imports":["BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Fentanyl.Fentanyl","BNF.Furosemide.Furosemide","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Ipratropium.Ipratropium","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Lorazepam.Lorazepam","BNF.Losartan.Losartan","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Nefopam.Nefopam","BNF.Nifedipine.Nifedipine","BNF.Oxycodone.Oxycodone","BNF.Ramipril.Ramipril","BNF.Spironolactone.Spironolactone","BNF.Temazepam.Temazepam","BNF.Tiotropium.Tiotropium","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of prochlorperazine and acebutolol can increase the risk of hypotension.","Concurrent use of prochlorperazine and aclidinium can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and alcohol (beverage) can increase the risk of hypotension.","Concurrent use of prochlorperazine and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and alfuzosin can increase the risk of hypotension.","Concurrent use of prochlorperazine and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and aliskiren can increase the risk of hypotension.","Concurrent use of prochlorperazine and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and alprostadil can increase the risk of hypotension.","Aluminium hydroxide decreases the absorption of prochlorperazine.","Concurrent use of prochlorperazine and amantadine can increase the risk of hypotension.","Concurrent use of prochlorperazine and amantadine can increase the risk of antimuscarinic effects.","Prochlorperazine is predicted to decrease the effects of amantadine. Manufacturer advises avoid.","Concurrent use of prochlorperazine and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and amitriptyline can increase the risk of hypotension.","Concurrent use of prochlorperazine and amitriptyline can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and amlodipine can increase the risk of hypotension.","Concurrent use of prochlorperazine and apomorphine can increase the risk of hypotension.","Prochlorperazine is predicted to decrease the effects of apomorphine. Manufacturer advises avoid.","Concurrent use of prochlorperazine and apraclonidine can increase the risk of hypotension.","Concurrent use of prochlorperazine and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and aripiprazole can increase the risk of hypotension.","Concurrent use of prochlorperazine and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and asenapine can increase the risk of hypotension.","Concurrent use of prochlorperazine and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and atenolol can increase the risk of hypotension.","Concurrent use of prochlorperazine and atropine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and avanafil can increase the risk of hypotension.","Concurrent use of prochlorperazine and azilsartan can increase the risk of hypotension.","Concurrent use of prochlorperazine and baclofen can increase the risk of hypotension.","Concurrent use of prochlorperazine and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and baclofen can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of prochlorperazine and benperidol can increase the risk of hypotension.","Concurrent use of prochlorperazine and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and betaxolol can increase the risk of hypotension.","Concurrent use of prochlorperazine and bisoprolol can increase the risk of hypotension.","Concurrent use of prochlorperazine and bortezomib can increase the risk of hypotension.","Concurrent use of prochlorperazine and brimonidine can increase the risk of hypotension.","Concurrent use of prochlorperazine and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and bromocriptine can increase the risk of hypotension.","Prochlorperazine is predicted to decrease the effects of bromocriptine. Manufacturer advises avoid.","Concurrent use of prochlorperazine and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and bumetanide can increase the risk of hypotension.","Concurrent use of prochlorperazine and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and cabergoline can increase the risk of hypotension.","Prochlorperazine is predicted to decrease the effects of cabergoline. Manufacturer advises avoid.","Concurrent use of prochlorperazine and canagliflozin can increase the risk of hypotension.","Concurrent use of prochlorperazine and candesartan can increase the risk of hypotension.","Concurrent use of prochlorperazine and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and captopril can increase the risk of hypotension.","Concurrent use of prochlorperazine and carteolol can increase the risk of hypotension.","Concurrent use of prochlorperazine and carvedilol can increase the risk of hypotension.","Concurrent use of prochlorperazine and celiprolol can increase the risk of hypotension.","Concurrent use of prochlorperazine and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and chlorothiazide can increase the risk of hypotension.","Concurrent use of prochlorperazine and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and chlorphenamine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and chlorpromazine can increase the risk of hypotension.","Concurrent use of prochlorperazine and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and chlorpromazine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and chlortalidone can increase the risk of hypotension.","Concurrent use of prochlorperazine and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and clemastine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and clevidipine can increase the risk of hypotension.","Concurrent use of prochlorperazine and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and clomipramine can increase the risk of hypotension.","Concurrent use of prochlorperazine and clomipramine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and clonidine can increase the risk of hypotension.","Concurrent use of prochlorperazine and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and clopamide can increase the risk of hypotension.","Concurrent use of prochlorperazine and clozapine can increase the risk of hypotension.","Concurrent use of prochlorperazine and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and clozapine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and cyclizine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of prochlorperazine and cyclopentolate can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and cyproheptadine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and dapagliflozin can increase the risk of hypotension.","Concurrent use of prochlorperazine and darifenacin can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and desflurane can increase the risk of hypotension.","Concurrent use of prochlorperazine and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Prochlorperazine is predicted to decrease the effects of dexamfetamine.","Concurrent use of prochlorperazine and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and diazoxide can increase the risk of hypotension.","Concurrent use of prochlorperazine and dicycloverine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and diltiazem can increase the risk of hypotension.","Concurrent use of prochlorperazine and dimenhydrinate can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and dipyridamole can increase the risk of hypotension.","Concurrent use of prochlorperazine and disopyramide can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and dosulepin can increase the risk of hypotension.","Concurrent use of prochlorperazine and dosulepin can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and doxazosin can increase the risk of hypotension.","Concurrent use of prochlorperazine and doxepin can increase the risk of hypotension.","Concurrent use of prochlorperazine and doxepin can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and droperidol can increase the risk of hypotension.","Concurrent use of prochlorperazine and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and empagliflozin can increase the risk of hypotension.","Concurrent use of prochlorperazine and enalapril can increase the risk of hypotension.","Concurrent use of prochlorperazine and eplerenone can increase the risk of hypotension.","Concurrent use of prochlorperazine and eprosartan can increase the risk of hypotension.","Concurrent use of prochlorperazine and esmolol can increase the risk of hypotension.","Concurrent use of prochlorperazine and etomidate can increase the risk of hypotension.","Concurrent use of prochlorperazine and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and felodipine can increase the risk of hypotension.","Concurrent use of prochlorperazine and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and fesoterodine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and flavoxate can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and flupentixol can increase the risk of hypotension.","Concurrent use of prochlorperazine and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and fluphenazine can increase the risk of hypotension.","Concurrent use of prochlorperazine and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and fosinopril can increase the risk of hypotension.","Concurrent use of prochlorperazine and furosemide can increase the risk of hypotension.","Concurrent use of prochlorperazine and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of prochlorperazine and glycopyrronium can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and guanethidine can increase the risk of hypotension.","Prochlorperazine is predicted to decrease the antihypertensive effects of guanethidine.","Concurrent use of prochlorperazine and guanfacine can increase the risk of hypotension.","Concurrent use of prochlorperazine and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and haloperidol can increase the risk of hypotension.","Concurrent use of prochlorperazine and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and haloperidol can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and histamine can increase the risk of hypotension.","Prochlorperazine is predicted to decrease the effects of histamine. Manufacturer advises avoid.","Concurrent use of prochlorperazine and homatropine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and hydralazine can increase the risk of hypotension.","Concurrent use of prochlorperazine and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of prochlorperazine and hydroflumethiazide can increase the risk of hypotension.","Concurrent use of prochlorperazine and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and hydroxyzine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and hyoscine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and imidapril can increase the risk of hypotension.","Concurrent use of prochlorperazine and imipramine can increase the risk of hypotension.","Concurrent use of prochlorperazine and imipramine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and indapamide can increase the risk of hypotension.","Concurrent use of prochlorperazine and indoramin can increase the risk of hypotension.","Concurrent use of prochlorperazine and ipratropium can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and irbesartan can increase the risk of hypotension.","Concurrent use of prochlorperazine and isocarboxazid can increase the risk of hypotension.","Isocarboxazid is predicted to increase the risk of neuroleptic malignant syndrome when given with prochlorperazine.","Concurrent use of prochlorperazine and isoflurane can increase the risk of hypotension.","Concurrent use of prochlorperazine and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of prochlorperazine and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of prochlorperazine and isradipine can increase the risk of hypotension.","Concurrent use of prochlorperazine and ketamine can increase the risk of hypotension.","Concurrent use of prochlorperazine and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and labetalol can increase the risk of hypotension.","Concurrent use of prochlorperazine and lacidipine can increase the risk of hypotension.","Concurrent use of prochlorperazine and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and lercanidipine can increase the risk of hypotension.","Concurrent use of prochlorperazine and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and levobunolol can increase the risk of hypotension.","Concurrent use of prochlorperazine and levodopa can increase the risk of hypotension.","Prochlorperazine decreases the effects of levodopa. Manufacturer advises avoid or monitor worsening parkinsonian symptoms.","Concurrent use of prochlorperazine and levomepromazine can increase the risk of hypotension.","Concurrent use of prochlorperazine and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and levomepromazine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Prochlorperazine is predicted to decrease the effects of lisdexamfetamine.","Concurrent use of prochlorperazine and lisinopril can increase the risk of hypotension.","Prochlorperazine potentially increases the risk of neurotoxicity when given with lithium.","Concurrent use of prochlorperazine and lofepramine can increase the risk of hypotension.","Concurrent use of prochlorperazine and lofepramine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and lofexidine can increase the risk of hypotension.","Concurrent use of prochlorperazine and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and losartan can increase the risk of hypotension.","Concurrent use of prochlorperazine and loxapine can increase the risk of hypotension.","Concurrent use of prochlorperazine and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and loxapine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and lurasidone can increase the risk of hypotension.","Concurrent use of prochlorperazine and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Magnesium carbonate decreases the absorption of prochlorperazine.","Magnesium trisilicate decreases the absorption of prochlorperazine.","Concurrent use of prochlorperazine and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and methyldopa can increase the risk of hypotension.","Concurrent use of prochlorperazine and metolazone can increase the risk of hypotension.","Concurrent use of prochlorperazine and metoprolol can increase the risk of hypotension.","Concurrent use of prochlorperazine and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and minoxidil can increase the risk of hypotension.","Concurrent use of prochlorperazine and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and moexipril can increase the risk of hypotension.","Concurrent use of prochlorperazine and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and moxisylyte can increase the risk of hypotension.","Concurrent use of prochlorperazine and moxonidine can increase the risk of hypotension.","Concurrent use of prochlorperazine and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and nadolol can increase the risk of hypotension.","Concurrent use of prochlorperazine and nebivolol can increase the risk of hypotension.","Concurrent use of prochlorperazine and nefopam can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and nicardipine can increase the risk of hypotension.","Concurrent use of prochlorperazine and nicorandil can increase the risk of hypotension.","Concurrent use of prochlorperazine and nifedipine can increase the risk of hypotension.","Concurrent use of prochlorperazine and nimodipine can increase the risk of hypotension.","Concurrent use of prochlorperazine and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and nitrous oxide can increase the risk of hypotension.","Concurrent use of prochlorperazine and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and nortriptyline can increase the risk of hypotension.","Concurrent use of prochlorperazine and nortriptyline can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and olanzapine can increase the risk of hypotension.","Concurrent use of prochlorperazine and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and olmesartan can increase the risk of hypotension.","Concurrent use of prochlorperazine and orphenadrine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and oxprenolol can increase the risk of hypotension.","Concurrent use of prochlorperazine and oxybutynin can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and paliperidone can increase the risk of hypotension.","Concurrent use of prochlorperazine and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and pergolide can increase the risk of hypotension.","Prochlorperazine is predicted to decrease the effects of pergolide. Manufacturer advises avoid.","Concurrent use of prochlorperazine and pericyazine can increase the risk of hypotension.","Concurrent use of prochlorperazine and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and perindopril can increase the risk of hypotension.","Concurrent use of prochlorperazine and perphenazine can increase the risk of hypotension.","Concurrent use of prochlorperazine and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and perphenazine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and phenelzine can increase the risk of hypotension.","Phenelzine is predicted to increase the risk of neuroleptic malignant syndrome when given with prochlorperazine.","Concurrent use of prochlorperazine and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and pimozide can increase the risk of hypotension.","Concurrent use of prochlorperazine and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and pimozide can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and pindolol can increase the risk of hypotension.","Concurrent use of prochlorperazine and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and pramipexole can increase the risk of hypotension.","Prochlorperazine is predicted to decrease the effects of pramipexole. Manufacturer advises avoid.","Concurrent use of prochlorperazine and prazosin can increase the risk of hypotension.","Concurrent use of prochlorperazine and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and procyclidine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and promazine can increase the risk of hypotension.","Concurrent use of prochlorperazine and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and promethazine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and propafenone can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and propantheline can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and propiverine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and propofol can increase the risk of hypotension.","Concurrent use of prochlorperazine and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and propranolol can increase the risk of hypotension.","Concurrent use of prochlorperazine and quetiapine can increase the risk of hypotension.","Concurrent use of prochlorperazine and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and quinagolide can increase the risk of hypotension.","Prochlorperazine is predicted to decrease the effects of quinagolide. Manufacturer advises avoid.","Concurrent use of prochlorperazine and quinapril can increase the risk of hypotension.","Concurrent use of prochlorperazine and ramipril can increase the risk of hypotension.","Concurrent use of prochlorperazine and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and riociguat can increase the risk of hypotension.","Concurrent use of prochlorperazine and risperidone can increase the risk of hypotension.","Concurrent use of prochlorperazine and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and ropinirole can increase the risk of hypotension.","Prochlorperazine is predicted to decrease the effects of ropinirole. Manufacturer advises avoid.","Concurrent use of prochlorperazine and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and rotigotine can increase the risk of hypotension.","Prochlorperazine is predicted to decrease the effects of rotigotine. Manufacturer advises avoid.","Concurrent use of prochlorperazine and sacubitril can increase the risk of hypotension.","Concurrent use of prochlorperazine and sapropterin can increase the risk of hypotension.","Concurrent use of prochlorperazine and selegiline can increase the risk of hypotension.","Concurrent use of prochlorperazine and sevoflurane can increase the risk of hypotension.","Concurrent use of prochlorperazine and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and sildenafil can increase the risk of hypotension.","Concurrent use of prochlorperazine and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of prochlorperazine and sodium oxybate can increase the risk of hypotension.","Concurrent use of prochlorperazine and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and solifenacin can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and sotalol can increase the risk of hypotension.","Concurrent use of prochlorperazine and spironolactone can increase the risk of hypotension.","Concurrent use of prochlorperazine and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and sulpiride can increase the risk of hypotension.","Concurrent use of prochlorperazine and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and tadalafil can increase the risk of hypotension.","Concurrent use of prochlorperazine and tamsulosin can increase the risk of hypotension.","Concurrent use of prochlorperazine and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and telmisartan can increase the risk of hypotension.","Concurrent use of prochlorperazine and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and terazosin can increase the risk of hypotension.","Concurrent use of prochlorperazine and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and thiopental can increase the risk of hypotension.","Concurrent use of prochlorperazine and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and timolol can increase the risk of hypotension.","Concurrent use of prochlorperazine and tiotropium can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and tizanidine can increase the risk of hypotension.","Concurrent use of prochlorperazine and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and tolterodine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and torasemide can increase the risk of hypotension.","Concurrent use of prochlorperazine and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and trandolapril can increase the risk of hypotension.","Concurrent use of prochlorperazine and tranylcypromine can increase the risk of hypotension.","Tranylcypromine is predicted to increase the risk of neuroleptic malignant syndrome when given with prochlorperazine.","Concurrent use of prochlorperazine and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and trifluoperazine can increase the risk of hypotension.","Concurrent use of prochlorperazine and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and trifluoperazine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and trihexyphenidyl can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and trimipramine can increase the risk of hypotension.","Concurrent use of prochlorperazine and trimipramine can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and tropicamide can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and trospium can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and umeclidinium can increase the risk of antimuscarinic effects.","Concurrent use of prochlorperazine and valsartan can increase the risk of hypotension.","Concurrent use of prochlorperazine and vardenafil can increase the risk of hypotension.","Concurrent use of prochlorperazine and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and verapamil can increase the risk of hypotension.","Concurrent use of prochlorperazine and xipamide can increase the risk of hypotension.","Concurrent use of prochlorperazine and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of prochlorperazine and zuclopenthixol can increase the risk of hypotension.","Concurrent use of prochlorperazine and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Quinine.Quinine","imports":["BNF.Amiodarone.Amiodarone","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisacodyl.Bisacodyl","BNF.Bumetanide.Bumetanide","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Digoxin.Digoxin","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Levomepromazine.Levomepromazine","BNF.Ondansetron.Ondansetron","BNF.Salbutamol.Salbutamol","BNF.Senna.Senna","BNF.Theophylline.Theophylline","BNF.Venlafaxine.Venlafaxine"],"interactioninfo":["Both quinine and amifampridine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Aminophylline is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and amiodarone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and amisulpride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Amphotericin is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and apomorphine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and arsenic trioxide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and artemether prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and artenimol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Atazanavir is predicted to affect the exposure to quinine.","Bambuterol is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Beclometasone is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and bedaquiline prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Betamethasone is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and bosutinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Budesonide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Bumetanide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and cabozantinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and ceritinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Chlorothiazide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and chlorpromazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Chlortalidone is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Cimetidine slightly increases the exposure to quinine.","Both quinine and citalopram prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and clarithromycin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and clomipramine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clopamide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and crizotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Cyclopenthiazide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Dantron is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Darunavir is predicted to affect the exposure to quinine.","Both quinine and dasatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Deflazacort is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and delamanid prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Dexamethasone is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Quinine increases the concentration of digoxin. Manufacturer advises monitor and adjust digoxin dose.","Both quinine and disopyramide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Docusate sodium is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Domperidone increases the risk of QT-prolongation when given with quinine. Manufacturer advises avoid.","Both quinine and dronedarone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and droperidol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and eribulin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Intravenous erythromycin increases the risk of QT-prolongation when given with quinine. Manufacturer advises avoid or monitor.","Both quinine and escitalopram prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Fingolimod increases the risk of QT-prolongation when given with quinine. Manufacturer advises avoid.","Both quinine and flecainide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Fludrocortisone is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and fluphenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Formoterol is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Fosamprenavir is predicted to affect the exposure to quinine.","Furosemide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Glycerol is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Granisetron is predicted to increase the risk of QT-prolongation when given with quinine.","Both quinine and haloperidol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Quinine is predicted to affect the exposure to histamine. Manufacturer advises avoid.","Hydrochlorothiazide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Hydrocortisone is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Hydroflumethiazide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and hydroxyzine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Indacaterol is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Indinavir is predicted to affect the exposure to quinine.","Ivabradine is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises avoid.","Both quinine and lapatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and levomepromazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and lithium prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and lofexidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Lopinavir is predicted to affect the exposure to quinine.","Mefloquine is predicted to increase the risk of QT-prolongation when given with quinine.","Both quinine and methadone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Methylprednisolone is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Metolazone is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Mizolastine is predicted to increase the risk of QT-prolongation when given with quinine. Manufacturer advises avoid.","Both quinine and moxifloxacin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and nilotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Olodaterol is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and ondansetron prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and osimertinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and paliperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Palonosetron is predicted to increase the risk of QT-prolongation when given with quinine.","Both quinine and panobinostat prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and pasireotide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and pazopanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Intravenous pentamidine potentially increases the risk of QT-prolongation when given with quinine.","Both quinine and pimozide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Prednisolone is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Prednisone is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and ranolazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Rifampicin decreases the exposure to quinine.","Both quinine and risperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Ritonavir is predicted to affect the exposure to quinine.","Salbutamol is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Salmeterol is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and saquinavir prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Saquinavir is predicted to affect the exposure to quinine.","Senna is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and sildenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Sodium picosulfate is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and sorafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and sotalol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and sulpiride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and sunitinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and telavancin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Terbutaline is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and tetrabenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Theophylline is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Tipranavir is predicted to affect the exposure to quinine.","Both quinine and tizanidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and tolterodine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Torasemide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and toremifene prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Triamcinolone is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and vandetanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and vardenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and vemurafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and venlafaxine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Vilanterol is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and vinflunine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both quinine and voriconazole prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Xipamide is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Both quinine and zuclopenthixol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation."]},{"name":"BNF.Ramipril.Ramipril","imports":["BNF.Amiloride.Amiloride","BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Diclofenac.Diclofenac","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Enoxaparin.Enoxaparin","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Naproxen.Naproxen","BNF.Nifedipine.Nifedipine","BNF.Prochlorperazine.Prochlorperazine","BNF.Spironolactone.Spironolactone","BNF.Trimethoprim.Trimethoprim"],"interactioninfo":["Concurrent use of ramipril and acebutolol can increase the risk of hypotension.","Concurrent use of ramipril and aceclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and acemetacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and alcohol (beverage) can increase the risk of hypotension.","Concurrent use of ramipril and alfuzosin can increase the risk of first-dose hypotension.","Concurrent use of ramipril and alfuzosin can increase the risk of hypotension.","Concurrent use of ramipril and aliskiren can increase the risk of hypotension.","Concurrent use of ramipril and aliskiren can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Ramipril increases the risk of renal impairment when given with aliskiren. Manufacturer advises use with caution or avoid aliskiren in selected patients.","Ramipril is predicted to increase the risk of hypersensitivity and haematological reactions when given with allopurinol.","Concurrent use of ramipril and alprostadil can increase the risk of hypotension.","Concurrent use of ramipril and amantadine can increase the risk of hypotension.","Concurrent use of ramipril and amiloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and amitriptyline can increase the risk of hypotension.","Concurrent use of ramipril and amlodipine can increase the risk of hypotension.","Concurrent use of ramipril and apomorphine can increase the risk of hypotension.","Concurrent use of ramipril and apraclonidine can increase the risk of hypotension.","Concurrent use of ramipril and aripiprazole can increase the risk of hypotension.","Concurrent use of ramipril and asenapine can increase the risk of hypotension.","Concurrent use of ramipril and atenolol can increase the risk of hypotension.","Concurrent use of ramipril and avanafil can increase the risk of hypotension.","Ramipril is predicted to increase the risk of anaemia and/or leucopenia when given with azathioprine.","Concurrent use of ramipril and azilsartan can increase the risk of first-dose hypotension.","Concurrent use of ramipril and azilsartan can increase the risk of hypotension.","Concurrent use of ramipril and azilsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and baclofen can increase the risk of hypotension.","Concurrent use of ramipril and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of ramipril and benperidol can increase the risk of hypotension.","Concurrent use of ramipril and benzydamine can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and betaxolol can increase the risk of hypotension.","Concurrent use of ramipril and bisoprolol can increase the risk of hypotension.","Concurrent use of ramipril and bortezomib can increase the risk of hypotension.","Concurrent use of ramipril and brimonidine can increase the risk of hypotension.","Concurrent use of ramipril and bromfenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and bromocriptine can increase the risk of hypotension.","Concurrent use of ramipril and bumetanide can increase the risk of hypotension.","Concurrent use of ramipril and cabergoline can increase the risk of hypotension.","Concurrent use of ramipril and canagliflozin can increase the risk of hypotension.","Concurrent use of ramipril and candesartan can increase the risk of first-dose hypotension.","Concurrent use of ramipril and candesartan can increase the risk of hypotension.","Concurrent use of ramipril and candesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and captopril can increase the risk of first-dose hypotension.","Concurrent use of ramipril and captopril can increase the risk of hypotension.","Concurrent use of ramipril and captopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and carteolol can increase the risk of hypotension.","Concurrent use of ramipril and carvedilol can increase the risk of hypotension.","Concurrent use of ramipril and celecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and celiprolol can increase the risk of hypotension.","Concurrent use of ramipril and chlorothiazide can increase the risk of hypotension.","Concurrent use of ramipril and chlorpromazine can increase the risk of hypotension.","Concurrent use of ramipril and chlortalidone can increase the risk of hypotension.","Concurrent use of ramipril and ciclosporin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and clevidipine can increase the risk of hypotension.","Concurrent use of ramipril and clomipramine can increase the risk of hypotension.","Concurrent use of ramipril and clonidine can increase the risk of hypotension.","Concurrent use of ramipril and clopamide can increase the risk of hypotension.","Concurrent use of ramipril and clozapine can increase the risk of hypotension.","Concurrent use of ramipril and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of ramipril and dalteparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and dapagliflozin can increase the risk of hypotension.","Concurrent use of ramipril and darbepoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and desflurane can increase the risk of hypotension.","Concurrent use of ramipril and dexibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and dexketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and diazoxide can increase the risk of hypotension.","Concurrent use of ramipril and diclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and diltiazem can increase the risk of hypotension.","Concurrent use of ramipril and dipyridamole can increase the risk of hypotension.","Concurrent use of ramipril and dosulepin can increase the risk of hypotension.","Concurrent use of ramipril and doxazosin can increase the risk of first-dose hypotension.","Concurrent use of ramipril and doxazosin can increase the risk of hypotension.","Concurrent use of ramipril and doxepin can increase the risk of hypotension.","Concurrent use of ramipril and droperidol can increase the risk of hypotension.","Concurrent use of ramipril and drospirenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and empagliflozin can increase the risk of hypotension.","Concurrent use of ramipril and enalapril can increase the risk of first-dose hypotension.","Concurrent use of ramipril and enalapril can increase the risk of hypotension.","Concurrent use of ramipril and enalapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and enoxaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and eplerenone can increase the risk of hypotension.","Concurrent use of ramipril and eplerenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and epoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and epoetin beta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and epoetin zeta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and eprosartan can increase the risk of first-dose hypotension.","Concurrent use of ramipril and eprosartan can increase the risk of hypotension.","Concurrent use of ramipril and eprosartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and esmolol can increase the risk of hypotension.","Concurrent use of ramipril and etodolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and etomidate can increase the risk of hypotension.","Concurrent use of ramipril and etoricoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and felbinac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and felodipine can increase the risk of hypotension.","Concurrent use of ramipril and fenoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and flupentixol can increase the risk of hypotension.","Concurrent use of ramipril and fluphenazine can increase the risk of hypotension.","Concurrent use of ramipril and flurbiprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and fosinopril can increase the risk of first-dose hypotension.","Concurrent use of ramipril and fosinopril can increase the risk of hypotension.","Concurrent use of ramipril and furosemide can increase the risk of hypotension.","Concurrent use of ramipril and glyceryl trinitrate can increase the risk of first-dose hypotension.","Concurrent use of ramipril and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of ramipril and guanethidine can increase the risk of hypotension.","Concurrent use of ramipril and guanfacine can increase the risk of hypotension.","Concurrent use of ramipril and haloperidol can increase the risk of hypotension.","Concurrent use of ramipril and heparin (unfractionated) can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and histamine can increase the risk of hypotension.","Concurrent use of ramipril and hydralazine can increase the risk of hypotension.","Concurrent use of ramipril and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of ramipril and hydroflumethiazide can increase the risk of hypotension.","Concurrent use of ramipril and ibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Ramipril is predicted to decrease the efficacy of icatibant and icatibant is predicted to decrease the efficacy of ramipril. Manufacturer advises avoid.","Concurrent use of ramipril and imidapril can increase the risk of first-dose hypotension.","Concurrent use of ramipril and imidapril can increase the risk of hypotension.","Concurrent use of ramipril and imidapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and imipramine can increase the risk of hypotension.","Concurrent use of ramipril and indapamide can increase the risk of hypotension.","Concurrent use of ramipril and indometacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and indoramin can increase the risk of first-dose hypotension.","Concurrent use of ramipril and indoramin can increase the risk of hypotension.","Concurrent use of ramipril and irbesartan can increase the risk of first-dose hypotension.","Concurrent use of ramipril and irbesartan can increase the risk of hypotension.","Concurrent use of ramipril and irbesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and isocarboxazid can increase the risk of hypotension.","Concurrent use of ramipril and isoflurane can increase the risk of hypotension.","Concurrent use of ramipril and isosorbide dinitrate can increase the risk of first-dose hypotension.","Concurrent use of ramipril and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of ramipril and isosorbide mononitrate can increase the risk of first-dose hypotension.","Concurrent use of ramipril and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of ramipril and isradipine can increase the risk of hypotension.","Concurrent use of ramipril and ketamine can increase the risk of hypotension.","Concurrent use of ramipril and ketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and ketorolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and labetalol can increase the risk of hypotension.","Concurrent use of ramipril and lacidipine can increase the risk of hypotension.","Concurrent use of ramipril and lercanidipine can increase the risk of hypotension.","Concurrent use of ramipril and levobunolol can increase the risk of hypotension.","Concurrent use of ramipril and levodopa can increase the risk of hypotension.","Concurrent use of ramipril and levomepromazine can increase the risk of hypotension.","Concurrent use of ramipril and lisinopril can increase the risk of first-dose hypotension.","Concurrent use of ramipril and lisinopril can increase the risk of hypotension.","Concurrent use of ramipril and lisinopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Ramipril is predicted to increase the concentration of lithium. Manufacturer advises monitor and adjust dose.","Concurrent use of ramipril and lofepramine can increase the risk of hypotension.","Concurrent use of ramipril and lofexidine can increase the risk of hypotension.","Concurrent use of ramipril and losartan can increase the risk of first-dose hypotension.","Concurrent use of ramipril and losartan can increase the risk of hypotension.","Concurrent use of ramipril and losartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and loxapine can increase the risk of hypotension.","Concurrent use of ramipril and lurasidone can increase the risk of hypotension.","Concurrent use of ramipril and mefenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and meloxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and methyldopa can increase the risk of hypotension.","Concurrent use of ramipril and metolazone can increase the risk of hypotension.","Concurrent use of ramipril and metoprolol can increase the risk of hypotension.","Concurrent use of ramipril and minoxidil can increase the risk of hypotension.","Concurrent use of ramipril and moexipril can increase the risk of first-dose hypotension.","Concurrent use of ramipril and moexipril can increase the risk of hypotension.","Concurrent use of ramipril and moexipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and moxisylyte can increase the risk of hypotension.","Concurrent use of ramipril and moxonidine can increase the risk of hypotension.","Concurrent use of ramipril and nabumetone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and nadolol can increase the risk of hypotension.","Concurrent use of ramipril and naproxen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and nebivolol can increase the risk of hypotension.","Concurrent use of ramipril and nepafenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and nicardipine can increase the risk of hypotension.","Concurrent use of ramipril and nicorandil can increase the risk of hypotension.","Concurrent use of ramipril and nifedipine can increase the risk of hypotension.","Concurrent use of ramipril and nimodipine can increase the risk of hypotension.","Concurrent use of ramipril and nitrous oxide can increase the risk of hypotension.","Concurrent use of ramipril and nortriptyline can increase the risk of hypotension.","Concurrent use of ramipril and olanzapine can increase the risk of hypotension.","Concurrent use of ramipril and olmesartan can increase the risk of first-dose hypotension.","Concurrent use of ramipril and olmesartan can increase the risk of hypotension.","Concurrent use of ramipril and olmesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and oxprenolol can increase the risk of hypotension.","Concurrent use of ramipril and paliperidone can increase the risk of hypotension.","Concurrent use of ramipril and parecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and pergolide can increase the risk of hypotension.","Concurrent use of ramipril and pericyazine can increase the risk of hypotension.","Concurrent use of ramipril and perindopril can increase the risk of first-dose hypotension.","Concurrent use of ramipril and perindopril can increase the risk of hypotension.","Concurrent use of ramipril and perindopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and perphenazine can increase the risk of hypotension.","Concurrent use of ramipril and phenelzine can increase the risk of hypotension.","Concurrent use of ramipril and pimozide can increase the risk of hypotension.","Concurrent use of ramipril and pindolol can increase the risk of hypotension.","Concurrent use of ramipril and piroxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and potassium canrenoate can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and potassium chloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and pramipexole can increase the risk of hypotension.","Concurrent use of ramipril and prazosin can increase the risk of first-dose hypotension.","Concurrent use of ramipril and prazosin can increase the risk of hypotension.","Concurrent use of ramipril and prochlorperazine can increase the risk of hypotension.","Concurrent use of ramipril and promazine can increase the risk of hypotension.","Concurrent use of ramipril and propofol can increase the risk of hypotension.","Concurrent use of ramipril and propranolol can increase the risk of hypotension.","Concurrent use of ramipril and quetiapine can increase the risk of hypotension.","Concurrent use of ramipril and quinagolide can increase the risk of hypotension.","Concurrent use of ramipril and quinapril can increase the risk of first-dose hypotension.","Concurrent use of ramipril and quinapril can increase the risk of hypotension.","Concurrent use of ramipril and quinapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and riociguat can increase the risk of hypotension.","Concurrent use of ramipril and risperidone can increase the risk of hypotension.","Concurrent use of ramipril and ropinirole can increase the risk of hypotension.","Concurrent use of ramipril and rotigotine can increase the risk of hypotension.","Concurrent use of ramipril and sacubitril can increase the risk of hypotension.","Concurrent use of ramipril and sapropterin can increase the risk of hypotension.","Concurrent use of ramipril and selegiline can increase the risk of hypotension.","Concurrent use of ramipril and sevoflurane can increase the risk of hypotension.","Concurrent use of ramipril and sildenafil can increase the risk of hypotension.","Ramipril is predicted to increase the risk of hypersensitivity when given with sodium aurothiomalate.","Concurrent use of ramipril and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of ramipril and sodium oxybate can increase the risk of hypotension.","Concurrent use of ramipril and sotalol can increase the risk of hypotension.","Concurrent use of ramipril and spironolactone can increase the risk of hypotension.","Concurrent use of ramipril and spironolactone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and sulindac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and sulpiride can increase the risk of hypotension.","Concurrent use of ramipril and tacrolimus can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and tadalafil can increase the risk of hypotension.","Concurrent use of ramipril and tamsulosin can increase the risk of first-dose hypotension.","Concurrent use of ramipril and tamsulosin can increase the risk of hypotension.","Concurrent use of ramipril and telmisartan can increase the risk of first-dose hypotension.","Concurrent use of ramipril and telmisartan can increase the risk of hypotension.","Concurrent use of ramipril and telmisartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and tenoxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and terazosin can increase the risk of first-dose hypotension.","Concurrent use of ramipril and terazosin can increase the risk of hypotension.","Concurrent use of ramipril and thiopental can increase the risk of hypotension.","Concurrent use of ramipril and tiaprofenic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and timolol can increase the risk of hypotension.","Concurrent use of ramipril and tinzaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and tizanidine can increase the risk of hypotension.","Concurrent use of ramipril and tolfenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and tolvaptan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and torasemide can increase the risk of hypotension.","Concurrent use of ramipril and trandolapril can increase the risk of first-dose hypotension.","Concurrent use of ramipril and trandolapril can increase the risk of hypotension.","Concurrent use of ramipril and trandolapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and tranylcypromine can increase the risk of hypotension.","Concurrent use of ramipril and triamterene can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and trifluoperazine can increase the risk of hypotension.","Concurrent use of ramipril and trimethoprim can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and trimipramine can increase the risk of hypotension.","Concurrent use of ramipril and valsartan can increase the risk of first-dose hypotension.","Concurrent use of ramipril and valsartan can increase the risk of hypotension.","Concurrent use of ramipril and valsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of ramipril and vardenafil can increase the risk of hypotension.","Concurrent use of ramipril and verapamil can increase the risk of hypotension.","Concurrent use of ramipril and xipamide can increase the risk of hypotension.","Concurrent use of ramipril and zuclopenthixol can increase the risk of hypotension."]},{"name":"BNF.Rivaroxaban.Rivaroxaban","imports":["BNF.Apixaban.Apixaban","BNF.Carbamazepine.Carbamazepine","BNF.Citalopram.Citalopram","BNF.Diclofenac.Diclofenac","BNF.Enoxaparin.Enoxaparin","BNF.Fluoxetine.Fluoxetine","BNF.Glucose.Glucose","BNF.Ibuprofen.Ibuprofen","BNF.Naproxen.Naproxen","BNF.Phenytoin.Phenytoin","BNF.Sertraline.Sertraline","BNF.Venlafaxine.Venlafaxine","BNF.Warfarin.Warfarin"],"interactioninfo":["Rivaroxaban is predicted to increase the risk of bleeding events when given with abciximab. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with aceclofenac. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with acemetacin. Manufacturer advises use with caution or avoid.","Both rivaroxaban and acenocoumarol can increase the risk of bleeding.","Both rivaroxaban and alteplase can increase the risk of bleeding.","Rivaroxaban is predicted to increase the risk of bleeding events when given with anagrelide. Manufacturer advises use with caution or avoid.","Both rivaroxaban and apixaban can increase the risk of bleeding.","Both rivaroxaban and argatroban can increase the risk of bleeding.","Rivaroxaban is predicted to increase the risk of bleeding events when given with aspirin. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with bevacizumab. Manufacturer advises use with caution or avoid.","Both rivaroxaban and bivalirudin can increase the risk of bleeding.","Rivaroxaban is predicted to increase the risk of bleeding events when given with cangrelor. Manufacturer advises use with caution or avoid.","Carbamazepine is predicted to moderately decrease the exposure to rivaroxaban. Manufacturer advises avoid unless patient can be monitored for signs of thrombosis.","Rivaroxaban is predicted to increase the risk of bleeding events when given with celecoxib. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with cilostazol. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with clopidogrel. Manufacturer advises use with caution or avoid.","Both rivaroxaban and dabigatran can increase the risk of bleeding.","Both rivaroxaban and dalteparin can increase the risk of bleeding.","Both rivaroxaban and danaparoid can increase the risk of bleeding.","Rivaroxaban is predicted to increase the risk of bleeding events when given with dapoxetine. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with dasatinib. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with dexibuprofen. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with dexketoprofen. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with dipyridamole. Manufacturer advises use with caution or avoid.","Dronedarone is predicted to increase the exposure to rivaroxaban. Manufacturer advises avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with duloxetine. Manufacturer advises use with caution or avoid.","Both rivaroxaban and edoxaban can increase the risk of bleeding.","Both rivaroxaban and enoxaparin can increase the risk of bleeding.","Enzalutamide is predicted to moderately decrease the exposure to rivaroxaban. Manufacturer advises avoid unless patient can be monitored for signs of thrombosis.","Rivaroxaban is predicted to increase the risk of bleeding events when given with epoprostenol. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with eptifibatide. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with escitalopram. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with etodolac. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with etoricoxib. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with fenoprofen. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with flurbiprofen. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with fluvoxamine. Manufacturer advises use with caution or avoid.","Both rivaroxaban and fondaparinux can increase the risk of bleeding.","Fosphenytoin is predicted to moderately decrease the exposure to rivaroxaban. Manufacturer advises avoid unless patient can be monitored for signs of thrombosis.","Both rivaroxaban and glucose can increase the risk of bleeding.","Both rivaroxaban and heparin (unfractionated) can increase the risk of bleeding.","Rivaroxaban is predicted to increase the risk of bleeding events when given with ibrutinib. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with iloprost. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with indometacin. Manufacturer advises use with caution or avoid.","Itraconazole is predicted to moderately increase the exposure to rivaroxaban. Manufacturer advises avoid.","Ketoconazole is predicted to moderately increase the exposure to rivaroxaban. Manufacturer advises avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with ketoprofen. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with ketorolac. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with mefenamic acid. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with meloxicam. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with nabumetone. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Both rivaroxaban and nicotinic acid can increase the risk of bleeding.","Both rivaroxaban and omega-3-acid ethyl esters can increase the risk of bleeding.","Rivaroxaban is predicted to increase the risk of bleeding events when given with parecoxib. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with paroxetine. Manufacturer advises use with caution or avoid.","Both rivaroxaban and phenindione can increase the risk of bleeding.","Phenobarbital is predicted to moderately decrease the exposure to rivaroxaban. Manufacturer advises avoid unless patient can be monitored for signs of thrombosis.","Phenytoin is predicted to moderately decrease the exposure to rivaroxaban. Manufacturer advises avoid unless patient can be monitored for signs of thrombosis.","Rivaroxaban is predicted to increase the risk of bleeding events when given with piroxicam. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with prasugrel. Manufacturer advises use with caution or avoid.","Primidone is predicted to moderately decrease the exposure to rivaroxaban. Manufacturer advises avoid unless patient can be monitored for signs of thrombosis.","Rivaroxaban is predicted to increase the risk of bleeding events when given with regorafenib. Manufacturer advises use with caution or avoid.","Both rivaroxaban and reteplase can increase the risk of bleeding.","Rifampicin is predicted to moderately decrease the exposure to rivaroxaban. Manufacturer advises avoid unless patient can be monitored for signs of thrombosis.","Ritonavir moderately increases the exposure to rivaroxaban. Manufacturer advises avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Both rivaroxaban and streptokinase can increase the risk of bleeding.","Rivaroxaban is predicted to increase the risk of bleeding events when given with sulfinpyrazone. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with sulindac. Manufacturer advises use with caution or avoid.","Both rivaroxaban and tenecteplase can increase the risk of bleeding.","Rivaroxaban is predicted to increase the risk of bleeding events when given with tenoxicam. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with tiaprofenic acid. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with ticagrelor. Manufacturer advises use with caution or avoid.","Both rivaroxaban and tinzaparin can increase the risk of bleeding.","Rivaroxaban is predicted to increase the risk of bleeding events when given with tirofiban. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with tolfenamic acid. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with trastuzumab. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with trastuzumab emtansine. Manufacturer advises use with caution or avoid.","Both rivaroxaban and urokinase can increase the risk of bleeding.","Rivaroxaban is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with vortioxetine. Manufacturer advises use with caution or avoid.","Both rivaroxaban and warfarin can increase the risk of bleeding."]},{"name":"BNF.Salbutamol.Salbutamol","imports":["BNF.Amiodarone.Amiodarone","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisacodyl.Bisacodyl","BNF.Bumetanide.Bumetanide","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Digoxin.Digoxin","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Ipratropium.Ipratropium","BNF.Levomepromazine.Levomepromazine","BNF.Ondansetron.Ondansetron","BNF.Quinine.Quinine","BNF.Senna.Senna","BNF.Theophylline.Theophylline","BNF.Venlafaxine.Venlafaxine"],"interactioninfo":["Salbutamol is predicted to increase the risk of torsade de pointes when given with amifampridine. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and aminophylline can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with amisulpride. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and amphotericin can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with apomorphine. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with arsenic trioxide. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with artemether. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with artenimol. Manufacturer advises use with caution or avoid.","Atomoxetine is predicted to increase the risk of cardiovascular side-effects when given with salbutamol (high-dose).","Concurrent use of salbutamol and bambuterol can increase the risk of hypokalaemia.","Concurrent use of salbutamol and beclometasone can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with bedaquiline. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and bendroflumethiazide can increase the risk of hypokalaemia.","Concurrent use of salbutamol and betamethasone can increase the risk of hypokalaemia.","Concurrent use of salbutamol and bisacodyl can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with bosutinib. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and budesonide can increase the risk of hypokalaemia.","Concurrent use of salbutamol and bumetanide can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with cabozantinib. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with ceritinib. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and chlorothiazide can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with chlorpromazine. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and chlortalidone can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with clomipramine. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and clopamide can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with crizotinib. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and cyclopenthiazide can increase the risk of hypokalaemia.","Concurrent use of salbutamol and dantron can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with dasatinib. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and deflazacort can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with delamanid. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and dexamethasone can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of digoxin toxicity when given with digoxin.","Salbutamol is predicted to increase the risk of torsade de pointes when given with disopyramide. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and docusate sodium can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with dronedarone. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with droperidol. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with eribulin. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with escitalopram. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with flecainide. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and fludrocortisone can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with fluphenazine. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and formoterol can increase the risk of hypokalaemia.","Concurrent use of salbutamol and furosemide can increase the risk of hypokalaemia.","Concurrent use of salbutamol and glycerol can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and hydrochlorothiazide can increase the risk of hypokalaemia.","Concurrent use of salbutamol and hydrocortisone can increase the risk of hypokalaemia.","Concurrent use of salbutamol and hydroflumethiazide can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with hydroxyzine. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and indacaterol can increase the risk of hypokalaemia.","Concurrent use of salbutamol and indapamide can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of glaucoma when given with ipratropium.","Isocarboxazid is predicted to increase the risk of cardiovascular side-effects when given with salbutamol.","Salbutamol is predicted to increase the risk of torsade de pointes when given with lapatinib. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of elevated blood pressure when given with linezolid. Manufacturer advises avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with lithium. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with lofexidine. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with methadone. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and methylprednisolone can increase the risk of hypokalaemia.","Concurrent use of salbutamol and metolazone can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with moxifloxacin. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with nilotinib. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and olodaterol can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with osimertinib. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with paliperidone. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with panobinostat. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with pasireotide. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with pazopanib. Manufacturer advises use with caution or avoid.","Phenelzine is predicted to increase the risk of cardiovascular side-effects when given with salbutamol.","Salbutamol is predicted to increase the risk of torsade de pointes when given with pimozide. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and prednisolone can increase the risk of hypokalaemia.","Concurrent use of salbutamol and prednisone can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with ranolazine. Manufacturer advises use with caution or avoid.","Rasagiline is predicted to increase the risk of severe hypertension when given with salbutamol. Manufacturer advises avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with risperidone. Manufacturer advises use with caution or avoid.","Safinamide is predicted to increase the risk of severe hypertension when given with salbutamol.","Concurrent use of salbutamol and salmeterol can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with saquinavir. Manufacturer advises use with caution or avoid.","Selegiline is predicted to increase the risk of severe hypertension when given with salbutamol. Manufacturer advises avoid.","Concurrent use of salbutamol and senna can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with sildenafil. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and sodium picosulfate can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with sorafenib. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with sotalol. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with sulpiride. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with sunitinib. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with telavancin. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and terbutaline can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with tetrabenazine. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and theophylline can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with tizanidine. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with tolterodine. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and torasemide can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with toremifene. Manufacturer advises use with caution or avoid.","Tranylcypromine is predicted to increase the risk of cardiovascular side-effects when given with salbutamol.","Concurrent use of salbutamol and triamcinolone can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with vandetanib. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with vardenafil. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with vemurafenib. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and vilanterol can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with vinflunine. Manufacturer advises use with caution or avoid.","Salbutamol is predicted to increase the risk of torsade de pointes when given with voriconazole. Manufacturer advises use with caution or avoid.","Concurrent use of salbutamol and xipamide can increase the risk of hypokalaemia.","Salbutamol is predicted to increase the risk of torsade de pointes when given with zuclopenthixol. Manufacturer advises use with caution or avoid."]},{"name":"BNF.Senna.Senna","imports":["BNF.Amiodarone.Amiodarone","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisacodyl.Bisacodyl","BNF.Bumetanide.Bumetanide","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Digoxin.Digoxin","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Levomepromazine.Levomepromazine","BNF.Ondansetron.Ondansetron","BNF.Quinine.Quinine","BNF.Salbutamol.Salbutamol","BNF.Theophylline.Theophylline","BNF.Venlafaxine.Venlafaxine"],"interactioninfo":["Senna is predicted to increase the risk of torsade de pointes when given with amifampridine. Manufacturer advises use with caution or avoid.","Concurrent use of senna and aminophylline can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with amisulpride. Manufacturer advises use with caution or avoid.","Concurrent use of senna and amphotericin can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with apomorphine. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with arsenic trioxide. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with artemether. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with artenimol. Manufacturer advises use with caution or avoid.","Concurrent use of senna and bambuterol can increase the risk of hypokalaemia.","Concurrent use of senna and beclometasone can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with bedaquiline. Manufacturer advises use with caution or avoid.","Concurrent use of senna and bendroflumethiazide can increase the risk of hypokalaemia.","Concurrent use of senna and betamethasone can increase the risk of hypokalaemia.","Concurrent use of senna and bisacodyl can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with bosutinib. Manufacturer advises use with caution or avoid.","Concurrent use of senna and budesonide can increase the risk of hypokalaemia.","Concurrent use of senna and bumetanide can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with cabozantinib. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with ceritinib. Manufacturer advises use with caution or avoid.","Concurrent use of senna and chlorothiazide can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with chlorpromazine. Manufacturer advises use with caution or avoid.","Concurrent use of senna and chlortalidone can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with clomipramine. Manufacturer advises use with caution or avoid.","Concurrent use of senna and clopamide can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with crizotinib. Manufacturer advises use with caution or avoid.","Concurrent use of senna and cyclopenthiazide can increase the risk of hypokalaemia.","Concurrent use of senna and dantron can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with dasatinib. Manufacturer advises use with caution or avoid.","Concurrent use of senna and deflazacort can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with delamanid. Manufacturer advises use with caution or avoid.","Concurrent use of senna and dexamethasone can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of digoxin toxicity when given with digoxin.","Senna is predicted to increase the risk of torsade de pointes when given with disopyramide. Manufacturer advises use with caution or avoid.","Concurrent use of senna and docusate sodium can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with dronedarone. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with droperidol. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with eribulin. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with escitalopram. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with flecainide. Manufacturer advises use with caution or avoid.","Concurrent use of senna and fludrocortisone can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with fluphenazine. Manufacturer advises use with caution or avoid.","Concurrent use of senna and formoterol can increase the risk of hypokalaemia.","Concurrent use of senna and furosemide can increase the risk of hypokalaemia.","Concurrent use of senna and glycerol can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of senna and hydrochlorothiazide can increase the risk of hypokalaemia.","Concurrent use of senna and hydrocortisone can increase the risk of hypokalaemia.","Concurrent use of senna and hydroflumethiazide can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with hydroxyzine. Manufacturer advises use with caution or avoid.","Concurrent use of senna and indacaterol can increase the risk of hypokalaemia.","Concurrent use of senna and indapamide can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with lapatinib. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with lithium. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with lofexidine. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with methadone. Manufacturer advises use with caution or avoid.","Concurrent use of senna and methylprednisolone can increase the risk of hypokalaemia.","Concurrent use of senna and metolazone can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with moxifloxacin. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with nilotinib. Manufacturer advises use with caution or avoid.","Concurrent use of senna and olodaterol can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with osimertinib. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with paliperidone. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with panobinostat. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with pasireotide. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with pazopanib. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with pimozide. Manufacturer advises use with caution or avoid.","Concurrent use of senna and prednisolone can increase the risk of hypokalaemia.","Concurrent use of senna and prednisone can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with ranolazine. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with risperidone. Manufacturer advises use with caution or avoid.","Concurrent use of senna and salbutamol can increase the risk of hypokalaemia.","Concurrent use of senna and salmeterol can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with saquinavir. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with sildenafil. Manufacturer advises use with caution or avoid.","Concurrent use of senna and sodium picosulfate can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with sorafenib. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with sotalol. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with sulpiride. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with sunitinib. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with telavancin. Manufacturer advises use with caution or avoid.","Concurrent use of senna and terbutaline can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with tetrabenazine. Manufacturer advises use with caution or avoid.","Concurrent use of senna and theophylline can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with tizanidine. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with tolterodine. Manufacturer advises use with caution or avoid.","Concurrent use of senna and torasemide can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with toremifene. Manufacturer advises use with caution or avoid.","Concurrent use of senna and triamcinolone can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with vandetanib. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with vardenafil. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with vemurafenib. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of senna and vilanterol can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with vinflunine. Manufacturer advises use with caution or avoid.","Senna is predicted to increase the risk of torsade de pointes when given with voriconazole. Manufacturer advises use with caution or avoid.","Concurrent use of senna and xipamide can increase the risk of hypokalaemia.","Senna is predicted to increase the risk of torsade de pointes when given with zuclopenthixol. Manufacturer advises use with caution or avoid."]},{"name":"BNF.Sertraline.Sertraline","imports":["BNF.Amiloride.Amiloride","BNF.Amitriptyline.Amitriptyline","BNF.Apixaban.Apixaban","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bumetanide.Bumetanide","BNF.Carbamazepine.Carbamazepine","BNF.Citalopram.Citalopram","BNF.Diclofenac.Diclofenac","BNF.Enoxaparin.Enoxaparin","BNF.Fentanyl.Fentanyl","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Glucose.Glucose","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Mirtazapine.Mirtazapine","BNF.Naproxen.Naproxen","BNF.Ondansetron.Ondansetron","BNF.Phenytoin.Phenytoin","BNF.Rivaroxaban.Rivaroxaban","BNF.Spironolactone.Spironolactone","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Trimethoprim.Trimethoprim","BNF.Venlafaxine.Venlafaxine","BNF.Warfarin.Warfarin"],"interactioninfo":["Concurrent use of sertraline and St John's Wort can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both sertraline and abciximab can increase the risk of bleeding.","Concurrent use of sertraline and aceclofenac can increase the risk of hyponatraemia.","Both sertraline and aceclofenac can increase the risk of bleeding.","Concurrent use of sertraline and acemetacin can increase the risk of hyponatraemia.","Both sertraline and acemetacin can increase the risk of bleeding.","Acenocoumarol is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Concurrent use of sertraline and almotriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Alteplase is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Concurrent use of sertraline and amiloride can increase the risk of hyponatraemia.","Concurrent use of sertraline and amitriptyline can increase the risk of hyponatraemia.","Both sertraline and anagrelide can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Argatroban is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Both sertraline and aspirin can increase the risk of bleeding.","Concurrent use of sertraline and bendroflumethiazide can increase the risk of hyponatraemia.","Both sertraline and bevacizumab can increase the risk of bleeding.","Bivalirudin is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Concurrent use of sertraline and bumetanide can increase the risk of hyponatraemia.","Concurrent use of sertraline and bupropion can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and buspirone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both sertraline and cangrelor can increase the risk of bleeding.","Concurrent use of sertraline and carbamazepine can increase the risk of hyponatraemia.","Concurrent use of sertraline and celecoxib can increase the risk of hyponatraemia.","Both sertraline and celecoxib can increase the risk of bleeding.","Concurrent use of sertraline and chlorothiazide can increase the risk of hyponatraemia.","Concurrent use of sertraline and chlortalidone can increase the risk of hyponatraemia.","Both sertraline and cilostazol can increase the risk of bleeding.","Cimetidine slightly increases the exposure to sertraline.","Concurrent use of sertraline and citalopram can increase the risk of hyponatraemia.","Concurrent use of sertraline and citalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both sertraline and citalopram can increase the risk of bleeding.","Concurrent use of sertraline and clomipramine can increase the risk of hyponatraemia.","Concurrent use of sertraline and clomipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and clopamide can increase the risk of hyponatraemia.","Both sertraline and clopidogrel can increase the risk of bleeding.","Concurrent use of sertraline and cyclopenthiazide can increase the risk of hyponatraemia.","Cyproheptadine potentially decreases the effects of sertraline.","Dabigatran is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Dalteparin is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Danaparoid is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Concurrent use of sertraline and dapoxetine can increase the risk of hyponatraemia.","Concurrent use of sertraline and dapoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both sertraline and dapoxetine can increase the risk of bleeding.","Both sertraline and dasatinib can increase the risk of bleeding.","Concurrent use of sertraline and desmopressin can increase the risk of hyponatraemia.","Concurrent use of sertraline and dexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and dexibuprofen can increase the risk of hyponatraemia.","Both sertraline and dexibuprofen can increase the risk of bleeding.","Concurrent use of sertraline and dexketoprofen can increase the risk of hyponatraemia.","Both sertraline and dexketoprofen can increase the risk of bleeding.","Concurrent use of sertraline and diclofenac can increase the risk of hyponatraemia.","Both sertraline and diclofenac can increase the risk of bleeding.","Both sertraline and dipyridamole can increase the risk of bleeding.","Concurrent use of sertraline and dosulepin can increase the risk of hyponatraemia.","Concurrent use of sertraline and doxepin can increase the risk of hyponatraemia.","Dronedarone is predicted to increase the exposure to sertraline.","Concurrent use of sertraline and duloxetine can increase the risk of hyponatraemia.","Concurrent use of sertraline and duloxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both sertraline and duloxetine can increase the risk of bleeding.","Edoxaban is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Concurrent use of sertraline and eletriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Enoxaparin is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Concurrent use of sertraline and eplerenone can increase the risk of hyponatraemia.","Both sertraline and epoprostenol can increase the risk of bleeding.","Both sertraline and eptifibatide can increase the risk of bleeding.","Concurrent use of sertraline and escitalopram can increase the risk of hyponatraemia.","Concurrent use of sertraline and escitalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both sertraline and escitalopram can increase the risk of bleeding.","Concurrent use of sertraline and etodolac can increase the risk of hyponatraemia.","Both sertraline and etodolac can increase the risk of bleeding.","Concurrent use of sertraline and etoricoxib can increase the risk of hyponatraemia.","Both sertraline and etoricoxib can increase the risk of bleeding.","Concurrent use of sertraline and fenoprofen can increase the risk of hyponatraemia.","Both sertraline and fenoprofen can increase the risk of bleeding.","Concurrent use of sertraline and fentanyl can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and fluoxetine can increase the risk of hyponatraemia.","Concurrent use of sertraline and fluoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both sertraline and fluoxetine can increase the risk of bleeding.","Concurrent use of sertraline and flurbiprofen can increase the risk of hyponatraemia.","Both sertraline and flurbiprofen can increase the risk of bleeding.","Concurrent use of sertraline and fluvoxamine can increase the risk of hyponatraemia.","Concurrent use of sertraline and fluvoxamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both sertraline and fluvoxamine can increase the risk of bleeding.","Fondaparinux is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Sertraline potentially increases the risk of toxicity when given with fosphenytoin. Manufacturer advises monitor concentration and adjust dose.","Concurrent use of sertraline and frovatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and furosemide can increase the risk of hyponatraemia.","Glucose is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Concurrent use of sertraline and granisetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Grapefruit juice moderately increases the exposure to sertraline. Manufacturer advises avoid.","Heparin (unfractionated) is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Concurrent use of sertraline and hydrochlorothiazide can increase the risk of hyponatraemia.","Concurrent use of sertraline and hydroflumethiazide can increase the risk of hyponatraemia.","Both sertraline and ibrutinib can increase the risk of bleeding.","Concurrent use of sertraline and ibuprofen can increase the risk of hyponatraemia.","Both sertraline and ibuprofen can increase the risk of bleeding.","Both sertraline and iloprost can increase the risk of bleeding.","Concurrent use of sertraline and imipramine can increase the risk of hyponatraemia.","Concurrent use of sertraline and imipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and indapamide can increase the risk of hyponatraemia.","Concurrent use of sertraline and indometacin can increase the risk of hyponatraemia.","Both sertraline and indometacin can increase the risk of bleeding.","Concurrent use of sertraline and isocarboxazid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and ketoprofen can increase the risk of hyponatraemia.","Both sertraline and ketoprofen can increase the risk of bleeding.","Concurrent use of sertraline and ketorolac can increase the risk of hyponatraemia.","Both sertraline and ketorolac can increase the risk of bleeding.","Concurrent use of sertraline and linezolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and lisdexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and lithium can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Lumacaftor is predicted to decrease the exposure to sertraline. Manufacturer advises adjust dose.","Concurrent use of sertraline and mefenamic acid can increase the risk of hyponatraemia.","Both sertraline and mefenamic acid can increase the risk of bleeding.","Concurrent use of sertraline and meloxicam can increase the risk of hyponatraemia.","Both sertraline and meloxicam can increase the risk of bleeding.","Concurrent use of sertraline and methadone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and methylthioninium chloride can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and metolazone can increase the risk of hyponatraemia.","Concurrent use of sertraline and mianserin can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and mirtazapine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Sertraline potentially increases the risk of prolonged neuromuscular blockade when given with mivacurium.","Concurrent use of sertraline and moclobemide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and nabumetone can increase the risk of hyponatraemia.","Both sertraline and nabumetone can increase the risk of bleeding.","Concurrent use of sertraline and naproxen can increase the risk of hyponatraemia.","Both sertraline and naproxen can increase the risk of bleeding.","Concurrent use of sertraline and naratriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Nicotinic acid is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Concurrent use of sertraline and nortriptyline can increase the risk of hyponatraemia.","Omega-3-acid ethyl esters is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Concurrent use of sertraline and ondansetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and palonosetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and parecoxib can increase the risk of hyponatraemia.","Both sertraline and parecoxib can increase the risk of bleeding.","Concurrent use of sertraline and paroxetine can increase the risk of hyponatraemia.","Concurrent use of sertraline and paroxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both sertraline and paroxetine can increase the risk of bleeding.","Concurrent use of sertraline and pentazocine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and pethidine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and phenelzine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Phenindione is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Sertraline potentially increases the risk of toxicity when given with phenytoin. Manufacturer advises monitor concentration and adjust dose.","Concurrent use of sertraline and piroxicam can increase the risk of hyponatraemia.","Both sertraline and piroxicam can increase the risk of bleeding.","Both sertraline and prasugrel can increase the risk of bleeding.","Concurrent use of sertraline and procarbazine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and rasagiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both sertraline and regorafenib can increase the risk of bleeding.","Reteplase is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Rivaroxaban is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Concurrent use of sertraline and rizatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and safinamide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and selegiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and sodium picosulfate can increase the risk of hyponatraemia.","Concurrent use of sertraline and spironolactone can increase the risk of hyponatraemia.","Streptokinase is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Both sertraline and sulfinpyrazone can increase the risk of bleeding.","Concurrent use of sertraline and sulindac can increase the risk of hyponatraemia.","Both sertraline and sulindac can increase the risk of bleeding.","Concurrent use of sertraline and sumatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Sertraline potentially increases the risk of prolonged neuromuscular blockade when given with suxamethonium.","Concurrent use of sertraline and tapentadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and tedizolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Tenecteplase is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Concurrent use of sertraline and tenoxicam can increase the risk of hyponatraemia.","Both sertraline and tenoxicam can increase the risk of bleeding.","Terbinafine is predicted to increase the exposure to sertraline.","Concurrent use of sertraline and tiaprofenic acid can increase the risk of hyponatraemia.","Both sertraline and tiaprofenic acid can increase the risk of bleeding.","Both sertraline and ticagrelor can increase the risk of bleeding.","Tinzaparin is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Both sertraline and tirofiban can increase the risk of bleeding.","Concurrent use of sertraline and tolfenamic acid can increase the risk of hyponatraemia.","Both sertraline and tolfenamic acid can increase the risk of bleeding.","Concurrent use of sertraline and torasemide can increase the risk of hyponatraemia.","Concurrent use of sertraline and tramadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and tranylcypromine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both sertraline and trastuzumab can increase the risk of bleeding.","Both sertraline and trastuzumab emtansine can increase the risk of bleeding.","Concurrent use of sertraline and trazodone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of sertraline and triamterene can increase the risk of hyponatraemia.","Concurrent use of sertraline and trimethoprim can increase the risk of hyponatraemia.","Concurrent use of sertraline and trimipramine can increase the risk of hyponatraemia.","Urokinase is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Concurrent use of sertraline and venlafaxine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both sertraline and venlafaxine can increase the risk of bleeding.","Concurrent use of sertraline and vortioxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both sertraline and vortioxetine can increase the risk of bleeding.","Warfarin is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Concurrent use of sertraline and xipamide can increase the risk of hyponatraemia.","Concurrent use of sertraline and zolmitriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs."]},{"name":"BNF.Simvastatin.Simvastatin","imports":["BNF.Amiodarone.Amiodarone","BNF.Amlodipine.Amlodipine","BNF.Atorvastatin.Atorvastatin","BNF.Carbamazepine.Carbamazepine","BNF.Clarithromycin.Clarithromycin","BNF.Diltiazem.Diltiazem","BNF.Doxycycline.Doxycycline","BNF.Paracetamol.Paracetamol","BNF.Phenytoin.Phenytoin","BNF.Pravastatin.Pravastatin"],"interactioninfo":["Concurrent use of simvastatin and alcohol (beverage) can increase the risk of hepatotoxicity.","Concurrent use of simvastatin and alectinib can increase the risk of hepatotoxicity.","Amiodarone increases the risk of rhabdomyolysis when given with simvastatin. Manufacturer advises adjust simvastatin dose.","Amlodipine slightly increases the exposure to simvastatin. Manufacturer advises adjust simvastatin dose.","Aprepitant is predicted to increase the exposure to simvastatin. Manufacturer advises use with caution and adjust simvastatin dose.","Concurrent use of simvastatin and asparaginase can increase the risk of hepatotoxicity.","Atazanavir is predicted to increase the exposure to simvastatin. Manufacturer advises avoid.","Concurrent use of simvastatin and atorvastatin can increase the risk of hepatotoxicity.","Bezafibrate increases the risk of rhabdomyolysis when given with simvastatin. Manufacturer advises adjust simvastatin dose.","Bosentan moderately decreases the exposure to simvastatin.","Concurrent use of simvastatin and carbamazepine can increase the risk of hepatotoxicity.","Carbamazepine moderately decreases the exposure to simvastatin. Manufacturer advises monitor and adjust dose.","Ceftobiprole is predicted to increase the concentration of simvastatin.","Ciclosporin markedly increases the exposure to simvastatin. Manufacturer advises avoid.","Ciprofibrate increases the risk of rhabdomyolysis when given with simvastatin. Manufacturer advises adjust simvastatin dose.","Clarithromycin is predicted to increase the exposure to simvastatin. Manufacturer advises avoid.","Cobicistat is predicted to increase the exposure to simvastatin. Manufacturer advises avoid.","Colchicine increases the risk of rhabdomyolysis when given with simvastatin.","Concurrent use of simvastatin and crisantaspase can increase the risk of hepatotoxicity.","Crizotinib is predicted to increase the exposure to simvastatin. Manufacturer advises use with caution and adjust simvastatin dose.","Concurrent use of simvastatin and daclizumab can increase the risk of hepatotoxicity.","Concurrent use of simvastatin and dactinomycin can increase the risk of hepatotoxicity.","Danazol increases the risk of rhabdomyolysis when given with simvastatin. Manufacturer advises avoid.","Concurrent use of simvastatin and dantrolene can increase the risk of hepatotoxicity.","Simvastatin is predicted to increase the risk of rhabdomyolysis when given with daptomycin.","Darunavir is predicted to increase the exposure to simvastatin. Manufacturer advises avoid.","Dasatinib is predicted to increase the exposure to simvastatin.","Concurrent use of simvastatin and demeclocycline can increase the risk of hepatotoxicity.","Concurrent use of simvastatin and didanosine can increase the risk of hepatotoxicity.","Diltiazem is predicted to increase the exposure to simvastatin. Manufacturer advises use with caution and adjust simvastatin dose.","Concurrent use of simvastatin and doxycycline can increase the risk of hepatotoxicity.","Dronedarone is predicted to increase the exposure to simvastatin. Manufacturer advises use with caution and adjust simvastatin dose.","Efavirenz moderately decreases the exposure to simvastatin.","Elbasvir is predicted to increase the exposure to simvastatin. Manufacturer advises adjust simvastatin dose.","Eltrombopag is predicted to increase the exposure to simvastatin. Manufacturer advises monitor and adjust dose.","Eluxadoline is predicted to increase the exposure to simvastatin.","Erythromycin is predicted to increase the exposure to simvastatin. Manufacturer advises use with caution and adjust simvastatin dose.","Eslicarbazepine moderately decreases the exposure to simvastatin. Manufacturer advises monitor and adjust dose.","Ezetimibe potentially increases the risk of rhabdomyolysis when given with simvastatin.","Fenofibrate increases the risk of rhabdomyolysis when given with simvastatin. Manufacturer advises adjust fenofibrate dose.","Concurrent use of simvastatin and fluconazole can increase the risk of hepatotoxicity.","Fluconazole is predicted to increase the exposure to simvastatin. Manufacturer advises use with caution and adjust simvastatin dose.","Concurrent use of simvastatin and fluvastatin can increase the risk of hepatotoxicity.","Fosamprenavir is predicted to increase the exposure to simvastatin. Manufacturer advises avoid.","Fosphenytoin potentially decreases the exposure to simvastatin.","Fusidic acid increases the risk of rhabdomyolysis when given with simvastatin. Manufacturer advises avoid.","Gemfibrozil increases the risk of rhabdomyolysis when given with simvastatin. Manufacturer advises avoid.","Grapefruit juice increases the exposure to simvastatin. Manufacturer advises avoid.","Grazoprevir is predicted to increase the exposure to simvastatin. Manufacturer advises adjust simvastatin dose.","Idelalisib is predicted to increase the exposure to simvastatin. Manufacturer advises avoid.","Imatinib is predicted to increase the exposure to simvastatin. Manufacturer advises use with caution and adjust simvastatin dose.","Indinavir is predicted to increase the exposure to simvastatin. Manufacturer advises use with caution and adjust simvastatin dose.","Isavuconazole is predicted to increase the exposure to simvastatin. Manufacturer advises use with caution and adjust simvastatin dose.","Concurrent use of simvastatin and isoniazid can increase the risk of hepatotoxicity.","Concurrent use of simvastatin and itraconazole can increase the risk of hepatotoxicity.","Itraconazole is predicted to increase the exposure to simvastatin. Manufacturer advises avoid.","Ketoconazole is predicted to increase the exposure to simvastatin. Manufacturer advises avoid.","Ledipasvir is predicted to increase the exposure to simvastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of simvastatin and leflunomide can increase the risk of hepatotoxicity.","Concurrent use of simvastatin and lenalidomide can increase the risk of hepatotoxicity.","Concurrent use of simvastatin and lomitapide can increase the risk of hepatotoxicity.","Lomitapide increases the exposure to simvastatin. Manufacturer advises monitor and adjust simvastatin dose.","Lopinavir is predicted to increase the exposure to simvastatin. Manufacturer advises avoid.","Concurrent use of simvastatin and lymecycline can increase the risk of hepatotoxicity.","Concurrent use of simvastatin and mercaptopurine can increase the risk of hepatotoxicity.","Concurrent use of simvastatin and methotrexate can increase the risk of hepatotoxicity.","Concurrent use of simvastatin and micafungin can increase the risk of hepatotoxicity.","Miconazole is predicted to increase the exposure to simvastatin. Manufacturer advises avoid.","Concurrent use of simvastatin and minocycline can increase the risk of hepatotoxicity.","Netupitant is predicted to increase the exposure to simvastatin. Manufacturer advises use with caution and adjust simvastatin dose.","Nevirapine moderately decreases the exposure to simvastatin.","Nicotinic acid is predicted to increase the risk of rhabdomyolysis when given with simvastatin.","Nilotinib is predicted to increase the exposure to simvastatin. Manufacturer advises use with caution and adjust simvastatin dose.","Concurrent use of simvastatin and oxytetracycline can increase the risk of hepatotoxicity.","Concurrent use of simvastatin and paracetamol can increase the risk of hepatotoxicity.","Concurrent use of simvastatin and pegaspargase can increase the risk of hepatotoxicity.","Phenytoin potentially decreases the exposure to simvastatin.","Posaconazole is predicted to increase the exposure to simvastatin. Manufacturer advises use with caution and adjust simvastatin dose.","Concurrent use of simvastatin and pravastatin can increase the risk of hepatotoxicity.","Ranolazine slightly increases the exposure to simvastatin. Manufacturer advises adjust simvastatin dose.","Rifampicin very markedly decreases the exposure to simvastatin.","Ritonavir is predicted to increase the exposure to simvastatin. Manufacturer advises avoid.","Concurrent use of simvastatin and rosuvastatin can increase the risk of hepatotoxicity.","Sacubitril is predicted to increase the exposure to simvastatin.","Saquinavir is predicted to increase the exposure to simvastatin. Manufacturer advises avoid.","Simeprevir slightly increases the exposure to simvastatin. Manufacturer advises monitor and adjust dose.","St John's Wort moderately decreases the exposure to simvastatin.","Concurrent use of simvastatin and sulfasalazine can increase the risk of hepatotoxicity.","Concurrent use of simvastatin and tetracycline can increase the risk of hepatotoxicity.","Ticagrelor slightly increases the exposure to simvastatin. Manufacturer advises adjust simvastatin dose.","Concurrent use of simvastatin and tigecycline can increase the risk of hepatotoxicity.","Tipranavir is predicted to increase the exposure to simvastatin. Manufacturer advises avoid.","Tocilizumab moderately decreases the exposure to simvastatin. Manufacturer advises monitor and adjust dose.","Concurrent use of simvastatin and trabectedin can increase the risk of hepatotoxicity.","Concurrent use of simvastatin and valproate can increase the risk of hepatotoxicity.","Velpatasvir is predicted to increase the exposure to simvastatin. Manufacturer advises monitor side effects and adjust dose.","Verapamil is predicted to increase the exposure to simvastatin. Manufacturer advises use with caution and adjust simvastatin dose.","Concurrent use of simvastatin and vincristine can increase the risk of hepatotoxicity.","Voriconazole is predicted to increase the exposure to simvastatin. Manufacturer advises avoid."]},{"name":"BNF.Spironolactone.Spironolactone","imports":["BNF.Amiloride.Amiloride","BNF.Amitriptyline.Amitriptyline","BNF.Amlodipine.Amlodipine","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Carbamazepine.Carbamazepine","BNF.Citalopram.Citalopram","BNF.Diclofenac.Diclofenac","BNF.Digoxin.Digoxin","BNF.Diltiazem.Diltiazem","BNF.Doxazosin.Doxazosin","BNF.Enoxaparin.Enoxaparin","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Naproxen.Naproxen","BNF.Nifedipine.Nifedipine","BNF.Prochlorperazine.Prochlorperazine","BNF.Ramipril.Ramipril","BNF.Sertraline.Sertraline","BNF.Trimethoprim.Trimethoprim"],"interactioninfo":["Concurrent use of spironolactone and acebutolol can increase the risk of hypotension.","Concurrent use of spironolactone and aceclofenac can increase the risk of hyponatraemia.","Concurrent use of spironolactone and aceclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and acemetacin can increase the risk of hyponatraemia.","Concurrent use of spironolactone and acemetacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and alcohol (beverage) can increase the risk of hypotension.","Concurrent use of spironolactone and alfuzosin can increase the risk of hypotension.","Concurrent use of spironolactone and aliskiren can increase the risk of hypotension.","Concurrent use of spironolactone and aliskiren can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and alprostadil can increase the risk of hypotension.","Concurrent use of spironolactone and amantadine can increase the risk of hypotension.","Concurrent use of spironolactone and amiloride can increase the risk of hyponatraemia.","Concurrent use of spironolactone and amiloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and amitriptyline can increase the risk of hyponatraemia.","Concurrent use of spironolactone and amitriptyline can increase the risk of hypotension.","Concurrent use of spironolactone and amlodipine can increase the risk of hypotension.","Concurrent use of spironolactone and apomorphine can increase the risk of hypotension.","Concurrent use of spironolactone and apraclonidine can increase the risk of hypotension.","Concurrent use of spironolactone and aripiprazole can increase the risk of hypotension.","Concurrent use of spironolactone and asenapine can increase the risk of hypotension.","Concurrent use of spironolactone and atenolol can increase the risk of hypotension.","Concurrent use of spironolactone and avanafil can increase the risk of hypotension.","Concurrent use of spironolactone and azilsartan can increase the risk of hypotension.","Concurrent use of spironolactone and azilsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and baclofen can increase the risk of hypotension.","Concurrent use of spironolactone and bendroflumethiazide can increase the risk of hyponatraemia.","Concurrent use of spironolactone and bendroflumethiazide can increase the risk of hypotension.","Concurrent use of spironolactone and benperidol can increase the risk of hypotension.","Concurrent use of spironolactone and benzydamine can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and betaxolol can increase the risk of hypotension.","Concurrent use of spironolactone and bisoprolol can increase the risk of hypotension.","Concurrent use of spironolactone and bortezomib can increase the risk of hypotension.","Concurrent use of spironolactone and brimonidine can increase the risk of hypotension.","Concurrent use of spironolactone and bromfenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and bromocriptine can increase the risk of hypotension.","Concurrent use of spironolactone and bumetanide can increase the risk of hyponatraemia.","Concurrent use of spironolactone and bumetanide can increase the risk of hypotension.","Concurrent use of spironolactone and cabergoline can increase the risk of hypotension.","Concurrent use of spironolactone and canagliflozin can increase the risk of hypotension.","Concurrent use of spironolactone and candesartan can increase the risk of hypotension.","Concurrent use of spironolactone and candesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and captopril can increase the risk of hypotension.","Concurrent use of spironolactone and captopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and carbamazepine can increase the risk of hyponatraemia.","Concurrent use of spironolactone and carteolol can increase the risk of hypotension.","Concurrent use of spironolactone and carvedilol can increase the risk of hypotension.","Concurrent use of spironolactone and celecoxib can increase the risk of hyponatraemia.","Concurrent use of spironolactone and celecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and celiprolol can increase the risk of hypotension.","Concurrent use of spironolactone and chlorothiazide can increase the risk of hyponatraemia.","Concurrent use of spironolactone and chlorothiazide can increase the risk of hypotension.","Concurrent use of spironolactone and chlorpromazine can increase the risk of hypotension.","Concurrent use of spironolactone and chlortalidone can increase the risk of hyponatraemia.","Concurrent use of spironolactone and chlortalidone can increase the risk of hypotension.","Concurrent use of spironolactone and ciclosporin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and citalopram can increase the risk of hyponatraemia.","Concurrent use of spironolactone and clevidipine can increase the risk of hypotension.","Concurrent use of spironolactone and clomipramine can increase the risk of hyponatraemia.","Concurrent use of spironolactone and clomipramine can increase the risk of hypotension.","Concurrent use of spironolactone and clonidine can increase the risk of hypotension.","Concurrent use of spironolactone and clopamide can increase the risk of hyponatraemia.","Concurrent use of spironolactone and clopamide can increase the risk of hypotension.","Concurrent use of spironolactone and clozapine can increase the risk of hypotension.","Concurrent use of spironolactone and cyclopenthiazide can increase the risk of hyponatraemia.","Concurrent use of spironolactone and cyclopenthiazide can increase the risk of hypotension.","Concurrent use of spironolactone and dalteparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and dapagliflozin can increase the risk of hypotension.","Concurrent use of spironolactone and dapoxetine can increase the risk of hyponatraemia.","Concurrent use of spironolactone and darbepoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and desflurane can increase the risk of hypotension.","Concurrent use of spironolactone and desmopressin can increase the risk of hyponatraemia.","Concurrent use of spironolactone and dexibuprofen can increase the risk of hyponatraemia.","Concurrent use of spironolactone and dexibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and dexketoprofen can increase the risk of hyponatraemia.","Concurrent use of spironolactone and dexketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and diazoxide can increase the risk of hypotension.","Concurrent use of spironolactone and diclofenac can increase the risk of hyponatraemia.","Concurrent use of spironolactone and diclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Spironolactone increases the concentration of digoxin. Manufacturer advises monitor and adjust dose.","Concurrent use of spironolactone and diltiazem can increase the risk of hypotension.","Concurrent use of spironolactone and dipyridamole can increase the risk of hypotension.","Concurrent use of spironolactone and dosulepin can increase the risk of hyponatraemia.","Concurrent use of spironolactone and dosulepin can increase the risk of hypotension.","Concurrent use of spironolactone and doxazosin can increase the risk of hypotension.","Concurrent use of spironolactone and doxepin can increase the risk of hyponatraemia.","Concurrent use of spironolactone and doxepin can increase the risk of hypotension.","Concurrent use of spironolactone and droperidol can increase the risk of hypotension.","Concurrent use of spironolactone and drospirenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and duloxetine can increase the risk of hyponatraemia.","Concurrent use of spironolactone and empagliflozin can increase the risk of hypotension.","Concurrent use of spironolactone and enalapril can increase the risk of hypotension.","Concurrent use of spironolactone and enalapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and enoxaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and eplerenone can increase the risk of hyponatraemia.","Concurrent use of spironolactone and eplerenone can increase the risk of hypotension.","Concurrent use of spironolactone and eplerenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and epoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and epoetin beta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and epoetin zeta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and eprosartan can increase the risk of hypotension.","Concurrent use of spironolactone and eprosartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and escitalopram can increase the risk of hyponatraemia.","Concurrent use of spironolactone and esmolol can increase the risk of hypotension.","Concurrent use of spironolactone and etodolac can increase the risk of hyponatraemia.","Concurrent use of spironolactone and etodolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and etomidate can increase the risk of hypotension.","Concurrent use of spironolactone and etoricoxib can increase the risk of hyponatraemia.","Concurrent use of spironolactone and etoricoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and felbinac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and felodipine can increase the risk of hypotension.","Concurrent use of spironolactone and fenoprofen can increase the risk of hyponatraemia.","Concurrent use of spironolactone and fenoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and fluoxetine can increase the risk of hyponatraemia.","Concurrent use of spironolactone and flupentixol can increase the risk of hypotension.","Concurrent use of spironolactone and fluphenazine can increase the risk of hypotension.","Concurrent use of spironolactone and flurbiprofen can increase the risk of hyponatraemia.","Concurrent use of spironolactone and flurbiprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and fluvoxamine can increase the risk of hyponatraemia.","Concurrent use of spironolactone and fosinopril can increase the risk of hypotension.","Concurrent use of spironolactone and furosemide can increase the risk of hyponatraemia.","Concurrent use of spironolactone and furosemide can increase the risk of hypotension.","Concurrent use of spironolactone and glyceryl trinitrate can increase the risk of hypotension.","Concurrent use of spironolactone and guanethidine can increase the risk of hypotension.","Concurrent use of spironolactone and guanfacine can increase the risk of hypotension.","Concurrent use of spironolactone and haloperidol can increase the risk of hypotension.","Concurrent use of spironolactone and heparin (unfractionated) can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and histamine can increase the risk of hypotension.","Concurrent use of spironolactone and hydralazine can increase the risk of hypotension.","Concurrent use of spironolactone and hydrochlorothiazide can increase the risk of hyponatraemia.","Concurrent use of spironolactone and hydrochlorothiazide can increase the risk of hypotension.","Concurrent use of spironolactone and hydroflumethiazide can increase the risk of hyponatraemia.","Concurrent use of spironolactone and hydroflumethiazide can increase the risk of hypotension.","Concurrent use of spironolactone and ibuprofen can increase the risk of hyponatraemia.","Concurrent use of spironolactone and ibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and imidapril can increase the risk of hypotension.","Concurrent use of spironolactone and imidapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and imipramine can increase the risk of hyponatraemia.","Concurrent use of spironolactone and imipramine can increase the risk of hypotension.","Concurrent use of spironolactone and indapamide can increase the risk of hyponatraemia.","Concurrent use of spironolactone and indapamide can increase the risk of hypotension.","Concurrent use of spironolactone and indometacin can increase the risk of hyponatraemia.","Concurrent use of spironolactone and indometacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and indoramin can increase the risk of hypotension.","Concurrent use of spironolactone and irbesartan can increase the risk of hypotension.","Concurrent use of spironolactone and irbesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and isocarboxazid can increase the risk of hypotension.","Concurrent use of spironolactone and isoflurane can increase the risk of hypotension.","Concurrent use of spironolactone and isosorbide dinitrate can increase the risk of hypotension.","Concurrent use of spironolactone and isosorbide mononitrate can increase the risk of hypotension.","Concurrent use of spironolactone and isradipine can increase the risk of hypotension.","Concurrent use of spironolactone and ketamine can increase the risk of hypotension.","Concurrent use of spironolactone and ketoprofen can increase the risk of hyponatraemia.","Concurrent use of spironolactone and ketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and ketorolac can increase the risk of hyponatraemia.","Concurrent use of spironolactone and ketorolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and labetalol can increase the risk of hypotension.","Concurrent use of spironolactone and lacidipine can increase the risk of hypotension.","Concurrent use of spironolactone and lercanidipine can increase the risk of hypotension.","Concurrent use of spironolactone and levobunolol can increase the risk of hypotension.","Concurrent use of spironolactone and levodopa can increase the risk of hypotension.","Concurrent use of spironolactone and levomepromazine can increase the risk of hypotension.","Concurrent use of spironolactone and lisinopril can increase the risk of hypotension.","Concurrent use of spironolactone and lisinopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Spironolactone potentially increases the concentration of lithium.","Concurrent use of spironolactone and lofepramine can increase the risk of hypotension.","Concurrent use of spironolactone and lofexidine can increase the risk of hypotension.","Concurrent use of spironolactone and losartan can increase the risk of hypotension.","Concurrent use of spironolactone and losartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and loxapine can increase the risk of hypotension.","Concurrent use of spironolactone and lurasidone can increase the risk of hypotension.","Concurrent use of spironolactone and mefenamic acid can increase the risk of hyponatraemia.","Concurrent use of spironolactone and mefenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and meloxicam can increase the risk of hyponatraemia.","Concurrent use of spironolactone and meloxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and methyldopa can increase the risk of hypotension.","Concurrent use of spironolactone and metolazone can increase the risk of hyponatraemia.","Concurrent use of spironolactone and metolazone can increase the risk of hypotension.","Concurrent use of spironolactone and metoprolol can increase the risk of hypotension.","Concurrent use of spironolactone and minoxidil can increase the risk of hypotension.","Spironolactone is predicted to decrease the effects of mitotane. Manufacturer advises avoid.","Concurrent use of spironolactone and moexipril can increase the risk of hypotension.","Concurrent use of spironolactone and moexipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and moxisylyte can increase the risk of hypotension.","Concurrent use of spironolactone and moxonidine can increase the risk of hypotension.","Concurrent use of spironolactone and nabumetone can increase the risk of hyponatraemia.","Concurrent use of spironolactone and nabumetone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and nadolol can increase the risk of hypotension.","Concurrent use of spironolactone and naproxen can increase the risk of hyponatraemia.","Concurrent use of spironolactone and naproxen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and nebivolol can increase the risk of hypotension.","Concurrent use of spironolactone and nepafenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and nicardipine can increase the risk of hypotension.","Concurrent use of spironolactone and nicorandil can increase the risk of hypotension.","Concurrent use of spironolactone and nifedipine can increase the risk of hypotension.","Concurrent use of spironolactone and nimodipine can increase the risk of hypotension.","Concurrent use of spironolactone and nitrous oxide can increase the risk of hypotension.","Concurrent use of spironolactone and nortriptyline can increase the risk of hyponatraemia.","Concurrent use of spironolactone and nortriptyline can increase the risk of hypotension.","Concurrent use of spironolactone and olanzapine can increase the risk of hypotension.","Concurrent use of spironolactone and olmesartan can increase the risk of hypotension.","Concurrent use of spironolactone and olmesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and oxprenolol can increase the risk of hypotension.","Concurrent use of spironolactone and paliperidone can increase the risk of hypotension.","Concurrent use of spironolactone and parecoxib can increase the risk of hyponatraemia.","Concurrent use of spironolactone and parecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and paroxetine can increase the risk of hyponatraemia.","Concurrent use of spironolactone and pergolide can increase the risk of hypotension.","Concurrent use of spironolactone and pericyazine can increase the risk of hypotension.","Concurrent use of spironolactone and perindopril can increase the risk of hypotension.","Concurrent use of spironolactone and perindopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and perphenazine can increase the risk of hypotension.","Concurrent use of spironolactone and phenelzine can increase the risk of hypotension.","Concurrent use of spironolactone and pimozide can increase the risk of hypotension.","Concurrent use of spironolactone and pindolol can increase the risk of hypotension.","Concurrent use of spironolactone and piroxicam can increase the risk of hyponatraemia.","Concurrent use of spironolactone and piroxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and potassium canrenoate can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and potassium chloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and pramipexole can increase the risk of hypotension.","Concurrent use of spironolactone and prazosin can increase the risk of hypotension.","Concurrent use of spironolactone and prochlorperazine can increase the risk of hypotension.","Concurrent use of spironolactone and promazine can increase the risk of hypotension.","Concurrent use of spironolactone and propofol can increase the risk of hypotension.","Concurrent use of spironolactone and propranolol can increase the risk of hypotension.","Concurrent use of spironolactone and quetiapine can increase the risk of hypotension.","Concurrent use of spironolactone and quinagolide can increase the risk of hypotension.","Concurrent use of spironolactone and quinapril can increase the risk of hypotension.","Concurrent use of spironolactone and quinapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and ramipril can increase the risk of hypotension.","Concurrent use of spironolactone and ramipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and riociguat can increase the risk of hypotension.","Concurrent use of spironolactone and risperidone can increase the risk of hypotension.","Concurrent use of spironolactone and ropinirole can increase the risk of hypotension.","Concurrent use of spironolactone and rotigotine can increase the risk of hypotension.","Concurrent use of spironolactone and sacubitril can increase the risk of hypotension.","Concurrent use of spironolactone and sapropterin can increase the risk of hypotension.","Concurrent use of spironolactone and selegiline can increase the risk of hypotension.","Concurrent use of spironolactone and sertraline can increase the risk of hyponatraemia.","Concurrent use of spironolactone and sevoflurane can increase the risk of hypotension.","Concurrent use of spironolactone and sildenafil can increase the risk of hypotension.","Concurrent use of spironolactone and sodium nitroprusside can increase the risk of hypotension.","Concurrent use of spironolactone and sodium oxybate can increase the risk of hypotension.","Concurrent use of spironolactone and sodium picosulfate can increase the risk of hyponatraemia.","Concurrent use of spironolactone and sotalol can increase the risk of hypotension.","Concurrent use of spironolactone and sulindac can increase the risk of hyponatraemia.","Concurrent use of spironolactone and sulindac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and sulpiride can increase the risk of hypotension.","Concurrent use of spironolactone and tacrolimus can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and tadalafil can increase the risk of hypotension.","Concurrent use of spironolactone and tamsulosin can increase the risk of hypotension.","Concurrent use of spironolactone and telmisartan can increase the risk of hypotension.","Concurrent use of spironolactone and telmisartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and tenoxicam can increase the risk of hyponatraemia.","Concurrent use of spironolactone and tenoxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and terazosin can increase the risk of hypotension.","Concurrent use of spironolactone and thiopental can increase the risk of hypotension.","Concurrent use of spironolactone and tiaprofenic acid can increase the risk of hyponatraemia.","Concurrent use of spironolactone and tiaprofenic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and timolol can increase the risk of hypotension.","Concurrent use of spironolactone and tinzaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and tizanidine can increase the risk of hypotension.","Concurrent use of spironolactone and tolfenamic acid can increase the risk of hyponatraemia.","Concurrent use of spironolactone and tolfenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and tolvaptan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and torasemide can increase the risk of hyponatraemia.","Concurrent use of spironolactone and torasemide can increase the risk of hypotension.","Concurrent use of spironolactone and trandolapril can increase the risk of hypotension.","Concurrent use of spironolactone and trandolapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and tranylcypromine can increase the risk of hypotension.","Concurrent use of spironolactone and triamterene can increase the risk of hyponatraemia.","Concurrent use of spironolactone and triamterene can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and trifluoperazine can increase the risk of hypotension.","Concurrent use of spironolactone and trimethoprim can increase the risk of hyponatraemia.","Concurrent use of spironolactone and trimethoprim can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and trimipramine can increase the risk of hyponatraemia.","Concurrent use of spironolactone and trimipramine can increase the risk of hypotension.","Concurrent use of spironolactone and valsartan can increase the risk of hypotension.","Concurrent use of spironolactone and valsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of spironolactone and vardenafil can increase the risk of hypotension.","Concurrent use of spironolactone and verapamil can increase the risk of hypotension.","Concurrent use of spironolactone and xipamide can increase the risk of hyponatraemia.","Concurrent use of spironolactone and xipamide can increase the risk of hypotension.","Concurrent use of spironolactone and zuclopenthixol can increase the risk of hypotension."]},{"name":"BNF.Temazepam.Temazepam","imports":["BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Fentanyl.Fentanyl","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Oxycodone.Oxycodone","BNF.Prochlorperazine.Prochlorperazine","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of temazepam and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of temazepam and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Theophylline.Theophylline","imports":["BNF.Adenosine.Adenosine","BNF.Amiodarone.Amiodarone","BNF.Atenolol.Atenolol","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisacodyl.Bisacodyl","BNF.Bisoprolol.Bisoprolol","BNF.Bumetanide.Bumetanide","BNF.Carbamazepine.Carbamazepine","BNF.Ciprofloxacin.Ciprofloxacin","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Digoxin.Digoxin","BNF.Furosemide.Furosemide","BNF.Haloperidol.Haloperidol","BNF.Indapamide.Indapamide","BNF.Levomepromazine.Levomepromazine","BNF.Ondansetron.Ondansetron","BNF.Phenytoin.Phenytoin","BNF.Quinine.Quinine","BNF.Salbutamol.Salbutamol","BNF.Senna.Senna","BNF.Venlafaxine.Venlafaxine"],"interactioninfo":["Acebutolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Aciclovir is predicted to increase the exposure to theophylline. Manufacturer advises monitor and adjust dose.","Theophylline decreases the efficacy of adenosine. Manufacturer advises separate administration by 24 hours.","Theophylline is predicted to increase the risk of torsade de pointes when given with amifampridine. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and aminophylline can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with amiodarone. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with amisulpride. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and amphotericin can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with apomorphine. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with arsenic trioxide. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with artemether. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with artenimol. Manufacturer advises use with caution or avoid.","Atenolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Azithromycin is predicted to increase the exposure to theophylline. Manufacturer advises adjust dose.","Concurrent use of theophylline and bambuterol can increase the risk of hypokalaemia.","Concurrent use of theophylline and beclometasone can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with bedaquiline. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and bendroflumethiazide can increase the risk of hypokalaemia.","Concurrent use of theophylline and betamethasone can increase the risk of hypokalaemia.","Betaxolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Concurrent use of theophylline and bisacodyl can increase the risk of hypokalaemia.","Bisoprolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Blinatumomab is predicted to transiently increase the exposure to theophylline. Manufacturer advises monitor and adjust dose.","Theophylline is predicted to increase the risk of torsade de pointes when given with bosutinib. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and budesonide can increase the risk of hypokalaemia.","Concurrent use of theophylline and bumetanide can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with cabozantinib. Manufacturer advises use with caution or avoid.","Caffeine citrate decreases the clearance of theophylline.","Carbamazepine potentially increases the clearance of theophylline and theophylline decreases the exposure to carbamazepine. Manufacturer advises adjust dose.","Carteolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Carvedilol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Celiprolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with ceritinib. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and chlorothiazide can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with chlorpromazine. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and chlortalidone can increase the risk of hypokalaemia.","Cimetidine increases the concentration of theophylline. Manufacturer advises adjust dose.","Ciprofloxacin is predicted to increase the exposure to theophylline. Manufacturer advises monitor and adjust dose.","Theophylline is predicted to increase the risk of torsade de pointes when given with citalopram. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with clarithromycin. Manufacturer advises use with caution or avoid.","Clarithromycin is predicted to increase the exposure to theophylline. Manufacturer advises adjust dose.","Theophylline is predicted to increase the risk of torsade de pointes when given with clomipramine. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and clopamide can increase the risk of hypokalaemia.","Combined hormonal contraceptives are predicted to increase the exposure to theophylline. Manufacturer advises monitor and adjust dose.","Theophylline is predicted to increase the risk of torsade de pointes when given with crizotinib. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and cyclopenthiazide can increase the risk of hypokalaemia.","Concurrent use of theophylline and dantron can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with dasatinib. Manufacturer advises use with caution or avoid.","Deferasirox increases the exposure to theophylline. Manufacturer advises avoid.","Concurrent use of theophylline and deflazacort can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with delamanid. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and dexamethasone can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of digoxin toxicity when given with digoxin.","Theophylline is predicted to increase the risk of torsade de pointes when given with disopyramide. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and docusate sodium can increase the risk of hypokalaemia.","Theophylline increases the risk of agitation when given with doxapram.","Theophylline is predicted to increase the risk of torsade de pointes when given with dronedarone. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with droperidol. Manufacturer advises use with caution or avoid.","Enteral feeds decrease the exposure to theophylline.","Ephedrine increases the risk of side-effects when given with theophylline. Manufacturer advises avoid in children.","Theophylline is predicted to increase the risk of torsade de pointes when given with eribulin. Manufacturer advises use with caution or avoid.","Erythromycin decreases the clearance of theophylline and theophylline potentially decreases the clearance of erythromycin. Manufacturer advises adjust dose.","Theophylline is predicted to increase the risk of torsade de pointes when given with escitalopram. Manufacturer advises use with caution or avoid.","Esmolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with flecainide. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and fludrocortisone can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with fluphenazine. Manufacturer advises use with caution or avoid.","Fluvoxamine moderately to markedly increases the exposure to theophylline. Manufacturer advises avoid.","Concurrent use of theophylline and formoterol can increase the risk of hypokalaemia.","Fosphenytoin is predicted to decrease the exposure to theophylline. Manufacturer advises adjust dose.","Concurrent use of theophylline and furosemide can increase the risk of hypokalaemia.","Concurrent use of theophylline and glycerol can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with haloperidol. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and hydrochlorothiazide can increase the risk of hypokalaemia.","Concurrent use of theophylline and hydrocortisone can increase the risk of hypokalaemia.","Concurrent use of theophylline and hydroflumethiazide can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with hydroxyzine. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and indacaterol can increase the risk of hypokalaemia.","Concurrent use of theophylline and indapamide can increase the risk of hypokalaemia.","Interferon alfa slightly increases the exposure to theophylline. Manufacturer advises adjust dose.","Interferon beta slightly increases the exposure to theophylline. Manufacturer advises adjust dose.","Isoniazid is predicted to affect the clearance of theophylline.","Labetalol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with lapatinib. Manufacturer advises use with caution or avoid.","Levobunolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with levomepromazine. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with lithium. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with lofexidine. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with methadone. Manufacturer advises use with caution or avoid.","Methotrexate decreases the clearance of theophylline.","Concurrent use of theophylline and methylprednisolone can increase the risk of hypokalaemia.","Concurrent use of theophylline and metolazone can increase the risk of hypokalaemia.","Metoprolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with moxifloxacin. Manufacturer advises use with caution or avoid.","Nadolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Nebivolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with nilotinib. Manufacturer advises use with caution or avoid.","Norfloxacin is predicted to increase the exposure to theophylline. Manufacturer advises adjust dose.","Obeticholic acid is predicted to increase the exposure to theophylline.","Concurrent use of theophylline and olodaterol can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with ondansetron. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with osimertinib. Manufacturer advises use with caution or avoid.","Oxprenolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with paliperidone. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with panobinostat. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with pasireotide. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with pazopanib. Manufacturer advises use with caution or avoid.","Peginterferon alfa slightly increases the exposure to theophylline. Manufacturer advises adjust dose.","Pentoxifylline increases the concentration of theophylline. Manufacturer advises monitor and adjust dose.","Phenobarbital is predicted to increase the clearance of theophylline. Manufacturer advises adjust dose.","Phenytoin is predicted to decrease the exposure to theophylline. Manufacturer advises adjust dose.","Theophylline is predicted to increase the risk of torsade de pointes when given with pimozide. Manufacturer advises use with caution or avoid.","Pindolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Concurrent use of theophylline and prednisolone can increase the risk of hypokalaemia.","Concurrent use of theophylline and prednisone can increase the risk of hypokalaemia.","Primidone is predicted to increase the clearance of theophylline. Manufacturer advises adjust dose.","Propranolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with quinine. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with ranolazine. Manufacturer advises use with caution or avoid.","Rifampicin is predicted to decrease the exposure to theophylline. Manufacturer advises adjust dose.","Theophylline is predicted to increase the risk of torsade de pointes when given with risperidone. Manufacturer advises use with caution or avoid.","Ritonavir is predicted to decrease the exposure to theophylline. Manufacturer advises adjust dose.","Theophylline is predicted to slightly increase the exposure to roflumilast. Manufacturer advises avoid.","Concurrent use of theophylline and salbutamol can increase the risk of hypokalaemia.","Concurrent use of theophylline and salmeterol can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with saquinavir. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and senna can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with sildenafil. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and sodium picosulfate can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with sorafenib. Manufacturer advises use with caution or avoid.","Sotalol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with sotalol. Manufacturer advises use with caution or avoid.","St John's Wort potentially decreases the exposure to theophylline.","Stiripentol is predicted to increase the exposure to theophylline. Manufacturer advises avoid.","Sucralfate potentially decreases the absorption of theophylline. Manufacturer advises separate administration by at least 2 hours.","Theophylline is predicted to increase the risk of torsade de pointes when given with sulpiride. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with sunitinib. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with telavancin. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and terbutaline can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with tetrabenazine. Manufacturer advises use with caution or avoid.","Timolol is predicted to increase the risk of bronchospasm when given with theophylline. Manufacturer advises avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with tizanidine. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with tolterodine. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and torasemide can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with toremifene. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and triamcinolone can increase the risk of hypokalaemia.","Valaciclovir is predicted to increase the exposure to theophylline.","Theophylline is predicted to increase the risk of torsade de pointes when given with vandetanib. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with vardenafil. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with vemurafenib. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and vilanterol can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with vinflunine. Manufacturer advises use with caution or avoid.","Theophylline is predicted to increase the risk of torsade de pointes when given with voriconazole. Manufacturer advises use with caution or avoid.","Concurrent use of theophylline and xipamide can increase the risk of hypokalaemia.","Theophylline is predicted to increase the risk of torsade de pointes when given with zuclopenthixol. Manufacturer advises use with caution or avoid."]},{"name":"BNF.Tiotropium.Tiotropium","imports":["BNF.Amitriptyline.Amitriptyline","BNF.Cyclizine.Cyclizine","BNF.Haloperidol.Haloperidol","BNF.Ipratropium.Ipratropium","BNF.Levomepromazine.Levomepromazine","BNF.Nefopam.Nefopam","BNF.Prochlorperazine.Prochlorperazine"],"interactioninfo":["Concurrent use of tiotropium and aclidinium can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and amantadine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and amitriptyline can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and atropine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and baclofen can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and chlorphenamine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and chlorpromazine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and clemastine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and clomipramine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and clozapine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and cyclizine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and cyclopentolate can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and cyproheptadine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and darifenacin can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and dicycloverine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and dimenhydrinate can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and disopyramide can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and dosulepin can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and doxepin can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and fesoterodine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and flavoxate can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and glycopyrronium can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and haloperidol can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and homatropine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and hydroxyzine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and hyoscine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and imipramine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and ipratropium can increase the risk of antimuscarinic effects.","Tiotropium decreases the absorption of levodopa.","Concurrent use of tiotropium and levomepromazine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and lofepramine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and loxapine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and nefopam can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and nortriptyline can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and orphenadrine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and oxybutynin can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and perphenazine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and pimozide can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and prochlorperazine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and procyclidine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and promethazine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and propafenone can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and propantheline can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and propiverine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and solifenacin can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and tolterodine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and trifluoperazine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and trihexyphenidyl can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and trimipramine can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and tropicamide can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and trospium can increase the risk of antimuscarinic effects.","Concurrent use of tiotropium and umeclidinium can increase the risk of antimuscarinic effects."]},{"name":"BNF.Tramadol.Tramadol","imports":["BNF.Carbamazepine.Carbamazepine","BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Citalopram.Citalopram","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Fentanyl.Fentanyl","BNF.Fluoxetine.Fluoxetine","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Ondansetron.Ondansetron","BNF.Oxycodone.Oxycodone","BNF.Prochlorperazine.Prochlorperazine","BNF.Sertraline.Sertraline","BNF.Temazepam.Temazepam","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of tramadol and St John's Wort can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Abiraterone is predicted to decrease the efficacy of tramadol.","Concurrent use of tramadol and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and almotriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Buprenorphine is predicted to increase the risk of opiate withdrawal when given with tramadol.","Concurrent use of tramadol and bupropion can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Bupropion is predicted to decrease the efficacy of tramadol.","Concurrent use of tramadol and buspirone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Carbamazepine decreases the concentration of tramadol. Manufacturer advises adjust dose.","Concurrent use of tramadol and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Cinacalcet is predicted to decrease the efficacy of tramadol.","Concurrent use of tramadol and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and citalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and clomipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and dapoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and dexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and duloxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Duloxetine is predicted to decrease the efficacy of tramadol.","Concurrent use of tramadol and eletriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and escitalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and fentanyl can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and fluoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fluoxetine is predicted to decrease the efficacy of tramadol.","Concurrent use of tramadol and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and fluvoxamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and frovatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and granisetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and imipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and isocarboxazid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Tramadol is predicted to increase the risk of CNS excitation or depression when given with isocarboxazid. Manufacturer advises avoid.","Concurrent use of tramadol and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and linezolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and lisdexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and lithium can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and methadone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and methylthioninium chloride can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and mianserin can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Mirabegron is predicted to decrease the efficacy of tramadol.","Concurrent use of tramadol and mirtazapine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and moclobemide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Nalmefene is predicted to decrease the efficacy of tramadol. Manufacturer advises avoid.","Concurrent use of tramadol and naratriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and ondansetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and palonosetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and paroxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Paroxetine is predicted to decrease the efficacy of tramadol.","Concurrent use of tramadol and pentazocine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Pentazocine is predicted to increase the risk of opiate withdrawal when given with tramadol.","Concurrent use of tramadol and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and pethidine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and phenelzine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Tramadol is predicted to increase the risk of CNS excitation or depression when given with phenelzine. Manufacturer advises avoid.","Concurrent use of tramadol and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and procarbazine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Propafenone is predicted to decrease the efficacy of tramadol.","Concurrent use of tramadol and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and rasagiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ritonavir is predicted to decrease the efficacy of tramadol.","Concurrent use of tramadol and rizatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and safinamide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and selegiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and sertraline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and sumatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and tapentadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and tedizolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Terbinafine is predicted to decrease the efficacy of tramadol.","Concurrent use of tramadol and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and tranylcypromine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Tramadol is predicted to increase the risk of CNS excitation or depression when given with tranylcypromine. Manufacturer advises avoid.","Concurrent use of tramadol and trazodone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and venlafaxine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and vortioxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and zolmitriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of tramadol and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of tramadol and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Trazodone.Trazodone","imports":["BNF.Carbamazepine.Carbamazepine","BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Diltiazem.Diltiazem","BNF.Fentanyl.Fentanyl","BNF.Fluoxetine.Fluoxetine","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Ondansetron.Ondansetron","BNF.Oxycodone.Oxycodone","BNF.Prochlorperazine.Prochlorperazine","BNF.Sertraline.Sertraline","BNF.Temazepam.Temazepam","BNF.Tramadol.Tramadol","BNF.Venlafaxine.Venlafaxine","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of trazodone and St John's Wort can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and almotriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Aprepitant is predicted to increase the exposure to trazodone.","Concurrent use of trazodone and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Atazanavir is predicted to moderately increase the exposure to trazodone. Manufacturer advises avoid or adjust dose.","Concurrent use of trazodone and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and bupropion can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and buspirone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Carbamazepine decreases the concentration of trazodone. Manufacturer advises adjust dose.","Concurrent use of trazodone and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and citalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Clarithromycin is predicted to moderately increase the exposure to trazodone. Manufacturer advises avoid or adjust dose.","Concurrent use of trazodone and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and clomipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Cobicistat is predicted to moderately increase the exposure to trazodone. Manufacturer advises avoid or adjust dose.","Concurrent use of trazodone and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Crizotinib is predicted to increase the exposure to trazodone.","Concurrent use of trazodone and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and dapoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Darunavir is predicted to moderately increase the exposure to trazodone. Manufacturer advises avoid or adjust dose.","Concurrent use of trazodone and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and dexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Diltiazem is predicted to increase the exposure to trazodone.","Concurrent use of trazodone and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Dronedarone is predicted to increase the exposure to trazodone.","Concurrent use of trazodone and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and duloxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and eletriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Erythromycin is predicted to increase the exposure to trazodone.","Concurrent use of trazodone and escitalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and fentanyl can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Fluconazole is predicted to increase the exposure to trazodone.","Concurrent use of trazodone and fluoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and fluvoxamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Fosamprenavir is predicted to moderately increase the exposure to trazodone. Manufacturer advises avoid or adjust dose.","Concurrent use of trazodone and frovatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and granisetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Idelalisib is predicted to moderately increase the exposure to trazodone. Manufacturer advises avoid or adjust dose.","Imatinib is predicted to increase the exposure to trazodone.","Concurrent use of trazodone and imipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Indinavir is predicted to increase the exposure to trazodone.","Isavuconazole is predicted to increase the exposure to trazodone.","Concurrent use of trazodone and isocarboxazid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Itraconazole is predicted to moderately increase the exposure to trazodone. Manufacturer advises avoid or adjust dose.","Concurrent use of trazodone and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ketoconazole is predicted to moderately increase the exposure to trazodone. Manufacturer advises avoid or adjust dose.","Concurrent use of trazodone and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and linezolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and lisdexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and lithium can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Lopinavir is predicted to moderately increase the exposure to trazodone. Manufacturer advises avoid or adjust dose.","Concurrent use of trazodone and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and methadone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and methylthioninium chloride can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and mianserin can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and mirtazapine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and moclobemide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and naratriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Netupitant is predicted to increase the exposure to trazodone.","Nilotinib is predicted to increase the exposure to trazodone.","Concurrent use of trazodone and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and ondansetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and palonosetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and paroxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and pentazocine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and pethidine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and phenelzine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Posaconazole is predicted to increase the exposure to trazodone.","Concurrent use of trazodone and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and procarbazine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and rasagiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ritonavir is predicted to moderately increase the exposure to trazodone. Manufacturer advises avoid or adjust dose.","Concurrent use of trazodone and rizatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and safinamide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Saquinavir is predicted to moderately increase the exposure to trazodone. Manufacturer advises avoid or adjust dose.","Concurrent use of trazodone and selegiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and sertraline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and sumatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and tapentadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and tedizolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Tipranavir is predicted to moderately increase the exposure to trazodone. Manufacturer advises avoid or adjust dose.","Concurrent use of trazodone and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and tramadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and tranylcypromine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and venlafaxine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Verapamil is predicted to increase the exposure to trazodone.","Voriconazole is predicted to moderately increase the exposure to trazodone. Manufacturer advises avoid or adjust dose.","Concurrent use of trazodone and vortioxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and zolmitriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of trazodone and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of trazodone and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Trimethoprim.Trimethoprim","imports":["BNF.Amiloride.Amiloride","BNF.Amitriptyline.Amitriptyline","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bumetanide.Bumetanide","BNF.Candesartan.Candesartan","BNF.Carbamazepine.Carbamazepine","BNF.Ceftazidime.Ceftazidime","BNF.Cefuroxime.Cefuroxime","BNF.Citalopram.Citalopram","BNF.Diclofenac.Diclofenac","BNF.Digoxin.Digoxin","BNF.Enoxaparin.Enoxaparin","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Lisinopril.Lisinopril","BNF.Losartan.Losartan","BNF.Naproxen.Naproxen","BNF.Phenytoin.Phenytoin","BNF.Ramipril.Ramipril","BNF.Sertraline.Sertraline","BNF.Spironolactone.Spironolactone","BNF.Vancomycin.Vancomycin","BNF.Warfarin.Warfarin"],"interactioninfo":["Concurrent use of trimethoprim and aceclofenac can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and aceclofenac can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and aceclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and acemetacin can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and acemetacin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and acemetacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Trimethoprim is predicted to increase the anticoagulant effect of acenocoumarol.","Concurrent use of trimethoprim and aciclovir can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and aliskiren can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and amikacin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and amiloride can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and amiloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and amitriptyline can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and amphotericin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and azilsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and bacitracin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and bendroflumethiazide can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and benzydamine can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and bromfenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and bumetanide can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and candesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and capreomycin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and captopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and carbamazepine can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and carboplatin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and cefaclor can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and cefadroxil can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and cefalexin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and cefixime can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and cefotaxime can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and cefradine can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and ceftaroline can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and ceftazidime can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and ceftobiprole can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and ceftolozane can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and ceftriaxone can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and cefuroxime can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and celecoxib can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and celecoxib can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and celecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and chlorothiazide can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and chlortalidone can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and ciclosporin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and ciclosporin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and cisplatin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and citalopram can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and clomipramine can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and clopamide can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and colistimethate can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and cyclopenthiazide can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and dalteparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and dapoxetine can increase the risk of hyponatraemia.","Dapsone increases the exposure to trimethoprim and trimethoprim increases the exposure to dapsone.","Concurrent use of trimethoprim and darbepoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and desmopressin can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and dexibuprofen can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and dexibuprofen can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and dexibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and dexketoprofen can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and dexketoprofen can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and dexketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and diclofenac can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and diclofenac can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and diclofenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Trimethoprim increases the concentration of digoxin.","Concurrent use of trimethoprim and dosulepin can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and doxepin can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and drospirenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and duloxetine can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and enalapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and enoxaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and eplerenone can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and eplerenone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and epoetin alfa can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and epoetin beta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and epoetin zeta can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and eprosartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and escitalopram can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and etodolac can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and etodolac can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and etodolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and etoricoxib can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and etoricoxib can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and etoricoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and felbinac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and fenoprofen can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and fenoprofen can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and fenoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and fluoxetine can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and flurbiprofen can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and flurbiprofen can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and flurbiprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and fluvoxamine can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and foscarnet can increase the risk of nephrotoxicity.","Trimethoprim increases the concentration of fosphenytoin.","Concurrent use of trimethoprim and furosemide can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and ganciclovir can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and gentamicin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and heparin (unfractionated) can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and hydrochlorothiazide can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and hydroflumethiazide can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and ibuprofen can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and ibuprofen can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and ibuprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and ifosfamide can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and imidapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and imipramine can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and indapamide can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and indometacin can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and indometacin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and indometacin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and irbesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and ketoprofen can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and ketoprofen can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and ketoprofen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and ketorolac can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and ketorolac can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and ketorolac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Trimethoprim slightly increases the exposure to lamivudine.","Concurrent use of trimethoprim and lisinopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and losartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and mefenamic acid can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and mefenamic acid can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and mefenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and meloxicam can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and meloxicam can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and meloxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and methotrexate can increase the risk of nephrotoxicity.","Trimethoprim is predicted to increase the risk of side-effects when given with methotrexate. Manufacturer advises avoid.","Concurrent use of trimethoprim and metolazone can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and moexipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and nabumetone can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and nabumetone can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and nabumetone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and naproxen can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and naproxen can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and naproxen can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and neomycin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and nepafenac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and nortriptyline can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and olmesartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and oxaliplatin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and parecoxib can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and parecoxib can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and parecoxib can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and paroxetine can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and pemetrexed can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and penicillamine can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and pentamidine can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and perindopril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Trimethoprim increases the concentration of phenytoin.","Concurrent use of trimethoprim and piroxicam can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and piroxicam can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and piroxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and polymyxins can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and potassium canrenoate can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and potassium chloride can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Pyrimethamine increases the risk of side-effects when given with trimethoprim.","Concurrent use of trimethoprim and quinapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and ramipril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Trimethoprim slightly increases the exposure to repaglinide. Manufacturer advises avoid or monitor blood glucose.","Rifampicin decreases the exposure to trimethoprim.","Trimethoprim is predicted to decrease the efficacy of sapropterin.","Concurrent use of trimethoprim and sertraline can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and sodium picosulfate can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and spironolactone can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and spironolactone can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and streptomycin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and sulindac can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and sulindac can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and sulindac can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and tacrolimus can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and tacrolimus can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and telavancin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and telmisartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and tenofovir can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and tenoxicam can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and tenoxicam can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and tenoxicam can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and tiaprofenic acid can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and tiaprofenic acid can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and tiaprofenic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and tinzaparin can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and tobramycin can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and tolfenamic acid can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and tolfenamic acid can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and tolfenamic acid can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and tolvaptan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and torasemide can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and trandolapril can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and triamterene can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and triamterene can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and trimipramine can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and valaciclovir can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and valganciclovir can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and valsartan can increase the risk of hyperkalaemia (hyperkalaemia is particularly notable when ACE inhibitors or angiotensin-II receptor antagonists are given with spironolactone or eplerenone).","Concurrent use of trimethoprim and vancomycin can increase the risk of nephrotoxicity.","Trimethoprim is predicted to increase the anticoagulant effect of warfarin.","Concurrent use of trimethoprim and xipamide can increase the risk of hyponatraemia.","Concurrent use of trimethoprim and zidovudine can increase the risk of nephrotoxicity.","Concurrent use of trimethoprim and zoledronic acid can increase the risk of nephrotoxicity."]},{"name":"BNF.Vancomycin.Vancomycin","imports":["BNF.Bumetanide.Bumetanide","BNF.Ceftazidime.Ceftazidime","BNF.Cefuroxime.Cefuroxime","BNF.Diclofenac.Diclofenac","BNF.Furosemide.Furosemide","BNF.Ibuprofen.Ibuprofen","BNF.Naproxen.Naproxen","BNF.Trimethoprim.Trimethoprim"],"interactioninfo":["Concurrent use of vancomycin and aceclofenac can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and acemetacin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and aciclovir can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and amikacin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and amikacin can increase the risk of ototoxicity.","Concurrent use of vancomycin and amphotericin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and bacitracin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and bumetanide can increase the risk of ototoxicity.","Concurrent use of vancomycin and capreomycin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and capreomycin can increase the risk of ototoxicity.","Concurrent use of vancomycin and carboplatin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and carboplatin can increase the risk of ototoxicity.","Concurrent use of vancomycin and cefaclor can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and cefadroxil can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and cefalexin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and cefixime can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and cefotaxime can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and cefradine can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and ceftaroline can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and ceftazidime can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and ceftobiprole can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and ceftolozane can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and ceftriaxone can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and cefuroxime can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and celecoxib can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and ciclosporin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and cisplatin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and cisplatin can increase the risk of ototoxicity.","Concurrent use of vancomycin and colistimethate can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and dexibuprofen can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and dexketoprofen can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and diclofenac can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and etodolac can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and etoricoxib can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and fenoprofen can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and flurbiprofen can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and foscarnet can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and furosemide can increase the risk of ototoxicity.","Concurrent use of vancomycin and ganciclovir can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and gentamicin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and gentamicin can increase the risk of ototoxicity.","Concurrent use of vancomycin and ibuprofen can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and ifosfamide can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and indometacin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and ketoprofen can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and ketorolac can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and mefenamic acid can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and meloxicam can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and methotrexate can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and nabumetone can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and naproxen can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and neomycin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and neomycin can increase the risk of ototoxicity.","Concurrent use of vancomycin and oxaliplatin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and oxaliplatin can increase the risk of ototoxicity.","Concurrent use of vancomycin and parecoxib can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and pemetrexed can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and penicillamine can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and pentamidine can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and piroxicam can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and polymyxins can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and streptomycin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and streptomycin can increase the risk of ototoxicity.","Concurrent use of vancomycin and sulindac can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and tacrolimus can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and telavancin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and telavancin can increase the risk of ototoxicity.","Concurrent use of vancomycin and tenofovir can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and tenoxicam can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and tiaprofenic acid can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and tobramycin can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and tobramycin can increase the risk of ototoxicity.","Concurrent use of vancomycin and tolfenamic acid can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and torasemide can increase the risk of ototoxicity.","Concurrent use of vancomycin and trimethoprim can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and valaciclovir can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and valganciclovir can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and vinblastine can increase the risk of ototoxicity.","Concurrent use of vancomycin and vincristine can increase the risk of ototoxicity.","Concurrent use of vancomycin and vindesine can increase the risk of ototoxicity.","Concurrent use of vancomycin and vinflunine can increase the risk of ototoxicity.","Concurrent use of vancomycin and vinorelbine can increase the risk of ototoxicity.","Concurrent use of vancomycin and zidovudine can increase the risk of nephrotoxicity.","Concurrent use of vancomycin and zoledronic acid can increase the risk of nephrotoxicity."]},{"name":"BNF.Venlafaxine.Venlafaxine","imports":["BNF.Amiodarone.Amiodarone","BNF.Apixaban.Apixaban","BNF.Bendroflumethiazide.Bendroflumethiazide","BNF.Bisacodyl.Bisacodyl","BNF.Bumetanide.Bumetanide","BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Diclofenac.Diclofenac","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Enoxaparin.Enoxaparin","BNF.Fentanyl.Fentanyl","BNF.Fluoxetine.Fluoxetine","BNF.Furosemide.Furosemide","BNF.Gabapentin.Gabapentin","BNF.Glucose.Glucose","BNF.Haloperidol.Haloperidol","BNF.Ibuprofen.Ibuprofen","BNF.Indapamide.Indapamide","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Naproxen.Naproxen","BNF.Ondansetron.Ondansetron","BNF.Oxycodone.Oxycodone","BNF.Prochlorperazine.Prochlorperazine","BNF.Quinine.Quinine","BNF.Rivaroxaban.Rivaroxaban","BNF.Salbutamol.Salbutamol","BNF.Senna.Senna","BNF.Sertraline.Sertraline","BNF.Temazepam.Temazepam","BNF.Theophylline.Theophylline","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Warfarin.Warfarin","BNF.Zopiclone.Zopiclone"],"interactioninfo":["Concurrent use of venlafaxine and St John's Wort can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and abciximab can increase the risk of bleeding.","Abiraterone potentially increases the exposure to venlafaxine.","Both venlafaxine and aceclofenac can increase the risk of bleeding.","Both venlafaxine and acemetacin can increase the risk of bleeding.","Acenocoumarol is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and almotriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Alteplase is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and amifampridine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Aminophylline is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and amiodarone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and amisulpride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Amphotericin is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and anagrelide can increase the risk of bleeding.","Apixaban is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and apomorphine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Argatroban is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and arsenic trioxide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and artemether prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and artenimol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and aspirin can increase the risk of bleeding.","Atazanavir is predicted to increase the exposure to venlafaxine.","Concurrent use of venlafaxine and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Bambuterol is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Beclometasone is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and bedaquiline prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Bendroflumethiazide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Betamethasone is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and bevacizumab can increase the risk of bleeding.","Bisacodyl is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Bivalirudin is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and bosutinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Budesonide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Bumetanide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and bupropion can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and buspirone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and cabozantinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and cangrelor can increase the risk of bleeding.","Concurrent use of venlafaxine and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and celecoxib can increase the risk of bleeding.","Both venlafaxine and ceritinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Chlorothiazide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and chlorpromazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Chlortalidone is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and cilostazol can increase the risk of bleeding.","Cimetidine slightly increases the exposure to venlafaxine.","Concurrent use of venlafaxine and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and citalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and citalopram prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and citalopram can increase the risk of bleeding.","Both venlafaxine and clarithromycin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Clarithromycin is predicted to increase the exposure to venlafaxine.","Concurrent use of venlafaxine and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and clomipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and clomipramine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Clopamide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and clopidogrel can increase the risk of bleeding.","Concurrent use of venlafaxine and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Cobicistat is predicted to increase the exposure to venlafaxine.","Concurrent use of venlafaxine and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and crizotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Cyclopenthiazide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Dabigatran is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Dalteparin is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Danaparoid is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Dantron is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and dapoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and dapoxetine can increase the risk of bleeding.","Darunavir is predicted to increase the exposure to venlafaxine.","Both venlafaxine and dasatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and dasatinib can increase the risk of bleeding.","Deflazacort is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and delamanid prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Dexamethasone is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and dexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and dexibuprofen can increase the risk of bleeding.","Both venlafaxine and dexketoprofen can increase the risk of bleeding.","Concurrent use of venlafaxine and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and diclofenac can increase the risk of bleeding.","Concurrent use of venlafaxine and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and dipyridamole can increase the risk of bleeding.","Both venlafaxine and disopyramide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Docusate sodium is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Domperidone increases the risk of QT-prolongation when given with venlafaxine. Manufacturer advises avoid.","Both venlafaxine and dronedarone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and droperidol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and duloxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and duloxetine can increase the risk of bleeding.","Edoxaban is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and eletriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Enoxaparin is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and epoprostenol can increase the risk of bleeding.","Both venlafaxine and eptifibatide can increase the risk of bleeding.","Both venlafaxine and eribulin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Intravenous erythromycin increases the risk of QT-prolongation when given with venlafaxine. Manufacturer advises avoid or monitor.","Concurrent use of venlafaxine and escitalopram can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and escitalopram prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and escitalopram can increase the risk of bleeding.","Both venlafaxine and etodolac can increase the risk of bleeding.","Concurrent use of venlafaxine and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and etoricoxib can increase the risk of bleeding.","Both venlafaxine and fenoprofen can increase the risk of bleeding.","Concurrent use of venlafaxine and fentanyl can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Fingolimod increases the risk of QT-prolongation when given with venlafaxine. Manufacturer advises avoid.","Both venlafaxine and flecainide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Fludrocortisone is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and fluoxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and fluoxetine can increase the risk of bleeding.","Concurrent use of venlafaxine and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and fluphenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and flurbiprofen can increase the risk of bleeding.","Concurrent use of venlafaxine and fluvoxamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and fluvoxamine can increase the risk of bleeding.","Fondaparinux is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Formoterol is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Fosamprenavir is predicted to increase the exposure to venlafaxine.","Concurrent use of venlafaxine and frovatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Furosemide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Glucose is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Glycerol is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and granisetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Granisetron is predicted to increase the risk of QT-prolongation when given with venlafaxine.","Concurrent use of venlafaxine and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and haloperidol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Venlafaxine slightly increases the exposure to haloperidol.","Heparin (unfractionated) is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Hydrochlorothiazide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Hydrocortisone is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Hydroflumethiazide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and hydroxyzine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and ibrutinib can increase the risk of bleeding.","Both venlafaxine and ibuprofen can increase the risk of bleeding.","Idelalisib is predicted to increase the exposure to venlafaxine.","Both venlafaxine and iloprost can increase the risk of bleeding.","Concurrent use of venlafaxine and imipramine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Indacaterol is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Indapamide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and indometacin can increase the risk of bleeding.","Concurrent use of venlafaxine and isocarboxazid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Itraconazole is predicted to increase the exposure to venlafaxine.","Ivabradine is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises avoid.","Concurrent use of venlafaxine and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ketoconazole is predicted to increase the exposure to venlafaxine.","Both venlafaxine and ketoprofen can increase the risk of bleeding.","Both venlafaxine and ketorolac can increase the risk of bleeding.","Concurrent use of venlafaxine and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and lapatinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and levomepromazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and linezolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and lisdexamfetamine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and lithium can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and lithium prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and lofexidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Lopinavir is predicted to increase the exposure to venlafaxine.","Concurrent use of venlafaxine and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and mefenamic acid can increase the risk of bleeding.","Mefloquine is predicted to increase the risk of QT-prolongation when given with venlafaxine.","Concurrent use of venlafaxine and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and meloxicam can increase the risk of bleeding.","Concurrent use of venlafaxine and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and methadone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and methadone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Methylprednisolone is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and methylthioninium chloride can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Metolazone is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and mianserin can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and mirtazapine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Mizolastine is predicted to increase the risk of QT-prolongation when given with venlafaxine. Manufacturer advises avoid.","Concurrent use of venlafaxine and moclobemide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and moxifloxacin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and nabumetone can increase the risk of bleeding.","Both venlafaxine and naproxen can increase the risk of bleeding.","Concurrent use of venlafaxine and naratriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Nicotinic acid is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and nilotinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Olodaterol is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Omega-3-acid ethyl esters is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and ondansetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and ondansetron prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and osimertinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and paliperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and palonosetron can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Palonosetron is predicted to increase the risk of QT-prolongation when given with venlafaxine.","Both venlafaxine and panobinostat prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and parecoxib can increase the risk of bleeding.","Concurrent use of venlafaxine and paroxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and paroxetine can increase the risk of bleeding.","Both venlafaxine and pasireotide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and pazopanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Intravenous pentamidine potentially increases the risk of QT-prolongation when given with venlafaxine.","Concurrent use of venlafaxine and pentazocine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and pethidine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and phenelzine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Phenindione is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and pimozide prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and piroxicam can increase the risk of bleeding.","Concurrent use of venlafaxine and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and prasugrel can increase the risk of bleeding.","Prednisolone is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Prednisone is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and procarbazine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and quinine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and ranolazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and rasagiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and regorafenib can increase the risk of bleeding.","Concurrent use of venlafaxine and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Reteplase is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and risperidone prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ritonavir is predicted to increase the exposure to venlafaxine.","Rivaroxaban is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and rizatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and safinamide can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Salbutamol is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Salmeterol is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and saquinavir prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Saquinavir is predicted to increase the exposure to venlafaxine.","Concurrent use of venlafaxine and selegiline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Senna is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and sertraline can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and sertraline can increase the risk of bleeding.","Concurrent use of venlafaxine and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and sildenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Sodium picosulfate is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and sorafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and sotalol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Streptokinase is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and sulfinpyrazone can increase the risk of bleeding.","Both venlafaxine and sulindac can increase the risk of bleeding.","Both venlafaxine and sulpiride prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and sumatriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and sunitinib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Tacrolimus potentially increases the risk of serotonin syndrome when given with venlafaxine.","Concurrent use of venlafaxine and tapentadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and tedizolid can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and telavancin prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Tenecteplase is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and tenoxicam can increase the risk of bleeding.","Terbutaline is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and tetrabenazine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Theophylline is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and tiaprofenic acid can increase the risk of bleeding.","Both venlafaxine and ticagrelor can increase the risk of bleeding.","Tinzaparin is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Tipranavir is predicted to increase the exposure to venlafaxine.","Both venlafaxine and tirofiban can increase the risk of bleeding.","Both venlafaxine and tizanidine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and tolfenamic acid can increase the risk of bleeding.","Both venlafaxine and tolterodine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Torasemide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and toremifene prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and tramadol can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and tranylcypromine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and trastuzumab can increase the risk of bleeding.","Both venlafaxine and trastuzumab emtansine can increase the risk of bleeding.","Concurrent use of venlafaxine and trazodone can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Triamcinolone is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Urokinase is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and vandetanib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and vardenafil prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and vemurafenib prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Vilanterol is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Both venlafaxine and vinflunine prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Both venlafaxine and voriconazole prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Voriconazole is predicted to increase the exposure to venlafaxine.","Concurrent use of venlafaxine and vortioxetine can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Both venlafaxine and vortioxetine can increase the risk of bleeding.","Warfarin is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Xipamide is predicted to increase the risk of torsade de pointes when given with venlafaxine. Manufacturer advises use with caution or avoid.","Concurrent use of venlafaxine and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and zolmitriptan can increase the risk of serotonin syndrome. See Antidepressant drugs for more information and specific advice on avoiding monoamine-oxidase inhibitors during and after administration of other serotonergic drugs.","Concurrent use of venlafaxine and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of venlafaxine and zopiclone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Both venlafaxine and zuclopenthixol prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.","Concurrent use of venlafaxine and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]},{"name":"BNF.Warfarin.Warfarin","imports":["BNF.Amiodarone.Amiodarone","BNF.Amoxicillin.Amoxicillin","BNF.Apixaban.Apixaban","BNF.Carbamazepine.Carbamazepine","BNF.Ciprofloxacin.Ciprofloxacin","BNF.Citalopram.Citalopram","BNF.Clarithromycin.Clarithromycin","BNF.Diclofenac.Diclofenac","BNF.Doxycycline.Doxycycline","BNF.Enoxaparin.Enoxaparin","BNF.Flucloxacillin.Flucloxacillin","BNF.Fluoxetine.Fluoxetine","BNF.Glucose.Glucose","BNF.Ibuprofen.Ibuprofen","BNF.Levofloxacin.Levofloxacin","BNF.Naproxen.Naproxen","BNF.Paracetamol.Paracetamol","BNF.Phenytoin.Phenytoin","BNF.Rivaroxaban.Rivaroxaban","BNF.Sertraline.Sertraline","BNF.Trimethoprim.Trimethoprim","BNF.Venlafaxine.Venlafaxine"],"interactioninfo":["Warfarin is predicted to increase the risk of bleeding events when given with abciximab. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with aceclofenac. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with acemetacin. Manufacturer advises use with caution or avoid.","Both warfarin and acenocoumarol can increase the risk of bleeding.","Both warfarin and alteplase can increase the risk of bleeding.","Amiodarone increases the anticoagulant effect of warfarin.","Amoxicillin potentially alters the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Ampicillin potentially alters the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Warfarin is predicted to increase the risk of bleeding events when given with anagrelide. Manufacturer advises use with caution or avoid.","Both warfarin and apixaban can increase the risk of bleeding.","Aprepitant decreases the anticoagulant effect of warfarin.","Both warfarin and argatroban can increase the risk of bleeding.","Warfarin is predicted to increase the risk of bleeding events when given with aspirin. Manufacturer advises use with caution or avoid.","Atazanavir is predicted to affect the anticoagulant effect of warfarin.","Axitinib is predicted to increase the risk of bleeding events when given with warfarin.","Azathioprine decreases the anticoagulant effect of warfarin.","Beclometasone is predicted to increase the effects of warfarin.","Benzylpenicillin potentially alters the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Betamethasone is predicted to increase the effects of warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with bevacizumab. Manufacturer advises use with caution or avoid.","Bezafibrate is predicted to increase the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Both warfarin and bivalirudin can increase the risk of bleeding.","Blinatumomab is predicted to transiently increase the exposure to warfarin. Manufacturer advises monitor and adjust dose.","Bosentan decreases the anticoagulant effect of warfarin.","Bosutinib is predicted to increase the risk of bleeding events when given with warfarin.","Budesonide is predicted to increase the effects of warfarin.","Cabozantinib is predicted to increase the risk of bleeding events when given with warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with cangrelor. Manufacturer advises use with caution or avoid.","Capecitabine increases the effects of warfarin. Manufacturer advises monitor INR and adjust dose.","Carbamazepine decreases the effects of warfarin. Manufacturer advises monitor and adjust dose.","Ceftriaxone potentially increases the risk of bleeding events when given with warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with celecoxib. Manufacturer advises use with caution or avoid.","Ceritinib is predicted to increase the exposure to warfarin. Manufacturer advises avoid.","Chloramphenicol potentially increases the anticoagulant effect of warfarin.","Ciclesonide is predicted to increase the effects of warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with cilostazol. Manufacturer advises use with caution or avoid.","Cimetidine increases the anticoagulant effect of warfarin.","Ciprofibrate is predicted to increase the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Ciprofloxacin increases the anticoagulant effect of warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with citalopram. Manufacturer advises use with caution or avoid.","Clarithromycin increases the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Warfarin is predicted to increase the risk of bleeding events when given with clopidogrel. Manufacturer advises use with caution or avoid.","Cranberry juice potentially increases the anticoagulant effect of warfarin. Manufacturer advises avoid.","Crizotinib is predicted to increase the risk of bleeding events when given with warfarin.","Both warfarin and dabigatran can increase the risk of bleeding.","Dabrafenib is predicted to decrease the anticoagulant effect of warfarin.","Both warfarin and dalteparin can increase the risk of bleeding.","Both warfarin and danaparoid can increase the risk of bleeding.","Danazol potentially increases the anticoagulant effect of warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with dapoxetine. Manufacturer advises use with caution or avoid.","Darunavir is predicted to affect the anticoagulant effect of warfarin.","Dasatinib is predicted to increase the risk of bleeding events when given with warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with dasatinib. Manufacturer advises use with caution or avoid.","Deflazacort is predicted to increase the effects of warfarin.","Demeclocycline increases the risk of bleeding events when given with warfarin.","Dexamethasone is predicted to increase the effects of warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with dexibuprofen. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with dexketoprofen. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with diclofenac. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with dipyridamole. Manufacturer advises use with caution or avoid.","Disulfiram increases the anticoagulant effect of warfarin. Manufacturer advises monitor and adjust dose.","Doxycycline increases the risk of bleeding events when given with warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with duloxetine. Manufacturer advises use with caution or avoid.","Both warfarin and edoxaban can increase the risk of bleeding.","Efavirenz is predicted to affect the concentration of warfarin. Manufacturer advises adjust dose.","Elvitegravir is predicted to decrease the anticoagulant effect of warfarin.","Both warfarin and enoxaparin can increase the risk of bleeding.","Enteral feeds (vitamin-K containing) potentially decrease the anticoagulant effect of warfarin.","Enzalutamide potentially decreases the exposure to warfarin. Manufacturer advises avoid or adjust dose and monitor INR.","Warfarin is predicted to increase the risk of bleeding events when given with epoprostenol. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with eptifibatide. Manufacturer advises use with caution or avoid.","Erlotinib increases the anticoagulant effect of warfarin.","Erythromycin increases the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Warfarin is predicted to increase the risk of bleeding events when given with escitalopram. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with etodolac. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with etoricoxib. Manufacturer advises use with caution or avoid.","Etravirine increases the anticoagulant effect of warfarin.","Fenofibrate is predicted to increase the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Warfarin is predicted to increase the risk of bleeding events when given with fenoprofen. Manufacturer advises use with caution or avoid.","Flucloxacillin potentially alters the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Fluconazole increases the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Fludrocortisone is predicted to increase the effects of warfarin.","Fluorouracil increases the anticoagulant effect of warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with fluoxetine. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with flurbiprofen. Manufacturer advises use with caution or avoid.","Fluticasone is predicted to increase the effects of warfarin.","Fluvastatin increases the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Warfarin is predicted to increase the risk of bleeding events when given with fluvoxamine. Manufacturer advises use with caution or avoid.","Both warfarin and fondaparinux can increase the risk of bleeding.","Fosamprenavir is predicted to affect the anticoagulant effect of warfarin.","Fosaprepitant is predicted to decrease the anticoagulant effect of warfarin.","Fosphenytoin is predicted to alter the anticoagulant effect of warfarin.","Gefitinib is predicted to increase the anticoagulant effect of warfarin.","Gemfibrozil is predicted to increase the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Glucagon increases the anticoagulant effect of warfarin.","Glucosamine increases the anticoagulant effect of warfarin. Manufacturer advises avoid.","Both warfarin and glucose can increase the risk of bleeding.","Griseofulvin potentially decreases the anticoagulant effect of warfarin.","Both warfarin and heparin (unfractionated) can increase the risk of bleeding.","Hydrocortisone is predicted to increase the effects of warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with ibrutinib. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with ibuprofen. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with iloprost. Manufacturer advises use with caution or avoid.","Imatinib is predicted to increase the risk of bleeding events when given with warfarin.","Indinavir is predicted to affect the anticoagulant effect of warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with indometacin. Manufacturer advises use with caution or avoid.","Influenza vaccine potentially increases the risk of bleeding events when given with warfarin.","Itraconazole potentially increases the anticoagulant effect of warfarin.","Ivacaftor is predicted to increase the anticoagulant effect of warfarin.","Ivermectin potentially increases the anticoagulant effect of warfarin.","Ketoconazole potentially increases the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Warfarin is predicted to increase the risk of bleeding events when given with ketoprofen. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with ketorolac. Manufacturer advises use with caution or avoid.","Lapatinib is predicted to increase the risk of bleeding events when given with warfarin.","Leflunomide increases the anticoagulant effect of warfarin.","Levofloxacin increases the anticoagulant effect of warfarin.","Lomitapide increases the exposure to warfarin. Manufacturer advises monitor INR and adjust dose.","Lopinavir is predicted to affect the anticoagulant effect of warfarin.","Lumacaftor is predicted to affect the exposure to warfarin.","Lymecycline increases the risk of bleeding events when given with warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with mefenamic acid. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with meloxicam. Manufacturer advises use with caution or avoid.","Mercaptopurine decreases the anticoagulant effect of warfarin.","Methylprednisolone is predicted to increase the effects of warfarin.","Metronidazole increases the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Miconazole greatly increases the anticoagulant effect of warfarin.","Minocycline increases the risk of bleeding events when given with warfarin.","Mometasone is predicted to increase the effects of warfarin.","Moxifloxacin increases the anticoagulant effect of warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with nabumetone. Manufacturer advises use with caution or avoid.","Nalidixic acid increases the anticoagulant effect of warfarin.","Nandrolone is predicted to increase the anticoagulant effect of warfarin. Manufacturer advises monitor and adjust dose.","Warfarin is predicted to increase the risk of bleeding events when given with naproxen. Manufacturer advises use with caution or avoid.","Nevirapine potentially alters the anticoagulant effect of warfarin.","Both warfarin and nicotinic acid can increase the risk of bleeding.","Nilotinib is predicted to increase the risk of bleeding events when given with warfarin.","Norfloxacin increases the anticoagulant effect of warfarin.","Obeticholic acid decreases the anticoagulant effect of warfarin.","Ofloxacin increases the anticoagulant effect of warfarin.","Both warfarin and omega-3-acid ethyl esters can increase the risk of bleeding.","Oxymetholone increases the anticoagulant effect of warfarin.","Oxytetracycline increases the risk of bleeding events when given with warfarin.","Paracetamol increases the anticoagulant effect of warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with parecoxib. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with paroxetine. Manufacturer advises use with caution or avoid.","Pazopanib is predicted to increase the risk of bleeding events when given with warfarin.","Both warfarin and phenindione can increase the risk of bleeding.","Phenobarbital decreases the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Phenoxymethylpenicillin potentially alters the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Phenytoin is predicted to alter the anticoagulant effect of warfarin.","Piperacillin potentially alters the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Warfarin is predicted to increase the risk of bleeding events when given with piroxicam. Manufacturer advises use with caution or avoid.","Pitolisant is predicted to decrease the exposure to warfarin.","Pivmecillinam potentially alters the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Ponatinib is predicted to increase the risk of bleeding events when given with warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with prasugrel. Manufacturer advises use with caution or avoid.","Prednisolone is predicted to increase the effects of warfarin.","Prednisone is predicted to increase the effects of warfarin.","Primidone decreases the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Propafenone increases the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Ranibizumab increases the risk of bleeding events when given with warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with regorafenib. Manufacturer advises use with caution or avoid.","Regorafenib is predicted to increase the risk of bleeding events when given with warfarin.","Both warfarin and reteplase can increase the risk of bleeding.","Rifampicin decreases the anticoagulant effect of warfarin.","Ritonavir is predicted to affect the anticoagulant effect of warfarin.","Both warfarin and rivaroxaban can increase the risk of bleeding.","Rosuvastatin increases the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Ruxolitinib is predicted to increase the risk of bleeding events when given with warfarin.","Saquinavir is predicted to affect the anticoagulant effect of warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with sertraline. Manufacturer advises use with caution or avoid.","Sorafenib increases the anticoagulant effect of warfarin.","St John's Wort decreases the anticoagulant effect of warfarin. Manufacturer advises avoid.","Both warfarin and streptokinase can increase the risk of bleeding.","Sucralfate potentially decreases the effects of warfarin. Manufacturer advises separate administration by 2 hours.","Sulfadiazine is predicted to increase the anticoagulant effect of warfarin.","Sulfamethoxazole increases the anticoagulant effect of warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with sulfinpyrazone. Manufacturer advises use with caution or avoid.","Sulfinpyrazone increases the anticoagulant effect of warfarin. Manufacturer advises avoid.","Warfarin is predicted to increase the risk of bleeding events when given with sulindac. Manufacturer advises use with caution or avoid.","Sunitinib is predicted to increase the risk of bleeding events when given with warfarin.","Tamoxifen increases the anticoagulant effect of warfarin.","Tegafur increases the anticoagulant effect of warfarin.","Temocillin potentially alters the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Both warfarin and tenecteplase can increase the risk of bleeding.","Warfarin is predicted to increase the risk of bleeding events when given with tenoxicam. Manufacturer advises use with caution or avoid.","Teriflunomide affects the anticoagulant effect of warfarin.","Tetracycline increases the risk of bleeding events when given with warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with tiaprofenic acid. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with ticagrelor. Manufacturer advises use with caution or avoid.","Ticarcillin potentially alters the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Tigecycline increases the risk of bleeding events when given with warfarin.","Tinidazole is predicted to increase the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Both warfarin and tinzaparin can increase the risk of bleeding.","Tipranavir is predicted to affect the anticoagulant effect of warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with tirofiban. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with tolfenamic acid. Manufacturer advises use with caution or avoid.","Toremifene is predicted to increase the anticoagulant effect of warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with trastuzumab. Manufacturer advises use with caution or avoid.","Warfarin is predicted to increase the risk of bleeding events when given with trastuzumab emtansine. Manufacturer advises use with caution or avoid.","Triamcinolone is predicted to increase the effects of warfarin.","Trimethoprim is predicted to increase the anticoagulant effect of warfarin.","Both warfarin and urokinase can increase the risk of bleeding.","Vandetanib is predicted to increase the risk of bleeding events when given with warfarin.","Venetoclax slightly increases the exposure to warfarin.","Warfarin is predicted to increase the risk of bleeding events when given with venlafaxine. Manufacturer advises use with caution or avoid.","Voriconazole increases the anticoagulant effect of warfarin. Manufacturer advises monitor INR and adjust dose.","Warfarin is predicted to increase the risk of bleeding events when given with vortioxetine. Manufacturer advises use with caution or avoid."]},{"name":"BNF.Zopiclone.Zopiclone","imports":["BNF.Carbamazepine.Carbamazepine","BNF.Chlordiazepoxide.Chlordiazepoxide","BNF.Clarithromycin.Clarithromycin","BNF.Clonazepam.Clonazepam","BNF.Codeine.Codeine","BNF.Cyclizine.Cyclizine","BNF.Diazepam.Diazepam","BNF.Dihydrocodeine.Dihydrocodeine","BNF.Diltiazem.Diltiazem","BNF.Fentanyl.Fentanyl","BNF.Gabapentin.Gabapentin","BNF.Haloperidol.Haloperidol","BNF.Ketamine.Ketamine","BNF.Levomepromazine.Levomepromazine","BNF.Lorazepam.Lorazepam","BNF.Midazolam.Midazolam","BNF.Mirtazapine.Mirtazapine","BNF.Morphine.Morphine","BNF.Oxycodone.Oxycodone","BNF.Phenytoin.Phenytoin","BNF.Prochlorperazine.Prochlorperazine","BNF.Temazepam.Temazepam","BNF.Tramadol.Tramadol","BNF.Trazodone.Trazodone","BNF.Venlafaxine.Venlafaxine"],"interactioninfo":["Concurrent use of zopiclone and agomelatine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and alcohol (beverage) can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and alfentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and alimemazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and alprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and amisulpride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and apraclonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Aprepitant is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and aripiprazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and articaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and asenapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Atazanavir is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and baclofen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and benperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and brimonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and buclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and bupivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and buprenorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and cannabis extract can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Carbamazepine is predicted to decrease the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and chloral hydrate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and chlordiazepoxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and chloroprocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and chlorphenamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and chlorpromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and cinnarizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Clarithromycin is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and clemastine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and clobazam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and clomethiazole can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and clonazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and clonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and clozapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Cobicistat is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and codeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Crizotinib is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and cyclizine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and cyproheptadine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Darunavir is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and desflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and dexmedetomidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and diamorphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and diazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and dihydrocodeine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Diltiazem is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and dipipanone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Dronedarone is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and droperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Enzalutamide is predicted to decrease the exposure to zopiclone. Manufacturer advises adjust dose.","Erythromycin is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and etomidate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and fentanyl can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Fluconazole is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and flupentixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and fluphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and flurazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Fosamprenavir is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Fosphenytoin is predicted to decrease the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and gabapentin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and guanfacine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and haloperidol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and hydromorphone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and hydroxyzine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Idelalisib is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Imatinib is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Indinavir is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Isavuconazole is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and isoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Itraconazole is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and ketamine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ketoconazole is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and ketotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and lamotrigine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and levetiracetam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and levomepromazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and lidocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and lofexidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Lopinavir is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and loprazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and lorazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and lormetazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and loxapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and lurasidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and melatonin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and mepivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and meprobamate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and meptazinol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and methadone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and methocarbamol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and mianserin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and midazolam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and mirtazapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and morphine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and moxonidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and nabilone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Netupitant is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Nilotinib is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and nitrazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and nitrous oxide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and olanzapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and oxazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and oxycodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and paliperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and papaveretum can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and pentazocine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and perampanel can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and pericyazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and perphenazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and pethidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and phenobarbital can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Phenobarbital is predicted to decrease the exposure to zopiclone. Manufacturer advises adjust dose.","Phenytoin is predicted to decrease the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and pimozide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and pizotifen can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Posaconazole is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and pregabalin can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and prilocaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and primidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Primidone is predicted to decrease the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and prochlorperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and promazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and promethazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and propofol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and quetiapine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and remifentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Rifampicin is predicted to decrease the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and risperidone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Ritonavir is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and ropivacaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Saquinavir is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and sevoflurane can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and sodium oxybate can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and sufentanil can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and sulpiride can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and tapentadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and temazepam can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and tetracaine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and thalidomide can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and thiopental can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Tipranavir is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and tizanidine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and tramadol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and trazodone can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and trifluoperazine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and venlafaxine can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Verapamil is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Voriconazole is predicted to increase the exposure to zopiclone. Manufacturer advises adjust dose.","Concurrent use of zopiclone and zaleplon can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and zolpidem can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing).","Concurrent use of zopiclone and zuclopenthixol can increase the risk of CNS depressant effects,which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing)."]}]
